{ "TCGA-B6-A0I9": { "demographics": { "SUBTYPE": "BRCA_Her2", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "44954053-0b93-4577-a436-42777e442300", "AGE": 62, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "3RD", "DAYS_LAST_FOLLOWUP": NaN, "DAYS_TO_BIRTH": -22798.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "11/2/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M1", "PATH_N_STAGE": "NX", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 11.90123944, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 11.90123944, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 11.90123944, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-B6-A0I9-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "B6", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 12.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2882, "MSI_SENSOR_SCORE": 0.58, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.4, "TISSUE_SOURCE_SITE": "Duke", "TBL_SCORE": 442.0 }, "treatments": [] }, "TCGA-A2-A3XW": { "demographics": { "SUBTYPE": "BRCA_Normal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "C02699B5-580A-4D55-971E-F4692B2CCE57", "AGE": 42, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 1712.0, "DAYS_TO_BIRTH": -15670.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "8/15/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 56.28431469, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 56.28431469, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 56.28431469, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 56.28431469, "GENETIC_ANCESTRY_LABEL": "AFR_ADMIX" }, "sample": { "SAMPLE_ID": "TCGA-A2-A3XW-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "A2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": NaN, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2963, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.266666667, "TISSUE_SOURCE_SITE": "Walter Reed", "TBL_SCORE": 58.0 }, "treatments": [ { "START_DATE": 69, "STOP_DATE": 139.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 69, "STOP_DATE": 139.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 153, "STOP_DATE": 223.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 341, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 265, "STOP_DATE": 308.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "28", "RADIATION_DOSAGE": "5040", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" }, { "START_DATE": 265, "STOP_DATE": 308.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 2", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "28", "RADIATION_DOSAGE": "5040", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-AO-A129": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "c70ee5e1-4703-4996-bb5c-f4cca0fb53ba", "AGE": 29, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "5TH", "DAYS_LAST_FOLLOWUP": 3286.0, "DAYS_TO_BIRTH": -10898.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/8/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 108.0316928, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 108.0316928, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 108.0316928, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 108.0316928, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AO-A129-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AO", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 9.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": NaN, "MSI_SENSOR_SCORE": 0.07, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 3.666666667, "TISSUE_SOURCE_SITE": "MSKCC", "TBL_SCORE": 278.0 }, "treatments": [ { "START_DATE": 67, "STOP_DATE": 162.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "600", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 67, "STOP_DATE": 162.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "175", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 67, "STOP_DATE": 162.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "60", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 216, "STOP_DATE": 246.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-B6-A0RL": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "5562455d-bbb8-46eb-a510-e8c6e1e26789", "AGE": 60, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "4TH", "DAYS_LAST_FOLLOWUP": NaN, "DAYS_TO_BIRTH": -22238.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "11/2/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 81.17171319, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 81.17171319, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 81.17171319, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 81.17171319, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-B6-A0RL-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "B6", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 9.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2985, "MSI_SENSOR_SCORE": 0.93, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.733333333, "TISSUE_SOURCE_SITE": "Duke", "TBL_SCORE": 141.0 }, "treatments": [] }, "TCGA-E9-A6HE": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "7E9C8D3C-790C-46AD-8F31-B557B7C26F69", "AGE": 45, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIC", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 847.0, "DAYS_TO_BIRTH": -16697.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "10/16/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N3", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 27.84627018, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 27.84627018, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 27.84627018, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 27.84627018, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E9-A6HE-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "E9", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 8.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3408, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.633333333, "TISSUE_SOURCE_SITE": "Asterand", "TBL_SCORE": 17.0 }, "treatments": [ { "START_DATE": 104, "STOP_DATE": 174.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 104, "STOP_DATE": 174.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 104, "STOP_DATE": 307.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 547, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 259, "STOP_DATE": 299.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "28", "RADIATION_DOSAGE": "50.4", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "gy" } ] }, "TCGA-B6-A1KI": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "1dafdd64-527d-4d46-bbdf-7a97774f881b", "AGE": 63, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE I", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 2236.0, "DAYS_TO_BIRTH": -23031.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/19/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 73.51152316, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 73.51152316, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 73.51152316, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 73.51152316, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-B6-A1KI-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "B6", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 29.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3202, "MSI_SENSOR_SCORE": 0.28, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.7, "TISSUE_SOURCE_SITE": "Duke", "TBL_SCORE": 5.0 }, "treatments": [] }, "TCGA-AC-A62V": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "D5F2B85A-94A9-4168-BBE8-149EC71342B0", "AGE": 58, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 2.0, "DAYS_TO_BIRTH": -21389.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "10/21/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M1", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 11.44097051, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 11.44097051, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 11.44097051, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-AC-A62V-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "AC", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 18.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3584, "MSI_SENSOR_SCORE": 0.07, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.266666667, "TISSUE_SOURCE_SITE": "International Genomics Consortium", "TBL_SCORE": 313.0 }, "treatments": [ { "START_DATE": 21, "STOP_DATE": 266.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Ancillary", "TREATMENT_SUBTYPE": null, "AGENT": "Denosumab", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Partial Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 114, "STOP_DATE": 245.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Partial Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 21, "STOP_DATE": 46.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Partial Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Distant Site", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "13", "RADIATION_DOSAGE": "3250", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-B6-A0I8": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "6e6408d6-6c48-4dfc-9f1c-28b7386e87b4", "AGE": 46, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE X", "AJCC_STAGING_EDITION": "4TH", "DAYS_LAST_FOLLOWUP": NaN, "DAYS_TO_BIRTH": -17073.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "11/2/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "NX", "PATH_T_STAGE": "T1", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 24.62438768, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 24.62438768, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 24.52575862, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-B6-A0I8-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "B6", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": NaN, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2944, "MSI_SENSOR_SCORE": 0.57, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 3.733333333, "TISSUE_SOURCE_SITE": "Duke", "TBL_SCORE": 506.0 }, "treatments": [] }, "TCGA-E9-A1RF": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "c694615c-b1c6-499c-8058-995633ebf948", "AGE": 68, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 200.0, "DAYS_TO_BIRTH": -25119.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "8/2/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N2", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 6.575270408, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 6.575270408, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 6.575270408, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 6.575270408, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E9-A1RF-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "E9", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 16.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2913, "MSI_SENSOR_SCORE": 0.41, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 4.266666667, "TISSUE_SOURCE_SITE": "Asterand", "TBL_SCORE": 337.0 }, "treatments": [ { "START_DATE": 30, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "20", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 54, "STOP_DATE": 194.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Fluorouracil", "NUMBER_OF_CYCLES": "5", "PRESCRIBED_DOSE": "1000", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "5000", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 54, "STOP_DATE": 194.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "5", "PRESCRIBED_DOSE": "100", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "500", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 54, "STOP_DATE": 194.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "5", "PRESCRIBED_DOSE": "1000", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "5000", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 118, "STOP_DATE": 144.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": "3740", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-AC-A2FG": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "39CDA4C9-E1C8-44C2-BAB7-F5849C12F879", "AGE": 79, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 1853.0, "DAYS_TO_BIRTH": -29211.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "9/21/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 60.91988033, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 60.91988033, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 60.91988033, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 60.91988033, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AC-A2FG-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AC", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 3.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3255, "MSI_SENSOR_SCORE": 0.66, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.9, "TISSUE_SOURCE_SITE": "International Genomics Consortium", "TBL_SCORE": 14.0 }, "treatments": [ { "START_DATE": 39, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-OL-A5RY": { "demographics": { "SUBTYPE": "BRCA_Normal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "8360CEC6-DAF6-41C9-9A4F-7FC03C958DCC", "AGE": 52, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 752.0, "DAYS_TO_BIRTH": -19216.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "5/16/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 24.72301673, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 24.72301673, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 24.72301673, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 24.72301673, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-OL-A5RY-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "OL", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2856, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.333333333, "TISSUE_SOURCE_SITE": "University of Chicago", "TBL_SCORE": 19.0 }, "treatments": [] }, "TCGA-A8-A09G": { "demographics": { "SUBTYPE": "BRCA_Her2", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "3927f736-3b5c-48c8-9d9e-83669ec44770", "AGE": 79, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIC", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 0.0, "DAYS_TO_BIRTH": -29006.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "5/27/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N3A", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": null, "RADIATION_THERAPY": null, "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 0.0, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 0.0, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 0.0, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 0.0, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A8-A09G-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 9.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2422, "MSI_SENSOR_SCORE": 0.11, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 8.033333333, "TISSUE_SOURCE_SITE": "Indivumed", "TBL_SCORE": 70.0 }, "treatments": [] }, "TCGA-AR-A24S": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "074e8b06-3929-4896-9263-3b80ad6a355b", "AGE": 61, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE I", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 2976.0, "DAYS_TO_BIRTH": -22587.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "8/30/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T1", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 97.84002367, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 97.84002367, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 97.84002367, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 97.84002367, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AR-A24S-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AR", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 16.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3249, "MSI_SENSOR_SCORE": 0.04, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.466666667, "TISSUE_SOURCE_SITE": "Mayo", "TBL_SCORE": 144.0 }, "treatments": [ { "START_DATE": 129, "STOP_DATE": 1124.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Exemestane", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "25", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 32, "STOP_DATE": 126.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 55, "STOP_DATE": 62.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "10", "RADIATION_DOSAGE": "3850", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-AC-A4ZE": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "0CF0D67C-2F7F-42A6-94F3-407D0EC46C88", "AGE": 63, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 890.0, "DAYS_TO_BIRTH": -23284.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "6/9/2015", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 29.25995332, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 29.25995332, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 29.25995332, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 29.25995332, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AC-A4ZE-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "AC", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 7.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3411, "MSI_SENSOR_SCORE": 0.43, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.5, "TISSUE_SOURCE_SITE": "International Genomics Consortium", "TBL_SCORE": 49.0 }, "treatments": [] }, "TCGA-AO-A124": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "b094e8b2-8ece-4b36-8025-18073a8b873c", "AGE": 38, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "5TH", "DAYS_LAST_FOLLOWUP": 3506.0, "DAYS_TO_BIRTH": -14174.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/7/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8523/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 115.2644903, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 115.2644903, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 115.2644903, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 115.2644903, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AO-A124-01", "ONCOTREE_CODE": "BRCNOS", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Carcinoma (NOS)", "TUMOR_TYPE": "Other", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AO", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 15.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3181, "MSI_SENSOR_SCORE": 2.42, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 4.533333333, "TISSUE_SOURCE_SITE": "MSKCC", "TBL_SCORE": 412.0 }, "treatments": [ { "START_DATE": 60, "STOP_DATE": 126.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "60", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "424", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 60, "STOP_DATE": 126.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "600", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "4240", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 147, "STOP_DATE": 238.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": "5", "PRESCRIBED_DOSE": "175", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "1600", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-D8-A1JT": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "cd781589-3820-45a2-906b-8d60cd02f3ef", "AGE": 70, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 405.0, "DAYS_TO_BIRTH": -25677.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/28/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8523/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 13.31492258, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 13.31492258, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 13.31492258, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 13.31492258, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D8-A1JT-01", "ONCOTREE_CODE": "BRCNOS", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Carcinoma (NOS)", "TUMOR_TYPE": "Other", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "D8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 18.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3311, "MSI_SENSOR_SCORE": 0.52, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.933333333, "TISSUE_SOURCE_SITE": "Greater Poland Cancer Center", "TBL_SCORE": 34.0 }, "treatments": [ { "START_DATE": 47, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": "Mg/Day", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-B6-A0RQ": { "demographics": { "SUBTYPE": "BRCA_Normal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "caa9b533-24b4-4ecd-9159-c165de049f6a", "AGE": 68, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "4TH", "DAYS_LAST_FOLLOWUP": NaN, "DAYS_TO_BIRTH": -25010.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/15/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 140.2833942, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 140.2833942, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 140.2833942, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 140.2833942, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-B6-A0RQ-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "B6", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": NaN, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2823, "MSI_SENSOR_SCORE": 0.02, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.366666667, "TISSUE_SOURCE_SITE": "Duke", "TBL_SCORE": 2.0 }, "treatments": [] }, "TCGA-B6-A400": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "D9A1C06F-7B50-46B0-878E-89E8C31863AE", "AGE": 43, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 215.0, "DAYS_TO_BIRTH": -16022.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/20/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N2A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "0:LIVING", "OS_MONTHS": 7.068415689, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 7.068415689, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 7.068415689, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 7.068415689, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-B6-A400-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "B6", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 6.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3369, "MSI_SENSOR_SCORE": 0.48, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.0, "TISSUE_SOURCE_SITE": "Duke", "TBL_SCORE": 170.0 }, "treatments": [] }, "TCGA-AC-A8OQ": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "DFAABD03-2D40-4422-B210-CAF112FF4229", "AGE": 72, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 34.0, "DAYS_TO_BIRTH": -26535.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "2/26/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": null, "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 1.117795969, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 1.117795969, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 1.117795969, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 1.117795969, "GENETIC_ANCESTRY_LABEL": "AFR_ADMIX" }, "sample": { "SAMPLE_ID": "TCGA-AC-A8OQ-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "AC", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 23.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3364, "MSI_SENSOR_SCORE": 0.32, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.6, "TISSUE_SOURCE_SITE": "International Genomics Consortium", "TBL_SCORE": 457.0 }, "treatments": [] }, "TCGA-A8-A06O": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "69054195-9e93-49e5-b820-69b0091cc2d4", "AGE": 60, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE I", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 396.0, "DAYS_TO_BIRTH": -22157.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "5/27/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": null, "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 13.01903541, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 13.01903541, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 13.01903541, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 13.01903541, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A8-A06O-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 22.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2642, "MSI_SENSOR_SCORE": 0.85, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.3, "TISSUE_SOURCE_SITE": "Indivumed", "TBL_SCORE": 114.0 }, "treatments": [ { "START_DATE": 62, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Letrozole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-A8-A07E": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "853456d8-2367-404e-abc9-020fe8bbd209", "AGE": 81, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE X", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 608.0, "DAYS_TO_BIRTH": -29800.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "5/27/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N3A", "PATH_T_STAGE": "T4B", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "Yes", "RACE": null, "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 19.98882204, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 19.98882204, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 19.98882204, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 19.98882204, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A8-A07E-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 6.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": NaN, "MSI_SENSOR_SCORE": 0.03, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.9, "TISSUE_SOURCE_SITE": "Indivumed", "TBL_SCORE": 93.0 }, "treatments": [ { "START_DATE": 0, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Letrozole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-LL-A50Y": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "91DA548B-5C64-49C3-A44A-1EF115F53311", "AGE": 84, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 762.0, "DAYS_TO_BIRTH": -30934.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/8/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 25.05178025, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 25.05178025, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 25.05178025, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 25.05178025, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-LL-A50Y-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "LL", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 4.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2801, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.8, "TISSUE_SOURCE_SITE": "Candler", "TBL_SCORE": 7.0 }, "treatments": [ { "START_DATE": 54, "STOP_DATE": 608.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-C8-A12V": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "7e1673f8-5758-4963-8804-d5e39f06205b", "AGE": 55, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 385.0, "DAYS_TO_BIRTH": -20346.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/22/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Asian", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 12.65739554, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 12.65739554, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 12.65739554, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-C8-A12V-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "C8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": NaN, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2736, "MSI_SENSOR_SCORE": 0.01, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.433333333, "TISSUE_SOURCE_SITE": "ILSBio", "TBL_SCORE": 45.0 }, "treatments": [] }, "TCGA-EW-A423": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "BDD08EC8-8892-4273-8F21-6FDE0F23C52D", "AGE": 75, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 533.0, "DAYS_TO_BIRTH": -27627.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Hispanic Or Latino", "FORM_COMPLETION_DATE": "1/4/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": null, "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 17.52309564, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 17.52309564, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 17.52309564, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 17.52309564, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-EW-A423-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "EW", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 28.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3097, "MSI_SENSOR_SCORE": 0.45, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.466666667, "TISSUE_SOURCE_SITE": "University of Miami", "TBL_SCORE": 87.0 }, "treatments": [ { "START_DATE": 205, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 52, "STOP_DATE": 162.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-A7-A426": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "D48E9F25-F083-4F88-A92D-C12D9F765BA6", "AGE": 50, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIC", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 364.0, "DAYS_TO_BIRTH": -18296.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "11/5/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N3A", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "0:LIVING", "OS_MONTHS": 11.96699214, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 11.96699214, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 11.96699214, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 11.96699214, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A7-A426-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "A7", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 7.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3006, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.0, "TISSUE_SOURCE_SITE": "Christiana Healthcare", "TBL_SCORE": 21.0 }, "treatments": [ { "START_DATE": 55, "STOP_DATE": 97.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 55, "STOP_DATE": 97.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 111, "STOP_DATE": 202.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 258, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 220, "STOP_DATE": 257.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "28", "RADIATION_DOSAGE": "5040", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" }, { "START_DATE": 220, "STOP_DATE": 257.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 2", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "28", "RADIATION_DOSAGE": "5040", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-BH-A0EA": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "1f601832-eee3-48fb-acf5-80c4a454f26e", "AGE": 72, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": NaN, "DAYS_TO_BIRTH": -26548.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "8/11/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 32.58046487, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 32.58046487, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 32.58046487, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 32.58046487, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A0EA-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 3.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2795, "MSI_SENSOR_SCORE": 0.05, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.833333333, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 3.0 }, "treatments": [ { "START_DATE": 84, "STOP_DATE": 363.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 363, "STOP_DATE": 522.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-GM-A2DD": { "demographics": { "SUBTYPE": "BRCA_Normal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "B343BFE0-7C23-4C6A-8C84-9EE39DB2ECDA", "AGE": 53, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE I", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 2282.0, "DAYS_TO_BIRTH": -19415.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/29/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 75.02383536, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 75.02383536, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 75.02383536, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 75.02383536, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-GM-A2DD-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "GM", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 20.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3056, "MSI_SENSOR_SCORE": 0.18, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.7, "TISSUE_SOURCE_SITE": "MD Anderson", "TBL_SCORE": 453.0 }, "treatments": [ { "START_DATE": 90, "STOP_DATE": 202.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Fluorouracil", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 90, "STOP_DATE": 202.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 90, "STOP_DATE": 202.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-S3-AA15": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "E783E518-C1E5-4EAC-8EAF-E2D65CCD9692", "AGE": 51, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 525.0, "DAYS_TO_BIRTH": -18659.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/18/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "CM0 (I+)", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 17.26008482, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 17.26008482, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 17.26008482, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 17.26008482, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-S3-AA15-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "S3", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": NaN, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3124, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.166666667, "TISSUE_SOURCE_SITE": "Albert Einstein Medical Center", "TBL_SCORE": 6.0 }, "treatments": [ { "START_DATE": 82, "STOP_DATE": 125.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 82, "STOP_DATE": 125.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 82, "STOP_DATE": 125.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Ancillary", "TREATMENT_SUBTYPE": null, "AGENT": "Pegfilgrastim", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 138, "STOP_DATE": 236.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 286, "STOP_DATE": 359.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "57", "RADIATION_DOSAGE": "114", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "gy" } ] }, "TCGA-C8-A1HG": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "0c23c380-363c-474d-b64c-b47f612a8225", "AGE": 50, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 345.0, "DAYS_TO_BIRTH": NaN, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/24/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "No", "PRIOR_DX": "No", "RACE": "Asian", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 11.34234145, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 11.34234145, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 11.34234145, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 11.34234145, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-C8-A1HG-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "C8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 16.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2608, "MSI_SENSOR_SCORE": 0.31, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.366666667, "TISSUE_SOURCE_SITE": "ILSBio", "TBL_SCORE": 255.0 }, "treatments": [] }, "TCGA-A1-A0SN": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "0dc337fa-da8b-42c4-b9a7-fb76d81c161f", "AGE": 50, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 1196.0, "DAYS_TO_BIRTH": -18401.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/23/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": null, "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 39.32011704, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 39.32011704, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 39.32011704, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 39.32011704, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A1-A0SN-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A1", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 18.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3423, "MSI_SENSOR_SCORE": 0.57, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.7, "TISSUE_SOURCE_SITE": "UCSF", "TBL_SCORE": 224.0 }, "treatments": [ { "START_DATE": 179, "STOP_DATE": 270.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 87, "STOP_DATE": 179.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin + Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 179, "STOP_DATE": 879.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Targeted Molecular Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Trastuzumab", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 331, "STOP_DATE": 361.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-EW-A1OX": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "5fc7ff35-d3f7-4687-8759-3542bd58e988", "AGE": 43, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 911.0, "DAYS_TO_BIRTH": -15837.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/18/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8523/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 29.95035671, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 29.95035671, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 29.95035671, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 29.95035671, "GENETIC_ANCESTRY_LABEL": "AFR_ADMIX" }, "sample": { "SAMPLE_ID": "TCGA-EW-A1OX-01", "ONCOTREE_CODE": "IMMC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Mixed Mucinous Carcinoma", "TUMOR_TYPE": "Mucinous Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "EW", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 1.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3465, "MSI_SENSOR_SCORE": 1.98, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.4, "TISSUE_SOURCE_SITE": "University of Miami", "TBL_SCORE": 84.0 }, "treatments": [ { "START_DATE": 227, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Goserelin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "3.6", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "SC", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 120, "STOP_DATE": 198.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "1314", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "tailorrx protocol", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "5256", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 227, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "20", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 120, "STOP_DATE": 198.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "164", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "tailorrx protocol", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "656", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 211, "STOP_DATE": 253.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": "6000", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-E9-A1NF": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "a8b1f6e7-2bcf-460d-b1c6-1792a9801119", "AGE": 60, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 610.0, "DAYS_TO_BIRTH": -21981.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "6/23/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8522/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 35.24344939, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 35.24344939, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 2.958871684, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 2.958871684, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E9-A1NF-01", "ONCOTREE_CODE": "BRCNOS", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Carcinoma (NOS)", "TUMOR_TYPE": "Mixed Histology (NOS)", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "E9", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 21.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3237, "MSI_SENSOR_SCORE": 0.77, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.7, "TISSUE_SOURCE_SITE": "Asterand", "TBL_SCORE": 368.0 }, "treatments": [ { "START_DATE": 21, "STOP_DATE": 63.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 21, "STOP_DATE": 63.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 21, "STOP_DATE": 63.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Fluorouracil", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 91, "STOP_DATE": 178.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Vincristine", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 91, "STOP_DATE": 178.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Mitomycin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 280, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-AO-A0JE": { "demographics": { "SUBTYPE": "BRCA_Her2", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "36fe6152-f61e-4948-9ccc-23ac01a9d77d", "AGE": 53, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": 2335.0, "DAYS_TO_BIRTH": -19516.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/20/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N2A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 76.76628201, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 76.76628201, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 76.76628201, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-AO-A0JE-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AO", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 12.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2746, "MSI_SENSOR_SCORE": 0.15, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.5, "TISSUE_SOURCE_SITE": "MSKCC", "TBL_SCORE": 259.0 }, "treatments": [ { "START_DATE": 119, "STOP_DATE": 462.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Targeted Molecular Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Trastuzumab", "NUMBER_OF_CYCLES": "22", "PRESCRIBED_DOSE": "6", "PRESCRIBED_DOSE_UNITS": "mg/kg", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "7869", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 63, "STOP_DATE": 105.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "60", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "428", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 63, "STOP_DATE": 105.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "600", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "4272", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 119, "STOP_DATE": 161.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "175", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "1220", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 202, "STOP_DATE": 243.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "30", "RADIATION_DOSAGE": "16000", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-AO-A03L": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "1174f6e4-ffbe-4e59-a000-8d861c968369", "AGE": 34, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 2442.0, "DAYS_TO_BIRTH": -12443.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/7/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N2", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Asian", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 80.28405168, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 80.28405168, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 80.28405168, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 80.28405168, "GENETIC_ANCESTRY_LABEL": "SAS_ADMIX" }, "sample": { "SAMPLE_ID": "TCGA-AO-A03L-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AO", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 23.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2649, "MSI_SENSOR_SCORE": 0.1, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.933333333, "TISSUE_SOURCE_SITE": "MSKCC", "TBL_SCORE": 201.0 }, "treatments": [ { "START_DATE": 36, "STOP_DATE": 140.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "600", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 36, "STOP_DATE": 140.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "175", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 227, "STOP_DATE": 2057.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "20", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 36, "STOP_DATE": 140.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "60", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 363, "STOP_DATE": 2057.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Leuprolide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IM", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 167, "STOP_DATE": 208.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "28", "RADIATION_DOSAGE": "10080", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-A8-A07S": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "a20fa2c4-a502-47e3-bfaa-2ec4cce3a859", "AGE": 73, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 243.0, "DAYS_TO_BIRTH": -26998.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "5/27/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8522/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": null, "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "0:LIVING", "OS_MONTHS": 7.988953546, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 7.988953546, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 7.988953546, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-A8-A07S-01", "ONCOTREE_CODE": "BRCNOS", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Carcinoma (NOS)", "TUMOR_TYPE": "Mixed Histology (NOS)", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 5.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": NaN, "MSI_SENSOR_SCORE": NaN, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": NaN, "TISSUE_SOURCE_SITE": "Indivumed", "TBL_SCORE": 13.0 }, "treatments": [ { "START_DATE": 151, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 121, "STOP_DATE": 151.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "gy" } ] }, "TCGA-D8-A1J9": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "d5e9a403-88ce-40fc-bb85-80cf3f8ff6bc", "AGE": 48, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 532.0, "DAYS_TO_BIRTH": -17879.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/29/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "No", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 17.49021929, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 17.49021929, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 17.49021929, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 17.49021929, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D8-A1J9-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "D8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 10.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3156, "MSI_SENSOR_SCORE": 0.08, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 5.966666667, "TISSUE_SOURCE_SITE": "Greater Poland Cancer Center", "TBL_SCORE": 245.0 }, "treatments": [] }, "TCGA-A2-A0CO": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "8E54232D-D8BB-4612-8B0E-4FEB076A60F9", "AGE": 85, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 3409.0, "DAYS_TO_BIRTH": -31404.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/21/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 114.8042213, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 114.8042213, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 114.8042213, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A2-A0CO-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 8.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2823, "MSI_SENSOR_SCORE": 0.01, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.0, "TISSUE_SOURCE_SITE": "Walter Reed", "TBL_SCORE": 8.0 }, "treatments": [ { "START_DATE": 84, "STOP_DATE": 512.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 513, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 93, "STOP_DATE": 127.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": "5000", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" }, { "START_DATE": 128, "STOP_DATE": 134.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 2", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": "1000", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-A2-A0CM": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "eb2dbb4f-66b6-4525-8323-431970f7a64e", "AGE": 40, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": NaN, "DAYS_TO_BIRTH": -14969.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/6/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 24.78876944, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 24.78876944, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 12.55876648, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 12.55876648, "GENETIC_ANCESTRY_LABEL": "AFR_ADMIX" }, "sample": { "SAMPLE_ID": "TCGA-A2-A0CM-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 24.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2921, "MSI_SENSOR_SCORE": 0.39, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.733333333, "TISSUE_SOURCE_SITE": "Walter Reed", "TBL_SCORE": 160.0 }, "treatments": [ { "START_DATE": 98, "STOP_DATE": 147.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "106", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "424", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 391, "STOP_DATE": 615.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Capecitabine", "NUMBER_OF_CYCLES": "8", "PRESCRIBED_DOSE": "2000-3500", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "5", "REGIMEN_INDICATION": "Progression", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "24400", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 98, "STOP_DATE": 147.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "1062", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "4248", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 391, "STOP_DATE": 433.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Other", "TREATMENT_SUBTYPE": "Bisphosphonate Therapy", "AGENT": "Zoledronic Acid", "NUMBER_OF_CYCLES": "2", "PRESCRIBED_DOSE": "4", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "6", "REGIMEN_INDICATION": "Progression", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "8", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 234, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "20", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "3", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 391, "STOP_DATE": 601.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": "8", "PRESCRIBED_DOSE": "100-131", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "4", "REGIMEN_INDICATION": "Progression", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "890", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-S3-A6ZF": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "FBEE40F1-D6D8-4156-8D42-36E09BB9F095", "AGE": 64, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 572.0, "DAYS_TO_BIRTH": -23650.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "11/12/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 18.80527337, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 18.80527337, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 18.80527337, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 18.80527337, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-S3-A6ZF-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "S3", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 19.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3361, "MSI_SENSOR_SCORE": 0.22, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.033333333, "TISSUE_SOURCE_SITE": "Albert Einstein Medical Center", "TBL_SCORE": 147.0 }, "treatments": [ { "START_DATE": 65, "STOP_DATE": 170.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 65, "STOP_DATE": 429.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Immunotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Trastuzumab", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 78, "STOP_DATE": 170.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Ancillary", "TREATMENT_SUBTYPE": null, "AGENT": "Pegfilgrastim", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 65, "STOP_DATE": 170.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 191, "STOP_DATE": 278.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Letrozole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 278, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-AO-A0JB": { "demographics": { "SUBTYPE": "BRCA_Normal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "3ea9412b-429e-4dcf-90cd-c53be06885a1", "AGE": 50, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": 1542.0, "DAYS_TO_BIRTH": -18561.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/19/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 50.69533485, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 50.69533485, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 50.69533485, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 50.69533485, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AO-A0JB-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AO", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 7.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2855, "MSI_SENSOR_SCORE": 0.96, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 3.133333333, "TISSUE_SOURCE_SITE": "MSKCC", "TBL_SCORE": 161.0 }, "treatments": [ { "START_DATE": 49, "STOP_DATE": 92.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "600", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "3680", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 49, "STOP_DATE": 92.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "60", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "368", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 175, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "20", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 105, "STOP_DATE": 147.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "175", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "1080", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 216, "STOP_DATE": 253.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "28", "RADIATION_DOSAGE": "15120", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-AC-A8OS": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "D5E655FE-3FBC-47B0-BA23-1D1DD01D591C", "AGE": 71, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 70.0, "DAYS_TO_BIRTH": -26248.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "2/26/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": null, "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 2.301344643, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 2.301344643, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 2.301344643, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 2.301344643, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AC-A8OS-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "AC", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 8.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3361, "MSI_SENSOR_SCORE": 0.01, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.366666667, "TISSUE_SOURCE_SITE": "International Genomics Consortium", "TBL_SCORE": 5.0 }, "treatments": [] }, "TCGA-E2-A15F": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "ec77a23d-84f5-47e4-bf2a-fa1c03baf3db", "AGE": 64, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE I", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 658.0, "DAYS_TO_BIRTH": -23660.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/13/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 21.63263964, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 21.63263964, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 21.63263964, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 21.63263964, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E2-A15F-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "E2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 9.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": NaN, "MSI_SENSOR_SCORE": 0.12, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.766666667, "TISSUE_SOURCE_SITE": "Roswell Park", "TBL_SCORE": 83.0 }, "treatments": [ { "START_DATE": 87, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": "1", "TOTAL_DOSE_UNITS": "Mg/Day", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 42, "STOP_DATE": 86.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "33", "RADIATION_DOSAGE": "6040", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-PL-A8LX": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "FE2CD610-AA52-4789-AC62-7683281BB22F", "AGE": 35, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 5.0, "DAYS_TO_BIRTH": -12840.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/25/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M1", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T4", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 0.16438176, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 0.16438176, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 0.16438176, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-PL-A8LX-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "PL", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 19.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.324, "MSI_SENSOR_SCORE": 0.04, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.966666667, "TISSUE_SOURCE_SITE": "Institute of Human Virology Nigeria", "TBL_SCORE": 51.0 }, "treatments": [] }, "TCGA-B6-A401": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "48FF0420-0F19-4E9D-A75D-6C54949A461A", "AGE": 47, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 2596.0, "DAYS_TO_BIRTH": -17438.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/20/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 85.3470099, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 85.3470099, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 85.3470099, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 85.3470099, "GENETIC_ANCESTRY_LABEL": "AFR_ADMIX" }, "sample": { "SAMPLE_ID": "TCGA-B6-A401-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "B6", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 24.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3196, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.633333333, "TISSUE_SOURCE_SITE": "Duke", "TBL_SCORE": 47.0 }, "treatments": [ { "START_DATE": 50, "STOP_DATE": 155.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 50, "STOP_DATE": 155.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 50, "STOP_DATE": 155.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 375, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Letrozole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 205, "STOP_DATE": 284.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-C8-A26Z": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "dc11b1c7-1f00-4813-b4b5-ecf776b2eb37", "AGE": 59, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 470.0, "DAYS_TO_BIRTH": NaN, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/21/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "No", "PRIOR_DX": "No", "RACE": "Asian", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 15.45188546, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 15.45188546, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 15.45188546, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 15.45188546, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-C8-A26Z-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "C8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 20.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3, "MSI_SENSOR_SCORE": 0.31, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.433333333, "TISSUE_SOURCE_SITE": "ILSBio", "TBL_SCORE": 169.0 }, "treatments": [ { "START_DATE": 11, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-BH-A0DD": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "dba9beec-5e51-48c0-9229-0ee286a02a1a", "AGE": 58, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 2486.0, "DAYS_TO_BIRTH": -21386.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "8/18/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "0:LIVING", "OS_MONTHS": 81.73061117, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 81.73061117, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 81.73061117, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 81.73061117, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A0DD-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 15.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.279, "MSI_SENSOR_SCORE": 0.28, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.666666667, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 201.0 }, "treatments": [ { "START_DATE": 105, "STOP_DATE": 217.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 105, "STOP_DATE": 217.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-AO-A1KQ": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "d2219a3f-4c55-4dee-9b08-c6f330dd1acf", "AGE": 84, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIB", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 1882.0, "DAYS_TO_BIRTH": -30859.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/1/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T4", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "0:LIVING", "OS_MONTHS": 61.87329454, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 61.87329454, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 61.87329454, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 61.87329454, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AO-A1KQ-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AO", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": NaN, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": NaN, "MSI_SENSOR_SCORE": NaN, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.0, "TISSUE_SOURCE_SITE": "MSKCC", "TBL_SCORE": 145.0 }, "treatments": [ { "START_DATE": 49, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "20", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-EW-A1P1": { "demographics": { "SUBTYPE": "BRCA_Normal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "f2e28af9-c40e-41c4-9e82-205cca38f26a", "AGE": 68, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIC", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 1210.0, "DAYS_TO_BIRTH": -24923.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/27/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N3B", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 39.78038597, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 39.78038597, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 33.33662097, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 33.33662097, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-EW-A1P1-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "EW", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3277, "MSI_SENSOR_SCORE": 1.16, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.066666667, "TISSUE_SOURCE_SITE": "University of Miami", "TBL_SCORE": 2.0 }, "treatments": [ { "START_DATE": 157, "STOP_DATE": 178.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "2", "PRESCRIBED_DOSE": "108", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "ac", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "217", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 77, "STOP_DATE": 119.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": "3", "PRESCRIBED_DOSE": "131", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "tac", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "377", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 140, "STOP_DATE": 147.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": "2", "PRESCRIBED_DOSE": "144", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "288", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 77, "STOP_DATE": 119.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "3", "PRESCRIBED_DOSE": "88", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "tac", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "252", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 77, "STOP_DATE": 119.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "3", "PRESCRIBED_DOSE": "875", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "tac", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "2515", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 157, "STOP_DATE": 178.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "2", "PRESCRIBED_DOSE": "1080", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "2172", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 281, "STOP_DATE": 322.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": "11,000", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-EW-A1IZ": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "c0f88fc5-56b0-4255-bbd1-9a21ced8b37b", "AGE": 53, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 554.0, "DAYS_TO_BIRTH": -19706.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/11/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N2A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 18.21349903, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 18.21349903, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 18.21349903, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 18.21349903, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-EW-A1IZ-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "EW", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 2.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.5417, "MSI_SENSOR_SCORE": 8.42, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 12.3, "TISSUE_SOURCE_SITE": "University of Miami", "TBL_SCORE": 47.0 }, "treatments": [ { "START_DATE": 70, "STOP_DATE": 176.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": "6", "PRESCRIBED_DOSE": "139", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "tac", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "834", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 199, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Letrozole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "2.5", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 70, "STOP_DATE": 176.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "6", "PRESCRIBED_DOSE": "69", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "tac", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "414", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 70, "STOP_DATE": 176.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "6", "PRESCRIBED_DOSE": "694", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "tac", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "4164", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 197, "STOP_DATE": 261.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Local Recurrence", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "8", "RADIATION_DOSAGE": "6,100", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-BH-A0BA": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "49dc3e68-6206-4f16-969f-a758cc7be8ed", "AGE": 51, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIC", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": 1132.0, "DAYS_TO_BIRTH": -18839.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "11/4/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8522/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N3A", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 37.21603051, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 37.21603051, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 37.21603051, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 37.21603051, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A0BA-01", "ONCOTREE_CODE": "BRCNOS", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Carcinoma (NOS)", "TUMOR_TYPE": "Mixed Histology (NOS)", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 34.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2723, "MSI_SENSOR_SCORE": 0.78, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.4, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 224.0 }, "treatments": [ { "START_DATE": 63, "STOP_DATE": 94.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 63, "STOP_DATE": 94.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 119, "STOP_DATE": 171.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 187, "STOP_DATE": 262.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "36", "RADIATION_DOSAGE": "6640", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-E9-A5FL": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "E3935CE4-64D3-4A66-BA11-D308B844B410", "AGE": 65, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 24.0, "DAYS_TO_BIRTH": -24053.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/22/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8575/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 0.789032449, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 0.789032449, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 0.789032449, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 0.789032449, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E9-A5FL-01", "ONCOTREE_CODE": "MBC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Metaplastic Breast Cancer", "TUMOR_TYPE": "Metaplastic Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "E9", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 20.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3043, "MSI_SENSOR_SCORE": 0.01, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.766666667, "TISSUE_SOURCE_SITE": "Asterand", "TBL_SCORE": 193.0 }, "treatments": [] }, "TCGA-AO-A12B": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "f6ed684f-ee7a-496c-80d5-6eacd494d16a", "AGE": 63, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 2989.0, "DAYS_TO_BIRTH": -23150.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/8/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 98.26741625, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 98.26741625, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 98.26741625, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 98.26741625, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-AO-A12B-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AO", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 19.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": NaN, "MSI_SENSOR_SCORE": 0.15, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.6, "TISSUE_SOURCE_SITE": "MSKCC", "TBL_SCORE": 3.0 }, "treatments": [ { "START_DATE": 45, "STOP_DATE": 118.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Fluorouracil", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "600", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "3924", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 45, "STOP_DATE": 118.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Methotrexate", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "40", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "261.6", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 45, "STOP_DATE": 118.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "600", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "3924", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 140, "STOP_DATE": 1980.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-BH-A0EB": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "ec6930e5-2d83-435a-9a57-a2c5c22caf02", "AGE": 69, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IA", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": 745.0, "DAYS_TO_BIRTH": -25259.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "11/9/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 24.49288227, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 24.49288227, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 24.49288227, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 24.49288227, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A0EB-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 19.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.28, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.533333333, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 37.0 }, "treatments": [ { "START_DATE": 55, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 73, "STOP_DATE": 118.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "33", "RADIATION_DOSAGE": "6040", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-BH-A0B9": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "5a57dc25-d252-4b22-b192-4de630d7002f", "AGE": 44, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IA", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": 1572.0, "DAYS_TO_BIRTH": -16310.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "11/4/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 51.68162541, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 51.68162541, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 51.68162541, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 51.68162541, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A0B9-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 8.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2664, "MSI_SENSOR_SCORE": 0.51, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.0, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 390.0 }, "treatments": [ { "START_DATE": 48, "STOP_DATE": 111.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "950", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "3800", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 48, "STOP_DATE": 111.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "95", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "380", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 132, "STOP_DATE": 180.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "34", "RADIATION_DOSAGE": "6240", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-D8-A1J8": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "62d70067-ff77-4f95-8b69-f537abaf74ce", "AGE": 77, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 431.0, "DAYS_TO_BIRTH": -28444.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/23/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "No", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 14.16970773, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 14.16970773, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 14.16970773, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 14.16970773, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D8-A1J8-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "D8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 19.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.4316, "MSI_SENSOR_SCORE": 4.8, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 23.1, "TISSUE_SOURCE_SITE": "Greater Poland Cancer Center", "TBL_SCORE": 21.0 }, "treatments": [ { "START_DATE": 32, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "20", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "hormone therapy", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": "Mg/Day", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-E2-A14W": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "eadb0562-2165-4adb-ad58-018e73f82780", "AGE": 78, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 974.0, "DAYS_TO_BIRTH": -28664.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/25/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "0:LIVING", "OS_MONTHS": 32.02156689, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 32.02156689, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 32.02156689, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 32.02156689, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-E2-A14W-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "E2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 5.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2597, "MSI_SENSOR_SCORE": 0.38, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 3.2, "TISSUE_SOURCE_SITE": "Roswell Park", "TBL_SCORE": 95.0 }, "treatments": [ { "START_DATE": 43, "STOP_DATE": 106.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "1122", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "3786", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 43, "STOP_DATE": 321.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Trastuzumab", "NUMBER_OF_CYCLES": "16", "PRESCRIBED_DOSE": "585", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "5964", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 169, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "20", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": "20", "TOTAL_DOSE_UNITS": "Mg/Day", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 43, "STOP_DATE": 106.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "140", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "473", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-E9-A1R0": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "f2da1d3f-f226-4c99-a97e-9b26f67d7a5d", "AGE": 58, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 860.0, "DAYS_TO_BIRTH": -21394.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/28/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 28.27366275, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 28.27366275, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 28.27366275, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E9-A1R0-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "E9", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 5.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2805, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.8, "TISSUE_SOURCE_SITE": "Asterand", "TBL_SCORE": 21.0 }, "treatments": [ { "START_DATE": 36, "STOP_DATE": 103.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "80", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "320", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 36, "STOP_DATE": 103.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "800", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "3200", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-A2-A0ER": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "7455d832-ad66-40df-85d7-3a7051c4498d", "AGE": 63, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IB", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 2263.0, "DAYS_TO_BIRTH": -23021.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "8/13/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1MI", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 74.39918467, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 74.39918467, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 74.39918467, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 74.39918467, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A2-A0ER-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 4.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2644, "MSI_SENSOR_SCORE": 0.06, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.9, "TISSUE_SOURCE_SITE": "Walter Reed", "TBL_SCORE": 55.0 }, "treatments": [ { "START_DATE": 98, "STOP_DATE": 140.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "104", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "416", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 98, "STOP_DATE": 140.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "1038", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "4152", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 183, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "3", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 154, "STOP_DATE": 154.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": "1", "PRESCRIBED_DOSE": "173", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "4", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "173", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 327, "STOP_DATE": 615.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Immunotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Nelipepimut-S", "NUMBER_OF_CYCLES": "7", "PRESCRIBED_DOSE": "1000", "PRESCRIBED_DOSE_UNITS": "ug", "REGIMEN_NUMBER": "5", "REGIMEN_INDICATION": "Other", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": "7000", "TOTAL_DOSE_UNITS": "Ug", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 200, "STOP_DATE": 246.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "33", "RADIATION_DOSAGE": "6040", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-D8-A27N": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "d5be2ab3-f748-480d-954b-385cf01b4c81", "AGE": 36, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 519.0, "DAYS_TO_BIRTH": -13243.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/18/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N2A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 17.06282671, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 17.06282671, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 17.06282671, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 17.06282671, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D8-A27N-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "D8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 8.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3201, "MSI_SENSOR_SCORE": 0.25, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.366666667, "TISSUE_SOURCE_SITE": "Greater Poland Cancer Center", "TBL_SCORE": 267.0 }, "treatments": [ { "START_DATE": 68, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel + Doxorubicin + Cyclophosphamide + Trastuzumab", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "60+600", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-A8-A06T": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "2c04a2f5-321e-4dea-8e00-268325da65cb", "AGE": 75, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 1614.0, "DAYS_TO_BIRTH": -27393.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "5/27/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "Yes", "RACE": null, "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 53.06243219, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 53.06243219, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 53.06243219, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 53.06243219, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A8-A06T-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 27.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2516, "MSI_SENSOR_SCORE": 0.2, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.866666667, "TISSUE_SOURCE_SITE": "Indivumed", "TBL_SCORE": 77.0 }, "treatments": [ { "START_DATE": 0, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-BH-A0BV": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "87f03d04-e651-4a6e-aea6-1c946aa46202", "AGE": 78, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": 1519.0, "DAYS_TO_BIRTH": -28699.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "11/9/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 49.93917875, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 49.93917875, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 49.93917875, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 49.93917875, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A0BV-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 14.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2495, "MSI_SENSOR_SCORE": 0.27, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.766666667, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 39.0 }, "treatments": [ { "START_DATE": 262, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 88, "STOP_DATE": 153.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 88, "STOP_DATE": 153.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 174, "STOP_DATE": 262.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": "12", "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-B6-A0IK": { "demographics": { "SUBTYPE": "BRCA_Her2", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "0491063c-14a7-4104-8002-1459126332f3", "AGE": 63, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIB", "AJCC_STAGING_EDITION": "4TH", "DAYS_LAST_FOLLOWUP": NaN, "DAYS_TO_BIRTH": -23150.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "11/2/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T4", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 18.77239702, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 18.77239702, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 16.07653615, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 16.07653615, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-B6-A0IK-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "B6", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 13.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2595, "MSI_SENSOR_SCORE": 0.25, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 3.8, "TISSUE_SOURCE_SITE": "Duke", "TBL_SCORE": 131.0 }, "treatments": [] }, "TCGA-A2-A0CS": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "d071c16b-7cee-45ed-8ec9-612418143815", "AGE": 73, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": 2298.0, "DAYS_TO_BIRTH": -26817.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "1/27/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M1", "PATH_N_STAGE": "N3A", "PATH_T_STAGE": "T4B", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 77.19367459, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 77.19367459, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 77.19367459, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A2-A0CS-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 17.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2726, "MSI_SENSOR_SCORE": 0.27, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.033333333, "TISSUE_SOURCE_SITE": "Walter Reed", "TBL_SCORE": 3.0 }, "treatments": [ { "START_DATE": 217, "STOP_DATE": 597.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Other", "TREATMENT_SUBTYPE": "Bisphosphonate Therapy", "AGENT": "Zoledronic Acid", "NUMBER_OF_CYCLES": "3", "PRESCRIBED_DOSE": "4", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Other", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "12", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 190, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 106, "STOP_DATE": 161.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "61", "RADIATION_DOSAGE": "11080", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-3C-AAAU": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "6E7D5EC6-A469-467C-B748-237353C23416", "AGE": 55, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE X", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 4047.0, "DAYS_TO_BIRTH": -20211.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "1/13/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "NX", "PATH_T_STAGE": "TX", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 133.0505967, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 133.0505967, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 59.44044449, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 59.44044449, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-3C-AAAU-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "3C", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 19.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3319, "MSI_SENSOR_SCORE": 0.55, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.8, "TISSUE_SOURCE_SITE": "Columbia University", "TBL_SCORE": 205.0 }, "treatments": [ { "START_DATE": 1828, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Goserelin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-A2-A04U": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "1c3610f7-e0aa-48d7-9a27-0dbaf6e244f9", "AGE": 47, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 2654.0, "DAYS_TO_BIRTH": -17474.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "1/5/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I+)", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 87.25383831, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 87.25383831, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 87.25383831, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 87.25383831, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A2-A04U-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 21.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.294, "MSI_SENSOR_SCORE": 1.39, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.633333333, "TISSUE_SOURCE_SITE": "Walter Reed", "TBL_SCORE": 1894.0 }, "treatments": [ { "START_DATE": 78, "STOP_DATE": 120.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "116", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "464", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 134, "STOP_DATE": 197.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "140-192", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "3", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "612", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 481, "STOP_DATE": 671.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Other", "TREATMENT_SUBTYPE": "Bisphosphonate Therapy", "AGENT": "Zoledronic Acid", "NUMBER_OF_CYCLES": "3", "PRESCRIBED_DOSE": "4", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "4", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "12", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 78, "STOP_DATE": 120.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "1160", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "4640", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-EW-A1P8": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "359f12f9-5c41-48a4-85bc-fd7e307bf7d8", "AGE": 58, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIC", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": NaN, "DAYS_TO_BIRTH": -21501.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/27/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N3B", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 7.857448138, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 7.857448138, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 6.805404872, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 6.805404872, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-EW-A1P8-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "EW", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 18.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3189, "MSI_SENSOR_SCORE": 1.23, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.933333333, "TISSUE_SOURCE_SITE": "University of Miami", "TBL_SCORE": 95.0 }, "treatments": [ { "START_DATE": 40, "STOP_DATE": 140.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Fluorouracil", "NUMBER_OF_CYCLES": "3", "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": "fec x3", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 40, "STOP_DATE": 140.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Epirubicin", "NUMBER_OF_CYCLES": "3", "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": "fec x3", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 40, "STOP_DATE": 140.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "3", "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": "fec x3", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-A8-A09Z": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "81e7a3d3-be70-4834-8018-4d2cc077a4e6", "AGE": 83, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 0.0, "DAYS_TO_BIRTH": -30590.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "5/27/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": null, "RADIATION_THERAPY": null, "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 0.0, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 0.0, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 0.0, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A8-A09Z-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 4.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.7713, "MSI_SENSOR_SCORE": 26.38, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 36.93333333, "TISSUE_SOURCE_SITE": "Indivumed", "TBL_SCORE": 15.0 }, "treatments": [] }, "TCGA-E2-A1LH": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "d8ecba6a-9fff-4993-a799-9a8d2aea524e", "AGE": 59, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE I", "AJCC_STAGING_EDITION": "5TH", "DAYS_LAST_FOLLOWUP": 3247.0, "DAYS_TO_BIRTH": -21628.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "6/3/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 106.7495151, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 106.7495151, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 106.7495151, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 106.7495151, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E2-A1LH-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "E2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 18.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3031, "MSI_SENSOR_SCORE": 0.18, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 6.066666667, "TISSUE_SOURCE_SITE": "Roswell Park", "TBL_SCORE": 234.0 }, "treatments": [ { "START_DATE": 41, "STOP_DATE": 104.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 41, "STOP_DATE": 104.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 147, "STOP_DATE": 189.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "30", "RADIATION_DOSAGE": "6000", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-LL-A6FP": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "5C9D8163-A68E-43CE-9CBA-EFFB7405761E", "AGE": 90, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 677.0, "DAYS_TO_BIRTH": -32873.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/3/2013", "HISTORY_NEOADJUVANT_TRTYN": "Yes", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "NX", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "No", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 22.25729033, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 22.25729033, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 22.25729033, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 22.25729033, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-LL-A6FP-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "LL", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 17.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3564, "MSI_SENSOR_SCORE": 0.9, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.7, "TISSUE_SOURCE_SITE": "Candler", "TBL_SCORE": 32.0 }, "treatments": [ { "START_DATE": 166, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 257, "STOP_DATE": 467.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-OL-A66L": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "AF0ACAA9-A61C-4E57-BC0D-453AD5BF193A", "AGE": 71, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 1301.0, "DAYS_TO_BIRTH": -26186.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "6/11/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 42.772134, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 42.772134, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 42.772134, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 42.772134, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-OL-A66L-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "OL", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 5.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3475, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.866666667, "TISSUE_SOURCE_SITE": "University of Chicago", "TBL_SCORE": 6.0 }, "treatments": [ { "START_DATE": 71, "STOP_DATE": 120.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": "6080", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-B6-A0X1": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "178b2c48-c07d-422e-ae17-8bcfd996ad51", "AGE": 48, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "4TH", "DAYS_LAST_FOLLOWUP": 5677.0, "DAYS_TO_BIRTH": -17624.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/14/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M1", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 245.0932045, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 245.0932045, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 16.1094125, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 16.1094125, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-B6-A0X1-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "B6", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 13.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2987, "MSI_SENSOR_SCORE": 1.54, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.266666667, "TISSUE_SOURCE_SITE": "Duke", "TBL_SCORE": 448.0 }, "treatments": [] }, "TCGA-A2-A0D4": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "75113445-d2d6-44a0-866c-c9175e6d214b", "AGE": 37, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 767.0, "DAYS_TO_BIRTH": -13805.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/21/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 25.21616202, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 25.21616202, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 25.21616202, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 25.21616202, "GENETIC_ANCESTRY_LABEL": "AFR_ADMIX" }, "sample": { "SAMPLE_ID": "TCGA-A2-A0D4-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 19.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2711, "MSI_SENSOR_SCORE": 0.86, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.2, "TISSUE_SOURCE_SITE": "Walter Reed", "TBL_SCORE": 113.0 }, "treatments": [ { "START_DATE": 57, "STOP_DATE": 99.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "1304", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "5216", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 279, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "20 mg daily", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "4", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 113, "STOP_DATE": 155.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "380", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "3", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "1520", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 57, "STOP_DATE": 99.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "130", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "520", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 203, "STOP_DATE": 244.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": "5040", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" }, { "START_DATE": 203, "STOP_DATE": 244.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 2", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": "5040", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" }, { "START_DATE": 245, "STOP_DATE": 251.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 3", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": "1000", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-D8-A1XB": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "d2694b09-7844-4496-865c-5d3d8cd03330", "AGE": 62, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 552.0, "DAYS_TO_BIRTH": -22976.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/16/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 18.14774633, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 18.14774633, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 18.14774633, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 18.14774633, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D8-A1XB-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "D8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 3.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.305, "MSI_SENSOR_SCORE": 0.18, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.2, "TISSUE_SOURCE_SITE": "Greater Poland Cancer Center", "TBL_SCORE": 31.0 }, "treatments": [ { "START_DATE": 74, "STOP_DATE": 111.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "25", "RADIATION_DOSAGE": "5000", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-A8-A083": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "afb9418e-91eb-4db1-aacf-12bd946c9ba0", "AGE": 67, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 0.0, "DAYS_TO_BIRTH": -24746.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "5/27/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": null, "RADIATION_THERAPY": null, "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 0.0, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 0.0, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 0.0, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 0.0, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A8-A083-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 8.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2715, "MSI_SENSOR_SCORE": 0.2, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.966666667, "TISSUE_SOURCE_SITE": "Indivumed", "TBL_SCORE": 12.0 }, "treatments": [] }, "TCGA-E2-A14S": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "c2b104ee-f914-4e79-9e1b-56bf88157472", "AGE": 65, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE I", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 1009.0, "DAYS_TO_BIRTH": -23878.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/6/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "0:LIVING", "OS_MONTHS": 33.17223921, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 33.17223921, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 33.17223921, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 33.17223921, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E2-A14S-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "E2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 8.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2912, "MSI_SENSOR_SCORE": 0.19, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.0, "TISSUE_SOURCE_SITE": "Roswell Park", "TBL_SCORE": 83.0 }, "treatments": [ { "START_DATE": 147, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Exemestane", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "25", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": "25", "TOTAL_DOSE_UNITS": "Mg/Day", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 50, "STOP_DATE": 119.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "148", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "592", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 50, "STOP_DATE": 119.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "1182", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "4728", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 160, "STOP_DATE": 212.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "34", "RADIATION_DOSAGE": "6280", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-S3-AA0Z": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "CFFE832C-8A81-4CDB-8B25-DF7F35AFAFDC", "AGE": 63, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 629.0, "DAYS_TO_BIRTH": -23314.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/18/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 20.67922543, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 20.67922543, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 20.67922543, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 20.67922543, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-S3-AA0Z-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "S3", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 12.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3531, "MSI_SENSOR_SCORE": 1.27, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.566666667, "TISSUE_SOURCE_SITE": "Albert Einstein Medical Center", "TBL_SCORE": 83.0 }, "treatments": [ { "START_DATE": 84, "STOP_DATE": 84.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Ancillary", "TREATMENT_SUBTYPE": null, "AGENT": "Pegfilgrastim", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 84, "STOP_DATE": 84.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 84, "STOP_DATE": 84.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 113, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-AC-A3TN": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "81B70C58-4A12-448C-A594-2ADE44F6A0AE", "AGE": 75, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 456.0, "DAYS_TO_BIRTH": -27421.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "8/1/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "0:LIVING", "OS_MONTHS": 14.99161653, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 14.99161653, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 14.99161653, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 14.99161653, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AC-A3TN-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "AC", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 4.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3194, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.0, "TISSUE_SOURCE_SITE": "International Genomics Consortium", "TBL_SCORE": 3.0 }, "treatments": [ { "START_DATE": 55, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 96, "STOP_DATE": 144.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": "6040", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-C8-A12M": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "dd0f8e5a-383d-4f03-bb71-0e115d4e442c", "AGE": 70, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 358.0, "DAYS_TO_BIRTH": -25811.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/12/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Asian", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 11.76973403, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 11.76973403, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 11.76973403, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 11.76973403, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-C8-A12M-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "C8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 17.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3153, "MSI_SENSOR_SCORE": 0.66, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.8, "TISSUE_SOURCE_SITE": "ILSBio", "TBL_SCORE": 411.0 }, "treatments": [] }, "TCGA-AR-A1AS": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "7d681cc6-689d-41c8-9e84-e13733089ec9", "AGE": 54, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 1150.0, "DAYS_TO_BIRTH": -20028.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "6/14/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Asian", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 37.80780485, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 37.80780485, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 37.80780485, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 37.80780485, "GENETIC_ANCESTRY_LABEL": "SAS" }, "sample": { "SAMPLE_ID": "TCGA-AR-A1AS-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AR", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 6.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2916, "MSI_SENSOR_SCORE": 0.17, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.966666667, "TISSUE_SOURCE_SITE": "Mayo", "TBL_SCORE": 23.0 }, "treatments": [ { "START_DATE": 57, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 29, "STOP_DATE": 43.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "2", "PRESCRIBED_DOSE": "60", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "200", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 29, "STOP_DATE": 43.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "2", "PRESCRIBED_DOSE": "600", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "1970", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 77, "STOP_DATE": 118.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "30", "RADIATION_DOSAGE": "6000", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-AC-A2FK": { "demographics": { "SUBTYPE": "BRCA_Normal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "79126E88-9CF8-45FF-BF91-A98DA3B304D7", "AGE": 45, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIC", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 2650.0, "DAYS_TO_BIRTH": -16627.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/13/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N3A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 87.12233291, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 87.12233291, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 87.12233291, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 87.12233291, "GENETIC_ANCESTRY_LABEL": "AMR" }, "sample": { "SAMPLE_ID": "TCGA-AC-A2FK-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AC", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2964, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.033333333, "TISSUE_SOURCE_SITE": "International Genomics Consortium", "TBL_SCORE": 0.0 }, "treatments": [ { "START_DATE": 51, "STOP_DATE": 174.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 51, "STOP_DATE": 174.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 294, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Letrozole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 51, "STOP_DATE": 174.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 243, "STOP_DATE": 280.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "28", "RADIATION_DOSAGE": "5040", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-BH-A18G": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "747083ff-0703-431b-aad4-f2adff739516", "AGE": 81, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IA", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": 149.0, "DAYS_TO_BIRTH": -29820.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "6/1/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.5", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.5", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 4.898576454, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 4.898576454, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 4.898576454, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 4.898576454, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A18G-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 1.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.7737, "MSI_SENSOR_SCORE": 26.46, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 41.83333333, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 15.0 }, "treatments": [ { "START_DATE": 103, "STOP_DATE": 149.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "25", "RADIATION_DOSAGE": "6000", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-A8-A06Z": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "2399caeb-ead2-4003-af38-809db4ac2e2b", "AGE": 84, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 31.0, "DAYS_TO_BIRTH": -30984.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "5/27/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": null, "RADIATION_THERAPY": null, "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 1.019166913, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 1.019166913, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 1.019166913, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A8-A06Z-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 24.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2674, "MSI_SENSOR_SCORE": 1.69, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.333333333, "TISSUE_SOURCE_SITE": "Indivumed", "TBL_SCORE": 214.0 }, "treatments": [] }, "TCGA-BH-A0BQ": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "b3bb8fd6-ee54-4813-b042-2bbe70115382", "AGE": 39, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE I", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 2255.0, "DAYS_TO_BIRTH": -14494.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "8/10/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 74.13617385, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 74.13617385, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 56.18568564, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 56.18568564, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A0BQ-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 5.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2795, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.5, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 10.0 }, "treatments": [] }, "TCGA-AC-A2FF": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "3CA67CD0-81DA-4F68-A9FA-F1A8C013C28D", "AGE": 40, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 2759.0, "DAYS_TO_BIRTH": NaN, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/23/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Asian", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 90.70585528, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 90.70585528, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 90.70585528, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 90.70585528, "GENETIC_ANCESTRY_LABEL": "SAS_ADMIX" }, "sample": { "SAMPLE_ID": "TCGA-AC-A2FF-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AC", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.322, "MSI_SENSOR_SCORE": 0.21, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.533333333, "TISSUE_SOURCE_SITE": "International Genomics Consortium", "TBL_SCORE": 38.0 }, "treatments": [ { "START_DATE": 70, "STOP_DATE": 153.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 70, "STOP_DATE": 153.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 153, "STOP_DATE": 245.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 382, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 336, "STOP_DATE": 377.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "28", "RADIATION_DOSAGE": "5040", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-B6-A40B": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "8539E15F-BA40-4219-AAEB-08D0AB101311", "AGE": 76, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE I", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 3152.0, "DAYS_TO_BIRTH": -27811.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/20/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T1B", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 103.6262616, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 103.6262616, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 103.6262616, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 103.6262616, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-B6-A40B-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "B6", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 7.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2948, "MSI_SENSOR_SCORE": 0.01, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.366666667, "TISSUE_SOURCE_SITE": "Duke", "TBL_SCORE": 24.0 }, "treatments": [] }, "TCGA-A2-A0CQ": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "ab34a9a2-d72d-4106-94fb-118844b1b60b", "AGE": 62, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 2695.0, "DAYS_TO_BIRTH": -22810.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "8/10/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T1", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 88.60176875, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 88.60176875, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 88.60176875, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 88.60176875, "GENETIC_ANCESTRY_LABEL": "AFR_ADMIX" }, "sample": { "SAMPLE_ID": "TCGA-A2-A0CQ-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 5.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2894, "MSI_SENSOR_SCORE": 0.07, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.0, "TISSUE_SOURCE_SITE": "Walter Reed", "TBL_SCORE": 2.0 }, "treatments": [ { "START_DATE": 99, "STOP_DATE": 162.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "104", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "416", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 99, "STOP_DATE": 162.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "1044", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "4176", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 201, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "3", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 492, "STOP_DATE": 628.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Immunotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "AE37", "NUMBER_OF_CYCLES": "6", "PRESCRIBED_DOSE": "100", "PRESCRIBED_DOSE_UNITS": "ug", "REGIMEN_NUMBER": "4", "REGIMEN_INDICATION": "Other", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": "600", "TOTAL_DOSE_UNITS": "Ug", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 188, "STOP_DATE": 236.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "33", "RADIATION_DOSAGE": "6040", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-E9-A243": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "d4a1ecdc-399c-4f82-aa7a-68a0c82ded3f", "AGE": 52, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 612.0, "DAYS_TO_BIRTH": -19035.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "8/17/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 20.12032745, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 20.12032745, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 10.02728737, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 10.02728737, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E9-A243-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "E9", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 21.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3063, "MSI_SENSOR_SCORE": 0.01, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.3, "TISSUE_SOURCE_SITE": "Asterand", "TBL_SCORE": 87.0 }, "treatments": [ { "START_DATE": 53, "STOP_DATE": 235.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Fluorouracil", "NUMBER_OF_CYCLES": "3", "PRESCRIBED_DOSE": "1500", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "4500", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 53, "STOP_DATE": 235.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Methotrexate", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "100", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "400", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 53, "STOP_DATE": 235.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Fluorouracil", "NUMBER_OF_CYCLES": "2", "PRESCRIBED_DOSE": "2000", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "4000", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 53, "STOP_DATE": 235.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "5", "PRESCRIBED_DOSE": "1600", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "8000", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 53, "STOP_DATE": 235.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Vincristine", "NUMBER_OF_CYCLES": "1", "PRESCRIBED_DOSE": "4", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "4", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 305, "STOP_DATE": 520.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Ancillary", "TREATMENT_SUBTYPE": null, "AGENT": "Pamidronic Acid", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Stable Disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 119, "STOP_DATE": 151.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "25", "RADIATION_DOSAGE": "4500", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" }, { "START_DATE": 119, "STOP_DATE": 151.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 2", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": "40", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "gy" } ] }, "TCGA-A8-A08C": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "78e1da41-127c-4e9c-aaaa-77a0d94c31d0", "AGE": 65, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 881.0, "DAYS_TO_BIRTH": -24017.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "5/27/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": null, "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "0:LIVING", "OS_MONTHS": 28.96406615, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 28.96406615, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 28.96406615, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 28.96406615, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A8-A08C-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 15.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2634, "MSI_SENSOR_SCORE": 0.16, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": NaN, "TISSUE_SOURCE_SITE": "Indivumed", "TBL_SCORE": 1.0 }, "treatments": [ { "START_DATE": 31, "STOP_DATE": 151.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Fluorouracil", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 31, "STOP_DATE": 151.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Epirubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 31, "STOP_DATE": 151.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 243, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 182, "STOP_DATE": 243.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "gy" } ] }, "TCGA-C8-A130": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "8cf54607-01ce-42b0-9bd9-8627edd9f3b7", "AGE": 52, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 370.0, "DAYS_TO_BIRTH": -19117.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/13/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N2", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Asian", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 12.16425026, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 12.16425026, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 12.16425026, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 12.16425026, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-C8-A130-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "C8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 20.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2892, "MSI_SENSOR_SCORE": 0.47, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.166666667, "TISSUE_SOURCE_SITE": "ILSBio", "TBL_SCORE": 470.0 }, "treatments": [] }, "TCGA-BH-A0B5": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "9da462b0-93c2-4305-89f6-7199a30399a7", "AGE": 40, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 2136.0, "DAYS_TO_BIRTH": -14920.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "8/2/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N2A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 70.22388796, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 70.22388796, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 70.22388796, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A0B5-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 21.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2673, "MSI_SENSOR_SCORE": 0.18, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.033333333, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 16.0 }, "treatments": [ { "START_DATE": 63, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 63, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 257, "STOP_DATE": 302.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "28", "RADIATION_DOSAGE": "5040", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" }, { "START_DATE": 257, "STOP_DATE": 302.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 2", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "43", "RADIATION_DOSAGE": "5936", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" }, { "START_DATE": 300, "STOP_DATE": 304.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 3", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "6", "RADIATION_DOSAGE": "100", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "gy" } ] }, "TCGA-A8-A09M": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "626b4ff0-2188-4a14-aac8-6703c624917f", "AGE": 75, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIC", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 1006.0, "DAYS_TO_BIRTH": -27455.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "5/27/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N3A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": null, "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 33.07361015, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 33.07361015, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 33.07361015, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 33.07361015, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A8-A09M-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 2.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2519, "MSI_SENSOR_SCORE": 0.31, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 4.366666667, "TISSUE_SOURCE_SITE": "Indivumed", "TBL_SCORE": 148.0 }, "treatments": [ { "START_DATE": 31, "STOP_DATE": 184.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 276, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Exemestane", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 214, "STOP_DATE": 276.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "gy" } ] }, "TCGA-A2-A25A": { "demographics": { "SUBTYPE": "BRCA_Normal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "aaea5f9c-b35b-47f8-93cb-bdc7b81844ff", "AGE": 44, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 3276.0, "DAYS_TO_BIRTH": -16084.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "6/21/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 107.7029293, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 107.7029293, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 107.7029293, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 107.7029293, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A2-A25A-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 5.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3222, "MSI_SENSOR_SCORE": 0.08, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 10.1, "TISSUE_SOURCE_SITE": "Walter Reed", "TBL_SCORE": 14.0 }, "treatments": [] }, "TCGA-WT-AB41": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "E7DB08A7-B439-4230-8DC4-1B54AF4736C4", "AGE": 55, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 1611.0, "DAYS_TO_BIRTH": NaN, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/16/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N1MI", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "Yes", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 52.96380314, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 52.96380314, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 52.96380314, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 52.96380314, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-WT-AB41-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "WT", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 8.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3366, "MSI_SENSOR_SCORE": 0.01, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.3, "TISSUE_SOURCE_SITE": "University of Kansas", "TBL_SCORE": 77.0 }, "treatments": [ { "START_DATE": 181, "STOP_DATE": 273.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 273, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 89, "STOP_DATE": 150.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 89, "STOP_DATE": 150.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-C8-A12Y": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "298a1710-deb4-4064-a0f2-da32d43aa217", "AGE": 44, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 1476.0, "DAYS_TO_BIRTH": NaN, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/13/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Asian", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 48.52549561, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 48.52549561, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 48.52549561, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 48.52549561, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-C8-A12Y-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "C8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 8.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2626, "MSI_SENSOR_SCORE": 0.2, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.133333333, "TISSUE_SOURCE_SITE": "ILSBio", "TBL_SCORE": 97.0 }, "treatments": [] }, "TCGA-D8-A1XR": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "70f34c5c-3671-44c8-9469-99f9786efec1", "AGE": 56, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 482.0, "DAYS_TO_BIRTH": -20488.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/16/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 15.84640168, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 15.84640168, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 15.84640168, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 15.84640168, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D8-A1XR-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "D8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 6.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3401, "MSI_SENSOR_SCORE": 0.28, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.9, "TISSUE_SOURCE_SITE": "Greater Poland Cancer Center", "TBL_SCORE": 21.0 }, "treatments": [ { "START_DATE": 105, "STOP_DATE": 168.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin + Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "60+600", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-D8-A1XM": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "92529232-8504-4541-b7e2-4df8f497c413", "AGE": 57, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 538.0, "DAYS_TO_BIRTH": -21056.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/16/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 17.6874774, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 17.6874774, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 17.6874774, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 17.6874774, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D8-A1XM-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "D8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 5.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2918, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.466666667, "TISSUE_SOURCE_SITE": "Greater Poland Cancer Center", "TBL_SCORE": 17.0 }, "treatments": [ { "START_DATE": 61, "STOP_DATE": 93.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "25", "RADIATION_DOSAGE": "5000", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-D8-A27P": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "c54d5507-bba5-4a1e-8885-3c3b1eed13c1", "AGE": 64, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 49.0, "DAYS_TO_BIRTH": -23576.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/18/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 1.61094125, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 1.61094125, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 1.61094125, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 1.61094125, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D8-A27P-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "D8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 2.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3071, "MSI_SENSOR_SCORE": 0.06, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.766666667, "TISSUE_SOURCE_SITE": "Greater Poland Cancer Center", "TBL_SCORE": 3.0 }, "treatments": [] }, "TCGA-A2-A1FZ": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "805bfe39-3695-43c2-93e4-d66d0559b89f", "AGE": 63, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 683.0, "DAYS_TO_BIRTH": -23055.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/21/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 22.45454844, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 22.45454844, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 22.45454844, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 22.45454844, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A2-A1FZ-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "A2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 2.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3362, "MSI_SENSOR_SCORE": 0.06, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.866666667, "TISSUE_SOURCE_SITE": "Walter Reed", "TBL_SCORE": 10.0 }, "treatments": [] }, "TCGA-E2-A154": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "24e39609-9645-43e5-960b-db5446eaea65", "AGE": 68, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE I", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 591.0, "DAYS_TO_BIRTH": -24999.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/7/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 19.42992406, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 19.42992406, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 19.42992406, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 19.42992406, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E2-A154-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "E2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 29.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2793, "MSI_SENSOR_SCORE": 0.22, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.4, "TISSUE_SOURCE_SITE": "Roswell Park", "TBL_SCORE": 24.0 }, "treatments": [ { "START_DATE": 325, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 32, "STOP_DATE": 77.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "33", "RADIATION_DOSAGE": "6040", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-A2-A0T5": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "36d77496-99f8-4911-ba7c-89fae32662aa", "AGE": 39, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": 531.0, "DAYS_TO_BIRTH": -14503.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "11/9/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 17.45734293, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 17.45734293, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 17.45734293, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 17.45734293, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A2-A0T5-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 5.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2978, "MSI_SENSOR_SCORE": 0.06, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.5, "TISSUE_SOURCE_SITE": "Walter Reed", "TBL_SCORE": 1.0 }, "treatments": [] }, "TCGA-AC-A5EH": { "demographics": { "SUBTYPE": "BRCA_Her2", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "D13FB44B-291B-4EA4-920C-142DAA8D1989", "AGE": 76, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 511.0, "DAYS_TO_BIRTH": -27964.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/12/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N1MI", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 16.79981589, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 16.79981589, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 16.79981589, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 16.79981589, "GENETIC_ANCESTRY_LABEL": "AFR_ADMIX" }, "sample": { "SAMPLE_ID": "TCGA-AC-A5EH-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "AC", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 25.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3111, "MSI_SENSOR_SCORE": 0.08, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 4.3, "TISSUE_SOURCE_SITE": "International Genomics Consortium", "TBL_SCORE": 138.0 }, "treatments": [ { "START_DATE": 163, "STOP_DATE": 216.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "33", "RADIATION_DOSAGE": "6040", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-E2-A1IH": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "ec0155ab-1b14-498d-8fa9-9f63e3ccb990", "AGE": 80, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE I", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 1026.0, "DAYS_TO_BIRTH": -29444.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/28/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 33.73113719, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 33.73113719, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 33.73113719, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 33.73113719, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E2-A1IH-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "E2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 22.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3225, "MSI_SENSOR_SCORE": 0.28, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.166666667, "TISSUE_SOURCE_SITE": "Roswell Park", "TBL_SCORE": 130.0 }, "treatments": [ { "START_DATE": 32, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Exemestane", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "25", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": "25", "TOTAL_DOSE_UNITS": "Mg/Day", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-LL-A73Z": { "demographics": { "SUBTYPE": "BRCA_Normal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "3E637872-F5E5-49D3-BB0D-9C16B8713382", "AGE": 55, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 137.0, "DAYS_TO_BIRTH": -20118.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "11/15/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M1", "PATH_N_STAGE": "NX", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "No", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 7.462931913, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 7.462931913, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 6.312259592, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-LL-A73Z-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "LL", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 11.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3448, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.333333333, "TISSUE_SOURCE_SITE": "Candler", "TBL_SCORE": 85.0 }, "treatments": [ { "START_DATE": 18, "STOP_DATE": 60.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Clinical Progressive Disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 18, "STOP_DATE": 60.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Clinical Progressive Disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 74, "STOP_DATE": 109.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Clinical Progressive Disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 123, "STOP_DATE": 179.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Fulvestrant", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Clinical Progressive Disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 125, "STOP_DATE": 151.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Radiographic Progressive Disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "16", "RADIATION_DOSAGE": "42.72", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "gy" } ] }, "TCGA-AC-A23C": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "dfd0b7ba-c7d3-498e-b455-346301865452", "AGE": 62, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 585.0, "DAYS_TO_BIRTH": -22751.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "7/14/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 19.23266594, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 19.23266594, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 19.23266594, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 19.23266594, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AC-A23C-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AC", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 4.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3232, "MSI_SENSOR_SCORE": 0.77, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 3.733333333, "TISSUE_SOURCE_SITE": "International Genomics Consortium", "TBL_SCORE": 196.0 }, "treatments": [ { "START_DATE": 77, "STOP_DATE": 204.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Chemo, NOS", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-5T-A9QA": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "2FD36838-5A83-433E-AC80-B1F77448E5AA", "AGE": 52, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 303.0, "DAYS_TO_BIRTH": -19031.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/23/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8523/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "NX", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "No", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 9.961534668, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 9.961534668, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 9.961534668, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-5T-A9QA-01", "ONCOTREE_CODE": "BRCNOS", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Carcinoma (NOS)", "TUMOR_TYPE": "Other", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "5T", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 14.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3379, "MSI_SENSOR_SCORE": 0.46, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.9, "TISSUE_SOURCE_SITE": "Holy Cross", "TBL_SCORE": 99.0 }, "treatments": [ { "START_DATE": 23, "STOP_DATE": 94.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 304, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Letrozole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 115, "STOP_DATE": 198.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 227, "STOP_DATE": 277.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "35", "RADIATION_DOSAGE": "6440", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-B6-A0IA": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "0807435a-e75e-4e04-8e45-ed0cd49a841a", "AGE": 51, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": 8391.0, "DAYS_TO_BIRTH": -18748.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "11/2/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8523/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 275.86547, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 275.86547, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 275.86547, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 275.86547, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-B6-A0IA-01", "ONCOTREE_CODE": "BRCNOS", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Carcinoma (NOS)", "TUMOR_TYPE": "Other", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "B6", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 6.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2676, "MSI_SENSOR_SCORE": 0.3, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.9, "TISSUE_SOURCE_SITE": "Duke", "TBL_SCORE": 49.0 }, "treatments": [] }, "TCGA-LD-A66U": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "38DC3E09-0B0E-4A29-B318-CC0352013DAE", "AGE": 44, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 646.0, "DAYS_TO_BIRTH": -16101.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "6/27/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N1MI", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 21.23812342, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 21.23812342, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 21.23812342, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 21.23812342, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-LD-A66U-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "LD", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 10.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3459, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.066666667, "TISSUE_SOURCE_SITE": "Hartford Hospital", "TBL_SCORE": 12.0 }, "treatments": [ { "START_DATE": 141, "STOP_DATE": 183.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 85, "STOP_DATE": 127.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 85, "STOP_DATE": 127.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 278, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 231, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "28", "RADIATION_DOSAGE": "4680", "RADIATION_TREATMENT_ONGOING": "Yes", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-E9-A1N9": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "994ca1f5-ad10-44ec-aa21-71fc2940653b", "AGE": 58, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 1101.0, "DAYS_TO_BIRTH": -21228.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "6/23/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8522/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 36.1968636, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 36.1968636, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 36.1968636, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 36.1968636, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E9-A1N9-01", "ONCOTREE_CODE": "BRCNOS", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Carcinoma (NOS)", "TUMOR_TYPE": "Mixed Histology (NOS)", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "E9", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 17.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3531, "MSI_SENSOR_SCORE": 1.1, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.6, "TISSUE_SOURCE_SITE": "Asterand", "TBL_SCORE": 456.0 }, "treatments": [ { "START_DATE": 14, "STOP_DATE": 91.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 119, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-A8-A082": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "5e4187c9-98f8-4bdb-a8da-6a914e96f47a", "AGE": 58, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": -31.0, "DAYS_TO_BIRTH": -21338.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "5/27/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": null, "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 18.04911727, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 18.04911727, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 18.04911727, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 18.04911727, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A8-A082-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 5.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2483, "MSI_SENSOR_SCORE": 0.1, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.666666667, "TISSUE_SOURCE_SITE": "Indivumed", "TBL_SCORE": 38.0 }, "treatments": [ { "START_DATE": 31, "STOP_DATE": 122.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Fluorouracil", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 31, "STOP_DATE": 122.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Epirubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 31, "STOP_DATE": 122.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 92, "STOP_DATE": 92.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 184, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Letrozole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 852, "STOP_DATE": 914.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Exemestane", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-OL-A5RU": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "B8A44FDF-9CB9-4123-9AB0-4BC198921FEE", "AGE": 63, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 1219.0, "DAYS_TO_BIRTH": -23108.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "5/16/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 40.07627314, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 40.07627314, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 40.07627314, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 40.07627314, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-OL-A5RU-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "OL", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 1.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3035, "MSI_SENSOR_SCORE": 0.03, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.133333333, "TISSUE_SOURCE_SITE": "University of Chicago", "TBL_SCORE": 13.0 }, "treatments": [ { "START_DATE": 71, "STOP_DATE": 134.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 71, "STOP_DATE": 134.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 160, "STOP_DATE": 197.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": "5040", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-A2-A0EW": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "8d5fe6e8-d2cc-481f-a6a1-9cb6e7982cde", "AGE": 53, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIC", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 905.0, "DAYS_TO_BIRTH": -19413.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "1/5/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N3A", "PATH_T_STAGE": "T1B", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 61.93904724, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 61.93904724, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 44.48170431, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A2-A0EW-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 2.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2504, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.5, "TISSUE_SOURCE_SITE": "Walter Reed", "TBL_SCORE": 55.0 }, "treatments": [ { "START_DATE": 221, "STOP_DATE": 812.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "4", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 85, "STOP_DATE": 127.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "115-116", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "463", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 85, "STOP_DATE": 127.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "1158", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "4632", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 141, "STOP_DATE": 184.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "334-338", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "3", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "1344", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 813, "STOP_DATE": 903.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Letrozole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 904, "STOP_DATE": 1001.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 1002, "STOP_DATE": 1365.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Exemestane", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Clinical Progressive Disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 1158, "STOP_DATE": 1422.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Ancillary", "TREATMENT_SUBTYPE": null, "AGENT": "Zoledronic Acid", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Clinical Progressive Disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 1366, "STOP_DATE": 1562.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Fulvestrant", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Clinical Progressive Disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 1425, "STOP_DATE": 1718.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Ancillary", "TREATMENT_SUBTYPE": null, "AGENT": "Denosumab", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Clinical Progressive Disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 1618, "STOP_DATE": 1722.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Clinical Progressive Disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 1696, "STOP_DATE": 1787.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Clinical Progressive Disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 211, "STOP_DATE": 249.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": "5040", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" }, { "START_DATE": 211, "STOP_DATE": 246.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 2", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": "4500", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" }, { "START_DATE": 252, "STOP_DATE": 256.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 3", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": "1000", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 1466, "STOP_DATE": 1480.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 4", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Radiographic Progressive Disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Distant Site", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": "3000", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-BH-A0BO": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "26573441-eedb-4364-966c-e7f803deef19", "AGE": 54, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE I", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 2197.0, "DAYS_TO_BIRTH": -19767.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "8/9/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T1B", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 72.22934543, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 72.22934543, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 72.22934543, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 72.22934543, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A0BO-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 3.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2673, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.733333333, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 7.0 }, "treatments": [ { "START_DATE": 72, "STOP_DATE": 119.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "33", "RADIATION_DOSAGE": "6040", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-C8-A26V": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "89414e79-7f89-42d9-8228-101b5bf2f31f", "AGE": 47, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 616.0, "DAYS_TO_BIRTH": -17468.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/21/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N2", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "No", "PRIOR_DX": "No", "RACE": "Asian", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 20.25183286, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 20.25183286, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 20.25183286, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 20.25183286, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-C8-A26V-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "C8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 4.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2978, "MSI_SENSOR_SCORE": 0.02, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.166666667, "TISSUE_SOURCE_SITE": "ILSBio", "TBL_SCORE": 39.0 }, "treatments": [ { "START_DATE": 247, "STOP_DATE": 613.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 212, "STOP_DATE": 247.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "25", "RADIATION_DOSAGE": "50", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "gy" } ] }, "TCGA-A2-A3KC": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "2D29A4AC-98E7-4663-9DD6-5681BC32AC2E", "AGE": 55, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 1102.0, "DAYS_TO_BIRTH": -20401.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/14/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "0:LIVING", "OS_MONTHS": 36.22973995, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 36.22973995, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 36.22973995, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 36.22973995, "GENETIC_ANCESTRY_LABEL": "AFR_ADMIX" }, "sample": { "SAMPLE_ID": "TCGA-A2-A3KC-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "A2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 6.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2846, "MSI_SENSOR_SCORE": 0.01, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.0, "TISSUE_SOURCE_SITE": "Walter Reed", "TBL_SCORE": 45.0 }, "treatments": [ { "START_DATE": 77, "STOP_DATE": 182.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": "6", "PRESCRIBED_DOSE": "159", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "3", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "954", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 77, "STOP_DATE": 182.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "6", "PRESCRIBED_DOSE": "1060", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "6360", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 203, "STOP_DATE": 1101.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "20", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "4", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 77, "STOP_DATE": 182.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "6", "PRESCRIBED_DOSE": "106", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "636", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 1102, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-A7-A26I": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "b2ecbc0f-2c30-4200-8d5e-7b95424bcadb", "AGE": 65, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 661.0, "DAYS_TO_BIRTH": -23948.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/29/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 21.7312687, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 21.7312687, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 21.7312687, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 21.7312687, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A7-A26I-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "A7", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 26.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3156, "MSI_SENSOR_SCORE": 0.68, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.166666667, "TISSUE_SOURCE_SITE": "Christiana Healthcare", "TBL_SCORE": 171.0 }, "treatments": [ { "START_DATE": 60, "STOP_DATE": 164.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "6", "PRESCRIBED_DOSE": "1130", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "6780", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 60, "STOP_DATE": 164.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": "6", "PRESCRIBED_DOSE": "140", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "840", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 213, "STOP_DATE": 258.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "33", "RADIATION_DOSAGE": "6100", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-BH-A0C1": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "d10a4887-373b-4726-a61d-126f950e4a06", "AGE": 61, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 1339.0, "DAYS_TO_BIRTH": -22377.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "8/11/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N2A", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 46.38853273, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 46.38853273, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 36.92014334, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 36.92014334, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A0C1-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 19.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3007, "MSI_SENSOR_SCORE": 0.08, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.066666667, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 46.0 }, "treatments": [ { "START_DATE": 119, "STOP_DATE": 1167.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Clinical Progressive Disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 119, "STOP_DATE": 1167.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Clinical Progressive Disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 84, "STOP_DATE": 101.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Radiographic Progressive Disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Distant Recurrence", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "14", "RADIATION_DOSAGE": "3500", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-PL-A8LV": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "389E5B18-8F89-41A9-9FA5-EFD4172836E2", "AGE": 54, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIB", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": -7.0, "DAYS_TO_BIRTH": -19746.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/25/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8510/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T4", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "No", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": null, "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 0.0, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 0.0, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 0.0, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-PL-A8LV-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Medullary Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "PL", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 24.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3512, "MSI_SENSOR_SCORE": 0.21, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 3.233333333, "TISSUE_SOURCE_SITE": "Institute of Human Virology Nigeria", "TBL_SCORE": 85.0 }, "treatments": [] }, "TCGA-A7-A26G": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "5ed024e8-d05e-4c65-9441-eda9930ccc82", "AGE": 50, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 722.0, "DAYS_TO_BIRTH": -18362.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "8/10/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8575/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I+)", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 23.73672617, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 23.73672617, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 23.73672617, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 23.73672617, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-A7-A26G-01", "ONCOTREE_CODE": "BRCNOS", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Carcinoma (NOS)", "TUMOR_TYPE": "Other", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "A7", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 10.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3251, "MSI_SENSOR_SCORE": 0.77, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.5, "TISSUE_SOURCE_SITE": "Christiana Healthcare", "TBL_SCORE": 417.0 }, "treatments": [ { "START_DATE": 89, "STOP_DATE": 152.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "160-168", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "648", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 89, "STOP_DATE": 152.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "1308-1344", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "5292", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-A7-A5ZX": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "BA80DB4E-D899-4DA4-AE49-5263D98E1530", "AGE": 48, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIC", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 336.0, "DAYS_TO_BIRTH": -17683.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/13/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N3A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 11.04645429, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 11.04645429, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 11.04645429, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A7-A5ZX-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "A7", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 3.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2904, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.066666667, "TISSUE_SOURCE_SITE": "Christiana Healthcare", "TBL_SCORE": 28.0 }, "treatments": [ { "START_DATE": 76, "STOP_DATE": 118.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 76, "STOP_DATE": 118.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 132, "STOP_DATE": 174.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 268, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 227, "STOP_DATE": 263.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "28", "RADIATION_DOSAGE": "5040", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" }, { "START_DATE": 227, "STOP_DATE": 263.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 2", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "28", "RADIATION_DOSAGE": "5040", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-A2-A0CR": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "4CF0F639-7940-48B6-8EA1-2A3494097CDB", "AGE": 54, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 3283.0, "DAYS_TO_BIRTH": -20075.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "6/5/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Asian", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 107.9330638, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 107.9330638, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 107.9330638, "GENETIC_ANCESTRY_LABEL": "EAS" }, "sample": { "SAMPLE_ID": "TCGA-A2-A0CR-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 6.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2975, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 4.5, "TISSUE_SOURCE_SITE": "Walter Reed", "TBL_SCORE": 11.0 }, "treatments": [ { "START_DATE": 105, "STOP_DATE": 147.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 105, "STOP_DATE": 147.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 140, "STOP_DATE": 203.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 224, "STOP_DATE": 300.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 315, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-B6-A0IP": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "1402082d-25c9-4148-8a1e-f58450b706bb", "AGE": 74, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IA", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": 3374.0, "DAYS_TO_BIRTH": -27047.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "11/2/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": null, "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 129.0725581, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 129.0725581, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 129.0725581, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 129.0725581, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-B6-A0IP-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "B6", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 2.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": NaN, "MSI_SENSOR_SCORE": 0.01, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.2, "TISSUE_SOURCE_SITE": "Duke", "TBL_SCORE": 7.0 }, "treatments": [] }, "TCGA-D8-A1JI": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "baf2afc8-f16c-488f-947c-efc9083c6bef", "AGE": 54, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 577.0, "DAYS_TO_BIRTH": -20072.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/30/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 18.96965513, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 18.96965513, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 18.96965513, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 18.96965513, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D8-A1JI-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "D8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 9.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3136, "MSI_SENSOR_SCORE": 0.29, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.8, "TISSUE_SOURCE_SITE": "Greater Poland Cancer Center", "TBL_SCORE": 69.0 }, "treatments": [ { "START_DATE": 41, "STOP_DATE": 162.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "6", "PRESCRIBED_DOSE": "2.5", "PRESCRIBED_DOSE_UNITS": "mg/m2/day", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 41, "STOP_DATE": 162.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 41, "STOP_DATE": 162.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Letrozole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 204, "STOP_DATE": 231.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "20", "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-BH-A2L8": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "BAC4B268-C781-4408-96D8-43A48FEC7418", "AGE": 45, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 612.0, "DAYS_TO_BIRTH": -16658.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/27/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 20.12032745, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 20.12032745, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 20.12032745, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 20.12032745, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A2L8-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 4.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3232, "MSI_SENSOR_SCORE": 0.05, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 14.26666667, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 2.0 }, "treatments": [ { "START_DATE": 136, "STOP_DATE": 197.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-JL-A3YX": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "75F6E476-233A-409C-A3EF-0240BE569813", "AGE": 46, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 352.0, "DAYS_TO_BIRTH": NaN, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "11/8/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Asian", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 11.57247592, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 11.57247592, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 11.57247592, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 11.57247592, "GENETIC_ANCESTRY_LABEL": "SAS_ADMIX" }, "sample": { "SAMPLE_ID": "TCGA-JL-A3YX-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "JL", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 15.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3019, "MSI_SENSOR_SCORE": 0.04, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.966666667, "TISSUE_SOURCE_SITE": "ABS - Research Metrics Pakistan", "TBL_SCORE": 20.0 }, "treatments": [] }, "TCGA-D8-A1XY": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "0130d616-885e-4a6c-9d03-2f17dd692a05", "AGE": 74, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 503.0, "DAYS_TO_BIRTH": -27106.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "6/9/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 16.53680508, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 16.53680508, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 16.53680508, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D8-A1XY-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "D8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 25.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.295, "MSI_SENSOR_SCORE": 0.21, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.433333333, "TISSUE_SOURCE_SITE": "Greater Poland Cancer Center", "TBL_SCORE": 84.0 }, "treatments": [ { "START_DATE": 421, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "20", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-A2-A0CL": { "demographics": { "SUBTYPE": "BRCA_Normal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "5c8983f2-9788-4dfa-971c-3ec457b6166e", "AGE": 37, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 3015.0, "DAYS_TO_BIRTH": -13556.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "1/28/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N2A", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 99.1222014, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 99.1222014, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 99.1222014, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-A2-A0CL-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 25.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2896, "MSI_SENSOR_SCORE": 0.13, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 4.433333333, "TISSUE_SOURCE_SITE": "Walter Reed", "TBL_SCORE": 248.0 }, "treatments": [ { "START_DATE": 269, "STOP_DATE": 504.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "10", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "4", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 69, "STOP_DATE": 112.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "1020", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "4080", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 752, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Other", "TREATMENT_SUBTYPE": "Bisphosphonate Therapy", "AGENT": "Zoledronic Acid", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "4", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "6", "REGIMEN_INDICATION": "Other", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 505, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "5", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 69, "STOP_DATE": 112.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "102", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "3", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "408", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 126, "STOP_DATE": 168.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "230-298", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "1006", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 126, "STOP_DATE": 168.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Gemcitabine", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": "Antimetabolite", "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 206, "STOP_DATE": 255.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "61", "RADIATION_DOSAGE": "11080", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-BH-A0HO": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "8332806e-f547-4aae-89af-6d5bec831fd2", "AGE": 48, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": 76.0, "DAYS_TO_BIRTH": -17710.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "11/11/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 2.498602755, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 2.498602755, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 2.498602755, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 2.498602755, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A0HO-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 2.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2619, "MSI_SENSOR_SCORE": 0.01, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.466666667, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 3.0 }, "treatments": [ { "START_DATE": 119, "STOP_DATE": 182.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "860", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "3440", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 210, "STOP_DATE": 287.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": "12", "PRESCRIBED_DOSE": "115", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "1380", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 119, "STOP_DATE": 182.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "86", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "344", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 378, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "20", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 312, "STOP_DATE": 369.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "33", "RADIATION_DOSAGE": "6060", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-A2-A0SU": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "c632675e-e8af-43cd-8744-5be3754c1c14", "AGE": 66, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": 1662.0, "DAYS_TO_BIRTH": -24219.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "11/17/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I+)", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 54.64049709, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 54.64049709, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 54.64049709, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 54.64049709, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A2-A0SU-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 4.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2844, "MSI_SENSOR_SCORE": 0.04, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.066666667, "TISSUE_SOURCE_SITE": "Walter Reed", "TBL_SCORE": 38.0 }, "treatments": [ { "START_DATE": 93, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-A7-A0D9": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "17baef7c-d97d-4b98-ab53-503ef856523d", "AGE": 37, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": 1139.0, "DAYS_TO_BIRTH": -13836.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "10/4/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 37.44616497, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 37.44616497, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 37.44616497, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 37.44616497, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A7-A0D9-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "A7", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 7.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2619, "MSI_SENSOR_SCORE": 0.34, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.333333333, "TISSUE_SOURCE_SITE": "Christiana Healthcare", "TBL_SCORE": 132.0 }, "treatments": [ { "START_DATE": 157, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "20", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": "4140", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 62, "STOP_DATE": 125.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "1080", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "4320", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 62, "STOP_DATE": 125.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "140", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "560", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-GM-A3NW": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "6DDAEE34-46EB-490C-BD13-F0AB963C4322", "AGE": 63, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 3361.0, "DAYS_TO_BIRTH": -23041.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "1/3/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 110.4974192, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 110.4974192, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 110.4974192, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 110.4974192, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-GM-A3NW-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "GM", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 7.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3265, "MSI_SENSOR_SCORE": 0.06, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.7, "TISSUE_SOURCE_SITE": "MD Anderson", "TBL_SCORE": 62.0 }, "treatments": [ { "START_DATE": 205, "STOP_DATE": 2055.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Stable Disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 65, "STOP_DATE": 181.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Fluorouracil", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Stable Disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 65, "STOP_DATE": 181.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Stable Disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 65, "STOP_DATE": 181.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Epirubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Stable Disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-A2-A3XX": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "53886143-C1C6-40E9-88E6-E4E5E0271FC8", "AGE": 49, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 1168.0, "DAYS_TO_BIRTH": -17981.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "8/15/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 47.30907059, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 47.30907059, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 47.30907059, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 47.30907059, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-A2-A3XX-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "A2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 23.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3153, "MSI_SENSOR_SCORE": 0.21, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.1, "TISSUE_SOURCE_SITE": "Walter Reed", "TBL_SCORE": 76.0 }, "treatments": [ { "START_DATE": 80, "STOP_DATE": 129.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 80, "STOP_DATE": 129.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 143, "STOP_DATE": 185.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-HN-A2NL": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "124B693C-77DC-4FA8-B703-54E8B5054A92", "AGE": 56, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 79.0, "DAYS_TO_BIRTH": -20483.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "5/30/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": null, "RADIATION_THERAPY": null, "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 2.597231811, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 2.597231811, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 2.597231811, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 2.597231811, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-HN-A2NL-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "HN", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 11.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3496, "MSI_SENSOR_SCORE": 2.05, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.433333333, "TISSUE_SOURCE_SITE": "Ontario Institute for Cancer Research (OICR)", "TBL_SCORE": 68.0 }, "treatments": [ { "START_DATE": 59, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 59, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-BH-A0B8": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "d3a75976-67d3-40fa-9f6f-cf2a3d7b773c", "AGE": 64, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE I", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": 1569.0, "DAYS_TO_BIRTH": -23380.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "11/3/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T1B", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "0:LIVING", "OS_MONTHS": 51.58299635, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 51.58299635, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 51.58299635, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 51.58299635, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A0B8-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": NaN, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2567, "MSI_SENSOR_SCORE": 1.28, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 4.0, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 54.0 }, "treatments": [ { "START_DATE": 114, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 63, "STOP_DATE": 114.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "36", "RADIATION_DOSAGE": "6640", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-A2-A0EV": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "7032ec9c-e96b-4642-a7b6-d0aee7a3add2", "AGE": 80, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 968.0, "DAYS_TO_BIRTH": -29285.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "8/11/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 31.82430878, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 31.82430878, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 31.82430878, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 31.82430878, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A2-A0EV-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 15.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3283, "MSI_SENSOR_SCORE": 0.2, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.1, "TISSUE_SOURCE_SITE": "Walter Reed", "TBL_SCORE": 85.0 }, "treatments": [] }, "TCGA-E9-A1R7": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "2680da86-c977-4611-b75f-df015283c023", "AGE": 64, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 1467.0, "DAYS_TO_BIRTH": -23397.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/28/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 48.22960844, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 48.22960844, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 48.22960844, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 48.22960844, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E9-A1R7-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "E9", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 13.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3563, "MSI_SENSOR_SCORE": 0.96, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.566666667, "TISSUE_SOURCE_SITE": "Asterand", "TBL_SCORE": 269.0 }, "treatments": [ { "START_DATE": 25, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Toremifene", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "60", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 53, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 50, "STOP_DATE": 76.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "25", "RADIATION_DOSAGE": "5000", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-A2-A25C": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "7aedb46a-48ec-4e0e-8baa-c9ea4c4a7cf1", "AGE": 50, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 523.0, "DAYS_TO_BIRTH": -18508.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/15/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 17.19433212, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 17.19433212, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 17.19433212, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 17.19433212, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A2-A25C-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "A2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 10.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.333, "MSI_SENSOR_SCORE": 0.98, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.133333333, "TISSUE_SOURCE_SITE": "Walter Reed", "TBL_SCORE": 65.0 }, "treatments": [ { "START_DATE": 108, "STOP_DATE": 193.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "5", "PRESCRIBED_DOSE": "87", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "435", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 108, "STOP_DATE": 193.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": "5", "PRESCRIBED_DOSE": "130", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "3", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "650", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 108, "STOP_DATE": 193.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "5", "PRESCRIBED_DOSE": "870", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "4350", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 292, "STOP_DATE": 325.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "20", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "4", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 325, "STOP_DATE": 475.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Letrozole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "2.5", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "5", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 476, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Exemestane", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "25", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "6", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 276, "STOP_DATE": 285.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "33", "RADIATION_DOSAGE": "6000", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" }, { "START_DATE": 234, "STOP_DATE": 287.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 2", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "28", "RADIATION_DOSAGE": "5040", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" }, { "START_DATE": 234, "STOP_DATE": 271.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 3", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "25", "RADIATION_DOSAGE": "4500", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-C8-A26Y": { "demographics": { "SUBTYPE": "BRCA_Her2", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "4d51159f-ab2f-40e3-a363-847c3654431e", "AGE": 90, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 394.0, "DAYS_TO_BIRTH": -32872.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/21/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "No", "PRIOR_DX": "No", "RACE": "Asian", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 12.9532827, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 12.9532827, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 12.9532827, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 12.9532827, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-C8-A26Y-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "C8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 20.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3403, "MSI_SENSOR_SCORE": 0.57, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 21.36666667, "TISSUE_SOURCE_SITE": "ILSBio", "TBL_SCORE": 260.0 }, "treatments": [] }, "TCGA-A2-A0ET": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "96f23d8a-be0f-4925-ba00-805dc293414c", "AGE": 58, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 1066.0, "DAYS_TO_BIRTH": -21464.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/20/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N2A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 35.04619128, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 35.04619128, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 35.04619128, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 35.04619128, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A2-A0ET-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 22.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2854, "MSI_SENSOR_SCORE": 0.64, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.433333333, "TISSUE_SOURCE_SITE": "Walter Reed", "TBL_SCORE": 31.0 }, "treatments": [ { "START_DATE": 183, "STOP_DATE": 225.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "341-342", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "1367", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 101, "STOP_DATE": 169.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "114-117", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "3", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "464", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 282, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1 mg daily", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "4", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 101, "STOP_DATE": 169.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "1140-1170", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "4650", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-D8-A1JF": { "demographics": { "SUBTYPE": "BRCA_Her2", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "dcd5e079-813a-4c1a-b320-0931468d2bbc", "AGE": 79, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 366.0, "DAYS_TO_BIRTH": -29199.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/28/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N2A", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 12.03274485, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 12.03274485, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 12.03274485, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 12.03274485, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D8-A1JF-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "D8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 24.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3033, "MSI_SENSOR_SCORE": 0.19, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.366666667, "TISSUE_SOURCE_SITE": "Greater Poland Cancer Center", "TBL_SCORE": 90.0 }, "treatments": [] }, "TCGA-PL-A8LZ": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "9087585F-E792-4F33-BAAA-56FFE0F745BE", "AGE": 29, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIB", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 302.0, "DAYS_TO_BIRTH": -10869.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/5/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N2", "PATH_T_STAGE": "T4B", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 9.928658316, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 9.928658316, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 9.928658316, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-PL-A8LZ-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "PL", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 21.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3284, "MSI_SENSOR_SCORE": 0.03, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.7, "TISSUE_SOURCE_SITE": "Institute of Human Virology Nigeria", "TBL_SCORE": 136.0 }, "treatments": [ { "START_DATE": 4, "STOP_DATE": 48.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-AC-A2B8": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "6E126B73-D3E8-4641-A128-306F3B313E40", "AGE": 84, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 677.0, "DAYS_TO_BIRTH": -31003.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/12/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 22.25729033, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 22.25729033, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 22.25729033, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 21.50113423, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AC-A2B8-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "AC", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 3.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3158, "MSI_SENSOR_SCORE": 0.54, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.766666667, "TISSUE_SOURCE_SITE": "International Genomics Consortium", "TBL_SCORE": 28.0 }, "treatments": [ { "START_DATE": 135, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Chemo, NOS", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 80, "STOP_DATE": 122.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-A2-A1FW": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "54883111-d475-4515-ba3f-fece8a71e79e", "AGE": 62, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 528.0, "DAYS_TO_BIRTH": -22779.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/11/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N2A", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 17.35871388, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 17.35871388, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 17.35871388, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 17.35871388, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A2-A1FW-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "A2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 21.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3305, "MSI_SENSOR_SCORE": 0.89, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.033333333, "TISSUE_SOURCE_SITE": "Walter Reed", "TBL_SCORE": 441.0 }, "treatments": [ { "START_DATE": 175, "STOP_DATE": 245.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 65, "STOP_DATE": 154.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 65, "STOP_DATE": 154.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": "3", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 364, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Letrozole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "2.5", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "4", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 277, "STOP_DATE": 324.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "52", "RADIATION_DOSAGE": "18120", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-BH-A18S": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "433427a1-bacf-4381-91ba-5fec8a0953f9", "AGE": 79, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE I", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": NaN, "DAYS_TO_BIRTH": -28974.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/2/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.3", "ICD_O_3_HISTOLOGY": "8523/3", "ICD_O_3_SITE": "C50.3", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": null, "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 66.04859125, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 66.04859125, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 66.04859125, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 66.04859125, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A18S-01", "ONCOTREE_CODE": "IMMC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Mixed Mucinous Carcinoma", "TUMOR_TYPE": "Mucinous Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 4.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2594, "MSI_SENSOR_SCORE": 0.17, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.866666667, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 58.0 }, "treatments": [] }, "TCGA-BH-A18V": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "6b960b58-28e1-41c6-bd6e-7e669c6aa4ef", "AGE": 48, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "5TH", "DAYS_LAST_FOLLOWUP": NaN, "DAYS_TO_BIRTH": -17682.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/2/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.4", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.4", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1B", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": null, "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 51.15560377, "DSS_STATUS": null, "DSS_MONTHS": 51.15560377, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 51.15560377, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 51.15560377, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A18V-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 16.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2785, "MSI_SENSOR_SCORE": 1.38, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 5.933333333, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 366.0 }, "treatments": [] }, "TCGA-C8-A12U": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "97b5f490-1cd9-4833-b903-5f4c6e45670d", "AGE": 46, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 385.0, "DAYS_TO_BIRTH": -17045.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/13/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Asian", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 12.65739554, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 12.65739554, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 12.65739554, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 12.65739554, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-C8-A12U-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "C8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 18.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2795, "MSI_SENSOR_SCORE": 0.73, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.5, "TISSUE_SOURCE_SITE": "ILSBio", "TBL_SCORE": 397.0 }, "treatments": [] }, "TCGA-OL-A66I": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "35BD694D-1DD2-466F-AB27-03320614B40E", "AGE": 36, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 714.0, "DAYS_TO_BIRTH": -13458.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "6/11/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N1MI", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 23.47371536, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 23.47371536, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 23.47371536, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 23.47371536, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-OL-A66I-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "OL", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 21.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3071, "MSI_SENSOR_SCORE": 0.01, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.3, "TISSUE_SOURCE_SITE": "University of Chicago", "TBL_SCORE": 301.0 }, "treatments": [ { "START_DATE": 43, "STOP_DATE": 312.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 43, "STOP_DATE": 312.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 43, "STOP_DATE": 312.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 239, "STOP_DATE": 285.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": "5041", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-E9-A54X": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "3DBC8D60-3A97-47B2-91D0-C18FB46B4365", "AGE": 85, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 727.0, "DAYS_TO_BIRTH": -31173.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "6/21/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8480/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T1B", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "0:LIVING", "OS_MONTHS": 23.90110793, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 23.90110793, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 23.90110793, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 23.90110793, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E9-A54X-01", "ONCOTREE_CODE": "IMMC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Mixed Mucinous Carcinoma", "TUMOR_TYPE": "Mucinous Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "E9", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 9.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2851, "MSI_SENSOR_SCORE": 0.02, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.0, "TISSUE_SOURCE_SITE": "Asterand", "TBL_SCORE": 29.0 }, "treatments": [] }, "TCGA-BH-A0W3": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "3c612e12-6de8-44fa-a095-805c45474821", "AGE": 58, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 728.0, "DAYS_TO_BIRTH": -21369.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "2/14/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 23.93398429, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 23.93398429, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 23.93398429, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A0W3-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 17.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2659, "MSI_SENSOR_SCORE": 0.33, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.466666667, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 35.0 }, "treatments": [ { "START_DATE": 63, "STOP_DATE": 98.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": "46", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "gy" }, { "START_DATE": 63, "STOP_DATE": 96.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 2", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": "46", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "gy" } ] }, "TCGA-D8-A1XO": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "6a186809-3422-41d0-83d2-867145830936", "AGE": 56, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 1682.0, "DAYS_TO_BIRTH": -20606.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/16/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 55.29802413, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 55.29802413, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 55.29802413, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 55.29802413, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D8-A1XO-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "D8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 7.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3015, "MSI_SENSOR_SCORE": 0.02, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.466666667, "TISSUE_SOURCE_SITE": "Greater Poland Cancer Center", "TBL_SCORE": 22.0 }, "treatments": [ { "START_DATE": 93, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 93, "STOP_DATE": 119.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "25", "RADIATION_DOSAGE": "4500", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-BH-A0W5": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "da9c10ea-c13f-4d88-8b94-a0cbc106d036", "AGE": 77, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 1288.0, "DAYS_TO_BIRTH": -28304.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "2/15/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 42.34474143, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 42.34474143, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 42.34474143, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 42.34474143, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A0W5-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 6.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2784, "MSI_SENSOR_SCORE": 0.01, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.866666667, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 1.0 }, "treatments": [ { "START_DATE": 22, "STOP_DATE": 144.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 113, "STOP_DATE": 144.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-AR-A0TW": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "8da3d6cf-381b-4d1b-93fa-41fd9d2b2e66", "AGE": 50, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": 3009.0, "DAYS_TO_BIRTH": -18263.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/10/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 98.92494329, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 98.92494329, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 24.29562416, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 24.29562416, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AR-A0TW-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AR", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 16.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2729, "MSI_SENSOR_SCORE": 0.2, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.6, "TISSUE_SOURCE_SITE": "Mayo", "TBL_SCORE": 436.0 }, "treatments": [ { "START_DATE": 125, "STOP_DATE": 167.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "175", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "1200", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 62, "STOP_DATE": 111.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "60", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "400", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 62, "STOP_DATE": 111.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "600", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "4050", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-OK-A5Q2": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "CD7FB75E-1C2E-4201-86D3-B3BA21F476BF", "AGE": 59, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 64.0, "DAYS_TO_BIRTH": -21555.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "1/22/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": null, "RADIATION_THERAPY": null, "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 2.104086531, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 2.104086531, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 2.104086531, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 2.104086531, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-OK-A5Q2-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "OK", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 3.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2873, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.866666667, "TISSUE_SOURCE_SITE": "Mount Sinai School of Medicine", "TBL_SCORE": 69.0 }, "treatments": [] }, "TCGA-A2-A0YH": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "298d33da-15af-48cb-b30f-eaf54e7baa43", "AGE": 53, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": 659.0, "DAYS_TO_BIRTH": -19596.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/14/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N2A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 21.66551599, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 21.66551599, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 21.66551599, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 21.66551599, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A2-A0YH-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 17.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3021, "MSI_SENSOR_SCORE": 0.26, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.266666667, "TISSUE_SOURCE_SITE": "Walter Reed", "TBL_SCORE": 109.0 }, "treatments": [ { "START_DATE": 74, "STOP_DATE": 179.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": "6", "PRESCRIBED_DOSE": "138", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "828", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 60, "STOP_DATE": 60.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "1", "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 74, "STOP_DATE": 179.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "6", "PRESCRIBED_DOSE": "1100", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "3", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "6600", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 214, "STOP_DATE": 264.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "33", "RADIATION_DOSAGE": "5940", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-A2-A0ST": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "12d31787-e54d-4729-ace8-9141043c92b8", "AGE": 62, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 3017.0, "DAYS_TO_BIRTH": -22922.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "11/9/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 99.18795411, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 99.18795411, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 99.18795411, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 99.18795411, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A2-A0ST-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": NaN, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.261, "MSI_SENSOR_SCORE": 0.01, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.5, "TISSUE_SOURCE_SITE": "Walter Reed", "TBL_SCORE": 32.0 }, "treatments": [ { "START_DATE": 287, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "5", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 44, "STOP_DATE": 85.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "98", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "392", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 85, "STOP_DATE": 155.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "287", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "3", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "1148", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 251, "STOP_DATE": 286.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Letrozole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "2.5", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "4", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 495, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "20", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "6", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 44, "STOP_DATE": 85.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "984", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "3936", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 190, "STOP_DATE": 233.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": "5040", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" }, { "START_DATE": 190, "STOP_DATE": 233.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 2", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": "5040", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" }, { "START_DATE": 236, "STOP_DATE": 240.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 3", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": "1000", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-A8-A09C": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "80f3f48a-cc21-415c-b181-c77e7ba1c563", "AGE": 69, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE X", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 31.0, "DAYS_TO_BIRTH": -25355.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "5/27/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "Yes", "RACE": null, "RADIATION_THERAPY": null, "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 1.019166913, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 1.019166913, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 1.019166913, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A8-A09C-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 19.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2644, "MSI_SENSOR_SCORE": 1.23, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.8, "TISSUE_SOURCE_SITE": "Indivumed", "TBL_SCORE": 214.0 }, "treatments": [] }, "TCGA-E2-A14V": { "demographics": { "SUBTYPE": "BRCA_Her2", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "3144f1fb-4342-4079-bfe8-940da4bfd88e", "AGE": 53, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 1042.0, "DAYS_TO_BIRTH": -19643.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/6/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 34.25715883, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 34.25715883, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 34.25715883, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 34.25715883, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E2-A14V-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "E2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 17.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2924, "MSI_SENSOR_SCORE": 0.26, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 3.666666667, "TISSUE_SOURCE_SITE": "Roswell Park", "TBL_SCORE": 293.0 }, "treatments": [ { "START_DATE": 55, "STOP_DATE": 97.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "1128", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "4512", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 55, "STOP_DATE": 97.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "112", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "448", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 118, "STOP_DATE": 195.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "152", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "1499", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 304, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "3", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 118, "STOP_DATE": 468.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Lapatinib", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1500", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "571500", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 253, "STOP_DATE": 303.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "36", "RADIATION_DOSAGE": "6640", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-E2-A10A": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "4da7abaf-ac7a-41c0-8033-5780a398545c", "AGE": 41, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 1229.0, "DAYS_TO_BIRTH": -15085.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "2/11/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 40.40503666, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 40.40503666, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 2.465726403, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 2.465726403, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-E2-A10A-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "E2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 6.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2721, "MSI_SENSOR_SCORE": 0.26, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.733333333, "TISSUE_SOURCE_SITE": "Roswell Park", "TBL_SCORE": 239.0 }, "treatments": [ { "START_DATE": 88, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Goserelin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "3.6", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "SC", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": "3.6", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 91, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "20", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 148, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Targeted Molecular Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Zoledronic Acid", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "4", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Progression", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 102, "STOP_DATE": 102.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Distant Recurrence", "COURSE_NUMBER": 2.0, "NUMBER_OF_FRACTIONS": "1", "RADIATION_DOSAGE": "2200", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Other", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" }, { "START_DATE": 119, "STOP_DATE": 130.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 2", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Distant Recurrence", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "5", "RADIATION_DOSAGE": "3000", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Other", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-EW-A1IX": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "e8614b7d-132e-4b4e-b1ae-df8bb4f2d4d4", "AGE": 48, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 1208.0, "DAYS_TO_BIRTH": -17597.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Hispanic Or Latino", "FORM_COMPLETION_DATE": "6/10/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8524/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T1B", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Asian", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 39.71463326, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 39.71463326, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 39.71463326, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 39.71463326, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-EW-A1IX-01", "ONCOTREE_CODE": "BRCNOS", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Carcinoma (NOS)", "TUMOR_TYPE": "Other", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "EW", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 3.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3778, "MSI_SENSOR_SCORE": 0.24, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.066666667, "TISSUE_SOURCE_SITE": "University of Miami", "TBL_SCORE": 36.0 }, "treatments": [ { "START_DATE": 871, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Letrozole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "2.5", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-BH-AB28": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "09D6E904-7184-4788-8A19-04F8C46CB13F", "AGE": 53, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 287.0, "DAYS_TO_BIRTH": -19570.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "6/30/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 9.435513036, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 9.435513036, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 9.435513036, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 9.435513036, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BH-AB28-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 4.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3199, "MSI_SENSOR_SCORE": 0.01, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.766666667, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 16.0 }, "treatments": [ { "START_DATE": 122, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 122, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-A2-A4S2": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "9DDC014D-9A8B-407B-845F-452A73F08E5E", "AGE": 62, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 643.0, "DAYS_TO_BIRTH": -22936.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "2/28/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8524/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N2", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 21.13949436, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 21.13949436, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 21.13949436, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 21.13949436, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A2-A4S2-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "A2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 13.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2957, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.9, "TISSUE_SOURCE_SITE": "Walter Reed", "TBL_SCORE": 23.0 }, "treatments": [ { "START_DATE": 47, "STOP_DATE": 96.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 47, "STOP_DATE": 96.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 110, "STOP_DATE": 173.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 261, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 224, "STOP_DATE": 260.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "25", "RADIATION_DOSAGE": "4500", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" }, { "START_DATE": 224, "STOP_DATE": 260.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 2", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "25", "RADIATION_DOSAGE": "4500", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" }, { "START_DATE": 261, "STOP_DATE": 271.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 3", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "7", "RADIATION_DOSAGE": "1400", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-AO-A0J2": { "demographics": { "SUBTYPE": "BRCA_Her2", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "d2f2560c-ec80-4fea-9474-c47a2e85ea95", "AGE": 41, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IA", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": 997.0, "DAYS_TO_BIRTH": -15324.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/19/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 32.77772298, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 32.77772298, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 32.77772298, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 32.77772298, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AO-A0J2-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AO", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 9.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2894, "MSI_SENSOR_SCORE": 1.15, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.766666667, "TISSUE_SOURCE_SITE": "MSKCC", "TBL_SCORE": 298.0 }, "treatments": [ { "START_DATE": 120, "STOP_DATE": 162.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "175", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "1040", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 64, "STOP_DATE": 106.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "60", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "360", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 64, "STOP_DATE": 106.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "600", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "3600", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-E9-A1R6": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "4842bac3-abaa-4900-871f-f2c3ba6457f5", "AGE": 63, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 339.0, "DAYS_TO_BIRTH": -23347.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/28/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 11.14508334, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 11.14508334, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 11.14508334, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 11.14508334, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E9-A1R6-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "E9", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 21.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3151, "MSI_SENSOR_SCORE": 0.43, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.933333333, "TISSUE_SOURCE_SITE": "Asterand", "TBL_SCORE": 161.0 }, "treatments": [ { "START_DATE": 66, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "20", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 96, "STOP_DATE": 125.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "23", "RADIATION_DOSAGE": "4600", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-BH-A18U": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "233b02f3-c4f0-4a67-9db5-e68d5cdaccb6", "AGE": 72, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": NaN, "DAYS_TO_BIRTH": -26426.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/2/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.4", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.4", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N2A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": null, "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 51.38573824, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 51.38573824, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 51.38573824, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 51.38573824, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A18U-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 24.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2674, "MSI_SENSOR_SCORE": 1.48, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 4.133333333, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 527.0 }, "treatments": [] }, "TCGA-A7-A2KD": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "92654F8D-5137-4FFD-AAA3-5AE38EB88226", "AGE": 53, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 679.0, "DAYS_TO_BIRTH": -19563.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "10/11/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N2A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "Yes", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 22.32304304, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 22.32304304, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 22.32304304, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 22.32304304, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-A7-A2KD-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "A7", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 17.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3212, "MSI_SENSOR_SCORE": 0.11, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.033333333, "TISSUE_SOURCE_SITE": "Christiana Healthcare", "TBL_SCORE": 268.0 }, "treatments": [ { "START_DATE": 57, "STOP_DATE": 161.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": "6", "PRESCRIBED_DOSE": "170", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "1020", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 118, "STOP_DATE": 161.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": "3", "PRESCRIBED_DOSE": "810", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "2430", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 57, "STOP_DATE": 97.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "3", "PRESCRIBED_DOSE": "1370", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "4110", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 57, "STOP_DATE": 435.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Targeted Molecular Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Trastuzumab", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 196, "STOP_DATE": 235.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "28", "RADIATION_DOSAGE": "5040", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-AN-A0AL": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "3e9f93c0-aa79-4b4c-bd6c-b3325912362a", "AGE": 41, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIB", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 227.0, "DAYS_TO_BIRTH": -15286.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/21/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T4", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 7.462931913, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 7.462931913, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 7.462931913, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 7.462931913, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AN-A0AL-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AN", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 6.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3054, "MSI_SENSOR_SCORE": 0.87, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.666666667, "TISSUE_SOURCE_SITE": "Cureline", "TBL_SCORE": 196.0 }, "treatments": [] }, "TCGA-BH-A6R9": { "demographics": { "SUBTYPE": "BRCA_Normal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "43CC074D-B85A-4B0B-8FEB-833094FFC565", "AGE": 61, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 160.0, "DAYS_TO_BIRTH": -22325.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "2/13/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8575/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 5.260216326, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 5.260216326, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 5.260216326, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 5.260216326, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A6R9-01", "ONCOTREE_CODE": "MBC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Metaplastic Breast Cancer", "TUMOR_TYPE": "Metaplastic Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.332, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.466666667, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 5.0 }, "treatments": [] }, "TCGA-E9-A2JT": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "B35FBE19-0E6D-427E-B9BE-EE3527B5FCA6", "AGE": 63, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 288.0, "DAYS_TO_BIRTH": -23318.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/20/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 9.468389388, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 9.468389388, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 9.468389388, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 9.468389388, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E9-A2JT-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "E9", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3161, "MSI_SENSOR_SCORE": 0.08, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.7, "TISSUE_SOURCE_SITE": "Asterand", "TBL_SCORE": 2.0 }, "treatments": [ { "START_DATE": 27, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 58, "STOP_DATE": 87.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "23", "RADIATION_DOSAGE": "46", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "gy" } ] }, "TCGA-AN-A0XU": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "a1da9db1-db11-4f4d-a249-c738db81b87e", "AGE": 54, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 10.0, "DAYS_TO_BIRTH": -20052.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/28/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 0.32876352, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 0.32876352, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 0.32876352, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 0.32876352, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AN-A0XU-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AN", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 10.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3016, "MSI_SENSOR_SCORE": 1.04, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 3.833333333, "TISSUE_SOURCE_SITE": "Cureline", "TBL_SCORE": 341.0 }, "treatments": [] }, "TCGA-A8-A08J": { "demographics": { "SUBTYPE": "BRCA_Her2", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "68177e92-4784-45d9-af14-4ce0c00eae74", "AGE": 52, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": NaN, "DAYS_TO_BIRTH": -19266.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "5/27/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8541/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M1", "PATH_N_STAGE": "N3", "PATH_T_STAGE": "T4B", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": null, "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 37.05164875, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 37.05164875, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 37.05164875, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A8-A08J-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 16.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.271, "MSI_SENSOR_SCORE": 0.49, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.2, "TISSUE_SOURCE_SITE": "Indivumed", "TBL_SCORE": 383.0 }, "treatments": [] }, "TCGA-A2-A04Y": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "9ce7ce09-4409-4fa3-9f78-b2b24716f860", "AGE": 53, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 1099.0, "DAYS_TO_BIRTH": -19533.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "8/9/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1MI", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 36.13111089, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 36.13111089, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 36.13111089, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 36.13111089, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A2-A04Y-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 4.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.293, "MSI_SENSOR_SCORE": 0.1, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.6, "TISSUE_SOURCE_SITE": "Walter Reed", "TBL_SCORE": 171.0 }, "treatments": [ { "START_DATE": 93, "STOP_DATE": 135.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "1200", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "4800", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 503, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Other", "TREATMENT_SUBTYPE": "Bisphosphonate Therapy", "AGENT": "Zoledronic Acid", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "4", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "7", "REGIMEN_INDICATION": "Other", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 273, "STOP_DATE": 371.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "10", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "5", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 93, "STOP_DATE": 135.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "120", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "480", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 149, "STOP_DATE": 226.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": "12", "PRESCRIBED_DOSE": "160-165", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "3", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "3900", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 149, "STOP_DATE": 659.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Targeted Molecular Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Trastuzumab", "NUMBER_OF_CYCLES": "22", "PRESCRIBED_DOSE": "170-600", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "4", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "10037", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 372, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "6", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 293, "STOP_DATE": 297.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": "1000", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" }, { "START_DATE": 251, "STOP_DATE": 290.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 2", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": "5040", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-E2-A15G": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "271e8024-a008-4bf0-9f6e-177f60096b1b", "AGE": 76, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 554.0, "DAYS_TO_BIRTH": -28013.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/13/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8522/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 18.21349903, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 18.21349903, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 18.21349903, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 18.21349903, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E2-A15G-01", "ONCOTREE_CODE": "BRCNOS", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Carcinoma (NOS)", "TUMOR_TYPE": "Mixed Histology (NOS)", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "E2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 16.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2697, "MSI_SENSOR_SCORE": 0.04, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.7, "TISSUE_SOURCE_SITE": "Roswell Park", "TBL_SCORE": 11.0 }, "treatments": [ { "START_DATE": 125, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": "1", "TOTAL_DOSE_UNITS": "Mg/Day", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 49, "STOP_DATE": 103.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": "6040", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-A1-A0SP": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "a9bb8159-32f0-454c-a946-b3286a52b9d5", "AGE": 40, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 584.0, "DAYS_TO_BIRTH": -14954.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/6/2010", "HISTORY_NEOADJUVANT_TRTYN": null, "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "Yes", "RACE": null, "RADIATION_THERAPY": null, "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 19.19978959, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 19.19978959, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 19.19978959, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 19.19978959, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A1-A0SP-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A1", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 13.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2779, "MSI_SENSOR_SCORE": 0.26, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.7, "TISSUE_SOURCE_SITE": "UCSF", "TBL_SCORE": 170.0 }, "treatments": [ { "START_DATE": 108, "STOP_DATE": 173.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": null, "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 215, "STOP_DATE": 259.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-A8-A092": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "38a8b734-9acc-42f9-b5b7-e51b0dfc6504", "AGE": 48, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 942.0, "DAYS_TO_BIRTH": -17807.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "5/27/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N2A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": null, "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 30.96952362, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 30.96952362, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 30.96952362, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 30.96952362, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A8-A092-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 24.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2734, "MSI_SENSOR_SCORE": 1.22, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.366666667, "TISSUE_SOURCE_SITE": "Indivumed", "TBL_SCORE": 40.0 }, "treatments": [ { "START_DATE": 30, "STOP_DATE": 91.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 30, "STOP_DATE": 153.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Epirubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 30, "STOP_DATE": 153.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 181, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 181, "STOP_DATE": 273.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": "60", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "gy" } ] }, "TCGA-E9-A228": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "b95eef8a-205f-4cf8-9d3c-ae51d406e1e0", "AGE": 58, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 1285.0, "DAYS_TO_BIRTH": -21294.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "8/2/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 42.24611237, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 42.24611237, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 42.24611237, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 42.24611237, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E9-A228-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "E9", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 3.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3505, "MSI_SENSOR_SCORE": 0.39, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.3, "TISSUE_SOURCE_SITE": "Asterand", "TBL_SCORE": 165.0 }, "treatments": [ { "START_DATE": 35, "STOP_DATE": 131.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "900", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "3600", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 35, "STOP_DATE": 131.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "90", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "360", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 287, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "20", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": "2240", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-E2-A3DX": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "31427699-E27A-4035-8925-6D8D6900D097", "AGE": 43, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIC", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 1325.0, "DAYS_TO_BIRTH": -15969.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "1/17/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N3", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "0:LIVING", "OS_MONTHS": 43.56116645, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 43.56116645, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 43.56116645, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E2-A3DX-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "E2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 2.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3153, "MSI_SENSOR_SCORE": 0.01, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.0, "TISSUE_SOURCE_SITE": "Roswell Park", "TBL_SCORE": 4.0 }, "treatments": [ { "START_DATE": 63, "STOP_DATE": 105.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 63, "STOP_DATE": 105.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 119, "STOP_DATE": 196.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 119, "STOP_DATE": 427.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Trastuzumab", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 280, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 218, "STOP_DATE": 262.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "33", "RADIATION_DOSAGE": "6040", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-D8-A1JP": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "752f4773-5a12-4485-a1f6-896e148ddf4d", "AGE": 73, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 639.0, "DAYS_TO_BIRTH": -26862.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/29/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 21.00798895, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 21.00798895, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 21.00798895, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 21.00798895, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D8-A1JP-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "D8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 4.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3315, "MSI_SENSOR_SCORE": 0.26, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 3.366666667, "TISSUE_SOURCE_SITE": "Greater Poland Cancer Center", "TBL_SCORE": 168.0 }, "treatments": [ { "START_DATE": 68, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "20", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-B6-A40C": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "FD0B1B8B-1A76-480A-B61C-D176E4E02C6B", "AGE": 51, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 2164.0, "DAYS_TO_BIRTH": -18852.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/20/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 71.14442582, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 71.14442582, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 71.14442582, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 71.14442582, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-B6-A40C-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "B6", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 8.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2977, "MSI_SENSOR_SCORE": 0.05, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.133333333, "TISSUE_SOURCE_SITE": "Duke", "TBL_SCORE": 22.0 }, "treatments": [ { "START_DATE": 37, "STOP_DATE": 107.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 37, "STOP_DATE": 107.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 128, "STOP_DATE": 170.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 218, "STOP_DATE": 254.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-E2-A152": { "demographics": { "SUBTYPE": "BRCA_Her2", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "a8015490-9740-45c9-8bd2-eb6d1beefc2e", "AGE": 56, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE I", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 2128.0, "DAYS_TO_BIRTH": -20705.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/6/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 69.96087714, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 69.96087714, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 1.77532301, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 1.77532301, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E2-A152-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "E2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 25.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2603, "MSI_SENSOR_SCORE": 0.43, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 4.133333333, "TISSUE_SOURCE_SITE": "Roswell Park", "TBL_SCORE": 78.0 }, "treatments": [ { "START_DATE": 63, "STOP_DATE": 217.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": "6", "PRESCRIBED_DOSE": "156", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "2641", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 42, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Trastuzumab", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "460", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": "12678", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 42, "STOP_DATE": 42.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "1", "PRESCRIBED_DOSE": "942", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "942", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 231, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "3", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": "1", "TOTAL_DOSE_UNITS": "Mg/Day", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 42, "STOP_DATE": 42.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": "1", "PRESCRIBED_DOSE": "118", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "118", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-BH-A0AZ": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "518f231c-f5f9-4a39-a97b-7fd5666d3e50", "AGE": 47, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 1919.0, "DAYS_TO_BIRTH": -17465.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/27/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "CM0 (I+)", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 63.08971957, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 63.08971957, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 63.08971957, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 63.08971957, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A0AZ-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 3.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2615, "MSI_SENSOR_SCORE": 0.16, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.933333333, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 68.0 }, "treatments": [ { "START_DATE": 126, "STOP_DATE": 209.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 126, "STOP_DATE": 209.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 209, "STOP_DATE": 293.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 126, "STOP_DATE": 482.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Immunotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Bevacizumab", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-A1-A0SE": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "c397e6c2-ba3a-4f5e-a258-c140611192fe", "AGE": 56, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE I", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 1321.0, "DAYS_TO_BIRTH": -20717.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/6/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8522/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": null, "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 43.42966105, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 43.42966105, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 43.42966105, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 43.42966105, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A1-A0SE-01", "ONCOTREE_CODE": "BRCNOS", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Carcinoma (NOS)", "TUMOR_TYPE": "Mixed Histology (NOS)", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A1", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 10.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2898, "MSI_SENSOR_SCORE": 0.01, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.933333333, "TISSUE_SOURCE_SITE": "UCSF", "TBL_SCORE": 49.0 }, "treatments": [] }, "TCGA-C8-A12N": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "b8a615f9-d19b-4b09-8ec8-0674e5c648cd", "AGE": 58, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 358.0, "DAYS_TO_BIRTH": -21428.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/12/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Asian", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 11.76973403, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 11.76973403, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 11.76973403, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 11.76973403, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-C8-A12N-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "C8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 4.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2847, "MSI_SENSOR_SCORE": 0.01, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.633333333, "TISSUE_SOURCE_SITE": "ILSBio", "TBL_SCORE": 5.0 }, "treatments": [] }, "TCGA-AO-A0J8": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "02bf5203-f9cd-4c5a-97b4-e5584dc22325", "AGE": 61, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": 680.0, "DAYS_TO_BIRTH": -22284.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/19/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I+)", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 22.35591939, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 22.35591939, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 22.35591939, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 22.35591939, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AO-A0J8-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AO", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 6.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2595, "MSI_SENSOR_SCORE": 0.15, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.733333333, "TISSUE_SOURCE_SITE": "MSKCC", "TBL_SCORE": 3.0 }, "treatments": [ { "START_DATE": 63, "STOP_DATE": 224.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "8", "PRESCRIBED_DOSE": "600", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "8800", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 63, "STOP_DATE": 224.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Methotrexate", "NUMBER_OF_CYCLES": "8", "PRESCRIBED_DOSE": "40", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "560", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 277, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 63, "STOP_DATE": 224.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Fluorouracil", "NUMBER_OF_CYCLES": "8", "PRESCRIBED_DOSE": "600", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "8800", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 252, "STOP_DATE": 281.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "21", "RADIATION_DOSAGE": "5240", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-A8-A09D": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "36449392-de76-4ee9-bc09-627a07e18727", "AGE": 47, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "5TH", "DAYS_LAST_FOLLOWUP": 1522.0, "DAYS_TO_BIRTH": -17440.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "5/27/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": null, "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 50.03780781, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 50.03780781, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 50.03780781, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 50.03780781, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A8-A09D-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 4.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2589, "MSI_SENSOR_SCORE": 0.16, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.3, "TISSUE_SOURCE_SITE": "Indivumed", "TBL_SCORE": 351.0 }, "treatments": [ { "START_DATE": 0, "STOP_DATE": 92.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 0, "STOP_DATE": 92.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 92, "STOP_DATE": 153.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 274, "STOP_DATE": 1400.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 1400, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 214, "STOP_DATE": 274.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": "67", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "gy" } ] }, "TCGA-D8-A142": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "ccb22ecc-6e18-44b8-ad48-6ab51314b16e", "AGE": 74, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 425.0, "DAYS_TO_BIRTH": -27313.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "2/25/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 13.97244962, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 13.97244962, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 13.97244962, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 13.97244962, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D8-A142-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "D8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": NaN, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2872, "MSI_SENSOR_SCORE": 0.29, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 3.833333333, "TISSUE_SOURCE_SITE": "Greater Poland Cancer Center", "TBL_SCORE": 260.0 }, "treatments": [ { "START_DATE": 61, "STOP_DATE": 271.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "6", "PRESCRIBED_DOSE": "100", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "cmf", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": "Mg/M2", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 61, "STOP_DATE": 271.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Methotrexate", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 61, "STOP_DATE": 271.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Fluorouracil", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-E2-A1LB": { "demographics": { "SUBTYPE": "BRCA_Her2", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "fa176764-a76f-44c7-b97a-cd6d21e052be", "AGE": 41, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 2306.0, "DAYS_TO_BIRTH": -15283.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "6/7/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 75.8128678, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 75.8128678, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 75.8128678, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 75.8128678, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-E2-A1LB-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "E2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 1.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3296, "MSI_SENSOR_SCORE": 0.45, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.433333333, "TISSUE_SOURCE_SITE": "Roswell Park", "TBL_SCORE": 60.0 }, "treatments": [ { "START_DATE": 121, "STOP_DATE": 199.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": "12", "PRESCRIBED_DOSE": "155", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "1860", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 121, "STOP_DATE": 441.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Trastuzumab", "NUMBER_OF_CYCLES": "24", "PRESCRIBED_DOSE": "496", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "11904", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 66, "STOP_DATE": 128.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "121", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "484", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 66, "STOP_DATE": 108.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "8", "PRESCRIBED_DOSE": "1206", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "4824", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 241, "STOP_DATE": 287.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "33", "RADIATION_DOSAGE": "6040", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-EW-A1P5": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "53d0af48-d7ea-42c9-8695-c614b89b415b", "AGE": 77, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 703.0, "DAYS_TO_BIRTH": -28177.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/11/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 23.11207548, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 23.11207548, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 23.11207548, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 23.11207548, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-EW-A1P5-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "EW", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 19.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.335, "MSI_SENSOR_SCORE": 0.28, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.566666667, "TISSUE_SOURCE_SITE": "University of Miami", "TBL_SCORE": 22.0 }, "treatments": [ { "START_DATE": 199, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 124, "STOP_DATE": 185.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-EW-A1PG": { "demographics": { "SUBTYPE": "BRCA_Normal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "da286247-e8bb-4941-a2af-2453fe61cd02", "AGE": 53, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 1051.0, "DAYS_TO_BIRTH": -19464.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/18/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 34.55304599, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 34.55304599, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 34.55304599, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 34.55304599, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-EW-A1PG-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "EW", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3521, "MSI_SENSOR_SCORE": 0.21, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.3, "TISSUE_SOURCE_SITE": "University of Miami", "TBL_SCORE": 17.0 }, "treatments": [ { "START_DATE": 263, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Exemestane", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "25", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 157, "STOP_DATE": 262.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Fluorouracil", "NUMBER_OF_CYCLES": "3", "PRESCRIBED_DOSE": "910", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "fec x3 then t x3", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "2730", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 157, "STOP_DATE": 262.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "3", "PRESCRIBED_DOSE": "910", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "fec x3 then t x3", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "2730", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 157, "STOP_DATE": 262.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Epirubicin", "NUMBER_OF_CYCLES": "3", "PRESCRIBED_DOSE": "182", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "fec x3 then t x3", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "546", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 157, "STOP_DATE": 262.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": "3", "PRESCRIBED_DOSE": "182", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "fec x3 then t x3", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "546", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-B6-A0IE": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "3f834fa7-6d7b-4b85-98c0-5c55d55b6c95", "AGE": 38, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": "4TH", "DAYS_LAST_FOLLOWUP": NaN, "DAYS_TO_BIRTH": -13982.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "11/2/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1B", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 65.52256962, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 65.52256962, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 27.4188776, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 27.4188776, "GENETIC_ANCESTRY_LABEL": "AFR_ADMIX" }, "sample": { "SAMPLE_ID": "TCGA-B6-A0IE-01", "ONCOTREE_CODE": "BRCNOS", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Carcinoma (NOS)", "TUMOR_TYPE": "Mixed Histology (NOS)", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "B6", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 12.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2736, "MSI_SENSOR_SCORE": 0.22, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.0, "TISSUE_SOURCE_SITE": "Duke", "TBL_SCORE": 112.0 }, "treatments": [] }, "TCGA-AR-A0U2": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "9ad603dc-3fd0-44f5-ae4e-64eeb1ae8d6d", "AGE": 47, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": NaN, "DAYS_TO_BIRTH": -17390.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "2/24/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N2", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 83.86757405, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 83.86757405, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 52.89805043, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 52.89805043, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AR-A0U2-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AR", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 22.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3097, "MSI_SENSOR_SCORE": 1.19, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.433333333, "TISSUE_SOURCE_SITE": "Mayo", "TBL_SCORE": 167.0 }, "treatments": [ { "START_DATE": 142, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-C8-A1HE": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "b26d41cd-393b-4cd4-8925-a9488f7de576", "AGE": 59, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 375.0, "DAYS_TO_BIRTH": NaN, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/24/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Asian", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 12.32863202, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 12.32863202, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 12.32863202, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 12.32863202, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-C8-A1HE-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "C8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 4.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3348, "MSI_SENSOR_SCORE": 0.82, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.233333333, "TISSUE_SOURCE_SITE": "ILSBio", "TBL_SCORE": 43.0 }, "treatments": [] }, "TCGA-JL-A3YW": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "A2434F47-2168-47D0-9BBB-981071597843", "AGE": 49, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 360.0, "DAYS_TO_BIRTH": NaN, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "11/8/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Asian", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "0:LIVING", "OS_MONTHS": 11.83548673, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 11.83548673, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 11.83548673, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 11.83548673, "GENETIC_ANCESTRY_LABEL": "SAS" }, "sample": { "SAMPLE_ID": "TCGA-JL-A3YW-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "JL", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 15.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3065, "MSI_SENSOR_SCORE": 0.02, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.0, "TISSUE_SOURCE_SITE": "ABS - Research Metrics Pakistan", "TBL_SCORE": 273.0 }, "treatments": [] }, "TCGA-C8-A1HN": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "86a18ae0-dfb1-49c3-b5c4-67ec331d6e40", "AGE": 56, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 394.0, "DAYS_TO_BIRTH": -20712.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "6/2/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "No", "PRIOR_DX": "No", "RACE": "Asian", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 12.9532827, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 12.9532827, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 12.9532827, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 12.9532827, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-C8-A1HN-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "C8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 20.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2734, "MSI_SENSOR_SCORE": 0.3, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.533333333, "TISSUE_SOURCE_SITE": "ILSBio", "TBL_SCORE": 463.0 }, "treatments": [] }, "TCGA-E9-A249": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "fb3607eb-858e-4ecd-8477-95140658c6d2", "AGE": 45, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 217.0, "DAYS_TO_BIRTH": -16689.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/22/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 7.134168393, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 7.134168393, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 7.134168393, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 7.134168393, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E9-A249-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "E9", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 23.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.339, "MSI_SENSOR_SCORE": 0.6, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.6, "TISSUE_SOURCE_SITE": "Asterand", "TBL_SCORE": 3.0 }, "treatments": [ { "START_DATE": 28, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "20", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 28, "STOP_DATE": 100.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "3", "PRESCRIBED_DOSE": "1000", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "3000", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 28, "STOP_DATE": 100.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "1", "PRESCRIBED_DOSE": "1200", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "1200", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 28, "STOP_DATE": 100.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 128, "STOP_DATE": 155.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": "13500", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-3C-AALJ": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "427D0648-3F77-4FFC-B52C-89855426D647", "AGE": 62, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 1474.0, "DAYS_TO_BIRTH": -22848.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/28/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 48.45974291, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 48.45974291, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 48.45974291, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 48.45974291, "GENETIC_ANCESTRY_LABEL": "AFR_ADMIX" }, "sample": { "SAMPLE_ID": "TCGA-3C-AALJ-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "3C", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 13.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3266, "MSI_SENSOR_SCORE": 0.31, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.933333333, "TISSUE_SOURCE_SITE": "Columbia University", "TBL_SCORE": 365.0 }, "treatments": [ { "START_DATE": 368, "STOP_DATE": 511.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Other", "TREATMENT_SUBTYPE": null, "AGENT": "Metformin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 154, "STOP_DATE": 490.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Trastuzumab", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 63, "STOP_DATE": 126.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 63, "STOP_DATE": 126.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 151, "STOP_DATE": 511.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Trastuzumab", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-D8-A73U": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "96F02BE7-F2DF-483C-8968-A5BD2D887206", "AGE": 88, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 492.0, "DAYS_TO_BIRTH": -32208.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/28/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "No", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 16.1751652, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 16.1751652, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 16.1751652, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 16.1751652, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D8-A73U-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "D8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 12.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3289, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 4.133333333, "TISSUE_SOURCE_SITE": "Greater Poland Cancer Center", "TBL_SCORE": 22.0 }, "treatments": [ { "START_DATE": 75, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-A2-A4S0": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "A53DD490-E0BA-419A-90C6-B905E241A8E5", "AGE": 77, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 706.0, "DAYS_TO_BIRTH": -28416.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "2/26/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8480/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": null, "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "0:LIVING", "OS_MONTHS": 23.21070454, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 23.21070454, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 23.21070454, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 23.21070454, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A2-A4S0-01", "ONCOTREE_CODE": "IMMC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Mixed Mucinous Carcinoma", "TUMOR_TYPE": "Mucinous Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "A2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.302, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": NaN, "TISSUE_SOURCE_SITE": "Walter Reed", "TBL_SCORE": 0.0 }, "treatments": [] }, "TCGA-OL-A5RZ": { "demographics": { "SUBTYPE": "BRCA_Her2", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "7E8713BD-0B17-4F09-9696-BC29707D862B", "AGE": 57, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 679.0, "DAYS_TO_BIRTH": -21038.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "5/16/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T1B", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 22.32304304, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 22.32304304, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 22.32304304, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 22.32304304, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-OL-A5RZ-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "OL", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 13.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.328, "MSI_SENSOR_SCORE": 0.31, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 3.233333333, "TISSUE_SOURCE_SITE": "University of Chicago", "TBL_SCORE": 356.0 }, "treatments": [ { "START_DATE": 239, "STOP_DATE": 331.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 239, "STOP_DATE": 331.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-D8-A73X": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "1BE375FE-5AE5-4E75-A729-69F86A661D9A", "AGE": 53, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 767.0, "DAYS_TO_BIRTH": -19607.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/28/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8211/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "No", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 25.21616202, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 25.21616202, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 25.21616202, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 25.21616202, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D8-A73X-01", "ONCOTREE_CODE": "BRCNOS", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Carcinoma (NOS)", "TUMOR_TYPE": "Other", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "D8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 5.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3195, "MSI_SENSOR_SCORE": 0.01, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.033333333, "TISSUE_SOURCE_SITE": "Greater Poland Cancer Center", "TBL_SCORE": 2.0 }, "treatments": [ { "START_DATE": 12, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 75, "STOP_DATE": 75.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "25", "RADIATION_DOSAGE": "50", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "gy" }, { "START_DATE": 41, "STOP_DATE": 53.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 2", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Stable Disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": "50", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "gy" } ] }, "TCGA-AN-A0AS": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "7c2a8440-0206-4039-8474-8d62f6c7de0c", "AGE": 70, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": 10.0, "DAYS_TO_BIRTH": -25658.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/28/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N2", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 0.32876352, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 0.32876352, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 0.32876352, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 0.32876352, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AN-A0AS-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AN", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 24.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2944, "MSI_SENSOR_SCORE": 0.25, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.4, "TISSUE_SOURCE_SITE": "Cureline", "TBL_SCORE": 391.0 }, "treatments": [] }, "TCGA-E9-A1R2": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "8631969d-4ac6-4fe1-9db3-d47db604494a", "AGE": 51, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIC", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 1063.0, "DAYS_TO_BIRTH": -18936.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/28/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N3", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 34.94756222, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 34.94756222, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 34.94756222, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E9-A1R2-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "E9", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 7.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3169, "MSI_SENSOR_SCORE": 0.31, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.833333333, "TISSUE_SOURCE_SITE": "Asterand", "TBL_SCORE": 66.0 }, "treatments": [ { "START_DATE": 36, "STOP_DATE": 144.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 36, "STOP_DATE": 144.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 36, "STOP_DATE": 144.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 174, "STOP_DATE": 223.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": "6240", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" }, { "START_DATE": 174, "STOP_DATE": 223.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 2", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": "5040", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-A8-A07O": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "cf9db1af-17f0-490e-8139-142bd704763a", "AGE": 51, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 304.0, "DAYS_TO_BIRTH": -18870.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "5/27/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": null, "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 9.99441102, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 9.99441102, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 9.99441102, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 9.99441102, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A8-A07O-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 11.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2673, "MSI_SENSOR_SCORE": 0.07, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.266666667, "TISSUE_SOURCE_SITE": "Indivumed", "TBL_SCORE": 239.0 }, "treatments": [ { "START_DATE": 61, "STOP_DATE": 151.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": null, "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 182, "STOP_DATE": 212.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-OL-A5S0": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "43B3BF47-7313-4DFB-952A-EC0B9D48E16C", "AGE": 66, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 620.0, "DAYS_TO_BIRTH": -24139.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "5/16/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 20.38333827, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 20.38333827, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 20.38333827, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 20.38333827, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-OL-A5S0-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "OL", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 21.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3131, "MSI_SENSOR_SCORE": 0.04, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.033333333, "TISSUE_SOURCE_SITE": "University of Chicago", "TBL_SCORE": 141.0 }, "treatments": [ { "START_DATE": 67, "STOP_DATE": 228.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 67, "STOP_DATE": 228.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Trastuzumab", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 153, "STOP_DATE": 202.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": "60.4", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "gy" } ] }, "TCGA-C8-A133": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "b8b6cebc-26dc-43ae-a94a-20da6018f7ae", "AGE": 65, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 0.0, "DAYS_TO_BIRTH": -23922.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/15/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8523/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": null, "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 0.0, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 0.0, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 0.0, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 0.0, "GENETIC_ANCESTRY_LABEL": "SAS_ADMIX" }, "sample": { "SAMPLE_ID": "TCGA-C8-A133-01", "ONCOTREE_CODE": "BRCNOS", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Carcinoma (NOS)", "TUMOR_TYPE": "Other", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "C8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2636, "MSI_SENSOR_SCORE": 0.01, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.8, "TISSUE_SOURCE_SITE": "ILSBio", "TBL_SCORE": 21.0 }, "treatments": [] }, "TCGA-B6-A0RE": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "08da7c4c-3067-4bcf-9d7a-78566df72e69", "AGE": 61, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE X", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": 7777.0, "DAYS_TO_BIRTH": -22449.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "11/2/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "TX", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 255.6793898, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 255.6793898, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 255.6793898, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 255.6793898, "GENETIC_ANCESTRY_LABEL": "AFR_ADMIX" }, "sample": { "SAMPLE_ID": "TCGA-B6-A0RE-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "B6", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 20.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3045, "MSI_SENSOR_SCORE": 1.22, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 4.666666667, "TISSUE_SOURCE_SITE": "Duke", "TBL_SCORE": 139.0 }, "treatments": [] }, "TCGA-E9-A226": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "dd67408e-46ba-4573-9415-d4814e9f84de", "AGE": 45, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 1038.0, "DAYS_TO_BIRTH": -16511.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "8/3/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N2", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 34.45441694, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 34.45441694, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 25.97231811, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 25.97231811, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E9-A226-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "E9", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 7.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3205, "MSI_SENSOR_SCORE": 0.31, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.033333333, "TISSUE_SOURCE_SITE": "Asterand", "TBL_SCORE": 146.0 }, "treatments": [ { "START_DATE": 13, "STOP_DATE": 205.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "6", "PRESCRIBED_DOSE": "100", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "500", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 13, "STOP_DATE": 205.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "6", "PRESCRIBED_DOSE": "1600", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "9600", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 13, "STOP_DATE": 205.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Fluorouracil", "NUMBER_OF_CYCLES": "6", "PRESCRIBED_DOSE": "2000", "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "7000", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 13, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "20", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 790, "STOP_DATE": 937.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Ancillary", "TREATMENT_SUBTYPE": null, "AGENT": "Pamidronic Acid", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Partial Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 94, "STOP_DATE": 117.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "20", "RADIATION_DOSAGE": "4000", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-AR-A2LJ": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "738E1ACC-1F0C-4A96-9C8A-222727EF5AF8", "AGE": 40, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 2632.0, "DAYS_TO_BIRTH": -14723.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "1/12/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "0:LIVING", "OS_MONTHS": 86.53055857, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 86.53055857, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 86.53055857, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 86.53055857, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AR-A2LJ-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AR", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 3.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2971, "MSI_SENSOR_SCORE": 0.01, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.0, "TISSUE_SOURCE_SITE": "Mayo", "TBL_SCORE": 45.0 }, "treatments": [ { "START_DATE": 42, "STOP_DATE": 84.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 42, "STOP_DATE": 84.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 98, "STOP_DATE": 175.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 98, "STOP_DATE": 465.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Immunotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Trastuzumab", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 190, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 196, "STOP_DATE": 231.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "25", "RADIATION_DOSAGE": "5000", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-BH-A0RX": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "e828455d-4680-41b2-8a1c-1582e3790d62", "AGE": 59, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": 170.0, "DAYS_TO_BIRTH": -21857.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "11/11/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 5.588979847, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 5.588979847, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 5.588979847, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 5.588979847, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A0RX-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": NaN, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2777, "MSI_SENSOR_SCORE": 0.01, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.3, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 50.0 }, "treatments": [ { "START_DATE": 50, "STOP_DATE": 155.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "6", "PRESCRIBED_DOSE": "1122", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "6808", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 50, "STOP_DATE": 155.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Fluorouracil", "NUMBER_OF_CYCLES": "6", "PRESCRIBED_DOSE": "1122", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "6808", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 50, "STOP_DATE": 155.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Methotrexate", "NUMBER_OF_CYCLES": "6", "PRESCRIBED_DOSE": "75", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "447", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-BH-A0HA": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "e666081b-caaf-4e8b-9446-807be71201a5", "AGE": 31, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE I", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 1611.0, "DAYS_TO_BIRTH": -11379.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "8/2/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 52.96380314, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 52.96380314, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 52.96380314, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 52.96380314, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A0HA-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 4.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.393, "MSI_SENSOR_SCORE": 8.53, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 11.03333333, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 29.0 }, "treatments": [] }, "TCGA-E9-A5UO": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "ED2617C3-5D3B-4688-9283-0F8A10E0B10D", "AGE": 41, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 785.0, "DAYS_TO_BIRTH": -15050.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/23/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8480/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 25.80793635, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 25.80793635, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 25.80793635, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 25.80793635, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E9-A5UO-01", "ONCOTREE_CODE": "IMMC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Mixed Mucinous Carcinoma", "TUMOR_TYPE": "Mucinous Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "E9", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 9.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2921, "MSI_SENSOR_SCORE": 0.19, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.8, "TISSUE_SOURCE_SITE": "Asterand", "TBL_SCORE": 174.0 }, "treatments": [] }, "TCGA-E9-A227": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "89a8da07-4487-47c6-8d3c-442a87e4f632", "AGE": 42, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 975.0, "DAYS_TO_BIRTH": -15602.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/28/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 32.05444324, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 32.05444324, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 32.05444324, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 32.05444324, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E9-A227-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "E9", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 2.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2776, "MSI_SENSOR_SCORE": 0.07, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.533333333, "TISSUE_SOURCE_SITE": "Asterand", "TBL_SCORE": 9.0 }, "treatments": [ { "START_DATE": 92, "STOP_DATE": 197.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 239, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 216, "STOP_DATE": 245.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "21", "RADIATION_DOSAGE": "5256", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-GM-A2DL": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "A76774FE-7298-4D68-A2B2-C1BAD93F0C31", "AGE": 50, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE I", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 3519.0, "DAYS_TO_BIRTH": -18475.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/29/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 115.6918828, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 115.6918828, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 115.6918828, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 115.6918828, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-GM-A2DL-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "GM", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 8.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3306, "MSI_SENSOR_SCORE": 0.23, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.466666667, "TISSUE_SOURCE_SITE": "MD Anderson", "TBL_SCORE": 157.0 }, "treatments": [ { "START_DATE": 158, "STOP_DATE": 1989.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 1990, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 110, "STOP_DATE": 151.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "30", "RADIATION_DOSAGE": "60", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "gy" } ] }, "TCGA-AC-A7VB": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "56230E4A-29CA-4F37-A0F9-730DBDFB6FA2", "AGE": 51, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 250.0, "DAYS_TO_BIRTH": -18806.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "2/26/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 8.21908801, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 8.21908801, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 8.21908801, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 8.21908801, "GENETIC_ANCESTRY_LABEL": "AFR_ADMIX" }, "sample": { "SAMPLE_ID": "TCGA-AC-A7VB-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "AC", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 8.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3405, "MSI_SENSOR_SCORE": 0.19, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.733333333, "TISSUE_SOURCE_SITE": "International Genomics Consortium", "TBL_SCORE": 257.0 }, "treatments": [] }, "TCGA-B6-A0WY": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "f475d460-75cd-4fe9-aa54-c90be12b4ef8", "AGE": 40, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": "4TH", "DAYS_LAST_FOLLOWUP": NaN, "DAYS_TO_BIRTH": -14778.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/14/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1B", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 113.7850544, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 113.7850544, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 66.11434395, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 66.11434395, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-B6-A0WY-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "B6", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 25.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2894, "MSI_SENSOR_SCORE": 0.08, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.033333333, "TISSUE_SOURCE_SITE": "Duke", "TBL_SCORE": 69.0 }, "treatments": [] }, "TCGA-A8-A06X": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "70931617-b3df-4a12-8e3f-2b2307602f48", "AGE": 77, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": NaN, "DAYS_TO_BIRTH": -28338.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "5/27/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": null, "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 31.00239997, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 31.00239997, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 31.00239997, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 31.00239997, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A8-A06X-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 11.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2615, "MSI_SENSOR_SCORE": 0.54, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 6.166666667, "TISSUE_SOURCE_SITE": "Indivumed", "TBL_SCORE": 274.0 }, "treatments": [ { "START_DATE": 61, "STOP_DATE": 92.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": "52", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "gy" } ] }, "TCGA-AC-A5XU": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "97677FD7-8523-48C5-A8CE-614FD4010551", "AGE": 74, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 455.0, "DAYS_TO_BIRTH": -27191.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/15/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 14.95874018, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 14.95874018, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 14.95874018, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 14.95874018, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-AC-A5XU-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "AC", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 4.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3039, "MSI_SENSOR_SCORE": 0.25, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.866666667, "TISSUE_SOURCE_SITE": "International Genomics Consortium", "TBL_SCORE": 435.0 }, "treatments": [ { "START_DATE": 235, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Letrozole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 156, "STOP_DATE": 199.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "30", "RADIATION_DOSAGE": "6000", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-B6-A0WS": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "197741de-a098-4f04-bb37-8ea8b3bb39bc", "AGE": 58, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE X", "AJCC_STAGING_EDITION": "4TH", "DAYS_LAST_FOLLOWUP": NaN, "DAYS_TO_BIRTH": -21230.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/15/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "NX", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "No", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 97.4783838, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 97.4783838, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 97.4783838, "GENETIC_ANCESTRY_LABEL": "AFR_ADMIX" }, "sample": { "SAMPLE_ID": "TCGA-B6-A0WS-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "B6", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 9.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2843, "MSI_SENSOR_SCORE": 0.12, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.466666667, "TISSUE_SOURCE_SITE": "Duke", "TBL_SCORE": 62.0 }, "treatments": [] }, "TCGA-AO-A03U": { "demographics": { "SUBTYPE": "BRCA_Normal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "0685edd2-ce1c-4e0e-8dda-393139af4223", "AGE": 31, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE I", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": NaN, "DAYS_TO_BIRTH": -11354.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "1/9/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8502/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 58.94729921, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 58.94729921, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 58.94729921, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 53.06243219, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AO-A03U-01", "ONCOTREE_CODE": "BRCNOS", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Carcinoma (NOS)", "TUMOR_TYPE": "Other", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AO", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 1.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": NaN, "MSI_SENSOR_SCORE": 0.01, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.166666667, "TISSUE_SOURCE_SITE": "MSKCC", "TBL_SCORE": 6.0 }, "treatments": [ { "START_DATE": 70, "STOP_DATE": 216.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Methotrexate", "NUMBER_OF_CYCLES": "8", "PRESCRIBED_DOSE": "40", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "576", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 70, "STOP_DATE": 216.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "8", "PRESCRIBED_DOSE": "600", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "8640", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 70, "STOP_DATE": 216.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Fluorouracil", "NUMBER_OF_CYCLES": "8", "PRESCRIBED_DOSE": "600", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "8640", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-AO-A0JI": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "e17c565c-9857-4df3-a352-903b53093c85", "AGE": 56, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": 1528.0, "DAYS_TO_BIRTH": -20694.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/7/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 50.23506592, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 50.23506592, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 50.23506592, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 50.23506592, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AO-A0JI-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AO", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 7.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2769, "MSI_SENSOR_SCORE": 0.28, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.466666667, "TISSUE_SOURCE_SITE": "MSKCC", "TBL_SCORE": 48.0 }, "treatments": [ { "START_DATE": 98, "STOP_DATE": 140.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "60", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "416", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 154, "STOP_DATE": 196.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "175", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "1220", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 224, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 98, "STOP_DATE": 140.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "600", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "4176", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-A8-A0A1": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "3efa245d-177d-4ef9-94f7-f554c54e345e", "AGE": 84, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 365.0, "DAYS_TO_BIRTH": -30742.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "5/27/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": null, "RADIATION_THERAPY": null, "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 11.9998685, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 11.9998685, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 11.9998685, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 11.9998685, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A8-A0A1-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 3.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2575, "MSI_SENSOR_SCORE": 0.03, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.5, "TISSUE_SOURCE_SITE": "Indivumed", "TBL_SCORE": 19.0 }, "treatments": [ { "START_DATE": 31, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-AR-A5QQ": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "3AF31FCF-AD0C-4FD9-A8E3-10F9176B5E9D", "AGE": 68, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": NaN, "DAYS_TO_BIRTH": -24841.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/15/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8575/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 10.58618536, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 10.58618536, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 9.895781964, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AR-A5QQ-01", "ONCOTREE_CODE": "BRCNOS", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Carcinoma (NOS)", "TUMOR_TYPE": "Other", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AR", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 7.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3139, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.233333333, "TISSUE_SOURCE_SITE": "Mayo", "TBL_SCORE": 26.0 }, "treatments": [ { "START_DATE": 69, "STOP_DATE": 91.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 69, "STOP_DATE": 91.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 119, "STOP_DATE": 143.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Ifosfamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 119, "STOP_DATE": 143.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Ancillary", "TREATMENT_SUBTYPE": null, "AGENT": "Sodium Mercaptoetansolfonato", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 119, "STOP_DATE": 143.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Ancillary", "TREATMENT_SUBTYPE": null, "AGENT": "Sodium Mercaptoetansolfonato", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 119, "STOP_DATE": 143.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Etoposide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-BH-A1FG": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "d4e7426c-9739-4585-9114-e564b13c7c02", "AGE": 88, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE I", "AJCC_STAGING_EDITION": "5TH", "DAYS_LAST_FOLLOWUP": NaN, "DAYS_TO_BIRTH": -32295.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/8/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "NX", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": null, "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 122.8260512, "DSS_STATUS": null, "DSS_MONTHS": 122.8260512, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 122.8260512, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A1FG-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 5.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.305, "MSI_SENSOR_SCORE": 0.44, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.6, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 24.0 }, "treatments": [] }, "TCGA-BH-A1FU": { "demographics": { "SUBTYPE": "BRCA_Normal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "c348a9b3-c901-4384-a222-144387bac0c5", "AGE": 44, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IA", "AJCC_STAGING_EDITION": "5TH", "DAYS_LAST_FOLLOWUP": NaN, "DAYS_TO_BIRTH": -16174.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/8/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": null, "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 55.49528224, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 55.49528224, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 55.49528224, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A1FU-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 26.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.29, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.733333333, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 59.0 }, "treatments": [] }, "TCGA-S3-AA14": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "929ACC67-B8BF-4F65-9110-380E44AB66B7", "AGE": 47, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE I", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 529.0, "DAYS_TO_BIRTH": -17352.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/18/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "CM0 (I+)", "PATH_N_STAGE": "N0 (I+)", "PATH_T_STAGE": "T1", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 17.39159023, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 17.39159023, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 17.39159023, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 17.39159023, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-S3-AA14-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "S3", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 2.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3335, "MSI_SENSOR_SCORE": 0.22, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.533333333, "TISSUE_SOURCE_SITE": "Albert Einstein Medical Center", "TBL_SCORE": 99.0 }, "treatments": [ { "START_DATE": 62, "STOP_DATE": 104.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 62, "STOP_DATE": 104.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 62, "STOP_DATE": 104.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Ancillary", "TREATMENT_SUBTYPE": null, "AGENT": "Pegfilgrastim", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 118, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Targeted Molecular Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Trastuzumab", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 118, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 221, "STOP_DATE": 267.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "35", "RADIATION_DOSAGE": "6440", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-AC-A3W7": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "2481A671-760B-428C-968D-42E25FD42AC5", "AGE": 66, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 471.0, "DAYS_TO_BIRTH": -24327.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "10/17/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "0:LIVING", "OS_MONTHS": 15.48476181, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 15.48476181, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 15.48476181, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 15.48476181, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AC-A3W7-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "AC", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 8.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3095, "MSI_SENSOR_SCORE": 0.01, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.0, "TISSUE_SOURCE_SITE": "International Genomics Consortium", "TBL_SCORE": 9.0 }, "treatments": [ { "START_DATE": 65, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Letrozole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-BH-A0BP": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "f251cb6c-d18e-4691-9c82-24ed1ac0abf9", "AGE": 76, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE I", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 1481.0, "DAYS_TO_BIRTH": -27917.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "8/9/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 75.48410428, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 75.48410428, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 75.48410428, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 75.48410428, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A0BP-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 15.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2933, "MSI_SENSOR_SCORE": 0.47, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 4.633333333, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 569.0 }, "treatments": [ { "START_DATE": 124, "STOP_DATE": 153.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "33", "RADIATION_DOSAGE": "5000", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" }, { "START_DATE": 162, "STOP_DATE": 162.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 2", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": "1600", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-BH-A0H6": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "aeb6a3a6-b57a-4c53-90e6-e833777dd2a1", "AGE": 82, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE I", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": 747.0, "DAYS_TO_BIRTH": -30125.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "11/10/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "NX", "PATH_T_STAGE": "T1B", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 24.55863497, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 24.55863497, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 24.55863497, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 24.55863497, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A0H6-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 3.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2585, "MSI_SENSOR_SCORE": 0.11, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.566666667, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 11.0 }, "treatments": [ { "START_DATE": 64, "STOP_DATE": 97.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "20", "RADIATION_DOSAGE": "5208", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-LL-A5YN": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "EF1B3332-CD7F-41BB-A2D3-2538E7BECC5C", "AGE": 46, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 447.0, "DAYS_TO_BIRTH": -16884.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/20/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 14.69572936, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 14.69572936, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 14.69572936, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 14.69572936, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-LL-A5YN-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "LL", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 5.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3071, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.933333333, "TISSUE_SOURCE_SITE": "Candler", "TBL_SCORE": 160.0 }, "treatments": [ { "START_DATE": 55, "STOP_DATE": 166.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 55, "STOP_DATE": 166.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 55, "STOP_DATE": 421.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Trastuzumab", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 229, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 194, "STOP_DATE": 224.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "22", "RADIATION_DOSAGE": "54.72", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "gy" } ] }, "TCGA-D8-A1XC": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "ee14e049-b891-4dda-a730-8ce99bd93baf", "AGE": 85, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIB", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 81.0, "DAYS_TO_BIRTH": -31220.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/16/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8480/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T4B", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 12.39438472, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 12.39438472, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 12.39438472, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D8-A1XC-01", "ONCOTREE_CODE": "IMMC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Mixed Mucinous Carcinoma", "TUMOR_TYPE": "Mucinous Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "D8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 2.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3219, "MSI_SENSOR_SCORE": 0.29, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.866666667, "TISSUE_SOURCE_SITE": "Greater Poland Cancer Center", "TBL_SCORE": 2.0 }, "treatments": [] }, "TCGA-A1-A0SF": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "4b620966-b4c7-4615-bf58-ca9d3226b9bd", "AGE": 54, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 1463.0, "DAYS_TO_BIRTH": -19731.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/24/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": null, "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 48.09810303, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 48.09810303, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 48.09810303, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 48.09810303, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A1-A0SF-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A1", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 14.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.4042, "MSI_SENSOR_SCORE": 0.36, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.666666667, "TISSUE_SOURCE_SITE": "UCSF", "TBL_SCORE": 58.0 }, "treatments": [ { "START_DATE": 65, "STOP_DATE": 126.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide + Docetaxel", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 157, "STOP_DATE": 918.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 1010, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Other", "TREATMENT_SUBTYPE": "Aromatase Inhibitor", "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-BH-A0H7": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "2021ed1f-dc75-4701-b8b8-1386466e4802", "AGE": 65, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": 702.0, "DAYS_TO_BIRTH": -23972.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "11/10/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N2A", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 23.07919913, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 23.07919913, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 23.07919913, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 23.07919913, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A0H7-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 21.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2539, "MSI_SENSOR_SCORE": 0.85, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.666666667, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 446.0 }, "treatments": [ { "START_DATE": 298, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 85, "STOP_DATE": 148.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "86", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "344", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 85, "STOP_DATE": 232.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Bevacizumab", "NUMBER_OF_CYCLES": "8", "PRESCRIBED_DOSE": "765", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "6120", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 85, "STOP_DATE": 148.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "860", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "3440", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 169, "STOP_DATE": 246.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": "12", "PRESCRIBED_DOSE": "115", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "1380", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 274, "STOP_DATE": 314.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "33", "RADIATION_DOSAGE": "6040", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-A7-A0CH": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "9de678e5-67ed-4453-a98b-7ac351d5d0f1", "AGE": 79, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": 1079.0, "DAYS_TO_BIRTH": -29104.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "10/4/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 35.47358385, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 35.47358385, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 35.47358385, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 35.47358385, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A7-A0CH-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "A7", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 3.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": NaN, "MSI_SENSOR_SCORE": 0.32, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.833333333, "TISSUE_SOURCE_SITE": "Christiana Healthcare", "TBL_SCORE": 9.0 }, "treatments": [ { "START_DATE": 107, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": "247", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-A8-A08O": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "5f5964a8-8e07-4620-98f0-93d162dbc31e", "AGE": 45, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 943.0, "DAYS_TO_BIRTH": -16681.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "5/27/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M1", "PATH_N_STAGE": "N3A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": null, "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 31.00239997, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 31.00239997, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 25.05178025, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A8-A08O-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 7.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2784, "MSI_SENSOR_SCORE": 0.08, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.7, "TISSUE_SOURCE_SITE": "Indivumed", "TBL_SCORE": 317.0 }, "treatments": [ { "START_DATE": 31, "STOP_DATE": 121.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Clinical Progressive Disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 790, "STOP_DATE": 790.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Vincristine", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Clinical Progressive Disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 366, "STOP_DATE": 397.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Clinical Progressive Disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 943, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 60, "STOP_DATE": 335.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Targeted Molecular Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Bevacizumab", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Clinical Progressive Disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 60, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Ancillary", "TREATMENT_SUBTYPE": null, "AGENT": "Ibandronate", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-A1-A0SQ": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "08de63a2-7b76-43c3-80dc-df748b1d81bc", "AGE": 45, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 554.0, "DAYS_TO_BIRTH": -16458.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "6/30/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": null, "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 18.21349903, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 18.21349903, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 18.21349903, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 18.21349903, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A1-A0SQ-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A1", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 3.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2921, "MSI_SENSOR_SCORE": 0.18, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.766666667, "TISSUE_SOURCE_SITE": "UCSF", "TBL_SCORE": 108.0 }, "treatments": [ { "START_DATE": 299, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 148, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin + Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 268, "STOP_DATE": 329.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-AN-A04D": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "49717f75-0f2d-4e1c-9a12-f1cd7877b80a", "AGE": 58, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": 52.0, "DAYS_TO_BIRTH": -21426.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/20/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": null, "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 1.709570306, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 1.709570306, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 1.709570306, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AN-A04D-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AN", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 4.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2756, "MSI_SENSOR_SCORE": 0.66, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.8, "TISSUE_SOURCE_SITE": "Cureline", "TBL_SCORE": 93.0 }, "treatments": [] }, "TCGA-OL-A66H": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "76BD9BB9-9A8B-4A90-BB7C-EAFE76472EE4", "AGE": 74, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IB", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 812.0, "DAYS_TO_BIRTH": -27280.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "6/11/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8480/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N1MI", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 26.68419323, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": NaN, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": NaN, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": NaN, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-OL-A66H-01", "ONCOTREE_CODE": "IMMC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Mixed Mucinous Carcinoma", "TUMOR_TYPE": "Mucinous Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "OL", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 2.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2986, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.633333333, "TISSUE_SOURCE_SITE": "University of Chicago", "TBL_SCORE": 13.0 }, "treatments": [ { "START_DATE": 68, "STOP_DATE": 105.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": "5040", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-OL-A6VQ": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "34126CD5-CC38-4198-8582-C14FB5DB7ACB", "AGE": 49, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 600.0, "DAYS_TO_BIRTH": -18151.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "2/20/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 19.72581122, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 19.72581122, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 19.72581122, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 19.72581122, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-OL-A6VQ-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "OL", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 8.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.336, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.3, "TISSUE_SOURCE_SITE": "University of Chicago", "TBL_SCORE": 7.0 }, "treatments": [] }, "TCGA-D8-A1XG": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "de531604-bd1a-49df-96c2-6de3ae703f1d", "AGE": 86, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIB", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 448.0, "DAYS_TO_BIRTH": -31748.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/16/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T4B", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 14.72860571, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 14.72860571, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 14.72860571, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 14.72860571, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D8-A1XG-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "D8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 4.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.327, "MSI_SENSOR_SCORE": 0.83, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.7, "TISSUE_SOURCE_SITE": "Greater Poland Cancer Center", "TBL_SCORE": 21.0 }, "treatments": [] }, "TCGA-D8-A145": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "4958c36f-1dc7-4f14-9dec-36e14107dbe3", "AGE": 80, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 410.0, "DAYS_TO_BIRTH": -29280.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "2/25/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 13.47930434, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 13.47930434, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 13.47930434, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 13.47930434, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D8-A145-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "D8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 4.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2879, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.433333333, "TISSUE_SOURCE_SITE": "Greater Poland Cancer Center", "TBL_SCORE": 28.0 }, "treatments": [ { "START_DATE": 42, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "20", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "tamoxifen daily", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-AR-A256": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "d3d545b3-457f-4389-821f-704cb24aff7f", "AGE": 45, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "5TH", "DAYS_LAST_FOLLOWUP": NaN, "DAYS_TO_BIRTH": -16642.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "8/31/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 93.82910872, "DSS_STATUS": null, "DSS_MONTHS": 93.82910872, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 53.91721735, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 53.91721735, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AR-A256-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AR", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 17.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3504, "MSI_SENSOR_SCORE": 4.53, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 5.666666667, "TISSUE_SOURCE_SITE": "Mayo", "TBL_SCORE": 570.0 }, "treatments": [ { "START_DATE": 38, "STOP_DATE": 101.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 38, "STOP_DATE": 101.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-AN-A0FW": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "e112b452-8850-4353-bfed-0dbdc243290b", "AGE": 67, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": 11.0, "DAYS_TO_BIRTH": -24692.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/28/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N2", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 0.361639872, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 0.361639872, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 0.361639872, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 0.361639872, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AN-A0FW-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AN", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 20.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3358, "MSI_SENSOR_SCORE": 0.56, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 3.566666667, "TISSUE_SOURCE_SITE": "Cureline", "TBL_SCORE": 290.0 }, "treatments": [] }, "TCGA-A2-A04X": { "demographics": { "SUBTYPE": "BRCA_Her2", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "733a2a0f-b37a-4b81-b49e-3c0f30d1eb37", "AGE": 34, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 1686.0, "DAYS_TO_BIRTH": -12642.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "8/9/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 55.42952954, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 55.42952954, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 55.42952954, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 55.42952954, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A2-A04X-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 8.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2774, "MSI_SENSOR_SCORE": 0.05, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.933333333, "TISSUE_SOURCE_SITE": "Walter Reed", "TBL_SCORE": 142.0 }, "treatments": [ { "START_DATE": 133, "STOP_DATE": 210.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": "12", "PRESCRIBED_DOSE": "154-156", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "1858", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 80, "STOP_DATE": 122.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "1140", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "4560", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 352, "STOP_DATE": 490.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "10", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 80, "STOP_DATE": 122.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "114", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "456", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 133, "STOP_DATE": 383.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Targeted Molecular Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Trastuzumab", "NUMBER_OF_CYCLES": "20", "PRESCRIBED_DOSE": "154-500", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "6471.5", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-GM-A2DI": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "66FA504C-4AE4-49AC-9355-1E063776DC0D", "AGE": 52, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE I", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 2590.0, "DAYS_TO_BIRTH": -19030.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/29/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I+)", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 85.14975178, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 85.14975178, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 85.14975178, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 85.14975178, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-GM-A2DI-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "GM", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 9.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3132, "MSI_SENSOR_SCORE": 0.14, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.266666667, "TISSUE_SOURCE_SITE": "MD Anderson", "TBL_SCORE": 44.0 }, "treatments": [ { "START_DATE": 70, "STOP_DATE": 133.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 154, "STOP_DATE": 217.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Fluorouracil", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 154, "STOP_DATE": 217.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Epirubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 154, "STOP_DATE": 217.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-AN-A0FD": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "c6086936-7544-4da0-8c0c-114166848483", "AGE": 71, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": 196.0, "DAYS_TO_BIRTH": -26007.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/20/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 6.443765, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 6.443765, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 6.443765, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 6.443765, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AN-A0FD-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AN", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 6.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3047, "MSI_SENSOR_SCORE": 0.25, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.066666667, "TISSUE_SOURCE_SITE": "Cureline", "TBL_SCORE": 255.0 }, "treatments": [] }, "TCGA-E9-A1QZ": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "b6b932ce-6856-4d94-9e6c-16dfbe51906f", "AGE": 61, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 755.0, "DAYS_TO_BIRTH": -22397.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/28/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 24.82164579, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 24.82164579, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 24.82164579, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 24.82164579, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E9-A1QZ-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "E9", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 11.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3184, "MSI_SENSOR_SCORE": 0.12, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.7, "TISSUE_SOURCE_SITE": "Asterand", "TBL_SCORE": 26.0 }, "treatments": [] }, "TCGA-B6-A0RU": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "6956473b-92e5-4069-a26b-b48e280e76f2", "AGE": 40, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IA", "AJCC_STAGING_EDITION": "3RD", "DAYS_LAST_FOLLOWUP": 8605.0, "DAYS_TO_BIRTH": -14920.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "11/2/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8523/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 282.9010093, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 282.9010093, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 101.1276589, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 101.1276589, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-B6-A0RU-01", "ONCOTREE_CODE": "BRCNOS", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Carcinoma (NOS)", "TUMOR_TYPE": "Other", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "B6", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 13.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2802, "MSI_SENSOR_SCORE": 0.25, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.533333333, "TISSUE_SOURCE_SITE": "Duke", "TBL_SCORE": 62.0 }, "treatments": [] }, "TCGA-C8-A9FZ": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "726C6892-0DCE-4869-A7A7-CC44C26FE843", "AGE": 49, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 592.0, "DAYS_TO_BIRTH": -18038.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/29/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8524/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "0:LIVING", "OS_MONTHS": 19.46280041, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 19.46280041, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 19.46280041, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 19.46280041, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-C8-A9FZ-01", "ONCOTREE_CODE": "BRCNOS", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Carcinoma (NOS)", "TUMOR_TYPE": "Mixed Histology (NOS)", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "C8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 7.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3305, "MSI_SENSOR_SCORE": 0.22, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.733333333, "TISSUE_SOURCE_SITE": "ILSBio", "TBL_SCORE": 134.0 }, "treatments": [ { "START_DATE": 29, "STOP_DATE": 99.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 29, "STOP_DATE": 99.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Fluorouracil", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 29, "STOP_DATE": 99.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 169, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 119, "STOP_DATE": 155.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "2", "RADIATION_DOSAGE": "44", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "gy" } ] }, "TCGA-E2-A14U": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "23B7AAEA-1119-4B10-AA1A-0AE255D2F2A6", "AGE": 74, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE I", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 1318.0, "DAYS_TO_BIRTH": -27389.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/6/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "0:LIVING", "OS_MONTHS": 43.33103199, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 43.33103199, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 43.33103199, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 43.33103199, "GENETIC_ANCESTRY_LABEL": "EUR_ADMIX" }, "sample": { "SAMPLE_ID": "TCGA-E2-A14U-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "E2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 3.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2891, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": NaN, "TISSUE_SOURCE_SITE": "Roswell Park", "TBL_SCORE": 2.0 }, "treatments": [ { "START_DATE": 129, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-A7-A13D": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "8785012f-f73e-4d68-87cf-1d804af32782", "AGE": 46, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": 965.0, "DAYS_TO_BIRTH": -17070.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "2/23/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 31.72567972, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 31.72567972, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 31.72567972, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 31.72567972, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-A7-A13D-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "A7", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 28.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3088, "MSI_SENSOR_SCORE": 2.07, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.933333333, "TISSUE_SOURCE_SITE": "Christiana Healthcare", "TBL_SCORE": 576.0 }, "treatments": [ { "START_DATE": 71, "STOP_DATE": 155.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "5", "PRESCRIBED_DOSE": "1410-1428", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "7104", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 71, "STOP_DATE": 155.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": "5", "PRESCRIBED_DOSE": "176-179", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "889", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 188, "STOP_DATE": 237.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "33", "RADIATION_DOSAGE": "6100", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-AR-A0U0": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "e3c336f5-c32f-4c5d-81fb-e2408ae145b2", "AGE": 73, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": 1988.0, "DAYS_TO_BIRTH": -26993.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "3/7/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 65.35818786, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 65.35818786, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 65.35818786, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 65.35818786, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AR-A0U0-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AR", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 20.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2984, "MSI_SENSOR_SCORE": 0.78, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.233333333, "TISSUE_SOURCE_SITE": "Mayo", "TBL_SCORE": 73.0 }, "treatments": [] }, "TCGA-AC-A5XS": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "D9627184-B972-4E00-8C11-B0B946AC357A", "AGE": 74, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 588.0, "DAYS_TO_BIRTH": -27160.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/15/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 19.331295, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 19.331295, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 19.331295, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 19.331295, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AC-A5XS-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "AC", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 9.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3059, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 27.13333333, "TISSUE_SOURCE_SITE": "International Genomics Consortium", "TBL_SCORE": 42.0 }, "treatments": [ { "START_DATE": 97, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Letrozole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-AR-A0TV": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "6439621e-da61-4723-91cc-c5d87d0a4abc", "AGE": 66, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 2288.0, "DAYS_TO_BIRTH": -24279.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "3/10/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": null, "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 75.22109347, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 75.22109347, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 75.22109347, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 75.22109347, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AR-A0TV-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AR", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 15.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2892, "MSI_SENSOR_SCORE": 0.3, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.9, "TISSUE_SOURCE_SITE": "Mayo", "TBL_SCORE": 278.0 }, "treatments": [] }, "TCGA-EW-A1P6": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "ee5744c0-a8dc-43f2-abdd-0b5529a3e9fb", "AGE": 64, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 562.0, "DAYS_TO_BIRTH": -23485.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/19/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 18.47650985, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 18.47650985, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 18.47650985, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-EW-A1P6-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "EW", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 5.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3383, "MSI_SENSOR_SCORE": 0.35, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.666666667, "TISSUE_SOURCE_SITE": "University of Miami", "TBL_SCORE": 23.0 }, "treatments": [ { "START_DATE": 162, "STOP_DATE": 205.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Fluorouracil", "NUMBER_OF_CYCLES": "3", "PRESCRIBED_DOSE": "870", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "2590", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 233, "STOP_DATE": 233.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": "1", "PRESCRIBED_DOSE": "164", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "164", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 162, "STOP_DATE": 205.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "3", "PRESCRIBED_DOSE": "870", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "2590", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 444, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "4", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 254, "STOP_DATE": 303.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": "8", "PRESCRIBED_DOSE": "131", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "3", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "1080", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 162, "STOP_DATE": 205.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Epirubicin", "NUMBER_OF_CYCLES": "3", "PRESCRIBED_DOSE": "172", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "518", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 321, "STOP_DATE": 386.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": "10,500", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-AC-A2FB": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "02BBB632-0F7F-439D-B8F0-C86A06237424", "AGE": 65, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 1234.0, "DAYS_TO_BIRTH": -23851.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/20/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 40.56941842, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 40.56941842, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 40.56941842, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 40.56941842, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AC-A2FB-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AC", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 4.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3286, "MSI_SENSOR_SCORE": 0.01, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.333333333, "TISSUE_SOURCE_SITE": "International Genomics Consortium", "TBL_SCORE": 44.0 }, "treatments": [ { "START_DATE": 101, "STOP_DATE": 205.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 212, "STOP_DATE": 443.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Trastuzumab", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 225, "STOP_DATE": 895.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-A2-A4RY": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "5A53EC47-E63F-44A2-8078-87659544FB04", "AGE": 46, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIC", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 648.0, "DAYS_TO_BIRTH": -17157.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "2/26/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N3A", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "0:LIVING", "OS_MONTHS": 21.30387612, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 21.30387612, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 21.30387612, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 21.30387612, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A2-A4RY-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "A2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2929, "MSI_SENSOR_SCORE": 0.01, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.0, "TISSUE_SOURCE_SITE": "Walter Reed", "TBL_SCORE": 6.0 }, "treatments": [ { "START_DATE": 58, "STOP_DATE": 164.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 58, "STOP_DATE": 164.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 58, "STOP_DATE": 164.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 203, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 192, "STOP_DATE": 238.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "25", "RADIATION_DOSAGE": "5000", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" }, { "START_DATE": 192, "STOP_DATE": 241.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 2", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "28", "RADIATION_DOSAGE": "5040", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" }, { "START_DATE": 224, "STOP_DATE": 231.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 3", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "5", "RADIATION_DOSAGE": "1000", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" }, { "START_DATE": 193, "STOP_DATE": 238.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 4", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "24", "RADIATION_DOSAGE": "4800", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-AR-A1AU": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "36220587-1c1c-4f92-b177-3b2155e7e273", "AGE": 39, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 2868.0, "DAYS_TO_BIRTH": -14564.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "6/14/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N2", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 94.28937765, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 94.28937765, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 94.28937765, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 94.28937765, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AR-A1AU-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AR", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 6.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2861, "MSI_SENSOR_SCORE": 0.16, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.6, "TISSUE_SOURCE_SITE": "Mayo", "TBL_SCORE": 180.0 }, "treatments": [ { "START_DATE": 43, "STOP_DATE": 85.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "60", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "460", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 43, "STOP_DATE": 85.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "600", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "4540", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 157, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "20", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 99, "STOP_DATE": 141.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "175", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "1320", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 159, "STOP_DATE": 202.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "16", "RADIATION_DOSAGE": "4680", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-D8-A1Y2": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "c7d7a770-23c0-4310-ab48-1f6152dc2849", "AGE": 71, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 433.0, "DAYS_TO_BIRTH": -26021.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "6/9/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 14.23546043, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 14.23546043, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 14.23546043, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 14.23546043, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D8-A1Y2-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "D8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 12.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3604, "MSI_SENSOR_SCORE": 0.37, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.6, "TISSUE_SOURCE_SITE": "Greater Poland Cancer Center", "TBL_SCORE": 56.0 }, "treatments": [ { "START_DATE": 66, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "20", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-E9-A1R5": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "23c21dea-3713-408f-ba56-f7c586e9f206", "AGE": 63, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 92.0, "DAYS_TO_BIRTH": -23116.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/28/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 3.024624388, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 3.024624388, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 3.024624388, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 3.024624388, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E9-A1R5-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "E9", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 10.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2892, "MSI_SENSOR_SCORE": 0.22, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.4, "TISSUE_SOURCE_SITE": "Asterand", "TBL_SCORE": 91.0 }, "treatments": [ { "START_DATE": 24, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "20", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 65, "STOP_DATE": 92.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "25", "RADIATION_DOSAGE": "5000", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-A7-A3IZ": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "15FF4B02-BB69-4D24-8A07-B82F428E428D", "AGE": 62, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 322.0, "DAYS_TO_BIRTH": -22997.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/12/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I+)", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "0:LIVING", "OS_MONTHS": 10.58618536, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 10.58618536, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 10.58618536, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 10.58618536, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A7-A3IZ-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "A7", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 5.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2964, "MSI_SENSOR_SCORE": 0.02, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.0, "TISSUE_SOURCE_SITE": "Christiana Healthcare", "TBL_SCORE": 78.0 }, "treatments": [ { "START_DATE": 73, "STOP_DATE": 134.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "129-131", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "522", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 73, "STOP_DATE": 134.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "1000", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "4000", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 124, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 181, "STOP_DATE": 226.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "33", "RADIATION_DOSAGE": "6100", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-BH-A0E6": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "6c0066e3-96df-4870-bcd3-98cda64082e9", "AGE": 69, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IA", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": 293.0, "DAYS_TO_BIRTH": -25408.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "11/9/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 9.632771148, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 9.632771148, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 9.632771148, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 9.632771148, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A0E6-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 20.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": NaN, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.3, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 120.0 }, "treatments": [ { "START_DATE": 58, "STOP_DATE": 121.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 58, "STOP_DATE": 121.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 145, "STOP_DATE": 191.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "32", "RADIATION_DOSAGE": "5860", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-A8-A095": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "29df128d-ace2-40cf-88ee-3f6f2170f159", "AGE": 45, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE I", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 1277.0, "DAYS_TO_BIRTH": -16742.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "5/27/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": null, "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 41.98310156, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 41.98310156, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 41.98310156, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 41.98310156, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A8-A095-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 9.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2437, "MSI_SENSOR_SCORE": 0.2, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 4.266666667, "TISSUE_SOURCE_SITE": "Indivumed", "TBL_SCORE": 9.0 }, "treatments": [ { "START_DATE": 0, "STOP_DATE": 120.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Fluorouracil", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 0, "STOP_DATE": 120.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 0, "STOP_DATE": 120.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 181, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 120, "STOP_DATE": 181.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "gy" } ] }, "TCGA-GM-A2DC": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "DD43FFD9-DA18-4AD3-ABE7-6F443C76A717", "AGE": 57, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 2535.0, "DAYS_TO_BIRTH": -21122.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/29/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 83.34155242, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 83.34155242, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 83.34155242, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 83.34155242, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-GM-A2DC-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "GM", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 18.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3191, "MSI_SENSOR_SCORE": 0.34, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.5, "TISSUE_SOURCE_SITE": "MD Anderson", "TBL_SCORE": 79.0 }, "treatments": [ { "START_DATE": 57, "STOP_DATE": 119.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Capecitabine", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 57, "STOP_DATE": 119.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 140, "STOP_DATE": 208.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": null, "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 140, "STOP_DATE": 208.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Epirubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 140, "STOP_DATE": 208.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 294, "STOP_DATE": 341.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Letrozole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 355, "STOP_DATE": 383.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 236, "STOP_DATE": 278.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "30", "RADIATION_DOSAGE": "60", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "gy" } ] }, "TCGA-OL-A6VO": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "398FB71B-CA83-44E7-BF0D-B1CA464B0283", "AGE": 43, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 858.0, "DAYS_TO_BIRTH": -15780.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/5/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 28.20791005, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 28.20791005, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 28.20791005, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 28.20791005, "GENETIC_ANCESTRY_LABEL": "AFR_ADMIX" }, "sample": { "SAMPLE_ID": "TCGA-OL-A6VO-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "OL", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 25.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3793, "MSI_SENSOR_SCORE": 1.89, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.1, "TISSUE_SOURCE_SITE": "University of Chicago", "TBL_SCORE": 227.0 }, "treatments": [ { "START_DATE": 71, "STOP_DATE": 147.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 71, "STOP_DATE": 147.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 156, "STOP_DATE": 201.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-E2-A1LL": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "2a84997d-ccee-4f46-bea2-752534f26416", "AGE": 73, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 1309.0, "DAYS_TO_BIRTH": -27028.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "6/3/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N2A", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 43.03514482, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 43.03514482, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 42.83788671, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 42.83788671, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-E2-A1LL-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "E2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 13.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.4091, "MSI_SENSOR_SCORE": 2.8, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.433333333, "TISSUE_SOURCE_SITE": "Roswell Park", "TBL_SCORE": 713.0 }, "treatments": [ { "START_DATE": 49, "STOP_DATE": 49.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "1", "PRESCRIBED_DOSE": "1260", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "1260", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 49, "STOP_DATE": 49.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": "1", "PRESCRIBED_DOSE": "158", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "158", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 105, "STOP_DATE": 147.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "28", "RADIATION_DOSAGE": "5040", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-A2-A0T6": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "08306ede-e74b-4be9-b768-7fd98647b6ac", "AGE": 50, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": 575.0, "DAYS_TO_BIRTH": -18334.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "11/17/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 18.90390242, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 18.90390242, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 18.90390242, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 18.90390242, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A2-A0T6-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 6.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2844, "MSI_SENSOR_SCORE": 0.04, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.566666667, "TISSUE_SOURCE_SITE": "Walter Reed", "TBL_SCORE": 7.0 }, "treatments": [ { "START_DATE": 95, "STOP_DATE": 204.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "6", "PRESCRIBED_DOSE": "900", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "3", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "5400", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 95, "STOP_DATE": 204.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": "6", "PRESCRIBED_DOSE": "135", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "810", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 95, "STOP_DATE": 204.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "6", "PRESCRIBED_DOSE": "90", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "540", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 232, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "20", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "4", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 231, "STOP_DATE": 279.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "33", "RADIATION_DOSAGE": "5940", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-BH-A0H9": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "0f64edec-0f1f-4025-8a53-75f9534f7828", "AGE": 69, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": 1247.0, "DAYS_TO_BIRTH": -25289.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "11/17/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 40.99681099, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 40.99681099, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 40.99681099, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 40.99681099, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A0H9-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 12.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2635, "MSI_SENSOR_SCORE": 0.36, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.2, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 164.0 }, "treatments": [ { "START_DATE": 101, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 225, "STOP_DATE": 263.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "35", "RADIATION_DOSAGE": "6300", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-V7-A7HQ": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "1285EB55-415C-494A-AA58-936F0427CDD0", "AGE": 75, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 2033.0, "DAYS_TO_BIRTH": -27684.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/31/2015", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N2A", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 66.8376237, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 66.8376237, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 66.8376237, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 66.8376237, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-V7-A7HQ-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "V7", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 6.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3439, "MSI_SENSOR_SCORE": 0.01, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.733333333, "TISSUE_SOURCE_SITE": "Medical College of Georgia", "TBL_SCORE": 34.0 }, "treatments": [ { "START_DATE": 129, "STOP_DATE": 1869.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Letrozole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 90, "STOP_DATE": 133.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "30", "RADIATION_DOSAGE": "60", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "gy" } ] }, "TCGA-D8-A1XF": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "6f6afd31-b5dd-48ab-b18f-6390ba18a5f0", "AGE": 45, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 463.0, "DAYS_TO_BIRTH": -16787.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/16/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 15.221751, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 15.221751, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 15.221751, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D8-A1XF-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "D8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 25.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3394, "MSI_SENSOR_SCORE": 1.82, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.933333333, "TISSUE_SOURCE_SITE": "Greater Poland Cancer Center", "TBL_SCORE": 77.0 }, "treatments": [ { "START_DATE": 311, "STOP_DATE": 356.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin + Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "60+600", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-A7-A0DA": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "3afa1e93-1df8-4e4c-aaa4-557463f4bb77", "AGE": 62, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": 1085.0, "DAYS_TO_BIRTH": -22708.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "1/10/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 35.67084196, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 35.67084196, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 35.67084196, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 35.67084196, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A7-A0DA-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "A7", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 16.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2908, "MSI_SENSOR_SCORE": 1.1, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 5.033333333, "TISSUE_SOURCE_SITE": "Christiana Healthcare", "TBL_SCORE": 270.0 }, "treatments": [ { "START_DATE": 65, "STOP_DATE": 107.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "100", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "400", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 65, "STOP_DATE": 107.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "990-1000", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "3990", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 122, "STOP_DATE": 199.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": "12", "PRESCRIBED_DOSE": "90-130", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "1435", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 226, "STOP_DATE": 274.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "33", "RADIATION_DOSAGE": "6100", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-A2-A0YD": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "2c6adb12-380d-4710-a7e6-93d5a0e53289", "AGE": 63, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": 769.0, "DAYS_TO_BIRTH": -23021.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/8/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I+)", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 25.28191472, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 25.28191472, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 25.28191472, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 25.28191472, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A2-A0YD-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 6.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3031, "MSI_SENSOR_SCORE": 0.14, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.866666667, "TISSUE_SOURCE_SITE": "Walter Reed", "TBL_SCORE": 4.0 }, "treatments": [ { "START_DATE": 143, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "3", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 63, "STOP_DATE": 136.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "110", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "440", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 63, "STOP_DATE": 136.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "1100", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "4400", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-E2-A156": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "f05d314c-5ec5-4e2a-b785-9a702716f111", "AGE": 61, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE I", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 726.0, "DAYS_TO_BIRTH": -22422.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/7/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 23.86823158, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 23.86823158, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 23.86823158, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 23.86823158, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E2-A156-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "E2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 2.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.253, "MSI_SENSOR_SCORE": 0.17, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.866666667, "TISSUE_SOURCE_SITE": "Roswell Park", "TBL_SCORE": 27.0 }, "treatments": [ { "START_DATE": 119, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": "1", "TOTAL_DOSE_UNITS": "Mg/Day", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 74, "STOP_DATE": 123.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "33", "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-BH-A18M": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "f63722c1-a0bb-4bf9-8a10-1d76a8e1a0ba", "AGE": 39, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": "5TH", "DAYS_LAST_FOLLOWUP": NaN, "DAYS_TO_BIRTH": -14532.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "6/15/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.3", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.3", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": null, "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 72.55810895, "DSS_STATUS": null, "DSS_MONTHS": 72.55810895, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 72.55810895, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 72.55810895, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A18M-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 4.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2674, "MSI_SENSOR_SCORE": 0.01, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.566666667, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 4.0 }, "treatments": [] }, "TCGA-S3-A6ZH": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "EC461EAF-F5CB-4225-A9A0-59D8E6C17EA6", "AGE": 29, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIC", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 641.0, "DAYS_TO_BIRTH": -10832.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "11/12/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N3A", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 21.07374166, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 21.07374166, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 21.07374166, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 21.07374166, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-S3-A6ZH-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "S3", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 20.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3286, "MSI_SENSOR_SCORE": 0.59, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.1, "TISSUE_SOURCE_SITE": "Albert Einstein Medical Center", "TBL_SCORE": 42.0 }, "treatments": [ { "START_DATE": 141, "STOP_DATE": 185.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 141, "STOP_DATE": 185.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 141, "STOP_DATE": 185.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Ancillary", "TREATMENT_SUBTYPE": null, "AGENT": "Pegfilgrastim", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 200, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 293, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 304, "STOP_DATE": 351.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "55", "RADIATION_DOSAGE": "110", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "gy" } ] }, "TCGA-AR-A1AP": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "9495f029-9882-4c9b-a557-b3aec9e91698", "AGE": 80, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE I", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 2856.0, "DAYS_TO_BIRTH": -29406.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "6/13/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T1", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 93.89486143, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 93.89486143, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 93.89486143, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 93.89486143, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AR-A1AP-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AR", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 12.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.288, "MSI_SENSOR_SCORE": 0.69, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.066666667, "TISSUE_SOURCE_SITE": "Mayo", "TBL_SCORE": 169.0 }, "treatments": [ { "START_DATE": 29, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-A7-A26J": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "6cb6f179-defd-4661-af0a-c353b74c0c49", "AGE": 49, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 627.0, "DAYS_TO_BIRTH": -17930.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/28/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 20.61347273, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 20.61347273, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 20.61347273, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 20.61347273, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A7-A26J-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "A7", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 18.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3412, "MSI_SENSOR_SCORE": 0.35, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.766666667, "TISSUE_SOURCE_SITE": "Christiana Healthcare", "TBL_SCORE": 47.0 }, "treatments": [ { "START_DATE": 92, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "20", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": "5540", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-D8-A140": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "2585edbd-3488-4100-a4ab-a161252a31ee", "AGE": 62, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 403.0, "DAYS_TO_BIRTH": -22900.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "2/26/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 13.24916987, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 13.24916987, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 13.24916987, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 13.24916987, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D8-A140-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "D8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 5.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2922, "MSI_SENSOR_SCORE": 0.07, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 3.166666667, "TISSUE_SOURCE_SITE": "Greater Poland Cancer Center", "TBL_SCORE": 364.0 }, "treatments": [ { "START_DATE": 27, "STOP_DATE": 181.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin + Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "60 doxorubicin+ 600 cph", "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": "4x chemotherapy", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "60 Doxorubicin+ 600 Cph", "TOTAL_DOSE_UNITS": "Mg/M2", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-A7-A4SF": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "D81594D9-DD6A-45C3-8BAD-61960611D78D", "AGE": 54, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 545.0, "DAYS_TO_BIRTH": -19985.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "2/25/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "0:LIVING", "OS_MONTHS": 17.91761186, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 17.91761186, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 17.91761186, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-A7-A4SF-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "A7", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 22.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.313, "MSI_SENSOR_SCORE": 0.57, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.0, "TISSUE_SOURCE_SITE": "Christiana Healthcare", "TBL_SCORE": 150.0 }, "treatments": [ { "START_DATE": 89, "STOP_DATE": 202.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 89, "STOP_DATE": 202.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 89, "STOP_DATE": 453.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Targeted Molecular Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Trastuzumab", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 306, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 232, "STOP_DATE": 279.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "33", "RADIATION_DOSAGE": "6100", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-EW-A1IY": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "5ff12cbe-a3e0-4ce6-8452-12b984a1baaf", "AGE": 38, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE I", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 258.0, "DAYS_TO_BIRTH": -14122.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/10/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Asian", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 8.482098826, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 8.482098826, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 8.482098826, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 8.482098826, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-EW-A1IY-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "EW", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 2.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.333, "MSI_SENSOR_SCORE": 0.36, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.933333333, "TISSUE_SOURCE_SITE": "University of Miami", "TBL_SCORE": 12.0 }, "treatments": [ { "START_DATE": 57, "STOP_DATE": 119.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide + Docetaxel", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "t:136;c:1092", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "tc regimen", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "T:544;C:4368", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-B6-A1KF": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "f30eb65f-fb44-4062-ac39-a38d072f655f", "AGE": 68, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "5TH", "DAYS_LAST_FOLLOWUP": 3088.0, "DAYS_TO_BIRTH": -24891.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/19/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 101.5221751, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 101.5221751, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 101.5221751, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 101.5221751, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-B6-A1KF-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "B6", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 22.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3198, "MSI_SENSOR_SCORE": 0.99, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.566666667, "TISSUE_SOURCE_SITE": "Duke", "TBL_SCORE": 93.0 }, "treatments": [] }, "TCGA-A8-A093": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "02f5ae33-a563-4ecb-9e33-dfa500a44931", "AGE": 61, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 546.0, "DAYS_TO_BIRTH": -22373.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "5/27/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "Yes", "RACE": null, "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 17.95048821, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 17.95048821, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 17.95048821, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 17.95048821, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A8-A093-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 22.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2626, "MSI_SENSOR_SCORE": 0.42, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 3.033333333, "TISSUE_SOURCE_SITE": "Indivumed", "TBL_SCORE": 29.0 }, "treatments": [ { "START_DATE": 28, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 28, "STOP_DATE": 59.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "gy" } ] }, "TCGA-A7-A0DC": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "cb9f5e50-f49d-4899-8895-9367afcc1015", "AGE": 63, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IA", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": 906.0, "DAYS_TO_BIRTH": -23294.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "10/4/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "0:LIVING", "OS_MONTHS": 29.78597495, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 29.78597495, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 29.78597495, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 29.78597495, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A7-A0DC-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "A7", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": NaN, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": NaN, "MSI_SENSOR_SCORE": NaN, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.0, "TISSUE_SOURCE_SITE": "Christiana Healthcare", "TBL_SCORE": 66.0 }, "treatments": [ { "START_DATE": 77, "STOP_DATE": 231.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "8", "PRESCRIBED_DOSE": "1032-1062", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "8346", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 77, "STOP_DATE": 231.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Methotrexate", "NUMBER_OF_CYCLES": "8", "PRESCRIBED_DOSE": "69-71", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "558", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 77, "STOP_DATE": 231.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Fluorouracil", "NUMBER_OF_CYCLES": "8", "PRESCRIBED_DOSE": "1032-1062", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "8346", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 264, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": "170", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 264, "STOP_DATE": 509.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": "245", "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "245", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 510, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 309, "STOP_DATE": 351.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "28", "RADIATION_DOSAGE": "5040", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-E2-A14R": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "4fba3deb-db94-44b5-a0f2-a575d270779e", "AGE": 62, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 1174.0, "DAYS_TO_BIRTH": -22686.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/6/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 38.5968373, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 38.5968373, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 38.5968373, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 31.92293783, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E2-A14R-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "E2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 11.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2927, "MSI_SENSOR_SCORE": 1.89, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 3.7, "TISSUE_SOURCE_SITE": "Roswell Park", "TBL_SCORE": 440.0 }, "treatments": [ { "START_DATE": 89, "STOP_DATE": 131.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "143", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "572", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 145, "STOP_DATE": 145.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": "1", "PRESCRIBED_DOSE": "413", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "413", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 128, "STOP_DATE": 187.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": "3", "PRESCRIBED_DOSE": "610", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "3", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "1832", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 89, "STOP_DATE": 131.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "1428", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "5712", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 210, "STOP_DATE": 259.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "33", "RADIATION_DOSAGE": "6040", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" }, { "START_DATE": 1026, "STOP_DATE": 1061.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 2", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": 2.0, "NUMBER_OF_FRACTIONS": "25", "RADIATION_DOSAGE": "4500", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-C8-A26X": { "demographics": { "SUBTYPE": "BRCA_Her2", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "70ab4f23-23c4-409f-a5cc-18a010c3a24e", "AGE": 58, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 376.0, "DAYS_TO_BIRTH": -21463.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/21/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T1", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "No", "PRIOR_DX": "No", "RACE": "Asian", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 12.36150837, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 12.36150837, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 12.36150837, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 12.36150837, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-C8-A26X-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "C8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 27.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3101, "MSI_SENSOR_SCORE": 0.06, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.3, "TISSUE_SOURCE_SITE": "ILSBio", "TBL_SCORE": 242.0 }, "treatments": [ { "START_DATE": 200, "STOP_DATE": 207.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Fluorouracil", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 200, "STOP_DATE": 207.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 200, "STOP_DATE": 207.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-EW-A2FW": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "E6F527A2-38EB-457E-BB39-3C5B9C0BCBEC", "AGE": 52, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 672.0, "DAYS_TO_BIRTH": -19085.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Hispanic Or Latino", "FORM_COMPLETION_DATE": "10/5/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8503/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 22.09290857, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 22.09290857, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 22.09290857, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 22.09290857, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-EW-A2FW-01", "ONCOTREE_CODE": "BRCNOS", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Carcinoma (NOS)", "TUMOR_TYPE": "Other", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "EW", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 5.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3328, "MSI_SENSOR_SCORE": 0.25, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.766666667, "TISSUE_SOURCE_SITE": "University of Miami", "TBL_SCORE": 158.0 }, "treatments": [ { "START_DATE": 112, "STOP_DATE": 154.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Fluorouracil", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 112, "STOP_DATE": 154.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Epirubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 112, "STOP_DATE": 154.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 175, "STOP_DATE": 217.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 0, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Exemestane", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 279, "STOP_DATE": 329.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "30", "RADIATION_DOSAGE": "6400", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-AO-A126": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "cc0902fd-a2fc-4327-929e-d4219e32e1d7", "AGE": 39, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": 3307.0, "DAYS_TO_BIRTH": -14264.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/7/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Asian", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 108.7220962, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 108.7220962, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 8.777985995, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 8.777985995, "GENETIC_ANCESTRY_LABEL": "EAS" }, "sample": { "SAMPLE_ID": "TCGA-AO-A126-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AO", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 4.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": NaN, "MSI_SENSOR_SCORE": 0.16, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.633333333, "TISSUE_SOURCE_SITE": "MSKCC", "TBL_SCORE": 83.0 }, "treatments": [ { "START_DATE": 91, "STOP_DATE": 238.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "8", "PRESCRIBED_DOSE": "600", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "7776", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 91, "STOP_DATE": 238.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Fluorouracil", "NUMBER_OF_CYCLES": "8", "PRESCRIBED_DOSE": "600", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "7776", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 323, "STOP_DATE": 1639.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Goserelin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Recurrence", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "SC", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 320, "STOP_DATE": 1795.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "20", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Recurrence", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 91, "STOP_DATE": 238.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Methotrexate", "NUMBER_OF_CYCLES": "8", "PRESCRIBED_DOSE": "40", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "520", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 384, "STOP_DATE": 421.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Recurrence", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Local Recurrence", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "25", "RADIATION_DOSAGE": "10000", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-E2-A159": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "d7308344-5bab-4073-bb4f-4d8cd8d7bd17", "AGE": 50, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 762.0, "DAYS_TO_BIRTH": -18621.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/7/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 25.05178025, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 25.05178025, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 25.05178025, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 25.05178025, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-E2-A159-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "E2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 18.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2551, "MSI_SENSOR_SCORE": 0.17, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 4.366666667, "TISSUE_SOURCE_SITE": "Roswell Park", "TBL_SCORE": 124.0 }, "treatments": [ { "START_DATE": 50, "STOP_DATE": 91.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "127", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "508", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 113, "STOP_DATE": 141.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": "3", "PRESCRIBED_DOSE": "378", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "1134", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 50, "STOP_DATE": 91.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "1272", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "5088", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 165, "STOP_DATE": 215.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "34", "RADIATION_DOSAGE": "6240", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-D8-A1JC": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "02e6f999-24f2-4ad2-9b92-df3ee2b082e5", "AGE": 59, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 480.0, "DAYS_TO_BIRTH": -21898.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/29/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N2A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 15.78064898, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 15.78064898, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 15.78064898, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 15.78064898, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D8-A1JC-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "D8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 14.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2977, "MSI_SENSOR_SCORE": 0.2, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.533333333, "TISSUE_SOURCE_SITE": "Greater Poland Cancer Center", "TBL_SCORE": 109.0 }, "treatments": [ { "START_DATE": 24, "STOP_DATE": 87.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "60", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "240", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 24, "STOP_DATE": 87.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 122, "STOP_DATE": 147.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": "4500", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-A7-A6VW": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "98E709E7-E195-4B37-9537-F6081AFFB609", "AGE": 48, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 285.0, "DAYS_TO_BIRTH": -17539.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "10/29/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 9.369760331, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 9.369760331, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 9.369760331, "GENETIC_ANCESTRY_LABEL": "AFR_ADMIX" }, "sample": { "SAMPLE_ID": "TCGA-A7-A6VW-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "A7", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 13.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3487, "MSI_SENSOR_SCORE": 0.47, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.866666667, "TISSUE_SOURCE_SITE": "Christiana Healthcare", "TBL_SCORE": 137.0 }, "treatments": [ { "START_DATE": 148, "STOP_DATE": 257.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 84, "STOP_DATE": 134.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 84, "STOP_DATE": 134.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 285, "STOP_DATE": 331.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "28", "RADIATION_DOSAGE": "50.4", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "gy" } ] }, "TCGA-C8-A12K": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "6b923e30-2ddc-407f-91b1-c202f1373fbb", "AGE": 80, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 0.0, "DAYS_TO_BIRTH": -29463.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/12/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Asian", "RADIATION_THERAPY": null, "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 0.0, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 0.0, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 0.0, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 0.0, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-C8-A12K-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "C8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 6.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2834, "MSI_SENSOR_SCORE": 0.14, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 4.166666667, "TISSUE_SOURCE_SITE": "ILSBio", "TBL_SCORE": 224.0 }, "treatments": [] }, "TCGA-BH-A1EN": { "demographics": { "SUBTYPE": "BRCA_Her2", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "858652b8-c4c2-41d8-be32-fdc88e1a7bb0", "AGE": 78, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "5TH", "DAYS_LAST_FOLLOWUP": NaN, "DAYS_TO_BIRTH": -28724.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/3/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "NX", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": null, "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 69.92800079, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 69.92800079, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 69.92800079, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 69.92800079, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A1EN-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 24.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3256, "MSI_SENSOR_SCORE": 0.37, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.133333333, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 128.0 }, "treatments": [] }, "TCGA-A2-A0D0": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "324bcba2-f6a4-45a6-807c-215bdffcca21", "AGE": 60, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 2048.0, "DAYS_TO_BIRTH": -22115.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/16/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 67.33076898, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 67.33076898, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 67.33076898, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 67.33076898, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-A2-A0D0-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 17.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3096, "MSI_SENSOR_SCORE": 1.96, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.466666667, "TISSUE_SOURCE_SITE": "Walter Reed", "TBL_SCORE": 428.0 }, "treatments": [ { "START_DATE": 62, "STOP_DATE": 125.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "153", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "612", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 62, "STOP_DATE": 125.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "1230", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "4920", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-EW-A1P3": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "1ff85ada-3cdd-4afb-b311-2c7befb52702", "AGE": 48, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 1611.0, "DAYS_TO_BIRTH": -17637.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "6/10/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 52.96380314, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 52.96380314, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 52.96380314, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 52.96380314, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-EW-A1P3-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "EW", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 11.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3187, "MSI_SENSOR_SCORE": 0.04, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.733333333, "TISSUE_SOURCE_SITE": "University of Miami", "TBL_SCORE": 16.0 }, "treatments": [ { "START_DATE": 261, "STOP_DATE": 1175.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Stable Disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 1181, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Letrozole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 105, "STOP_DATE": 147.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Fluorouracil", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 105, "STOP_DATE": 147.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Epirubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 105, "STOP_DATE": 147.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 167, "STOP_DATE": 233.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Stable Disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-AN-A0XT": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "3e25056d-d137-49f5-abaa-f68509426600", "AGE": 54, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 10.0, "DAYS_TO_BIRTH": -19794.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/28/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N2", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 0.32876352, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 0.32876352, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 0.32876352, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 0.32876352, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AN-A0XT-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AN", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 9.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2982, "MSI_SENSOR_SCORE": 0.31, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.366666667, "TISSUE_SOURCE_SITE": "Cureline", "TBL_SCORE": 125.0 }, "treatments": [] }, "TCGA-D8-A1Y0": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "ced2c048-b047-43ff-b0e7-cd7ad480850c", "AGE": 65, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 472.0, "DAYS_TO_BIRTH": -24083.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "6/9/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N2A", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 15.51763816, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 15.51763816, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 15.51763816, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D8-A1Y0-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "D8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 10.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.312, "MSI_SENSOR_SCORE": 1.12, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.866666667, "TISSUE_SOURCE_SITE": "Greater Poland Cancer Center", "TBL_SCORE": 120.0 }, "treatments": [ { "START_DATE": 62, "STOP_DATE": 167.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide + Methotrexate + Fluorouracil", "NUMBER_OF_CYCLES": "6", "PRESCRIBED_DOSE": "970+58.2+970", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "5820+349.2+5820", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 540, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "20", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 201, "STOP_DATE": 232.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "25", "RADIATION_DOSAGE": "5000", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-AO-A12F": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "495f9eda-b9be-4eef-bae1-766a4bfbd68e", "AGE": 36, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 1471.0, "DAYS_TO_BIRTH": -13409.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/8/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 60.55824046, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 60.55824046, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 60.55824046, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 60.55824046, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AO-A12F-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AO", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 21.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3132, "MSI_SENSOR_SCORE": 1.59, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.166666667, "TISSUE_SOURCE_SITE": "MSKCC", "TBL_SCORE": 290.0 }, "treatments": [ { "START_DATE": 63, "STOP_DATE": 189.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "175", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 63, "STOP_DATE": 189.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "600", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 63, "STOP_DATE": 189.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "60", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 220, "STOP_DATE": 254.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "25", "RADIATION_DOSAGE": "5000", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-AO-A12D": { "demographics": { "SUBTYPE": "BRCA_Her2", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "2fe854b4-bac9-4801-9a1c-ee99388e8082", "AGE": 43, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 2515.0, "DAYS_TO_BIRTH": -15774.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/8/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 82.68402538, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 82.68402538, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 82.68402538, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 82.68402538, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AO-A12D-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AO", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 16.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2829, "MSI_SENSOR_SCORE": 0.07, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.766666667, "TISSUE_SOURCE_SITE": "MSKCC", "TBL_SCORE": 306.0 }, "treatments": [ { "START_DATE": 170, "STOP_DATE": 503.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Targeted Molecular Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Trastuzumab", "NUMBER_OF_CYCLES": "17", "PRESCRIBED_DOSE": "6", "PRESCRIBED_DOSE_UNITS": "mg/kg", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 65, "STOP_DATE": 128.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "600", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "3984", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 149, "STOP_DATE": 212.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "200", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "1728", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 65, "STOP_DATE": 128.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "60", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "400", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 282, "STOP_DATE": 316.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "25", "RADIATION_DOSAGE": "10000", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-OL-A5D7": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "C8F39325-5382-447C-9291-A6915FC978B8", "AGE": 70, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 1780.0, "DAYS_TO_BIRTH": -25643.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/19/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 58.51990663, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 58.51990663, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 58.51990663, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 58.51990663, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-OL-A5D7-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "OL", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 14.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2907, "MSI_SENSOR_SCORE": 0.15, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.766666667, "TISSUE_SOURCE_SITE": "University of Chicago", "TBL_SCORE": 339.0 }, "treatments": [ { "START_DATE": 41, "STOP_DATE": 104.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 41, "STOP_DATE": 104.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 134, "STOP_DATE": 550.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": "5040", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-D8-A13Z": { "demographics": { "SUBTYPE": "BRCA_Her2", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "5a17dcd9-5ced-4a69-8069-23c7fd0649d1", "AGE": 51, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 635.0, "DAYS_TO_BIRTH": -18942.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "2/27/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N2A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 20.87648355, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 20.87648355, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 20.87648355, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 20.87648355, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D8-A13Z-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "D8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 27.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2975, "MSI_SENSOR_SCORE": 0.33, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.766666667, "TISSUE_SOURCE_SITE": "Greater Poland Cancer Center", "TBL_SCORE": 334.0 }, "treatments": [ { "START_DATE": 52, "STOP_DATE": 157.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "6", "PRESCRIBED_DOSE": "6x97.8", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "586.8", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 52, "STOP_DATE": 157.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 52, "STOP_DATE": 157.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 184, "STOP_DATE": 210.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "18", "RADIATION_DOSAGE": "4500", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-AN-A0G0": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "96312510-c126-485d-8109-ed81844a1dc3", "AGE": 56, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": 16.0, "DAYS_TO_BIRTH": -20504.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/29/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "0:LIVING", "OS_MONTHS": 0.526021633, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 0.526021633, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 0.526021633, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 0.526021633, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AN-A0G0-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AN", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": NaN, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3083, "MSI_SENSOR_SCORE": 0.73, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.066666667, "TISSUE_SOURCE_SITE": "Cureline", "TBL_SCORE": 3662.0 }, "treatments": [] }, "TCGA-BH-A0DX": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "035cb359-eac3-484a-9e88-3ddc739440a3", "AGE": 62, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE I", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 2156.0, "DAYS_TO_BIRTH": -22833.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "8/11/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T1B", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 70.881415, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 70.881415, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 70.881415, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 70.881415, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A0DX-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 4.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2882, "MSI_SENSOR_SCORE": 0.02, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.966666667, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 136.0 }, "treatments": [ { "START_DATE": 79, "STOP_DATE": 143.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 79, "STOP_DATE": 143.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 143, "STOP_DATE": 171.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 143, "STOP_DATE": 171.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Methotrexate", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 171, "STOP_DATE": 221.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "36", "RADIATION_DOSAGE": "5040", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-A8-A07Z": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "a272171b-44f5-47a5-89be-7520413c01ad", "AGE": 85, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 1371.0, "DAYS_TO_BIRTH": -31351.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "5/27/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": null, "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 45.07347865, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 45.07347865, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 45.07347865, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 45.07347865, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A8-A07Z-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 11.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2957, "MSI_SENSOR_SCORE": 2.61, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.5, "TISSUE_SOURCE_SITE": "Indivumed", "TBL_SCORE": 8.0 }, "treatments": [] }, "TCGA-B6-A1KC": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "1502c7d7-1535-4e56-9f34-30623acd50d5", "AGE": 67, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 1326.0, "DAYS_TO_BIRTH": -24791.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/19/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 43.59404281, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 43.59404281, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 43.59404281, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 43.59404281, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-B6-A1KC-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "B6", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 27.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3311, "MSI_SENSOR_SCORE": 1.45, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.866666667, "TISSUE_SOURCE_SITE": "Duke", "TBL_SCORE": 38.0 }, "treatments": [] }, "TCGA-B6-A0WZ": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "08740d7f-5a5e-4dfa-bd48-7fbf228a7a28", "AGE": 50, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "4TH", "DAYS_LAST_FOLLOWUP": 6292.0, "DAYS_TO_BIRTH": -18584.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/14/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1B", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 206.858007, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 206.858007, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 206.858007, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 168.2282934, "GENETIC_ANCESTRY_LABEL": "AFR_ADMIX" }, "sample": { "SAMPLE_ID": "TCGA-B6-A0WZ-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "B6", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 11.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2808, "MSI_SENSOR_SCORE": 0.04, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.866666667, "TISSUE_SOURCE_SITE": "Duke", "TBL_SCORE": 11.0 }, "treatments": [] }, "TCGA-C8-A1HO": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "b3354b72-2637-4edc-9a95-e55801d3ac13", "AGE": 34, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIC", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 375.0, "DAYS_TO_BIRTH": -12715.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/12/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N3", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "No", "PRIOR_DX": "No", "RACE": "Asian", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 12.32863202, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 12.32863202, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 12.32863202, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 12.32863202, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-C8-A1HO-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "C8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 5.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3394, "MSI_SENSOR_SCORE": 0.91, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.933333333, "TISSUE_SOURCE_SITE": "ILSBio", "TBL_SCORE": 132.0 }, "treatments": [ { "START_DATE": -49, "STOP_DATE": -45.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Fluorouracil", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": -49, "STOP_DATE": -45.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Epirubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": -49, "STOP_DATE": -45.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-AR-A0U4": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "71f97b63-c970-44ee-98c2-e02e663d5a40", "AGE": 54, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 3261.0, "DAYS_TO_BIRTH": -19729.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/10/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 107.209784, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 107.209784, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 107.209784, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 107.209784, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AR-A0U4-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AR", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 11.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": NaN, "MSI_SENSOR_SCORE": 0.17, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 4.833333333, "TISSUE_SOURCE_SITE": "Mayo", "TBL_SCORE": 330.0 }, "treatments": [ { "START_DATE": 53, "STOP_DATE": 98.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "60", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "540", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 112, "STOP_DATE": 154.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "175", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "1560", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 53, "STOP_DATE": 98.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "600", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "5380", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-E2-A150": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "4ac693e9-10f3-46b3-9d46-df3af7b0d259", "AGE": 48, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 1935.0, "DAYS_TO_BIRTH": -17580.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/6/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 63.6157412, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 63.6157412, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 63.6157412, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 63.6157412, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E2-A150-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "E2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 16.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2718, "MSI_SENSOR_SCORE": 0.51, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.3, "TISSUE_SOURCE_SITE": "Roswell Park", "TBL_SCORE": 277.0 }, "treatments": [ { "START_DATE": 24, "STOP_DATE": 66.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "1218", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "4872", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 80, "STOP_DATE": 129.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "398", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "1719", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 24, "STOP_DATE": 96.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "122", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "488", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 154, "STOP_DATE": 202.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "33", "RADIATION_DOSAGE": "6040", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-AC-A6IW": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "8183F0FB-2303-4D7B-BCCD-55E5031FC7DF", "AGE": 73, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 413.0, "DAYS_TO_BIRTH": -26896.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "10/15/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 13.57793339, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 13.57793339, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 13.57793339, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 13.57793339, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-AC-A6IW-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "AC", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 13.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3474, "MSI_SENSOR_SCORE": 0.32, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 4.366666667, "TISSUE_SOURCE_SITE": "International Genomics Consortium", "TBL_SCORE": 224.0 }, "treatments": [] }, "TCGA-A8-A08R": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "6412854a-f874-469e-9d1f-8bd3ae5bd41d", "AGE": 52, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 30.0, "DAYS_TO_BIRTH": -19298.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "5/27/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": null, "RADIATION_THERAPY": null, "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 0.986290561, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 0.986290561, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 0.986290561, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 0.986290561, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-A8-A08R-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 17.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2989, "MSI_SENSOR_SCORE": 0.41, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 7.566666667, "TISSUE_SOURCE_SITE": "Indivumed", "TBL_SCORE": 179.0 }, "treatments": [] }, "TCGA-AR-A0TP": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "ab89bb2e-da84-4116-a8cd-49aad7bbfd4d", "AGE": 43, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 4275.0, "DAYS_TO_BIRTH": -15812.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "2/25/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 140.546405, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 140.546405, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 140.546405, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 140.546405, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AR-A0TP-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AR", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 5.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3145, "MSI_SENSOR_SCORE": 1.38, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.8, "TISSUE_SOURCE_SITE": "Mayo", "TBL_SCORE": 145.0 }, "treatments": [ { "START_DATE": 32, "STOP_DATE": 97.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "60", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "555", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 32, "STOP_DATE": 97.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "600", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "5510", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 125, "STOP_DATE": 166.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "30", "RADIATION_DOSAGE": "6000", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-AR-A250": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "a0963e93-b63e-4de2-86c1-81302e271d3e", "AGE": 58, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 2707.0, "DAYS_TO_BIRTH": -21309.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "8/30/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 88.99628497, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 88.99628497, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 88.99628497, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 88.99628497, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AR-A250-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AR", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 19.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3337, "MSI_SENSOR_SCORE": 1.63, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 3.933333333, "TISSUE_SOURCE_SITE": "Mayo", "TBL_SCORE": 165.0 }, "treatments": [ { "START_DATE": 45, "STOP_DATE": 88.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 45, "STOP_DATE": 88.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 102, "STOP_DATE": 179.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 102, "STOP_DATE": 102.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Immunotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Trastuzumab", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 109, "STOP_DATE": 179.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Immunotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Trastuzumab", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 193, "STOP_DATE": 466.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Immunotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Trastuzumab", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 194, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-A2-A1G6": { "demographics": { "SUBTYPE": "BRCA_Normal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "295cf595-4a29-46a3-a0c5-e5f08f947031", "AGE": 50, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 501.0, "DAYS_TO_BIRTH": -18514.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/22/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N2A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 16.47105237, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 16.47105237, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 16.47105237, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 16.47105237, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A2-A1G6-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "A2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": NaN, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3082, "MSI_SENSOR_SCORE": 0.07, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.266666667, "TISSUE_SOURCE_SITE": "Walter Reed", "TBL_SCORE": 0.0 }, "treatments": [ { "START_DATE": 132, "STOP_DATE": 172.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": "3", "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": "3", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 69, "STOP_DATE": 119.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 69, "STOP_DATE": 119.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 249, "STOP_DATE": 283.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "25", "RADIATION_DOSAGE": "4500", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" }, { "START_DATE": 249, "STOP_DATE": 283.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 2", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": 2.0, "NUMBER_OF_FRACTIONS": "25", "RADIATION_DOSAGE": "4500", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" }, { "START_DATE": 284, "STOP_DATE": 293.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 3", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": 3.0, "NUMBER_OF_FRACTIONS": "8", "RADIATION_DOSAGE": "1600", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-AO-A03T": { "demographics": { "SUBTYPE": "BRCA_Normal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "dd6b64a8-d546-4fd1-bbbd-ac9703791cae", "AGE": 42, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 1456.0, "DAYS_TO_BIRTH": -15540.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/19/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 69.82937173, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 69.82937173, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 69.82937173, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 69.82937173, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AO-A03T-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AO", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 6.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2639, "MSI_SENSOR_SCORE": 0.02, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.966666667, "TISSUE_SOURCE_SITE": "MSKCC", "TBL_SCORE": 50.0 }, "treatments": [ { "START_DATE": 80, "STOP_DATE": 122.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "600", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "4032", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 136, "STOP_DATE": 178.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "175", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "1176", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 1130, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Letrozole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "2.5", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "3", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 232, "STOP_DATE": 1095.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "20", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 80, "STOP_DATE": 122.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "60", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "404", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 1095, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Leuprolide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "7.5", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "3", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IM", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-A8-A09X": { "demographics": { "SUBTYPE": "BRCA_Her2", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "27b05b15-a44b-45ed-a6e3-e7d1ca488ea9", "AGE": 62, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIC", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": NaN, "DAYS_TO_BIRTH": -22858.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "5/27/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N3A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": null, "RADIATION_THERAPY": null, "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 14.00532597, "DSS_STATUS": null, "DSS_MONTHS": 14.00532597, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 14.00532597, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A8-A09X-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 21.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2478, "MSI_SENSOR_SCORE": 0.01, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.533333333, "TISSUE_SOURCE_SITE": "Indivumed", "TBL_SCORE": 92.0 }, "treatments": [] }, "TCGA-A2-A0T7": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "43d5632e-7272-4aad-9496-7f5a99671223", "AGE": 51, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": 631.0, "DAYS_TO_BIRTH": -18756.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "11/17/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I+)", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 20.74497814, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 20.74497814, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 20.74497814, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 20.74497814, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A2-A0T7-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 12.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3038, "MSI_SENSOR_SCORE": 0.02, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.766666667, "TISSUE_SOURCE_SITE": "Walter Reed", "TBL_SCORE": 91.0 }, "treatments": [ { "START_DATE": 117, "STOP_DATE": 145.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "3", "PRESCRIBED_DOSE": "1100", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 117, "STOP_DATE": 145.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "3", "PRESCRIBED_DOSE": "110", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 365, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "20", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "4", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 159, "STOP_DATE": 243.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": "12", "PRESCRIBED_DOSE": "145", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "3", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-EW-A1J2": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "a381275f-8858-4793-a8a2-0ca9db7274c8", "AGE": 50, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 403.0, "DAYS_TO_BIRTH": -18558.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/27/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N1MI", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 13.24916987, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 13.24916987, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 13.24916987, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 13.24916987, "GENETIC_ANCESTRY_LABEL": "SAS" }, "sample": { "SAMPLE_ID": "TCGA-EW-A1J2-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "EW", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 4.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3199, "MSI_SENSOR_SCORE": 0.13, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.1, "TISSUE_SOURCE_SITE": "University of Miami", "TBL_SCORE": 14.0 }, "treatments": [ { "START_DATE": 76, "STOP_DATE": 140.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "135", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "tc", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 150, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 76, "STOP_DATE": 140.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "1080", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "tc", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-AC-A7VC": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "2B36853F-34D3-47C5-BA6A-E5A93233D2B1", "AGE": 56, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 1.0, "DAYS_TO_BIRTH": -20479.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/29/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8575/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": null, "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 0.032876352, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 0.032876352, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 0.032876352, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 0.032876352, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AC-A7VC-01", "ONCOTREE_CODE": "MBC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Metaplastic Breast Cancer", "TUMOR_TYPE": "Metaplastic Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "AC", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 1.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3371, "MSI_SENSOR_SCORE": 0.02, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.5, "TISSUE_SOURCE_SITE": "International Genomics Consortium", "TBL_SCORE": 33.0 }, "treatments": [] }, "TCGA-AQ-A54O": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "35CA5E2A-861A-4DD2-A4CE-D294CF080DA3", "AGE": 51, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 1001.0, "DAYS_TO_BIRTH": -18694.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "2/26/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "Yes", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "0:LIVING", "OS_MONTHS": 32.90922839, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 32.90922839, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 32.90922839, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 32.90922839, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-AQ-A54O-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "AQ", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 20.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2926, "MSI_SENSOR_SCORE": 0.08, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.6, "TISSUE_SOURCE_SITE": "UNC", "TBL_SCORE": 129.0 }, "treatments": [ { "START_DATE": 77, "STOP_DATE": 118.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 77, "STOP_DATE": 118.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 132, "STOP_DATE": 176.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 199, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-A1-A0SH": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "a6a863d9-b39d-4965-b47f-79a1bcf3c976", "AGE": 39, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 1437.0, "DAYS_TO_BIRTH": -14595.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/6/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": null, "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 47.24331788, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 47.24331788, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 47.24331788, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 47.24331788, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A1-A0SH-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A1", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 2.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.4765, "MSI_SENSOR_SCORE": 0.02, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 3.133333333, "TISSUE_SOURCE_SITE": "UCSF", "TBL_SCORE": 35.0 }, "treatments": [ { "START_DATE": 102, "STOP_DATE": 179.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide + Docetaxel", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-EW-A2FR": { "demographics": { "SUBTYPE": "BRCA_Her2", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "AF97E043-88CB-4F99-8F8B-9BCBCCCDF842", "AGE": 59, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIC", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 1673.0, "DAYS_TO_BIRTH": -21628.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "10/12/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N3A", "PATH_T_STAGE": "T1B", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 55.00213696, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 55.00213696, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 55.00213696, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 55.00213696, "GENETIC_ANCESTRY_LABEL": "SAS" }, "sample": { "SAMPLE_ID": "TCGA-EW-A2FR-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "EW", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 22.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2905, "MSI_SENSOR_SCORE": 0.02, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.266666667, "TISSUE_SOURCE_SITE": "University of Miami", "TBL_SCORE": 182.0 }, "treatments": [ { "START_DATE": 34, "STOP_DATE": 76.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Epirubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 34, "STOP_DATE": 76.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Fluorouracil", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 34, "STOP_DATE": 76.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 97, "STOP_DATE": 174.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Stable Disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-AN-A0FN": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "c2a742fe-3e8b-4210-85a6-7191a1123609", "AGE": 61, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 218.0, "DAYS_TO_BIRTH": -22629.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/28/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 7.167044745, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 7.167044745, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 7.167044745, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 7.167044745, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AN-A0FN-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AN", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 3.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3094, "MSI_SENSOR_SCORE": 0.05, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.333333333, "TISSUE_SOURCE_SITE": "Cureline", "TBL_SCORE": 10.0 }, "treatments": [] }, "TCGA-A8-A090": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "f4b69043-4a67-48e3-a4d1-72a21ae2d175", "AGE": 74, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 0.0, "DAYS_TO_BIRTH": -27121.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "5/27/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": null, "RADIATION_THERAPY": null, "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 0.0, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 0.0, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 0.0, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 0.0, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A8-A090-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 17.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2517, "MSI_SENSOR_SCORE": 0.5, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.133333333, "TISSUE_SOURCE_SITE": "Indivumed", "TBL_SCORE": 141.0 }, "treatments": [] }, "TCGA-AR-A1AV": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "daf62b56-6dd2-4ab7-adaa-f296bb86a0a5", "AGE": 68, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 1864.0, "DAYS_TO_BIRTH": -24875.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Hispanic Or Latino", "FORM_COMPLETION_DATE": "6/14/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "0:LIVING", "OS_MONTHS": 61.2815202, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 61.2815202, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 61.2815202, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 61.2815202, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AR-A1AV-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AR", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 23.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2618, "MSI_SENSOR_SCORE": 0.47, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.4, "TISSUE_SOURCE_SITE": "Mayo", "TBL_SCORE": 44.0 }, "treatments": [ { "START_DATE": 175, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "20", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 126, "STOP_DATE": 170.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "175", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "1450", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 50, "STOP_DATE": 105.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "60", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "505", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 50, "STOP_DATE": 105.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "600", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "5080", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 194, "STOP_DATE": 239.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "33", "RADIATION_DOSAGE": "6040", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-E9-A229": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "cea9d8f9-e18c-4947-a461-5f712e3c1e6d", "AGE": 37, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 1148.0, "DAYS_TO_BIRTH": -13817.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "8/2/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 37.74205214, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 37.74205214, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 37.74205214, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 37.74205214, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E9-A229-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "E9", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 4.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3246, "MSI_SENSOR_SCORE": 0.02, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.7, "TISSUE_SOURCE_SITE": "Asterand", "TBL_SCORE": 130.0 }, "treatments": [ { "START_DATE": 24, "STOP_DATE": 182.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "6", "PRESCRIBED_DOSE": "90", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "360", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 24, "STOP_DATE": 182.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "6", "PRESCRIBED_DOSE": "900", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "3600", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 24, "STOP_DATE": 182.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Fluorouracil", "NUMBER_OF_CYCLES": "6", "PRESCRIBED_DOSE": "700", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "4200", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 207, "STOP_DATE": 235.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "19", "RADIATION_DOSAGE": "3800", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-C8-A3M8": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "C1E704D6-A33B-4891-90BD-992B0040C075", "AGE": 68, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 394.0, "DAYS_TO_BIRTH": -24877.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/6/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Asian", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 12.9532827, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 12.9532827, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 12.9532827, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 12.9532827, "GENETIC_ANCESTRY_LABEL": "EAS" }, "sample": { "SAMPLE_ID": "TCGA-C8-A3M8-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "C8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 9.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2895, "MSI_SENSOR_SCORE": 0.05, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.433333333, "TISSUE_SOURCE_SITE": "ILSBio", "TBL_SCORE": 95.0 }, "treatments": [ { "START_DATE": 79, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-AC-A6IX": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "7486A2B3-B09F-4E9C-9864-8B51B58D9FB3", "AGE": 49, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIC", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 373.0, "DAYS_TO_BIRTH": -17969.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "10/21/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N3A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 12.26287931, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 12.26287931, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 12.26287931, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 12.26287931, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AC-A6IX-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "AC", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 5.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3363, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.633333333, "TISSUE_SOURCE_SITE": "International Genomics Consortium", "TBL_SCORE": 116.0 }, "treatments": [] }, "TCGA-A8-A07U": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "59bf0ce4-715a-4017-bccb-c59916e78324", "AGE": 66, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 760.0, "DAYS_TO_BIRTH": -24411.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "5/27/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N2A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": null, "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 24.98602755, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 24.98602755, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 24.98602755, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 24.98602755, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A8-A07U-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 26.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2869, "MSI_SENSOR_SCORE": 0.01, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.066666667, "TISSUE_SOURCE_SITE": "Indivumed", "TBL_SCORE": 75.0 }, "treatments": [ { "START_DATE": 30, "STOP_DATE": 30.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Fluorouracil", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 30, "STOP_DATE": 30.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Epirubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 30, "STOP_DATE": 30.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 212, "STOP_DATE": 242.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": "60", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "gy" } ] }, "TCGA-AC-A3EH": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "FAC173A8-1613-4BD4-87BA-83A2CFE8A37D", "AGE": 79, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIC", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 17.0, "DAYS_TO_BIRTH": -29014.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/24/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8022/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N3", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 6.476641352, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 6.476641352, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 6.476641352, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 6.476641352, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AC-A3EH-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "AC", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 13.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3295, "MSI_SENSOR_SCORE": 0.18, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.0, "TISSUE_SOURCE_SITE": "International Genomics Consortium", "TBL_SCORE": 57.0 }, "treatments": [] }, "TCGA-BH-A1FL": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "14d1d84e-99e1-41ad-8892-3b4da3d4f948", "AGE": 69, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "5TH", "DAYS_LAST_FOLLOWUP": NaN, "DAYS_TO_BIRTH": -25558.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/8/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1B", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": null, "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 55.00213696, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 55.00213696, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 55.00213696, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A1FL-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 4.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3396, "MSI_SENSOR_SCORE": 0.94, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.6, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 26.0 }, "treatments": [] }, "TCGA-E9-A5FK": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "B304302A-F2B9-4CD7-AB14-C21EDF7778EA", "AGE": 60, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIC", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 812.0, "DAYS_TO_BIRTH": -22199.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/22/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N3", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 26.69559786, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 26.69559786, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 26.69559786, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 26.69559786, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E9-A5FK-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "E9", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": NaN, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2958, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.733333333, "TISSUE_SOURCE_SITE": "Asterand", "TBL_SCORE": 29.0 }, "treatments": [ { "START_DATE": 21, "STOP_DATE": 200.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 21, "STOP_DATE": 200.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Methotrexate", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 21, "STOP_DATE": 200.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Fluorouracil", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 130, "STOP_DATE": 154.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": "80", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "gy" } ] }, "TCGA-E2-A15J": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "1fef9454-b3e8-4d9d-a9aa-aa1f1a32b80c", "AGE": 51, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE I", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 1640.0, "DAYS_TO_BIRTH": -18771.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/13/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 53.91721735, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 53.91721735, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 53.91721735, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 53.91721735, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E2-A15J-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "E2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 5.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2733, "MSI_SENSOR_SCORE": 0.19, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.666666667, "TISSUE_SOURCE_SITE": "Roswell Park", "TBL_SCORE": 19.0 }, "treatments": [ { "START_DATE": 151, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "20", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": "20", "TOTAL_DOSE_UNITS": "Mg/Day", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 65, "STOP_DATE": 128.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "1008", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "4032", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 65, "STOP_DATE": 128.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "126", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "504", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-AC-A3YI": { "demographics": { "SUBTYPE": "BRCA_Normal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "A45D296E-EFC0-479E-B2F6-BAD834668CDF", "AGE": 74, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIC", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 707.0, "DAYS_TO_BIRTH": -27143.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "10/8/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N3A", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 23.24358089, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 23.24358089, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 23.24358089, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 23.24358089, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AC-A3YI-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "AC", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.281, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.466666667, "TISSUE_SOURCE_SITE": "International Genomics Consortium", "TBL_SCORE": 48.0 }, "treatments": [ { "START_DATE": 82, "STOP_DATE": 167.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 82, "STOP_DATE": 167.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Methotrexate", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 82, "STOP_DATE": 167.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Fluorouracil", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 250, "STOP_DATE": 297.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "30", "RADIATION_DOSAGE": "6000", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-OL-A5DA": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "4E509F73-99C7-48EB-A3A4-D34E3BFACE33", "AGE": 61, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 1783.0, "DAYS_TO_BIRTH": -22411.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/23/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 58.61853569, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 58.61853569, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 58.61853569, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 58.61853569, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-OL-A5DA-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "OL", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 6.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3041, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.033333333, "TISSUE_SOURCE_SITE": "University of Chicago", "TBL_SCORE": 102.0 }, "treatments": [] }, "TCGA-BH-A0BF": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "e6b79d7a-ed6b-459a-b040-d142616e7ab4", "AGE": 56, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 782.0, "DAYS_TO_BIRTH": -20691.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "8/5/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1MI", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 43.5282901, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 43.5282901, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 43.5282901, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 43.5282901, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A0BF-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 12.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2908, "MSI_SENSOR_SCORE": 0.02, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.7, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 100.0 }, "treatments": [] }, "TCGA-A2-A0CV": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "ad7fcc89-82a3-48aa-8461-581c1a857677", "AGE": 41, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 3011.0, "DAYS_TO_BIRTH": -15289.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "1/28/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Asian", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 98.99069599, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 98.99069599, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 98.99069599, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 98.99069599, "GENETIC_ANCESTRY_LABEL": "EAS" }, "sample": { "SAMPLE_ID": "TCGA-A2-A0CV-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 24.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2792, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.733333333, "TISSUE_SOURCE_SITE": "Walter Reed", "TBL_SCORE": 5.0 }, "treatments": [ { "START_DATE": 120, "STOP_DATE": 176.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "276", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "3", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "1104", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 64, "STOP_DATE": 106.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "950", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "3800", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 64, "STOP_DATE": 106.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "95", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "380", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 274, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "10", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "4", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 229, "STOP_DATE": 263.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-AC-A3TM": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "67C73260-A242-4BBA-87C5-D2302556DFF7", "AGE": 50, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 762.0, "DAYS_TO_BIRTH": -18535.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "8/1/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1MI", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "0:LIVING", "OS_MONTHS": 25.05178025, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 25.05178025, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 25.05178025, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 25.05178025, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AC-A3TM-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "AC", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 5.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3054, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.0, "TISSUE_SOURCE_SITE": "International Genomics Consortium", "TBL_SCORE": 54.0 }, "treatments": [ { "START_DATE": 132, "STOP_DATE": 213.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 132, "STOP_DATE": 213.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 132, "STOP_DATE": 213.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Immunotherapy", "TREATMENT_SUBTYPE": null, "AGENT": null, "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": "Biological Therapy/Monoclonal Antibody", "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 272, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 219, "STOP_DATE": 266.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "33", "RADIATION_DOSAGE": "5040", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-BH-A1ET": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "8986a141-eae7-4157-b695-02cc6fc3b071", "AGE": 55, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE I", "AJCC_STAGING_EDITION": "5TH", "DAYS_LAST_FOLLOWUP": NaN, "DAYS_TO_BIRTH": -20425.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/7/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T1", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": null, "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 82.84840714, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 82.84840714, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 82.84840714, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A1ET-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 3.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2606, "MSI_SENSOR_SCORE": 0.06, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.833333333, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 15.0 }, "treatments": [] }, "TCGA-E2-A574": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "029CE650-5E5A-4100-8596-CD94300E7EF5", "AGE": 44, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 1179.0, "DAYS_TO_BIRTH": -16195.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "6/20/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 38.76121906, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 38.76121906, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 38.76121906, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 38.76121906, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-E2-A574-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "E2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 27.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3525, "MSI_SENSOR_SCORE": 1.55, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 3.033333333, "TISSUE_SOURCE_SITE": "Roswell Park", "TBL_SCORE": 199.0 }, "treatments": [ { "START_DATE": 64, "STOP_DATE": 106.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 64, "STOP_DATE": 106.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 120, "STOP_DATE": 162.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 195, "STOP_DATE": 246.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "36", "RADIATION_DOSAGE": "6640", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-A7-A4SE": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "DBF6F981-15CC-40AD-91AC-A66360405FBD", "AGE": 54, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 644.0, "DAYS_TO_BIRTH": -20080.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "2/22/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 21.17237071, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 21.17237071, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 21.17237071, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 21.17237071, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-A7-A4SE-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "A7", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 15.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3212, "MSI_SENSOR_SCORE": 0.28, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 6.133333333, "TISSUE_SOURCE_SITE": "Christiana Healthcare", "TBL_SCORE": 181.0 }, "treatments": [ { "START_DATE": 49, "STOP_DATE": 91.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 49, "STOP_DATE": 91.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 105, "STOP_DATE": 154.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-D8-A27R": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "0b23b5fe-6c7e-4297-bc55-f93fcb830ac4", "AGE": 41, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIC", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 307.0, "DAYS_TO_BIRTH": -15122.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/18/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N3A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 10.09304008, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 10.09304008, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 10.09304008, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 10.09304008, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D8-A27R-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "D8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 21.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3162, "MSI_SENSOR_SCORE": 0.28, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.133333333, "TISSUE_SOURCE_SITE": "Greater Poland Cancer Center", "TBL_SCORE": 213.0 }, "treatments": [ { "START_DATE": 57, "STOP_DATE": 218.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin + Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "60+600", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "240+2400", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 237, "STOP_DATE": 262.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "25", "RADIATION_DOSAGE": "4500", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-C8-A12Q": { "demographics": { "SUBTYPE": "BRCA_Her2", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "a824b3bd-34d5-4cc1-a92f-f9d6ac0f1814", "AGE": 78, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": 2.0, "DAYS_TO_BIRTH": -28733.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/13/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N2", "PATH_T_STAGE": "T1", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Asian", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 12.65739554, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 12.65739554, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 12.65739554, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-C8-A12Q-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "C8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 13.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2593, "MSI_SENSOR_SCORE": 0.35, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 3.266666667, "TISSUE_SOURCE_SITE": "ILSBio", "TBL_SCORE": 400.0 }, "treatments": [] }, "TCGA-LL-A441": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "69FC24FC-CFE2-487A-935F-1A954B30B709", "AGE": 62, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 996.0, "DAYS_TO_BIRTH": -22772.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "11/5/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "0:LIVING", "OS_MONTHS": 32.74484663, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 32.74484663, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 32.74484663, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 32.74484663, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-LL-A441-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "LL", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 11.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2995, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.0, "TISSUE_SOURCE_SITE": "Candler", "TBL_SCORE": 102.0 }, "treatments": [ { "START_DATE": 61, "STOP_DATE": 133.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 61, "STOP_DATE": 133.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 153, "STOP_DATE": 216.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "33", "RADIATION_DOSAGE": "6600", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-BH-A0HQ": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "f31c21b6-0f7f-435b-9e24-97c909755c36", "AGE": 56, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": 1121.0, "DAYS_TO_BIRTH": -20719.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "11/11/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I+)", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 36.85439064, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 36.85439064, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 36.85439064, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 36.85439064, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A0HQ-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 23.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2971, "MSI_SENSOR_SCORE": 0.21, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.9, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 8.0 }, "treatments": [ { "START_DATE": 70, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 104, "STOP_DATE": 156.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "36", "RADIATION_DOSAGE": "6640", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-A2-A3Y0": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "174850B4-5EC2-462B-A890-89BD1716B3C2", "AGE": 57, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 1546.0, "DAYS_TO_BIRTH": -21024.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "8/24/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 50.82684025, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 50.82684025, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 50.82684025, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-A2-A3Y0-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 6.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3062, "MSI_SENSOR_SCORE": 0.07, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 4.966666667, "TISSUE_SOURCE_SITE": "Walter Reed", "TBL_SCORE": 184.0 }, "treatments": [ { "START_DATE": 74, "STOP_DATE": 137.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 74, "STOP_DATE": 137.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 165, "STOP_DATE": 247.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-AO-A1KS": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "bb8d42d3-ad65-4d88-ae1d-f9aadfc7962d", "AGE": 69, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 16.0, "DAYS_TO_BIRTH": -25230.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/1/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 11.50672321, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 11.50672321, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 11.50672321, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 11.50672321, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AO-A1KS-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AO", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 24.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3351, "MSI_SENSOR_SCORE": 0.26, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.1, "TISSUE_SOURCE_SITE": "MSKCC", "TBL_SCORE": 119.0 }, "treatments": [ { "START_DATE": 155, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-C8-A12T": { "demographics": { "SUBTYPE": "BRCA_Her2", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "71229981-97c2-4ae1-a130-fe5de336b37d", "AGE": 43, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 0.0, "DAYS_TO_BIRTH": NaN, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/11/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Asian", "RADIATION_THERAPY": null, "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 0.0, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 0.0, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 0.0, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 0.0, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-C8-A12T-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "C8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 2.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2886, "MSI_SENSOR_SCORE": 0.09, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 5.133333333, "TISSUE_SOURCE_SITE": "ILSBio", "TBL_SCORE": 122.0 }, "treatments": [] }, "TCGA-E2-A15E": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "0a2a3529-f645-4967-9a58-89ee20b8bb62", "AGE": 40, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 630.0, "DAYS_TO_BIRTH": -14894.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/25/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 20.71210179, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 20.71210179, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 20.71210179, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 20.71210179, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E2-A15E-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "E2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 23.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2752, "MSI_SENSOR_SCORE": 0.09, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.133333333, "TISSUE_SOURCE_SITE": "Roswell Park", "TBL_SCORE": 286.0 }, "treatments": [ { "START_DATE": 63, "STOP_DATE": 105.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "954", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "3816", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 119, "STOP_DATE": 489.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Trastuzumab", "NUMBER_OF_CYCLES": "24", "PRESCRIBED_DOSE": "232", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "6098", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 63, "STOP_DATE": 105.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "95", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "380", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 77, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Other", "TREATMENT_SUBTYPE": "Clinical Trial - Bisphosphonates As Adjuvant Therapy", "AGENT": "Clodronic Acid", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1600", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "3", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 119, "STOP_DATE": 198.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": "12", "PRESCRIBED_DOSE": "130", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "1560", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 451, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Exemestane", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "25", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "5", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 203, "STOP_DATE": 448.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "20", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "4", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "4900", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 218, "STOP_DATE": 275.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "33", "RADIATION_DOSAGE": "6040", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-BH-A208": { "demographics": { "SUBTYPE": "BRCA_Normal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "ddcbdac6-9e43-4146-a611-d033125eba14", "AGE": 48, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "5TH", "DAYS_LAST_FOLLOWUP": NaN, "DAYS_TO_BIRTH": -17715.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/8/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1B", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": null, "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 57.82950324, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 57.82950324, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 57.82950324, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A208-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 19.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2965, "MSI_SENSOR_SCORE": 0.23, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.966666667, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 123.0 }, "treatments": [] }, "TCGA-D8-A1XZ": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "2c90d5e3-ac8c-4c86-a06f-42ccc064eb49", "AGE": 81, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 466.0, "DAYS_TO_BIRTH": -29916.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "6/9/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N2A", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 15.32038005, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 15.32038005, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 15.32038005, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 15.32038005, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D8-A1XZ-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "D8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 18.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2954, "MSI_SENSOR_SCORE": 0.2, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.4, "TISSUE_SOURCE_SITE": "Greater Poland Cancer Center", "TBL_SCORE": 336.0 }, "treatments": [ { "START_DATE": 94, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen + Anastrozole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "20+1", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 69, "STOP_DATE": 93.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "25", "RADIATION_DOSAGE": "4500", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-A8-A07G": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "8cf8b620-7ab6-4b6e-84bc-ff5a83f381fa", "AGE": 65, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 577.0, "DAYS_TO_BIRTH": -23926.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "5/27/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": null, "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 18.96965513, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 18.96965513, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 18.96965513, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 18.96965513, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A8-A07G-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 5.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2784, "MSI_SENSOR_SCORE": 0.03, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.966666667, "TISSUE_SOURCE_SITE": "Indivumed", "TBL_SCORE": 119.0 }, "treatments": [ { "START_DATE": 59, "STOP_DATE": 181.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Fluorouracil", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 59, "STOP_DATE": 181.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Methotrexate", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 59, "STOP_DATE": 181.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 243, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Letrozole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 181, "STOP_DATE": 212.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-A7-A5ZV": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "0EC70E40-07DF-461D-8FF9-351240A0D454", "AGE": 62, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 368.0, "DAYS_TO_BIRTH": -22966.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/14/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8010/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 12.09849755, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 12.09849755, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 12.09849755, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 12.09849755, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-A7-A5ZV-01", "ONCOTREE_CODE": "BRCNOS", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Carcinoma (NOS)", "TUMOR_TYPE": "Infiltrating Carcinoma (NOS)", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "A7", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 19.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": NaN, "MSI_SENSOR_SCORE": 0.91, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 5.4, "TISSUE_SOURCE_SITE": "Christiana Healthcare", "TBL_SCORE": 378.0 }, "treatments": [ { "START_DATE": 95, "STOP_DATE": 137.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 95, "STOP_DATE": 137.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 151, "STOP_DATE": 193.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 270, "STOP_DATE": 316.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "33", "RADIATION_DOSAGE": "6100", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-BH-A18L": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "9ddc3e7b-8b54-4a83-8335-8053940f56c1", "AGE": 50, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": NaN, "DAYS_TO_BIRTH": -18519.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "6/9/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1MI", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": null, "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 26.6627215, "DSS_STATUS": null, "DSS_MONTHS": 26.6627215, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 26.6627215, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 26.6627215, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A18L-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 27.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2851, "MSI_SENSOR_SCORE": 0.77, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.5, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 105.0 }, "treatments": [] }, "TCGA-AQ-A0Y5": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "d0b78f3f-a198-437a-ab8c-204345d3b75d", "AGE": 70, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": NaN, "DAYS_TO_BIRTH": -25793.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/7/2011", "HISTORY_NEOADJUVANT_TRTYN": "Yes", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N2A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 5.654732551, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 5.654732551, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 5.654732551, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 5.654732551, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AQ-A0Y5-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "AQ", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 20.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3277, "MSI_SENSOR_SCORE": 0.27, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.833333333, "TISSUE_SOURCE_SITE": "UNC", "TBL_SCORE": 213.0 }, "treatments": [ { "START_DATE": 83, "STOP_DATE": 146.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "75", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "300", "TOTAL_DOSE_UNITS": "Mg/M2", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 83, "STOP_DATE": 146.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "600", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "2400", "TOTAL_DOSE_UNITS": "Mg/M2", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 83, "STOP_DATE": 146.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Trastuzumab", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "8", "PRESCRIBED_DOSE_UNITS": "mg/kg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "32", "TOTAL_DOSE_UNITS": "Mg/Kg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-BH-A1FH": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "1783cac1-253a-40af-a9ac-48dfb20e1ab8", "AGE": 47, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "5TH", "DAYS_LAST_FOLLOWUP": NaN, "DAYS_TO_BIRTH": -17172.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/8/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M1", "PATH_N_STAGE": "N1B", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": null, "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 33.99414801, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 33.99414801, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 33.99414801, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A1FH-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": NaN, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3365, "MSI_SENSOR_SCORE": 0.05, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.8, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 150.0 }, "treatments": [] }, "TCGA-BH-A0H0": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "96457ebf-ae88-41f4-97e5-cdc3163418aa", "AGE": 69, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IA", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": 461.0, "DAYS_TO_BIRTH": -25223.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "11/10/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 15.15599829, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 15.15599829, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 15.15599829, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 15.15599829, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A0H0-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 10.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2461, "MSI_SENSOR_SCORE": 0.7, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.6, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 35.0 }, "treatments": [ { "START_DATE": 67, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 97, "STOP_DATE": 148.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "36", "RADIATION_DOSAGE": "6640", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-E2-A14P": { "demographics": { "SUBTYPE": "BRCA_Her2", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "e4fc0909-f284-4471-866d-d8967b6adcbc", "AGE": 79, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIC", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 1246.0, "DAYS_TO_BIRTH": -28923.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/31/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N3", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 40.96393464, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 40.96393464, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 40.96393464, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 40.96393464, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E2-A14P-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "E2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 14.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2906, "MSI_SENSOR_SCORE": 0.72, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.1, "TISSUE_SOURCE_SITE": "Roswell Park", "TBL_SCORE": 788.0 }, "treatments": [ { "START_DATE": 39, "STOP_DATE": 396.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Trastuzumab", "NUMBER_OF_CYCLES": "3", "PRESCRIBED_DOSE": "570", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "10568", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 47, "STOP_DATE": 90.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "30", "RADIATION_DOSAGE": "6000", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-BH-A0B3": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "18eb4dfc-556f-4bf3-a411-4780209ed1e0", "AGE": 53, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": 1203.0, "DAYS_TO_BIRTH": -19479.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "11/3/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 39.5502515, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 39.5502515, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 39.5502515, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 39.5502515, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A0B3-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 8.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.265, "MSI_SENSOR_SCORE": 0.41, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.466666667, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 149.0 }, "treatments": [ { "START_DATE": 52, "STOP_DATE": 115.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "113", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "454", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 136, "STOP_DATE": 213.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": "12", "PRESCRIBED_DOSE": "154", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "1873", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 52, "STOP_DATE": 115.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "1128", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "4540", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 24, "STOP_DATE": 72.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-EW-A6SD": { "demographics": { "SUBTYPE": "BRCA_Her2", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "42378DBC-A123-4CF9-8502-165E89FDA271", "AGE": 32, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 1010.0, "DAYS_TO_BIRTH": -12006.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/14/2015", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 33.20511556, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 33.20511556, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 33.20511556, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 33.20511556, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-EW-A6SD-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "EW", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 24.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3517, "MSI_SENSOR_SCORE": 0.34, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.5, "TISSUE_SOURCE_SITE": "University of Miami", "TBL_SCORE": 315.0 }, "treatments": [ { "START_DATE": 86, "STOP_DATE": 198.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel + Carboplatin + Trastuzumab", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 239, "STOP_DATE": 288.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "23", "RADIATION_DOSAGE": "46", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-B6-A0WT": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "d7195183-9fe4-4b17-bcfd-9367d2e539ce", "AGE": 61, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "4TH", "DAYS_LAST_FOLLOWUP": 5739.0, "DAYS_TO_BIRTH": -22362.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/14/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 188.6773844, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 188.6773844, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 126.9684716, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 126.9684716, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-B6-A0WT-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "B6", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 3.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2875, "MSI_SENSOR_SCORE": 0.05, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.466666667, "TISSUE_SOURCE_SITE": "Duke", "TBL_SCORE": 49.0 }, "treatments": [] }, "TCGA-D8-A1X8": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "8624354c-af25-423c-9c71-48a5dd821097", "AGE": 62, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 783.0, "DAYS_TO_BIRTH": -22995.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/16/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N2A", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 25.74218365, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 25.74218365, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 25.74218365, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 25.74218365, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D8-A1X8-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "D8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 3.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.4478, "MSI_SENSOR_SCORE": 1.18, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.766666667, "TISSUE_SOURCE_SITE": "Greater Poland Cancer Center", "TBL_SCORE": 23.0 }, "treatments": [ { "START_DATE": 23, "STOP_DATE": 182.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin + Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "60+600", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 209, "STOP_DATE": 239.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "25", "RADIATION_DOSAGE": "5000", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-A8-A096": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "d7cac141-9269-4733-83ce-e1bc0b503254", "AGE": 73, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 0.0, "DAYS_TO_BIRTH": -26723.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "5/27/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": null, "RADIATION_THERAPY": null, "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 0.0, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 0.0, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 0.0, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 0.0, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A8-A096-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 2.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2556, "MSI_SENSOR_SCORE": 0.1, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.966666667, "TISSUE_SOURCE_SITE": "Indivumed", "TBL_SCORE": 4.0 }, "treatments": [] }, "TCGA-AQ-A54N": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "58090433-D8D1-4499-A235-810C3E9D5B74", "AGE": 51, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 78.0, "DAYS_TO_BIRTH": -18741.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Hispanic Or Latino", "FORM_COMPLETION_DATE": "2/26/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "Yes", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "0:LIVING", "OS_MONTHS": 2.564355459, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 2.564355459, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 2.564355459, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 2.564355459, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-AQ-A54N-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "AQ", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 23.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.331, "MSI_SENSOR_SCORE": 1.1, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.0, "TISSUE_SOURCE_SITE": "UNC", "TBL_SCORE": 494.0 }, "treatments": [] }, "TCGA-E2-A15R": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "33b7bf50-53f4-4839-aa83-9665f85671d8", "AGE": 64, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 1732.0, "DAYS_TO_BIRTH": -23570.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/14/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 56.94184173, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 56.94184173, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 56.94184173, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 56.94184173, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E2-A15R-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "E2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 9.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2856, "MSI_SENSOR_SCORE": 0.35, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.133333333, "TISSUE_SOURCE_SITE": "Roswell Park", "TBL_SCORE": 63.0 }, "treatments": [ { "START_DATE": 92, "STOP_DATE": 134.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "90", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "360", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 266, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "3", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 92, "STOP_DATE": 134.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "900", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "3600", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 148, "STOP_DATE": 197.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "268", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "1072", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 218, "STOP_DATE": 267.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "33", "RADIATION_DOSAGE": "5900", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-AC-A6NO": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "8D9B50D1-139B-4447-AE9C-E54764D9E2A7", "AGE": 43, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 51.0, "DAYS_TO_BIRTH": -15996.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/10/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": null, "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 1.676693954, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 1.676693954, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 1.676693954, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 1.676693954, "GENETIC_ANCESTRY_LABEL": "AFR_ADMIX" }, "sample": { "SAMPLE_ID": "TCGA-AC-A6NO-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "AC", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 8.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.331, "MSI_SENSOR_SCORE": 0.01, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.866666667, "TISSUE_SOURCE_SITE": "International Genomics Consortium", "TBL_SCORE": 4.0 }, "treatments": [] }, "TCGA-A2-A0YK": { "demographics": { "SUBTYPE": "BRCA_Normal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "8f34cb4c-5798-47a0-89a1-f0ee26a8ae93", "AGE": 61, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": 588.0, "DAYS_TO_BIRTH": -22625.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/28/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 19.331295, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 19.331295, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 19.331295, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A2-A0YK-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 6.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3819, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 10.6, "TISSUE_SOURCE_SITE": "Walter Reed", "TBL_SCORE": 33.0 }, "treatments": [ { "START_DATE": 78, "STOP_DATE": 141.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "140", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "560", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 78, "STOP_DATE": 141.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "1115", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "4460", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-B6-A0RP": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "451e1a67-47e6-4738-99d7-fb7771ef61a3", "AGE": 73, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIB", "AJCC_STAGING_EDITION": "4TH", "DAYS_LAST_FOLLOWUP": NaN, "DAYS_TO_BIRTH": -26941.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "11/2/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8522/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1B", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 102.7714765, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 102.7714765, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 91.62639314, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 91.62639314, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-B6-A0RP-01", "ONCOTREE_CODE": "BRCNOS", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Carcinoma (NOS)", "TUMOR_TYPE": "Mixed Histology (NOS)", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "B6", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 20.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2791, "MSI_SENSOR_SCORE": 0.01, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.7, "TISSUE_SOURCE_SITE": "Duke", "TBL_SCORE": 5.0 }, "treatments": [] }, "TCGA-E2-A15M": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "59be60a3-e0f6-4d63-b98c-574ef92428c4", "AGE": 66, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 235.0, "DAYS_TO_BIRTH": -24266.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/14/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 11.04645429, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 11.04645429, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 11.04645429, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 11.04645429, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E2-A15M-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "E2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 16.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2772, "MSI_SENSOR_SCORE": 0.3, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 5.033333333, "TISSUE_SOURCE_SITE": "Roswell Park", "TBL_SCORE": 182.0 }, "treatments": [ { "START_DATE": 202, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "1", "TOTAL_DOSE_UNITS": "Mg/Day", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 140, "STOP_DATE": 211.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": "6600", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-EW-A1OZ": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "8f912a40-3251-4e1f-ae65-1f93d71f9881", "AGE": 56, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 1229.0, "DAYS_TO_BIRTH": -20664.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/11/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 40.40503666, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 40.40503666, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 40.40503666, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 40.40503666, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-EW-A1OZ-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "EW", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 16.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3658, "MSI_SENSOR_SCORE": 3.86, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.766666667, "TISSUE_SOURCE_SITE": "University of Miami", "TBL_SCORE": 312.0 }, "treatments": [ { "START_DATE": 144, "STOP_DATE": 228.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "552", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "1961", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 144, "STOP_DATE": 186.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": "3", "PRESCRIBED_DOSE": "142", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "426", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 144, "STOP_DATE": 487.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Trastuzumab", "NUMBER_OF_CYCLES": "17", "PRESCRIBED_DOSE": "516", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "8772", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 256, "STOP_DATE": 291.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": "5", "PRESCRIBED_DOSE": "152", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "599", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 301, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Exemestane", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "25", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-E9-A244": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "a4c59287-1ad5-46a5-8040-e591e6ce064f", "AGE": 54, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 21.0, "DAYS_TO_BIRTH": -19778.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/15/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 0.690403393, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 0.690403393, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 0.690403393, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 0.690403393, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E9-A244-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "E9", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 13.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3557, "MSI_SENSOR_SCORE": 1.22, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.7, "TISSUE_SOURCE_SITE": "Asterand", "TBL_SCORE": 346.0 }, "treatments": [ { "START_DATE": 16, "STOP_DATE": 16.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "1", "PRESCRIBED_DOSE": "100", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "100", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 16, "STOP_DATE": 16.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "1", "PRESCRIBED_DOSE": "1000", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "1000", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-EW-A6S9": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "9676E46B-8F29-43CD-AB65-EB6A535CCED4", "AGE": 34, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 463.0, "DAYS_TO_BIRTH": -12755.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/13/2015", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 15.221751, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 15.221751, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 15.221751, "GENETIC_ANCESTRY_LABEL": "AFR_ADMIX" }, "sample": { "SAMPLE_ID": "TCGA-EW-A6S9-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": null, "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": null, "TISSUE_SOURCE_SITE_CODE": "EW", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 4.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3458, "MSI_SENSOR_SCORE": 0.54, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.833333333, "TISSUE_SOURCE_SITE": "University of Miami", "TBL_SCORE": 218.0 }, "treatments": [] }, "TCGA-E2-A15C": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "da840a22-8d30-4682-bbd0-8fa87bd40528", "AGE": 61, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE I", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 694.0, "DAYS_TO_BIRTH": -22583.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/13/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 22.81618832, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 22.81618832, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 22.81618832, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 22.81618832, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E2-A15C-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "E2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 9.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2691, "MSI_SENSOR_SCORE": 0.12, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.166666667, "TISSUE_SOURCE_SITE": "Roswell Park", "TBL_SCORE": 2.0 }, "treatments": [ { "START_DATE": 65, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 55, "STOP_DATE": 102.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "33", "RADIATION_DOSAGE": "6040", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-AR-A24L": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "de646f6a-6d50-4be2-b3cd-f17554b234df", "AGE": 26, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 2221.0, "DAYS_TO_BIRTH": -9706.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "8/12/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 94.22362495, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 94.22362495, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 46.48716179, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 46.48716179, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AR-A24L-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AR", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 8.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3085, "MSI_SENSOR_SCORE": 0.09, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.333333333, "TISSUE_SOURCE_SITE": "Mayo", "TBL_SCORE": 84.0 }, "treatments": [ { "START_DATE": 145, "STOP_DATE": 1414.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "20", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 243, "STOP_DATE": 275.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "25", "RADIATION_DOSAGE": "5000", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-A2-A0SY": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "dc696e3c-f448-468f-a576-f4429be0338a", "AGE": 62, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": 1347.0, "DAYS_TO_BIRTH": -22928.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "11/12/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 44.2844462, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 44.2844462, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 44.2844462, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 44.2844462, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A2-A0SY-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 2.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2804, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 3.866666667, "TISSUE_SOURCE_SITE": "Walter Reed", "TBL_SCORE": 42.0 }, "treatments": [ { "START_DATE": 256, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "5", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 216, "STOP_DATE": 263.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "33", "RADIATION_DOSAGE": "6040", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-A2-A3XU": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "A8E7D8A4-BBF0-496B-B387-8E014CFDCEA6", "AGE": 35, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": NaN, "DAYS_TO_BIRTH": -13046.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "8/29/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1MI", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 29.98323306, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 29.98323306, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 18.87102607, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 18.87102607, "GENETIC_ANCESTRY_LABEL": "AFR_ADMIX" }, "sample": { "SAMPLE_ID": "TCGA-A2-A3XU-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 10.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3179, "MSI_SENSOR_SCORE": 0.6, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.7, "TISSUE_SOURCE_SITE": "Walter Reed", "TBL_SCORE": 51.0 }, "treatments": [ { "START_DATE": 596, "STOP_DATE": 718.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Clinical Progressive Disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 657, "STOP_DATE": 902.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Capecitabine", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Clinical Progressive Disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-D8-A1XQ": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "3886b4fb-ba22-4a50-b11a-a6893951f170", "AGE": 69, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 499.0, "DAYS_TO_BIRTH": -25345.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/16/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 16.40529967, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 16.40529967, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 16.40529967, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 16.40529967, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D8-A1XQ-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "D8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 10.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.6331, "MSI_SENSOR_SCORE": 16.36, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 26.63333333, "TISSUE_SOURCE_SITE": "Greater Poland Cancer Center", "TBL_SCORE": 405.0 }, "treatments": [] }, "TCGA-C8-A275": { "demographics": { "SUBTYPE": "BRCA_Her2", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "ce887e90-0660-4f44-a3a4-b3b894cb7eda", "AGE": 56, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 1.0, "DAYS_TO_BIRTH": -20774.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/21/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T1", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "No", "PRIOR_DX": "No", "RACE": "Asian", "RADIATION_THERAPY": null, "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 0.032876352, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 0.032876352, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 0.032876352, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 0.032876352, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-C8-A275-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "C8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 5.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3138, "MSI_SENSOR_SCORE": 0.24, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 3.533333333, "TISSUE_SOURCE_SITE": "ILSBio", "TBL_SCORE": 147.0 }, "treatments": [] }, "TCGA-A2-A3XT": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "C72CB184-462D-4009-9CDB-848782FF8A76", "AGE": 45, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 2770.0, "DAYS_TO_BIRTH": -16649.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "8/17/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 91.06749515, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 91.06749515, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 91.06749515, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 91.06749515, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-A2-A3XT-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 14.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3073, "MSI_SENSOR_SCORE": 0.16, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.266666667, "TISSUE_SOURCE_SITE": "Walter Reed", "TBL_SCORE": 101.0 }, "treatments": [ { "START_DATE": 35, "STOP_DATE": 83.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Partial Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 35, "STOP_DATE": 83.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Partial Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 97, "STOP_DATE": 161.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Partial Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 233, "STOP_DATE": 275.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "28", "RADIATION_DOSAGE": "5040", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" }, { "START_DATE": 233, "STOP_DATE": 275.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 2", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "28", "RADIATION_DOSAGE": "5040", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" }, { "START_DATE": 233, "STOP_DATE": 275.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 3", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "28", "RADIATION_DOSAGE": "868", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" }, { "START_DATE": 278, "STOP_DATE": 282.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 4", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "5", "RADIATION_DOSAGE": "1000", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-AC-A3HN": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "E37AE674-A107-4EB3-94D8-B86B0035A9F7", "AGE": 87, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 496.0, "DAYS_TO_BIRTH": -32061.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/13/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 16.30667061, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 16.30667061, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 16.30667061, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 16.30667061, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AC-A3HN-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "AC", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 5.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2907, "MSI_SENSOR_SCORE": 0.02, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.433333333, "TISSUE_SOURCE_SITE": "International Genomics Consortium", "TBL_SCORE": 19.0 }, "treatments": [] }, "TCGA-C8-A1HJ": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "a855c228-a263-44df-87a0-cbc32187e3f5", "AGE": 53, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 5.0, "DAYS_TO_BIRTH": -19629.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "6/1/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Asian", "RADIATION_THERAPY": null, "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 0.16438176, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 0.16438176, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 0.16438176, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 0.16438176, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-C8-A1HJ-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "C8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 8.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3679, "MSI_SENSOR_SCORE": 0.8, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 3.2, "TISSUE_SOURCE_SITE": "ILSBio", "TBL_SCORE": 168.0 }, "treatments": [] }, "TCGA-AO-A12E": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "2cbeadff-a8a3-4787-9d4e-f6b74c3ab5d9", "AGE": 51, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 1743.0, "DAYS_TO_BIRTH": -18721.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/8/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I+)", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 70.42114607, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 70.42114607, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 70.42114607, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 70.42114607, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AO-A12E-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AO", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 18.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": NaN, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.9, "TISSUE_SOURCE_SITE": "MSKCC", "TBL_SCORE": 47.0 }, "treatments": [ { "START_DATE": 222, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "20", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 141, "STOP_DATE": 184.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "175", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "1192", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 85, "STOP_DATE": 127.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "600", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "4080", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 85, "STOP_DATE": 127.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "60", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "408", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 251, "STOP_DATE": 288.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "28", "RADIATION_DOSAGE": "10080", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-A7-A56D": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "F062CBD0-2426-40AC-A4BE-E74AC61FA2A7", "AGE": 84, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 448.0, "DAYS_TO_BIRTH": -30783.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/1/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 14.72860571, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 14.72860571, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 14.72860571, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 14.72860571, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-A7-A56D-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "A7", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 14.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2912, "MSI_SENSOR_SCORE": 0.06, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 8.266666667, "TISSUE_SOURCE_SITE": "Christiana Healthcare", "TBL_SCORE": 220.0 }, "treatments": [ { "START_DATE": 157, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-A2-A0EX": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "9d8702e1-1a36-4bca-85ab-5f11d58d7953", "AGE": 46, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 752.0, "DAYS_TO_BIRTH": -16858.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "8/13/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I+)", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 24.72301673, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 24.72301673, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 24.72301673, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 24.72301673, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A2-A0EX-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 5.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2822, "MSI_SENSOR_SCORE": 0.01, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.9, "TISSUE_SOURCE_SITE": "Walter Reed", "TBL_SCORE": 90.0 }, "treatments": [ { "START_DATE": 172, "STOP_DATE": 222.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Leuprolide", "NUMBER_OF_CYCLES": "3", "PRESCRIBED_DOSE": "3.75", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IM", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "11.25", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 273, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Goserelin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "3.6 mg monthly", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "3", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "SC", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 165, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "10 mg", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-A2-A259": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "3fc3755d-a3f8-4e2c-813f-ff124f2a75c1", "AGE": 70, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE I", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 1596.0, "DAYS_TO_BIRTH": -25666.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "6/20/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 52.47065786, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 52.47065786, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 52.47065786, "GENETIC_ANCESTRY_LABEL": "AFR_ADMIX" }, "sample": { "SAMPLE_ID": "TCGA-A2-A259-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 4.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3052, "MSI_SENSOR_SCORE": 0.1, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.733333333, "TISSUE_SOURCE_SITE": "Walter Reed", "TBL_SCORE": 22.0 }, "treatments": [ { "START_DATE": 96, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-AR-A24K": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "599c3701-df7a-4a75-a347-fa9b510dd242", "AGE": 46, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 1548.0, "DAYS_TO_BIRTH": -16961.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "8/12/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 50.89259296, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 50.89259296, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 50.89259296, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 50.89259296, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AR-A24K-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AR", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 18.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3624, "MSI_SENSOR_SCORE": 1.28, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.966666667, "TISSUE_SOURCE_SITE": "Mayo", "TBL_SCORE": 103.0 }, "treatments": [ { "START_DATE": 195, "STOP_DATE": 241.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "33", "RADIATION_DOSAGE": "6040", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-A8-A07L": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "e89a9deb-6321-4e61-b412-b4993d4277dd", "AGE": 58, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 975.0, "DAYS_TO_BIRTH": -21428.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "5/27/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": null, "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 32.05444324, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 32.05444324, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 32.05444324, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 32.05444324, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A8-A07L-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 5.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2776, "MSI_SENSOR_SCORE": 1.33, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.666666667, "TISSUE_SOURCE_SITE": "Indivumed", "TBL_SCORE": 274.0 }, "treatments": [ { "START_DATE": 31, "STOP_DATE": 122.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": null, "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 184, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 153, "STOP_DATE": 184.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-C8-A27B": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "f0d8a1fe-e313-44f1-99cc-b965cbeeff0e", "AGE": 48, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 439.0, "DAYS_TO_BIRTH": -17763.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/21/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "No", "PRIOR_DX": "No", "RACE": "Asian", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 14.43271855, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 14.43271855, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 14.43271855, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 14.43271855, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-C8-A27B-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "C8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 14.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.394, "MSI_SENSOR_SCORE": 3.02, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 4.1, "TISSUE_SOURCE_SITE": "ILSBio", "TBL_SCORE": 163.0 }, "treatments": [ { "START_DATE": 62, "STOP_DATE": 85.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Fluorouracil", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 62, "STOP_DATE": 85.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 62, "STOP_DATE": 85.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 62, "STOP_DATE": 85.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-A8-A09B": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "3828b534-908e-4953-a3fb-07d01cf49c7d", "AGE": 58, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIB", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 365.0, "DAYS_TO_BIRTH": -21520.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "5/27/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T4B", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": null, "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 11.9998685, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 11.9998685, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 11.9998685, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 11.9998685, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A8-A09B-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 26.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2659, "MSI_SENSOR_SCORE": 0.27, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.333333333, "TISSUE_SOURCE_SITE": "Indivumed", "TBL_SCORE": 49.0 }, "treatments": [ { "START_DATE": 30, "STOP_DATE": 30.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Fluorouracil", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 30, "STOP_DATE": 30.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Epirubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 30, "STOP_DATE": 30.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 153, "STOP_DATE": 242.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 153, "STOP_DATE": 181.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": "50", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "gy" } ] }, "TCGA-A7-A0CE": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "9d95a65b-e41d-4f93-92d4-99dce29ff40d", "AGE": 57, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": 1074.0, "DAYS_TO_BIRTH": -20863.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "10/4/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 35.30920209, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 35.30920209, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 35.30920209, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 35.30920209, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A7-A0CE-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "A7", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 10.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.281, "MSI_SENSOR_SCORE": 1.68, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 6.0, "TISSUE_SOURCE_SITE": "Christiana Healthcare", "TBL_SCORE": 137.0 }, "treatments": [ { "START_DATE": 63, "STOP_DATE": 105.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "130", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "520", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 119, "STOP_DATE": 161.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "380", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "1520", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 63, "STOP_DATE": 105.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "1310-1320", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "5250", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 189, "STOP_DATE": 238.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "33", "RADIATION_DOSAGE": "6100", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-AR-A1AL": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "1f99e4d4-4e8b-4cc1-a129-227a2a82780e", "AGE": 60, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 2971.0, "DAYS_TO_BIRTH": -22023.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "6/15/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 97.67564191, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 97.67564191, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 97.67564191, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 97.67564191, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AR-A1AL-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AR", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 3.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.251, "MSI_SENSOR_SCORE": 0.01, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.8, "TISSUE_SOURCE_SITE": "Mayo", "TBL_SCORE": 10.0 }, "treatments": [ { "START_DATE": 192, "STOP_DATE": 366.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 387, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Letrozole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "2.5", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 153, "STOP_DATE": 192.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "30", "RADIATION_DOSAGE": "6000", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-D8-A1X5": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "eb93df3d-9e25-4e4c-9a5d-350f296e5acf", "AGE": 81, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIC", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 565.0, "DAYS_TO_BIRTH": -29734.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "6/9/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N3A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 18.5751389, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 18.5751389, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 18.5751389, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 18.5751389, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D8-A1X5-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "D8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 20.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3194, "MSI_SENSOR_SCORE": 0.4, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.566666667, "TISSUE_SOURCE_SITE": "Greater Poland Cancer Center", "TBL_SCORE": 256.0 }, "treatments": [ { "START_DATE": 55, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": "14", "PRESCRIBED_DOSE": "20", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": "280", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 55, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "20", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 113, "STOP_DATE": 140.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "45", "RADIATION_DOSAGE": "9000", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-A7-A5ZW": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "523E24A2-51B9-4658-BE2F-42E5FCCEBB17", "AGE": 47, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 326.0, "DAYS_TO_BIRTH": -17529.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/13/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 10.71769077, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 10.71769077, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 10.71769077, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 10.71769077, "GENETIC_ANCESTRY_LABEL": "AFR_ADMIX" }, "sample": { "SAMPLE_ID": "TCGA-A7-A5ZW-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "A7", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 2.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2967, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.966666667, "TISSUE_SOURCE_SITE": "Christiana Healthcare", "TBL_SCORE": 1.0 }, "treatments": [ { "START_DATE": 71, "STOP_DATE": 176.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 71, "STOP_DATE": 176.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 269, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 207, "STOP_DATE": 252.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "33", "RADIATION_DOSAGE": "6100", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-BH-A0DE": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "7f0bbba1-9bc3-45db-bdda-eb3319bb15d2", "AGE": 62, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 2372.0, "DAYS_TO_BIRTH": -22656.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "8/11/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 77.98270704, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 77.98270704, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 77.98270704, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 77.98270704, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A0DE-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 7.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2792, "MSI_SENSOR_SCORE": 0.04, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.9, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 23.0 }, "treatments": [ { "START_DATE": 105, "STOP_DATE": 149.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "33", "RADIATION_DOSAGE": "6040", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-AQ-A1H3": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "82ec33dd-e783-4c74-9a87-797a699e11df", "AGE": 49, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIC", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 989.0, "DAYS_TO_BIRTH": -18177.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/20/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N3A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 32.51471217, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 32.51471217, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 32.51471217, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 32.51471217, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AQ-A1H3-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "AQ", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 9.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3378, "MSI_SENSOR_SCORE": 0.28, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.666666667, "TISSUE_SOURCE_SITE": "UNC", "TBL_SCORE": 6.0 }, "treatments": [ { "START_DATE": 239, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "20", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 64, "STOP_DATE": 106.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "600", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 64, "STOP_DATE": 106.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "60", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 120, "STOP_DATE": 162.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "175", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 188, "STOP_DATE": 226.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "28", "RADIATION_DOSAGE": "5040", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" }, { "START_DATE": 188, "STOP_DATE": 233.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 2", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "33", "RADIATION_DOSAGE": "6040", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-E2-A108": { "demographics": { "SUBTYPE": "BRCA_Normal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "4f04bd10-9902-4a23-b15d-4f4409d79499", "AGE": 64, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 837.0, "DAYS_TO_BIRTH": -23530.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "2/11/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N2A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 27.51750666, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 27.51750666, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 27.51750666, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 27.51750666, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E2-A108-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "E2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 9.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": NaN, "MSI_SENSOR_SCORE": 0.01, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 4.533333333, "TISSUE_SOURCE_SITE": "Roswell Park", "TBL_SCORE": 30.0 }, "treatments": [ { "START_DATE": 151, "STOP_DATE": 187.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": "12", "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 102, "STOP_DATE": 144.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 244, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Letrozole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "2.5", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "3", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 95, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 266, "STOP_DATE": 306.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 2.0, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": "4860", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" }, { "START_DATE": 307, "STOP_DATE": 313.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 2", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 2.0, "NUMBER_OF_FRACTIONS": "5", "RADIATION_DOSAGE": "1000", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" }, { "START_DATE": 264, "STOP_DATE": 306.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 3", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 2.0, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": "5040", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-AR-A0TZ": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "c7c34fd9-3021-45b7-b6ff-30b4196585a8", "AGE": 43, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": 2316.0, "DAYS_TO_BIRTH": -15720.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/7/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M1", "PATH_N_STAGE": "N2", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 107.2426604, "DSS_STATUS": null, "DSS_MONTHS": 107.2426604, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 43.16665023, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 43.16665023, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AR-A0TZ-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AR", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 9.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3295, "MSI_SENSOR_SCORE": 0.45, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.866666667, "TISSUE_SOURCE_SITE": "Mayo", "TBL_SCORE": 83.0 }, "treatments": [] }, "TCGA-E2-A1IU": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "001cef41-ff86-4d3f-a140-a647ac4b10a1", "AGE": 60, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 337.0, "DAYS_TO_BIRTH": -22279.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/29/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (MOL+)", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 11.07933064, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 11.07933064, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 11.07933064, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 11.07933064, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E2-A1IU-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "E2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 3.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3121, "MSI_SENSOR_SCORE": 0.99, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.733333333, "TISSUE_SOURCE_SITE": "Roswell Park", "TBL_SCORE": 44.0 }, "treatments": [ { "START_DATE": 36, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": "1", "TOTAL_DOSE_UNITS": "Mg/Day", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-A1-A0SM": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "784de7ac-8424-42eb-83d4-a1bebaa42b97", "AGE": 77, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 242.0, "DAYS_TO_BIRTH": -28198.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/6/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": null, "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "0:LIVING", "OS_MONTHS": 7.956077194, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 7.956077194, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 7.956077194, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 7.956077194, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A1-A0SM-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A1", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 3.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.259, "MSI_SENSOR_SCORE": 0.12, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.633333333, "TISSUE_SOURCE_SITE": "UCSF", "TBL_SCORE": 60.0 }, "treatments": [] }, "TCGA-D8-A1JE": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "115bc72c-116f-40c1-be9b-e3dd7650efae", "AGE": 62, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 575.0, "DAYS_TO_BIRTH": -22683.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/28/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 18.90390242, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 18.90390242, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 18.90390242, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 18.90390242, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D8-A1JE-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "D8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 24.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3658, "MSI_SENSOR_SCORE": 0.8, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.933333333, "TISSUE_SOURCE_SITE": "Greater Poland Cancer Center", "TBL_SCORE": 16.0 }, "treatments": [ { "START_DATE": 103, "STOP_DATE": 162.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "9", "PRESCRIBED_DOSE": "600", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "540", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 103, "STOP_DATE": 162.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-AR-A24T": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "9e3de467-fb0d-4021-89f8-b34968a7c7bc", "AGE": 46, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIC", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 3202.0, "DAYS_TO_BIRTH": -17135.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "8/30/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N3", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 105.2700792, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 105.2700792, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 105.2700792, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 105.2700792, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AR-A24T-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AR", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": NaN, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3378, "MSI_SENSOR_SCORE": 0.17, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.766666667, "TISSUE_SOURCE_SITE": "Mayo", "TBL_SCORE": 33.0 }, "treatments": [ { "START_DATE": 38, "STOP_DATE": 80.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "60", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "420", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 189, "STOP_DATE": 1864.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "20", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 38, "STOP_DATE": 80.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "600", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "4270", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 1995, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Letrozole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "2.5", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "3", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 94, "STOP_DATE": 157.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "175", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "1260", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 189, "STOP_DATE": 225.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "25", "RADIATION_DOSAGE": "5000", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-E9-A1RD": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "5fe3c51f-65e2-4da6-8924-a6fae17c022d", "AGE": 67, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 34.0, "DAYS_TO_BIRTH": -24719.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/28/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 1.117795969, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 1.117795969, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 1.117795969, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 1.117795969, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E9-A1RD-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "E9", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 12.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3053, "MSI_SENSOR_SCORE": 0.05, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.7, "TISSUE_SOURCE_SITE": "Asterand", "TBL_SCORE": 1.0 }, "treatments": [ { "START_DATE": 13, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "20", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-AN-A0XV": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "ac18b3a3-8d52-4e35-8625-673171a7fd92", "AGE": 67, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 162.0, "DAYS_TO_BIRTH": -24779.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/29/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N2", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 5.325969031, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 5.325969031, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 5.325969031, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 5.325969031, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AN-A0XV-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AN", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 2.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2715, "MSI_SENSOR_SCORE": 0.08, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.066666667, "TISSUE_SOURCE_SITE": "Cureline", "TBL_SCORE": 132.0 }, "treatments": [] }, "TCGA-A8-A08I": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "7acf33e7-c386-45fd-8c9a-469600378687", "AGE": 53, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 365.0, "DAYS_TO_BIRTH": -19389.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "5/27/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": null, "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 11.9998685, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 11.9998685, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 11.9998685, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 11.9998685, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A8-A08I-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 19.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": NaN, "MSI_SENSOR_SCORE": 1.21, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.133333333, "TISSUE_SOURCE_SITE": "Indivumed", "TBL_SCORE": 266.0 }, "treatments": [ { "START_DATE": 31, "STOP_DATE": 153.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Fluorouracil", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 31, "STOP_DATE": 153.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Epirubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 31, "STOP_DATE": 153.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 212, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Letrozole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 184, "STOP_DATE": 212.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "gy" } ] }, "TCGA-AO-A0J4": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "a9b7d7fe-be31-4f71-afee-c1bfdf511888", "AGE": 41, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IA", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": 1587.0, "DAYS_TO_BIRTH": -15052.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/19/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 52.17477069, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 52.17477069, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 52.17477069, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 52.17477069, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-AO-A0J4-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AO", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 19.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2752, "MSI_SENSOR_SCORE": 0.14, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 3.466666667, "TISSUE_SOURCE_SITE": "MSKCC", "TBL_SCORE": 159.0 }, "treatments": [ { "START_DATE": 131, "STOP_DATE": 175.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "600", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "4000", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 131, "STOP_DATE": 175.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "60", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "400", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 189, "STOP_DATE": 203.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": "2", "PRESCRIBED_DOSE": "175", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "580", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 265, "STOP_DATE": 294.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "21", "RADIATION_DOSAGE": "5240", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-C8-A12X": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "65cde5d5-1efc-4e30-b1bd-a93598794f2c", "AGE": 62, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 385.0, "DAYS_TO_BIRTH": -22889.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/13/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8480/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Asian", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 12.65739554, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 12.65739554, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 12.65739554, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 12.65739554, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-C8-A12X-01", "ONCOTREE_CODE": "IMMC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Mixed Mucinous Carcinoma", "TUMOR_TYPE": "Mucinous Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "C8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 10.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2827, "MSI_SENSOR_SCORE": 0.26, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.533333333, "TISSUE_SOURCE_SITE": "ILSBio", "TBL_SCORE": 65.0 }, "treatments": [] }, "TCGA-GI-A2C8": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "33fe5833-d7a0-43d7-a03d-56985ea448a6", "AGE": 63, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIB", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 225.0, "DAYS_TO_BIRTH": -23103.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "10/21/2011", "HISTORY_NEOADJUVANT_TRTYN": "Yes", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T4B", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 7.397179209, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 7.397179209, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 7.397179209, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 7.397179209, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-GI-A2C8-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "GI", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 13.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3289, "MSI_SENSOR_SCORE": 0.19, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 3.533333333, "TISSUE_SOURCE_SITE": "ABS - IUPUI", "TBL_SCORE": 328.0 }, "treatments": [] }, "TCGA-B6-A0IC": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "b804f7ae-da8f-4414-be11-f880f1859160", "AGE": 90, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE X", "AJCC_STAGING_EDITION": "3RD", "DAYS_LAST_FOLLOWUP": NaN, "DAYS_TO_BIRTH": -32872.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "11/2/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8503/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "NX", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 50.69533485, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 50.69533485, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 50.69533485, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 50.69533485, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-B6-A0IC-01", "ONCOTREE_CODE": "BRCNOS", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Carcinoma (NOS)", "TUMOR_TYPE": "Other", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "B6", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 4.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.269, "MSI_SENSOR_SCORE": 0.11, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.0, "TISSUE_SOURCE_SITE": "Duke", "TBL_SCORE": 30.0 }, "treatments": [] }, "TCGA-AR-A5QP": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "3C275152-D04B-440C-9621-2FC05EA977B6", "AGE": 54, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 1185.0, "DAYS_TO_BIRTH": -19805.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/15/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 38.95847717, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 38.95847717, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 38.95847717, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AR-A5QP-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AR", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 8.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3078, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.866666667, "TISSUE_SOURCE_SITE": "Mayo", "TBL_SCORE": 28.0 }, "treatments": [ { "START_DATE": 46, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 42, "STOP_DATE": 70.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "20", "RADIATION_DOSAGE": "5256", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-AR-A0U3": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "c5f00132-1c6b-4337-af6f-596c652665cc", "AGE": 59, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 4080.0, "DAYS_TO_BIRTH": -21755.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Hispanic Or Latino", "FORM_COMPLETION_DATE": "2/25/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 134.1355163, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 134.1355163, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 134.1355163, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 134.1355163, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AR-A0U3-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AR", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 14.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2992, "MSI_SENSOR_SCORE": 0.58, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.033333333, "TISSUE_SOURCE_SITE": "Mayo", "TBL_SCORE": 226.0 }, "treatments": [ { "START_DATE": 95, "STOP_DATE": 137.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "175", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "1590", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 166, "STOP_DATE": 2015.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 41, "STOP_DATE": 69.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "3", "PRESCRIBED_DOSE": "600", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "4160", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 41, "STOP_DATE": 69.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "3", "PRESCRIBED_DOSE": "60", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "420", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 171, "STOP_DATE": 210.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "30", "RADIATION_DOSAGE": "6000", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-A7-A0CD": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "09765b0a-94f6-47d2-af56-93368084ac3a", "AGE": 66, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE I", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 1165.0, "DAYS_TO_BIRTH": -24242.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "10/5/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T1", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 38.30095013, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 38.30095013, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 38.30095013, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 38.30095013, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A7-A0CD-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "A7", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 27.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2652, "MSI_SENSOR_SCORE": 0.63, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.733333333, "TISSUE_SOURCE_SITE": "Christiana Healthcare", "TBL_SCORE": 8.0 }, "treatments": [ { "START_DATE": 112, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1 mg daily", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 70, "STOP_DATE": 74.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "10", "RADIATION_DOSAGE": "3400", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Other", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-BH-A0EE": { "demographics": { "SUBTYPE": "BRCA_Her2", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "ca76c6fc-ff30-4833-884d-3a94fe53ff17", "AGE": 68, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": 943.0, "DAYS_TO_BIRTH": -24850.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "11/9/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 31.00239997, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 31.00239997, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 31.00239997, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 31.00239997, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A0EE-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 22.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2743, "MSI_SENSOR_SCORE": 0.09, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 4.1, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 150.0 }, "treatments": [ { "START_DATE": 47, "STOP_DATE": 173.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": "6", "PRESCRIBED_DOSE": "130", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "839", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 47, "STOP_DATE": 173.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": "6", "PRESCRIBED_DOSE": "130", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "839", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 47, "STOP_DATE": 411.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Trastuzumab", "NUMBER_OF_CYCLES": "17", "PRESCRIBED_DOSE": "549", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "6800", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 47, "STOP_DATE": 173.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": "6", "PRESCRIBED_DOSE": "540", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "2632", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-A7-A4SD": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "8C09F413-E938-4F2E-A414-84F0E7FCFE41", "AGE": 52, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 441.0, "DAYS_TO_BIRTH": -19131.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "2/19/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 14.49847125, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 14.49847125, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 14.49847125, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 14.49847125, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-A7-A4SD-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "A7", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 20.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3243, "MSI_SENSOR_SCORE": 0.21, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.966666667, "TISSUE_SOURCE_SITE": "Christiana Healthcare", "TBL_SCORE": 241.0 }, "treatments": [ { "START_DATE": 64, "STOP_DATE": 134.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 64, "STOP_DATE": 134.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-LD-A7W6": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "0B0F9938-CE1E-4814-8821-0132D137EB9E", "AGE": 54, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 404.0, "DAYS_TO_BIRTH": -20077.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "2/3/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.2", "ICD_O_3_HISTOLOGY": "8524/3", "ICD_O_3_SITE": "C50.2", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 13.28204622, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 13.28204622, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 13.28204622, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 13.28204622, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-LD-A7W6-01", "ONCOTREE_CODE": "BRCNOS", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Carcinoma (NOS)", "TUMOR_TYPE": "Other", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "LD", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 4.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.329, "MSI_SENSOR_SCORE": 0.01, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.966666667, "TISSUE_SOURCE_SITE": "Hartford Hospital", "TBL_SCORE": 50.0 }, "treatments": [ { "START_DATE": 146, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Letrozole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-BH-A0C0": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "7875018b-91dc-4ab1-83b0-ee3883e2816e", "AGE": 62, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": 1270.0, "DAYS_TO_BIRTH": -23006.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "11/8/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 41.75296709, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 41.75296709, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 41.75296709, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 41.75296709, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A0C0-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 16.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.251, "MSI_SENSOR_SCORE": 0.3, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 6.166666667, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 286.0 }, "treatments": [ { "START_DATE": 57, "STOP_DATE": 162.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": "6", "PRESCRIBED_DOSE": "620", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "3740", "TOTAL_DOSE_UNITS": "Mg/Day", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 57, "STOP_DATE": 162.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": "6", "PRESCRIBED_DOSE": "116", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "710", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 158, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 204, "STOP_DATE": 249.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "33", "RADIATION_DOSAGE": "6040", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-AN-A0FL": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "baf1207d-7d1a-4cad-ba58-62c26be2415e", "AGE": 62, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": 231.0, "DAYS_TO_BIRTH": -22805.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/28/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 7.594437321, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 7.594437321, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 7.594437321, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 7.594437321, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AN-A0FL-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AN", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 7.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2919, "MSI_SENSOR_SCORE": 0.62, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 5.066666667, "TISSUE_SOURCE_SITE": "Cureline", "TBL_SCORE": 293.0 }, "treatments": [] }, "TCGA-AR-A24Q": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "28e9048a-e540-42de-a1f4-4ef894fccc4c", "AGE": 49, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 3172.0, "DAYS_TO_BIRTH": -18084.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "8/30/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 104.2837887, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 104.2837887, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 104.2837887, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 104.2837887, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AR-A24Q-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AR", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 16.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3299, "MSI_SENSOR_SCORE": 0.42, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 5.433333333, "TISSUE_SOURCE_SITE": "Mayo", "TBL_SCORE": 196.0 }, "treatments": [ { "START_DATE": 79, "STOP_DATE": 79.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Immunotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Trastuzumab", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "4", "PRESCRIBED_DOSE_UNITS": "mg/kg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "260", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 87, "STOP_DATE": 155.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": "3", "PRESCRIBED_DOSE": "60", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "970", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 180, "STOP_DATE": 511.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Immunotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Trastuzumab", "NUMBER_OF_CYCLES": "14", "PRESCRIBED_DOSE": "6", "PRESCRIBED_DOSE_UNITS": "mg/kg", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "7387", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 36, "STOP_DATE": 50.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "2", "PRESCRIBED_DOSE": "60", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "220", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 36, "STOP_DATE": 50.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "2", "PRESCRIBED_DOSE": "600", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "2210", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 79, "STOP_DATE": 155.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": "1", "PRESCRIBED_DOSE": "90", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "310", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 208, "STOP_DATE": 1988.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "3", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 86, "STOP_DATE": 155.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Immunotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Trastuzumab", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "2", "PRESCRIBED_DOSE_UNITS": "mg/kg", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "1400", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 196, "STOP_DATE": 230.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "25", "RADIATION_DOSAGE": "5000", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-AR-A1AI": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "9848307d-1bd5-40c1-b655-a33297aaf74f", "AGE": 47, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 3296.0, "DAYS_TO_BIRTH": -17229.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "6/15/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8510/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 108.3604563, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 108.3604563, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 19.331295, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 19.331295, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AR-A1AI-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Medullary Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AR", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 22.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2776, "MSI_SENSOR_SCORE": 0.79, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.333333333, "TISSUE_SOURCE_SITE": "Mayo", "TBL_SCORE": 258.0 }, "treatments": [ { "START_DATE": 35, "STOP_DATE": 77.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "60", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "550", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 91, "STOP_DATE": 134.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "175", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "1520", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 35, "STOP_DATE": 77.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "600", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "5500", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-E2-A10B": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "f801aeed-dc43-49d7-a319-84c8851979d9", "AGE": 67, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 1141.0, "DAYS_TO_BIRTH": -24577.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "2/22/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 37.51191768, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 37.51191768, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 6.410888648, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E2-A10B-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "E2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 35.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": NaN, "MSI_SENSOR_SCORE": 0.98, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.533333333, "TISSUE_SOURCE_SITE": "Roswell Park", "TBL_SCORE": 10.0 }, "treatments": [ { "START_DATE": 232, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": "1", "TOTAL_DOSE_UNITS": "Mg/Day", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 252, "STOP_DATE": 398.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": "7", "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "1922", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 252, "STOP_DATE": 398.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": "8", "PRESCRIBED_DOSE": "312", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "1556", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 657, "STOP_DATE": 748.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Pemetrexed", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "624", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "4", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "2484", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 301, "STOP_DATE": 301.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Bevacizumab", "NUMBER_OF_CYCLES": "1", "PRESCRIBED_DOSE": "840", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "3", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "840", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 230, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 368, "STOP_DATE": 413.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "30", "RADIATION_DOSAGE": "6000", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-E9-A1NC": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "e74aea7c-ca14-49df-b5cf-dacb839ac27a", "AGE": 61, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 1203.0, "DAYS_TO_BIRTH": -22355.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "6/23/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8522/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 39.5502515, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 39.5502515, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 39.5502515, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 39.5502515, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E9-A1NC-01", "ONCOTREE_CODE": "BRCNOS", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Carcinoma (NOS)", "TUMOR_TYPE": "Mixed Histology (NOS)", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "E9", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 5.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3228, "MSI_SENSOR_SCORE": 0.17, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.2, "TISSUE_SOURCE_SITE": "Asterand", "TBL_SCORE": 172.0 }, "treatments": [ { "START_DATE": 10, "STOP_DATE": 122.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 10, "STOP_DATE": 122.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Fluorouracil", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 10, "STOP_DATE": 122.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 134, "STOP_DATE": 708.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-EW-A1IW": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "5e2cbc56-97f9-4b94-ade2-a3f739bcc7be", "AGE": 80, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 371.0, "DAYS_TO_BIRTH": -29529.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/27/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 12.19712661, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 12.19712661, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 12.19712661, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 12.19712661, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-EW-A1IW-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "EW", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 6.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2984, "MSI_SENSOR_SCORE": 0.17, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.666666667, "TISSUE_SOURCE_SITE": "University of Miami", "TBL_SCORE": 83.0 }, "treatments": [ { "START_DATE": 71, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Exemestane", "NUMBER_OF_CYCLES": "6", "PRESCRIBED_DOSE": "25", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-BH-A1EX": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "7b892055-c59d-4550-8688-ad039790af3d", "AGE": 67, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "5TH", "DAYS_LAST_FOLLOWUP": NaN, "DAYS_TO_BIRTH": -24544.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/7/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1B", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": null, "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 49.57753888, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 49.57753888, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 49.57753888, "GENETIC_ANCESTRY_LABEL": "EAS" }, "sample": { "SAMPLE_ID": "TCGA-BH-A1EX-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 12.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2931, "MSI_SENSOR_SCORE": 0.23, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.8, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 6.0 }, "treatments": [] }, "TCGA-PL-A8LY": { "demographics": { "SUBTYPE": "BRCA_Normal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "9BA11EA8-97D3-464A-90A4-EC1151BE9088", "AGE": 30, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 8.0, "DAYS_TO_BIRTH": -11199.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/26/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "No", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 0.263010816, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 0.263010816, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 0.263010816, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-PL-A8LY-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "PL", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3461, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.133333333, "TISSUE_SOURCE_SITE": "Institute of Human Virology Nigeria", "TBL_SCORE": 0.0 }, "treatments": [] }, "TCGA-4H-AAAK": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "6623FC5E-00BE-4476-967A-CBD55F676EA6", "AGE": 50, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 348.0, "DAYS_TO_BIRTH": -18371.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "11/13/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N2A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 11.44097051, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 11.44097051, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 11.44097051, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 11.44097051, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-4H-AAAK-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "4H", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 7.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3411, "MSI_SENSOR_SCORE": 0.01, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.7, "TISSUE_SOURCE_SITE": "Proteogenex, Inc.", "TBL_SCORE": 36.0 }, "treatments": [ { "START_DATE": 27, "STOP_DATE": 98.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 27, "STOP_DATE": 98.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 27, "STOP_DATE": 98.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Fluorouracil", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-BH-A0HX": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "3b01d064-8c00-4972-9f07-407eac8e7534", "AGE": 54, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": 829.0, "DAYS_TO_BIRTH": -19900.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "11/11/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 27.25449584, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 27.25449584, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 27.25449584, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 27.25449584, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A0HX-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 18.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2855, "MSI_SENSOR_SCORE": 0.43, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.933333333, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 179.0 }, "treatments": [ { "START_DATE": 278, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 117, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 117, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-AR-A0TQ": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "5dc1bee9-c44d-4fdc-9ae5-83426c4d6880", "AGE": 27, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 2991.0, "DAYS_TO_BIRTH": -9873.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/7/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 98.33316895, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 98.33316895, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 98.33316895, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 98.33316895, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AR-A0TQ-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AR", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 11.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2818, "MSI_SENSOR_SCORE": 0.13, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.066666667, "TISSUE_SOURCE_SITE": "Mayo", "TBL_SCORE": 91.0 }, "treatments": [ { "START_DATE": 100, "STOP_DATE": 226.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Immunotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Trastuzumab", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "2", "PRESCRIBED_DOSE_UNITS": "mg/kg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "3900", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 254, "STOP_DATE": 482.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Immunotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Trastuzumab", "NUMBER_OF_CYCLES": "13", "PRESCRIBED_DOSE": "6", "PRESCRIBED_DOSE_UNITS": "mg/kg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "9720", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 37, "STOP_DATE": 79.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "600", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "5560", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 37, "STOP_DATE": 1864.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Triptorelin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "3.75", "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IM", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "270", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 93, "STOP_DATE": 93.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Immunotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Trastuzumab", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "4", "PRESCRIBED_DOSE_UNITS": "mg/kg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "495", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 114, "STOP_DATE": 226.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": "3", "PRESCRIBED_DOSE": "80", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "1785", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 233, "STOP_DATE": 1867.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Exemestane", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "25", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 37, "STOP_DATE": 79.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "60", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "550", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 93, "STOP_DATE": 107.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": "1", "PRESCRIBED_DOSE": "60", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "435", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 250, "STOP_DATE": 289.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "30", "RADIATION_DOSAGE": "6000", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-C8-A1HL": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "a8a199c9-d781-4e6c-af8c-c85d60c7cd40", "AGE": 38, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 317.0, "DAYS_TO_BIRTH": NaN, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "6/2/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8480/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "Yes", "RACE": "Asian", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 10.4218036, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 10.4218036, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 10.4218036, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 10.4218036, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-C8-A1HL-01", "ONCOTREE_CODE": "BRCNOS", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Carcinoma (NOS)", "TUMOR_TYPE": "Other", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "C8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 12.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2644, "MSI_SENSOR_SCORE": 0.26, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.9, "TISSUE_SOURCE_SITE": "ILSBio", "TBL_SCORE": 114.0 }, "treatments": [] }, "TCGA-AO-A03R": { "demographics": { "SUBTYPE": "BRCA_Normal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "2e82e576-3095-4aee-9853-65f676647c34", "AGE": 57, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": 2091.0, "DAYS_TO_BIRTH": -20930.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/19/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 68.74445212, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 68.74445212, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 68.74445212, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 68.74445212, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AO-A03R-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AO", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 8.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2568, "MSI_SENSOR_SCORE": 0.09, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.233333333, "TISSUE_SOURCE_SITE": "MSKCC", "TBL_SCORE": 37.0 }, "treatments": [ { "START_DATE": 192, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Letrozole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "2.5", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 123, "STOP_DATE": 165.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "175", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "1240", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 67, "STOP_DATE": 109.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "600", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "4248", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 67, "STOP_DATE": 109.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "60", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "424", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 200, "STOP_DATE": 245.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "23", "RADIATION_DOSAGE": "10540", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-A8-A07R": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "72e486b8-a866-4916-b2e4-8b4bb5dcd92d", "AGE": 80, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIC", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 273.0, "DAYS_TO_BIRTH": -29251.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "5/27/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N3A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": null, "RADIATION_THERAPY": null, "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "0:LIVING", "OS_MONTHS": 8.975244107, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 8.975244107, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 8.975244107, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A8-A07R-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 13.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2971, "MSI_SENSOR_SCORE": 3.2, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.0, "TISSUE_SOURCE_SITE": "Indivumed", "TBL_SCORE": 267.0 }, "treatments": [ { "START_DATE": 181, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Ancillary", "TREATMENT_SUBTYPE": null, "AGENT": "Zoledronic Acid", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 120, "STOP_DATE": 151.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "gy" } ] }, "TCGA-AN-A0XP": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "cf0e7e4e-b857-4db5-9ae2-551a899f77be", "AGE": 69, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 9.0, "DAYS_TO_BIRTH": -25305.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/25/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N2", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 0.295887168, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 0.295887168, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 0.295887168, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 0.295887168, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AN-A0XP-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AN", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 14.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2804, "MSI_SENSOR_SCORE": 0.03, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.866666667, "TISSUE_SOURCE_SITE": "Cureline", "TBL_SCORE": 9.0 }, "treatments": [] }, "TCGA-A2-A04Q": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "b5fba77b-1f50-4e71-95b2-566afba4bdd7", "AGE": 48, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 2385.0, "DAYS_TO_BIRTH": -17660.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "8/10/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T1", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 78.41009962, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 78.41009962, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 78.41009962, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 78.41009962, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A2-A04Q-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 11.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2846, "MSI_SENSOR_SCORE": 0.03, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.566666667, "TISSUE_SOURCE_SITE": "Walter Reed", "TBL_SCORE": 48.0 }, "treatments": [ { "START_DATE": 23, "STOP_DATE": 85.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "100-102", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "204", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 43, "STOP_DATE": 85.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "1000-1020", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "4048", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-D8-A1XV": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "87b85935-a058-44ad-8fb6-8511130eaffe", "AGE": 84, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 461.0, "DAYS_TO_BIRTH": -30830.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/16/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8480/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 15.15599829, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 15.15599829, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 15.15599829, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 15.15599829, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D8-A1XV-01", "ONCOTREE_CODE": "IMMC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Mixed Mucinous Carcinoma", "TUMOR_TYPE": "Mucinous Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "D8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 1.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2846, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.9, "TISSUE_SOURCE_SITE": "Greater Poland Cancer Center", "TBL_SCORE": 4.0 }, "treatments": [] }, "TCGA-E2-A1L8": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "eebad74f-5961-4e91-b0eb-157a2f6f952b", "AGE": 52, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 2240.0, "DAYS_TO_BIRTH": -19187.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "6/7/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "Yes", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 73.64302857, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 73.64302857, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 73.64302857, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 73.64302857, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-E2-A1L8-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "E2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 20.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.329, "MSI_SENSOR_SCORE": 0.53, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.9, "TISSUE_SOURCE_SITE": "Roswell Park", "TBL_SCORE": 64.0 }, "treatments": [ { "START_DATE": 246, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "4", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": "1", "TOTAL_DOSE_UNITS": "Mg/Day", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 211, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Other", "TREATMENT_SUBTYPE": "Phase III Clinical Trial", "AGENT": "Clodronic Acid", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1600", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "3", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": "1600", "TOTAL_DOSE_UNITS": "Mg/Day", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 57, "STOP_DATE": 99.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "3", "PRESCRIBED_DOSE": "132", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "396", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 113, "STOP_DATE": 155.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "428", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "1712", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 57, "STOP_DATE": 99.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "3", "PRESCRIBED_DOSE": "1320", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "3960", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 198, "STOP_DATE": 245.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "33", "RADIATION_DOSAGE": "6040", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-BH-A1EV": { "demographics": { "SUBTYPE": "BRCA_Her2", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "417dea5f-f68e-4dab-940e-43ae8c67e5e6", "AGE": 45, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": "5TH", "DAYS_LAST_FOLLOWUP": NaN, "DAYS_TO_BIRTH": -16504.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/7/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1B", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 11.9998685, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 11.9998685, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 11.9998685, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A1EV-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 18.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2679, "MSI_SENSOR_SCORE": 0.41, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.833333333, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 427.0 }, "treatments": [ { "START_DATE": 48, "STOP_DATE": 139.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Radiographic Progressive Disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": "6000", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" }, { "START_DATE": 48, "STOP_DATE": 139.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 2", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Radiographic Progressive Disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": "5000", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-GM-A5PX": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "F7064D01-29D8-49A2-AD60-1E0C5F148F3E", "AGE": 65, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 551.0, "DAYS_TO_BIRTH": -23753.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/12/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1MI", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 18.11486997, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 18.11486997, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 18.11486997, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 18.11486997, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-GM-A5PX-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "GM", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 3.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2788, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.8, "TISSUE_SOURCE_SITE": "MD Anderson", "TBL_SCORE": 9.0 }, "treatments": [ { "START_DATE": 112, "STOP_DATE": 236.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 265, "STOP_DATE": 339.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Exemestane", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 340, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-A7-A3IY": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "6B4E0262-F589-4532-B578-9F2D76C19D90", "AGE": 71, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE I", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 345.0, "DAYS_TO_BIRTH": -26042.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/19/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8480/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "0:LIVING", "OS_MONTHS": 11.34234145, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 11.34234145, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 11.34234145, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 11.34234145, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A7-A3IY-01", "ONCOTREE_CODE": "IMMC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Mixed Mucinous Carcinoma", "TUMOR_TYPE": "Mucinous Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "A7", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 1.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3096, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": NaN, "TISSUE_SOURCE_SITE": "Christiana Healthcare", "TBL_SCORE": 15.0 }, "treatments": [ { "START_DATE": 151, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 70, "STOP_DATE": 116.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "33", "RADIATION_DOSAGE": "6100", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-A1-A0SK": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "a5b44d66-c162-46b5-9df2-86305f0385c5", "AGE": 54, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": NaN, "DAYS_TO_BIRTH": -20048.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/6/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8013/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Asian", "RADIATION_THERAPY": null, "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 31.79143242, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 31.79143242, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 31.79143242, "GENETIC_ANCESTRY_LABEL": "EAS" }, "sample": { "SAMPLE_ID": "TCGA-A1-A0SK-01", "ONCOTREE_CODE": "BRCNOS", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Carcinoma (NOS)", "TUMOR_TYPE": "Other", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A1", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 16.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2902, "MSI_SENSOR_SCORE": 1.02, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.033333333, "TISSUE_SOURCE_SITE": "UCSF", "TBL_SCORE": 205.0 }, "treatments": [] }, "TCGA-EW-A1OV": { "demographics": { "SUBTYPE": "BRCA_Her2", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "ac68d219-5670-4ddd-8df6-8aa7ad59e5c7", "AGE": 56, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 789.0, "DAYS_TO_BIRTH": -20764.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/27/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N1MI", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 25.93944176, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 25.93944176, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 25.93944176, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 25.93944176, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-EW-A1OV-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "EW", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 18.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3521, "MSI_SENSOR_SCORE": 0.96, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 3.3, "TISSUE_SOURCE_SITE": "University of Miami", "TBL_SCORE": 51.0 }, "treatments": [ { "START_DATE": 203, "STOP_DATE": 252.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "3", "PRESCRIBED_DOSE": "890", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "2690", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 273, "STOP_DATE": 314.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": "3", "PRESCRIBED_DOSE": "180", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "545", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 203, "STOP_DATE": 252.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Epirubicin", "NUMBER_OF_CYCLES": "3", "PRESCRIBED_DOSE": "178", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "538", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 203, "STOP_DATE": 252.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Fluorouracil", "NUMBER_OF_CYCLES": "3", "PRESCRIBED_DOSE": "890", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "2690", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-AN-A0AM": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "00a2d166-78c9-4687-a195-3d6315c27574", "AGE": 56, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": 5.0, "DAYS_TO_BIRTH": -20713.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/28/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 0.16438176, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 0.16438176, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 0.16438176, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 0.16438176, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AN-A0AM-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AN", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 21.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2894, "MSI_SENSOR_SCORE": 0.09, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.933333333, "TISSUE_SOURCE_SITE": "Cureline", "TBL_SCORE": 700.0 }, "treatments": [] }, "TCGA-S3-AA17": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "49A2FD48-744D-4D88-B9B4-8C778D4F48FD", "AGE": 64, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 424.0, "DAYS_TO_BIRTH": -23642.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/21/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "CM0 (I+)", "PATH_N_STAGE": "N1MI", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "Yes", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 13.93957327, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 13.93957327, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 13.93957327, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 13.93957327, "GENETIC_ANCESTRY_LABEL": "AFR_ADMIX" }, "sample": { "SAMPLE_ID": "TCGA-S3-AA17-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "S3", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 9.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3284, "MSI_SENSOR_SCORE": 0.02, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.966666667, "TISSUE_SOURCE_SITE": "Albert Einstein Medical Center", "TBL_SCORE": 83.0 }, "treatments": [ { "START_DATE": 99, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 119, "STOP_DATE": 162.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "30", "RADIATION_DOSAGE": "6000", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-E2-A1LE": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "7317E605-93BA-49A9-8743-20613B02767A", "AGE": 71, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIC", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": NaN, "DAYS_TO_BIRTH": -26239.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "6/7/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N3A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 28.89831344, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 28.89831344, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 11.86836309, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 11.86836309, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E2-A1LE-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "E2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 13.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2998, "MSI_SENSOR_SCORE": 0.02, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.0, "TISSUE_SOURCE_SITE": "Roswell Park", "TBL_SCORE": 581.0 }, "treatments": [ { "START_DATE": 54, "STOP_DATE": 54.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": "1", "PRESCRIBED_DOSE": "134", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "134", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 54, "STOP_DATE": 54.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "1", "PRESCRIBED_DOSE": "1074", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "1074", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 468, "STOP_DATE": 530.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Gemcitabine", "NUMBER_OF_CYCLES": "3", "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Recurrence", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 54, "STOP_DATE": 54.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Trastuzumab", "NUMBER_OF_CYCLES": "1", "PRESCRIBED_DOSE": "635", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "635", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 101, "STOP_DATE": 146.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-E9-A1RI": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "dd3bfb26-b534-4917-9c4d-9fe7b6477762", "AGE": 43, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 1449.0, "DAYS_TO_BIRTH": -15942.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/28/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8522/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N2", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 47.63783411, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 47.63783411, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 47.63783411, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 47.63783411, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E9-A1RI-01", "ONCOTREE_CODE": "BRCNOS", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Carcinoma (NOS)", "TUMOR_TYPE": "Mixed Histology (NOS)", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "E9", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 6.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3058, "MSI_SENSOR_SCORE": 0.08, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.466666667, "TISSUE_SOURCE_SITE": "Asterand", "TBL_SCORE": 25.0 }, "treatments": [ { "START_DATE": 32, "STOP_DATE": 78.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Fluorouracil", "NUMBER_OF_CYCLES": "1", "PRESCRIBED_DOSE": "1000", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "1000", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 32, "STOP_DATE": 78.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "3", "PRESCRIBED_DOSE": "100", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "300", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 28, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "20", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 418, "STOP_DATE": 425.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Leuprolide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 32, "STOP_DATE": 78.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "3", "PRESCRIBED_DOSE": "1000", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "3000", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 137, "STOP_DATE": 169.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "62", "RADIATION_DOSAGE": "12400", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-A7-A425": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "A8F5C479-8685-4E2D-BB60-63F1CC651083", "AGE": 70, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIC", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 447.0, "DAYS_TO_BIRTH": -25678.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "11/5/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N3A", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 14.69572936, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 14.69572936, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 13.77519151, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 13.77519151, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A7-A425-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "A7", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 25.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3052, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.933333333, "TISSUE_SOURCE_SITE": "Christiana Healthcare", "TBL_SCORE": 36.0 }, "treatments": [ { "START_DATE": 127, "STOP_DATE": 197.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 127, "STOP_DATE": 197.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 211, "STOP_DATE": 288.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 378, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 317, "STOP_DATE": 359.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Radiographic Progressive Disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "28", "RADIATION_DOSAGE": "5040", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" }, { "START_DATE": 317, "STOP_DATE": 352.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 2", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Radiographic Progressive Disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "25", "RADIATION_DOSAGE": "4500", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-E2-A1IG": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "bc0bc70f-c6cf-4dbc-9dc3-8b7bc5f381a4", "AGE": 45, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 2140.0, "DAYS_TO_BIRTH": -16757.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/28/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1MI", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 70.35539337, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 70.35539337, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 70.35539337, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 70.35539337, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E2-A1IG-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "E2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 4.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3128, "MSI_SENSOR_SCORE": 0.15, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.433333333, "TISSUE_SOURCE_SITE": "Roswell Park", "TBL_SCORE": 87.0 }, "treatments": [ { "START_DATE": 52, "STOP_DATE": 94.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "99", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "396", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 108, "STOP_DATE": 150.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "290", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "1160", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 234, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "20", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "3", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": "20", "TOTAL_DOSE_UNITS": "Mg/Day", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 52, "STOP_DATE": 94.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "990", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "3960", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 1991, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Letrozole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 178, "STOP_DATE": 222.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "33", "RADIATION_DOSAGE": "6040", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-D8-A1XA": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "739cb132-51e9-41be-8064-311a13da0d74", "AGE": 64, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 839.0, "DAYS_TO_BIRTH": -23387.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/18/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 27.58325936, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 27.58325936, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 27.58325936, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 27.58325936, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D8-A1XA-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "D8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 17.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3223, "MSI_SENSOR_SCORE": 1.02, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.8, "TISSUE_SOURCE_SITE": "Greater Poland Cancer Center", "TBL_SCORE": 39.0 }, "treatments": [ { "START_DATE": 140, "STOP_DATE": 185.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "30", "RADIATION_DOSAGE": "6000", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-BH-A0BG": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "4f608829-ffc4-4527-886e-6bc764ab29f5", "AGE": 73, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE I", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 1871.0, "DAYS_TO_BIRTH": -26988.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "8/8/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T1", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 61.51165467, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 61.51165467, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 61.51165467, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 61.51165467, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A0BG-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 19.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3111, "MSI_SENSOR_SCORE": 0.7, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.133333333, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 61.0 }, "treatments": [ { "START_DATE": 84, "STOP_DATE": 131.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "28", "RADIATION_DOSAGE": "5040", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-BH-A0EI": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "22b35927-1c3f-4f98-ba42-deafc56b677a", "AGE": 51, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 1926.0, "DAYS_TO_BIRTH": -18741.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "8/11/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 63.31985403, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 63.31985403, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 63.31985403, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 63.31985403, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A0EI-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 6.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2722, "MSI_SENSOR_SCORE": 0.07, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.533333333, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 52.0 }, "treatments": [ { "START_DATE": 274, "STOP_DATE": 321.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "33", "RADIATION_DOSAGE": "5040", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" }, { "START_DATE": 350, "STOP_DATE": 350.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 2", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": "900", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-LD-A7W5": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "A06FF6AE-B0DD-4516-A75C-0DB71694B46B", "AGE": 52, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIC", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 216.0, "DAYS_TO_BIRTH": -19169.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "2/3/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N3A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 7.101292041, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 7.101292041, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 7.101292041, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-LD-A7W5-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "LD", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 23.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3317, "MSI_SENSOR_SCORE": 0.01, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.4, "TISSUE_SOURCE_SITE": "Hartford Hospital", "TBL_SCORE": 259.0 }, "treatments": [ { "START_DATE": 82, "STOP_DATE": 145.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Stable Disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 82, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-E2-A158": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "a6edb6ca-ae9f-4da7-8ebe-92d83d2987fb", "AGE": 43, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 450.0, "DAYS_TO_BIRTH": -15903.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/7/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1MI", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 14.79435842, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 14.79435842, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 14.79435842, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 14.79435842, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E2-A158-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "E2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 7.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2697, "MSI_SENSOR_SCORE": 1.53, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 3.2, "TISSUE_SOURCE_SITE": "Roswell Park", "TBL_SCORE": 209.0 }, "treatments": [ { "START_DATE": 450, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "3", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-A2-A3XS": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "A78B04B4-2380-4803-963E-E4E633CD69AB", "AGE": 62, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": NaN, "DAYS_TO_BIRTH": -23000.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "8/15/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N2A", "PATH_T_STAGE": "T1", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 33.92839531, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 33.92839531, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 22.42167209, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 22.42167209, "GENETIC_ANCESTRY_LABEL": "AFR_ADMIX" }, "sample": { "SAMPLE_ID": "TCGA-A2-A3XS-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 22.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3169, "MSI_SENSOR_SCORE": 0.38, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.0, "TISSUE_SOURCE_SITE": "Walter Reed", "TBL_SCORE": 120.0 }, "treatments": [ { "START_DATE": 112, "STOP_DATE": 154.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 112, "STOP_DATE": 154.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 167, "STOP_DATE": 210.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 281, "STOP_DATE": 682.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Clinical Progressive Disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 695, "STOP_DATE": 806.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Clinical Progressive Disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 895, "STOP_DATE": 958.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Ancillary", "TREATMENT_SUBTYPE": null, "AGENT": "Bevacizumab", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Clinical Progressive Disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 874, "STOP_DATE": 980.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Capecitabine", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Clinical Progressive Disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 986, "STOP_DATE": 1022.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Vinorelbine", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Clinical Progressive Disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-E2-A1IE": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "2d0d7ff4-7866-4ae1-9cf1-a3c7f4cbe48d", "AGE": 61, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 2362.0, "DAYS_TO_BIRTH": -22510.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/26/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 77.65394352, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 77.65394352, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 59.50619719, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 59.50619719, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E2-A1IE-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "E2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 5.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3239, "MSI_SENSOR_SCORE": 0.38, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.6, "TISSUE_SOURCE_SITE": "Roswell Park", "TBL_SCORE": 111.0 }, "treatments": [ { "START_DATE": 252, "STOP_DATE": 437.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "3", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "185", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 500, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "20", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "4", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": "20", "TOTAL_DOSE_UNITS": "Mg/Day", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 118, "STOP_DATE": 171.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "341", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "1364", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 62, "STOP_DATE": 104.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "1182", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IM", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "4728", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 62, "STOP_DATE": 104.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "118", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "472", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 1844, "STOP_DATE": 1928.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Letrozole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Clinical Progressive Disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 1928, "STOP_DATE": 2187.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Fulvestrant", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Clinical Progressive Disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 2187, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Exemestane", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 2187, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Everolimus", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 200, "STOP_DATE": 251.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "33", "RADIATION_DOSAGE": "6080", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-A2-A0T3": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "058dcb78-bed1-40c3-a6c2-a0cc40065531", "AGE": 37, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IB", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 1516.0, "DAYS_TO_BIRTH": -13680.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "2/21/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1MI", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 49.84054969, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 49.84054969, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 49.84054969, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 49.84054969, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A2-A0T3-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 31.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2828, "MSI_SENSOR_SCORE": 0.51, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.0, "TISSUE_SOURCE_SITE": "Walter Reed", "TBL_SCORE": 165.0 }, "treatments": [ { "START_DATE": 70, "STOP_DATE": 177.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": "6", "PRESCRIBED_DOSE": "155", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "930", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 70, "STOP_DATE": 177.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "6", "PRESCRIBED_DOSE": "1030", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "3", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "6180", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 70, "STOP_DATE": 177.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "6", "PRESCRIBED_DOSE": "103", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "618", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 203, "STOP_DATE": 248.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "33", "RADIATION_DOSAGE": "10440", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-C8-A134": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "f1692f4b-ce1b-4fc5-ac55-1022ecae0d1e", "AGE": 52, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 383.0, "DAYS_TO_BIRTH": -19010.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/15/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Asian", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 12.59164283, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 12.59164283, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 12.59164283, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 12.59164283, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-C8-A134-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "C8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 8.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2972, "MSI_SENSOR_SCORE": 0.31, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.8, "TISSUE_SOURCE_SITE": "ILSBio", "TBL_SCORE": 142.0 }, "treatments": [ { "START_DATE": 38, "STOP_DATE": 41.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Fluorouracil", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 38, "STOP_DATE": 41.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Epirubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 38, "STOP_DATE": 41.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-E2-A1B6": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "e0b1bcd2-1139-44b9-98b3-67bcf92bcc39", "AGE": 44, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 867.0, "DAYS_TO_BIRTH": -16370.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/25/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 28.50379722, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 28.50379722, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 28.50379722, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 28.50379722, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E2-A1B6-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "E2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": NaN, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2514, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.433333333, "TISSUE_SOURCE_SITE": "Roswell Park", "TBL_SCORE": 2.0 }, "treatments": [] }, "TCGA-B6-A0X4": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "4e42fdc5-2a8b-49e9-87ef-6db7a6692d08", "AGE": 62, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "4TH", "DAYS_LAST_FOLLOWUP": NaN, "DAYS_TO_BIRTH": -22688.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/14/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1B", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 28.27366275, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 28.27366275, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 23.53946806, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 23.53946806, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-B6-A0X4-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "B6", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2706, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.6, "TISSUE_SOURCE_SITE": "Duke", "TBL_SCORE": 5.0 }, "treatments": [] }, "TCGA-A8-A091": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "f39edd06-1016-4e8e-a42e-12f7e699ddc5", "AGE": 61, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 1004.0, "DAYS_TO_BIRTH": -22554.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "5/27/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "Yes", "RACE": null, "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 33.00785745, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 33.00785745, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 7.988953546, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 7.988953546, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A8-A091-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 17.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.277, "MSI_SENSOR_SCORE": 0.28, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.633333333, "TISSUE_SOURCE_SITE": "Indivumed", "TBL_SCORE": 90.0 }, "treatments": [ { "START_DATE": 0, "STOP_DATE": 123.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Fluorouracil", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 0, "STOP_DATE": 123.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Epirubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 0, "STOP_DATE": 123.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 184, "STOP_DATE": 639.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Stable Disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 639, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Letrozole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 700, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Ancillary", "TREATMENT_SUBTYPE": null, "AGENT": "Zoledronic Acid", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 580, "STOP_DATE": 669.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Ancillary", "TREATMENT_SUBTYPE": null, "AGENT": "Pamidronic Acid", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Stable Disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 123, "STOP_DATE": 184.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "gy" } ] }, "TCGA-EW-A1J1": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "ed6cef77-1bd9-4e3b-b576-550a91e4253a", "AGE": 38, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 575.0, "DAYS_TO_BIRTH": -14122.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/11/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 18.90390242, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 18.90390242, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 18.90390242, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 18.90390242, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-EW-A1J1-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "EW", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 13.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3332, "MSI_SENSOR_SCORE": 0.91, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.5, "TISSUE_SOURCE_SITE": "University of Miami", "TBL_SCORE": 76.0 }, "treatments": [ { "START_DATE": 71, "STOP_DATE": 176.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": "6", "PRESCRIBED_DOSE": "152", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "tac", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 276, "STOP_DATE": 497.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "20", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "tam", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 513, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Goserelin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "3.6", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "SC", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 71, "STOP_DATE": 176.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "6", "PRESCRIBED_DOSE": "1015", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "tac", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 71, "STOP_DATE": 176.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "6", "PRESCRIBED_DOSE": "101", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "tac", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 209, "STOP_DATE": 254.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "42", "RADIATION_DOSAGE": "6,100", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-E9-A248": { "demographics": { "SUBTYPE": "BRCA_Her2", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "539bbbed-43fb-4fef-9c67-6406f58b186a", "AGE": 51, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 59.0, "DAYS_TO_BIRTH": -18684.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/22/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 1.93970477, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 1.93970477, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 1.93970477, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 1.93970477, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E9-A248-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "E9", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 15.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.31, "MSI_SENSOR_SCORE": 0.31, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.966666667, "TISSUE_SOURCE_SITE": "Asterand", "TBL_SCORE": 263.0 }, "treatments": [ { "START_DATE": 16, "STOP_DATE": 59.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "2", "PRESCRIBED_DOSE": "100", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "200", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 16, "STOP_DATE": 59.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "2", "PRESCRIBED_DOSE": "1000", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "2000", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-BH-A18I": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "9c1ceb7d-6fed-4c2f-a89a-bf3c5b15ca58", "AGE": 53, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 1093.0, "DAYS_TO_BIRTH": -19489.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "6/7/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.2", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.2", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "CM0 (I+)", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 35.93385278, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 35.93385278, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 35.93385278, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 35.93385278, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A18I-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 5.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2534, "MSI_SENSOR_SCORE": 0.04, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.833333333, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 62.0 }, "treatments": [ { "START_DATE": 121, "STOP_DATE": 220.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 121, "STOP_DATE": 220.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-E2-A570": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "CDD8C046-FD97-482A-A11F-2217B321C4D1", "AGE": 47, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IB", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 931.0, "DAYS_TO_BIRTH": -17456.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "6/21/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1MI", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 30.60788375, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 30.60788375, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 30.60788375, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 30.60788375, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-E2-A570-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "E2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 7.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3341, "MSI_SENSOR_SCORE": 0.04, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.7, "TISSUE_SOURCE_SITE": "Roswell Park", "TBL_SCORE": 7.0 }, "treatments": [ { "START_DATE": 252, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-A2-A3XY": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "DEBA32E4-0E68-4711-941B-3B63BD965AFB", "AGE": 49, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 1064.0, "DAYS_TO_BIRTH": -18059.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "8/14/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 35.93385278, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 35.93385278, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 26.36683434, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 26.36683434, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-A2-A3XY-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "A2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 8.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2994, "MSI_SENSOR_SCORE": 0.02, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.0, "TISSUE_SOURCE_SITE": "Walter Reed", "TBL_SCORE": 182.0 }, "treatments": [ { "START_DATE": 86, "STOP_DATE": 149.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 86, "STOP_DATE": 149.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 170, "STOP_DATE": 170.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 170, "STOP_DATE": 170.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 184, "STOP_DATE": 254.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 816, "STOP_DATE": 913.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Clinical Progressive Disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 816, "STOP_DATE": 1019.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Gemcitabine", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Clinical Progressive Disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 1040, "STOP_DATE": 1061.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Clinical Progressive Disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 816, "STOP_DATE": 1058.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Ancillary", "TREATMENT_SUBTYPE": null, "AGENT": "Denosumab", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Clinical Progressive Disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 1074, "STOP_DATE": 1082.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 2", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Radiographic Progressive Disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Distant Site", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "6", "RADIATION_DOSAGE": "1800", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-E2-A1B5": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "7241b3d4-31ee-4fd2-a4a5-35a9d5f37d6a", "AGE": 46, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 984.0, "DAYS_TO_BIRTH": -17039.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/25/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 32.35033041, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 32.35033041, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 32.35033041, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 32.35033041, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E2-A1B5-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "E2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 5.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2663, "MSI_SENSOR_SCORE": 0.88, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.133333333, "TISSUE_SOURCE_SITE": "Roswell Park", "TBL_SCORE": 70.0 }, "treatments": [ { "START_DATE": 190, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "20", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 130, "STOP_DATE": 174.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": "6000", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-E2-A1L6": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "2e32f31f-9817-4935-b259-96c59936ee33", "AGE": 44, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 1648.0, "DAYS_TO_BIRTH": -16403.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "6/7/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1MI", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 54.18022816, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 54.18022816, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 54.18022816, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 54.18022816, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E2-A1L6-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "E2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 5.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3113, "MSI_SENSOR_SCORE": 0.3, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.666666667, "TISSUE_SOURCE_SITE": "Roswell Park", "TBL_SCORE": 16.0 }, "treatments": [ { "START_DATE": 49, "STOP_DATE": 91.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "95", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "380", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 49, "STOP_DATE": 91.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "935", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "3740", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 49, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Other", "TREATMENT_SUBTYPE": "Phase III Clinical Trial", "AGENT": "Triptorelin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "3.75", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "3", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IM", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 105, "STOP_DATE": 147.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "270", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "1080", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 49, "STOP_DATE": 1120.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Other", "TREATMENT_SUBTYPE": "Phase III Clinical Trial", "AGENT": "Clodronic Acid", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1600", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "3", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "1600", "TOTAL_DOSE_UNITS": "Mg/Day", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 148, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "20", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "4", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": "20", "TOTAL_DOSE_UNITS": "Mg/Day", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-BH-A1FN": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "6dd0dd7b-62ff-4fd1-a99a-b265f1a91dca", "AGE": 34, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "5TH", "DAYS_LAST_FOLLOWUP": NaN, "DAYS_TO_BIRTH": -12525.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/8/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": null, "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 72.06496367, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 72.06496367, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 72.06496367, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A1FN-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 12.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3038, "MSI_SENSOR_SCORE": 0.72, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 3.266666667, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 338.0 }, "treatments": [] }, "TCGA-A8-A09A": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "b205bba0-1870-4458-9088-8817e20389fe", "AGE": 40, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE X", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 304.0, "DAYS_TO_BIRTH": -14883.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "5/27/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "NX", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": null, "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 9.99441102, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 9.99441102, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 9.99441102, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A8-A09A-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 13.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.256, "MSI_SENSOR_SCORE": 0.03, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 6.966666667, "TISSUE_SOURCE_SITE": "Indivumed", "TBL_SCORE": 196.0 }, "treatments": [ { "START_DATE": 243, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 182, "STOP_DATE": 212.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "gy" } ] }, "TCGA-PE-A5DD": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "B0700958-5F90-4546-B35F-635CD506889B", "AGE": 64, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 1953.0, "DAYS_TO_BIRTH": -23686.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/6/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Asian", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 64.20751553, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 64.20751553, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 64.20751553, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 64.20751553, "GENETIC_ANCESTRY_LABEL": "EAS_ADMIX" }, "sample": { "SAMPLE_ID": "TCGA-PE-A5DD-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "PE", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 8.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2898, "MSI_SENSOR_SCORE": 0.05, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.8, "TISSUE_SOURCE_SITE": "Fox Chase", "TBL_SCORE": 35.0 }, "treatments": [ { "START_DATE": 191, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Letrozole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 38, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": null, "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 130, "STOP_DATE": 160.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-E2-A105": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "b0bcb829-cee0-4247-bb75-093a5bea89ee", "AGE": 79, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 1308.0, "DAYS_TO_BIRTH": -28855.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "2/11/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 43.00226847, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 43.00226847, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 43.00226847, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 43.00226847, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E2-A105-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "E2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 6.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": NaN, "MSI_SENSOR_SCORE": 0.21, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.8, "TISSUE_SOURCE_SITE": "Roswell Park", "TBL_SCORE": 191.0 }, "treatments": [ { "START_DATE": 65, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": "1", "TOTAL_DOSE_UNITS": "Mg/Day", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 61, "STOP_DATE": 122.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": "6000", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-E2-A15T": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "e68ebfd4-3688-4caa-9e38-7764f9258c30", "AGE": 65, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 1563.0, "DAYS_TO_BIRTH": -24054.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/14/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 51.38573824, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 51.38573824, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 51.38573824, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 51.38573824, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E2-A15T-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "E2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 5.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.283, "MSI_SENSOR_SCORE": 0.15, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.8, "TISSUE_SOURCE_SITE": "Roswell Park", "TBL_SCORE": 72.0 }, "treatments": [ { "START_DATE": 34, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": "1", "TOTAL_DOSE_UNITS": "Mg/Day", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-BH-A0B7": { "demographics": { "SUBTYPE": "BRCA_Her2", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "214a4507-d974-4b3e-8525-7408fccc6a0f", "AGE": 42, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 2559.0, "DAYS_TO_BIRTH": -15593.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "8/4/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 84.13058487, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 84.13058487, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 84.13058487, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 84.13058487, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A0B7-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 10.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2803, "MSI_SENSOR_SCORE": 0.02, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.366666667, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 204.0 }, "treatments": [ { "START_DATE": 105, "STOP_DATE": 168.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 196, "STOP_DATE": 378.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 305, "STOP_DATE": 356.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "28", "RADIATION_DOSAGE": "5040", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" }, { "START_DATE": 305, "STOP_DATE": 356.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 2", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "27", "RADIATION_DOSAGE": "4860", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-AR-A1AW": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "a12fd22a-7f84-4b6e-b6d8-012e38eb73d7", "AGE": 65, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 2632.0, "DAYS_TO_BIRTH": -23855.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "6/14/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 86.53055857, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 86.53055857, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 86.53055857, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 86.53055857, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AR-A1AW-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AR", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 12.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2572, "MSI_SENSOR_SCORE": 0.02, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.0, "TISSUE_SOURCE_SITE": "Mayo", "TBL_SCORE": 78.0 }, "treatments": [ { "START_DATE": 50, "STOP_DATE": 50.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": "1", "PRESCRIBED_DOSE": "75", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "150", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 50, "STOP_DATE": 50.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "1", "PRESCRIBED_DOSE": "600", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "1210", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 157, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 76, "STOP_DATE": 115.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "30", "RADIATION_DOSAGE": "6000", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-A2-A0D3": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "4a16429b-884f-4c95-8683-feeedf0d6a55", "AGE": 42, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 1873.0, "DAYS_TO_BIRTH": -15524.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "1/28/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 61.57740737, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 61.57740737, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 61.57740737, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 61.57740737, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A2-A0D3-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 5.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2747, "MSI_SENSOR_SCORE": 0.01, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.833333333, "TISSUE_SOURCE_SITE": "Walter Reed", "TBL_SCORE": 17.0 }, "treatments": [ { "START_DATE": 69, "STOP_DATE": 173.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": "6", "PRESCRIBED_DOSE": "142", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "852", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 195, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "10", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "3", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 69, "STOP_DATE": 196.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Targeted Molecular Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Trastuzumab", "NUMBER_OF_CYCLES": "19", "PRESCRIBED_DOSE": "2-460", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "4", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "2917", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 69, "STOP_DATE": 173.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": "6", "PRESCRIBED_DOSE": "768", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "4608", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-C8-A3M7": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "959FF069-8A49-4C9B-85C2-5291CAC0ACFF", "AGE": 60, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIB", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 1.0, "DAYS_TO_BIRTH": -22096.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/6/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T4B", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Asian", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 33.99414801, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 33.99414801, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 33.99414801, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 33.99414801, "GENETIC_ANCESTRY_LABEL": "EAS" }, "sample": { "SAMPLE_ID": "TCGA-C8-A3M7-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "C8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 8.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3138, "MSI_SENSOR_SCORE": 0.01, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 4.333333333, "TISSUE_SOURCE_SITE": "ILSBio", "TBL_SCORE": 48.0 }, "treatments": [] }, "TCGA-B6-A0IG": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "34ab0cb8-bf19-4cbb-b4eb-3c45ee5aa60b", "AGE": 50, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "4TH", "DAYS_LAST_FOLLOWUP": NaN, "DAYS_TO_BIRTH": -18433.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "11/2/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1B", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 146.4970247, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 146.4970247, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 146.4970247, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-B6-A0IG-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "B6", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 11.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": NaN, "MSI_SENSOR_SCORE": 0.24, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.233333333, "TISSUE_SOURCE_SITE": "Duke", "TBL_SCORE": 157.0 }, "treatments": [] }, "TCGA-EW-A3E8": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "C0B7B798-3383-4A45-A455-9ECA5810739E", "AGE": 60, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 1035.0, "DAYS_TO_BIRTH": -21922.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Hispanic Or Latino", "FORM_COMPLETION_DATE": "2/8/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "0:LIVING", "OS_MONTHS": 34.02702436, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 34.02702436, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 34.02702436, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 34.02702436, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-EW-A3E8-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "EW", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 4.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2998, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.0, "TISSUE_SOURCE_SITE": "University of Miami", "TBL_SCORE": 72.0 }, "treatments": [ { "START_DATE": 196, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 165, "STOP_DATE": 196.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "30", "RADIATION_DOSAGE": "60", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "gy" } ] }, "TCGA-B6-A0RM": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "151f3677-6854-4265-9126-d92c646c67ae", "AGE": 57, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE X", "AJCC_STAGING_EDITION": "4TH", "DAYS_LAST_FOLLOWUP": NaN, "DAYS_TO_BIRTH": -21047.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "11/2/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "NX", "PATH_T_STAGE": "TX", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 78.01558339, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 78.01558339, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 78.01558339, "GENETIC_ANCESTRY_LABEL": "AFR_ADMIX" }, "sample": { "SAMPLE_ID": "TCGA-B6-A0RM-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "B6", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 4.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2781, "MSI_SENSOR_SCORE": 0.09, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.933333333, "TISSUE_SOURCE_SITE": "Duke", "TBL_SCORE": 16.0 }, "treatments": [] }, "TCGA-BH-A42V": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "57CF380D-AB52-467F-B9AE-740B2F84C820", "AGE": 41, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IB", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 635.0, "DAYS_TO_BIRTH": -15158.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "1/17/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1MI", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 20.87648355, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 20.87648355, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 20.87648355, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 20.87648355, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-BH-A42V-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 2.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2894, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.366666667, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 35.0 }, "treatments": [ { "START_DATE": 92, "STOP_DATE": 141.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "36", "RADIATION_DOSAGE": "66.4", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "gy" } ] }, "TCGA-B6-A0I5": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "1a18974d-967c-4727-b42e-12ae7be66589", "AGE": 49, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "3RD", "DAYS_LAST_FOLLOWUP": 8556.0, "DAYS_TO_BIRTH": -18038.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "11/2/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1B", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 281.2900681, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 281.2900681, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 281.2900681, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 281.2900681, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-B6-A0I5-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "B6", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 11.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2711, "MSI_SENSOR_SCORE": 0.08, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.833333333, "TISSUE_SOURCE_SITE": "Duke", "TBL_SCORE": 4.0 }, "treatments": [] }, "TCGA-E2-A15L": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "37242f5a-25ae-4b1f-9ce6-09ce1dc92539", "AGE": 65, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 626.0, "DAYS_TO_BIRTH": -23845.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/13/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 20.58059638, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 20.58059638, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 20.58059638, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 20.58059638, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-E2-A15L-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "E2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 3.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2725, "MSI_SENSOR_SCORE": 0.03, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.266666667, "TISSUE_SOURCE_SITE": "Roswell Park", "TBL_SCORE": 9.0 }, "treatments": [ { "START_DATE": 45, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": "1", "TOTAL_DOSE_UNITS": "Mg/Day", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-AC-A23G": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "A721DAC6-0126-476C-B2D4-2DBF7406454B", "AGE": 76, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 2248.0, "DAYS_TO_BIRTH": -27934.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "7/14/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "0:LIVING", "OS_MONTHS": 73.90603939, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 73.90603939, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 73.90603939, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 73.90603939, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AC-A23G-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AC", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 18.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3164, "MSI_SENSOR_SCORE": 0.01, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": NaN, "TISSUE_SOURCE_SITE": "International Genomics Consortium", "TBL_SCORE": 23.0 }, "treatments": [ { "START_DATE": 109, "STOP_DATE": 190.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 109, "STOP_DATE": 190.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 190, "STOP_DATE": 220.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 237, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-BH-A0W4": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "0772cdbe-8b0d-452b-8df1-bd70d1306363", "AGE": 46, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 759.0, "DAYS_TO_BIRTH": -16911.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "2/15/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 24.9531512, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 24.9531512, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 24.9531512, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A0W4-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 2.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2662, "MSI_SENSOR_SCORE": 0.03, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.1, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 4.0 }, "treatments": [] }, "TCGA-A2-A04N": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "197428f7-bd77-4c5f-8119-87157b5c35b9", "AGE": 66, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IA", "AJCC_STAGING_EDITION": "5TH", "DAYS_LAST_FOLLOWUP": 4354.0, "DAYS_TO_BIRTH": -24155.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Hispanic Or Latino", "FORM_COMPLETION_DATE": "1/27/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 143.1436368, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 143.1436368, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 143.1436368, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 143.1436368, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A2-A04N-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 3.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2911, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.366666667, "TISSUE_SOURCE_SITE": "Walter Reed", "TBL_SCORE": 13.0 }, "treatments": [ { "START_DATE": 42, "STOP_DATE": 107.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "113", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "452", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 308, "STOP_DATE": 2121.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "3", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 42, "STOP_DATE": 107.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "1130", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "4520", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 143, "STOP_DATE": 191.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "30", "RADIATION_DOSAGE": "6000", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-EW-A1PH": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "4da999a0-ef41-4a0b-b1d1-446b39cc855a", "AGE": 52, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 607.0, "DAYS_TO_BIRTH": -19073.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/27/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 19.95594569, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 19.95594569, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 19.95594569, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 19.95594569, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-EW-A1PH-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "EW", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 11.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2948, "MSI_SENSOR_SCORE": 0.74, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.566666667, "TISSUE_SOURCE_SITE": "University of Miami", "TBL_SCORE": 288.0 }, "treatments": [ { "START_DATE": 98, "STOP_DATE": 140.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Epirubicin", "NUMBER_OF_CYCLES": "3", "PRESCRIBED_DOSE": "167", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "501", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 98, "STOP_DATE": 140.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "3", "PRESCRIBED_DOSE": "835", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "2505", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 215, "STOP_DATE": 271.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": "8", "PRESCRIBED_DOSE": "124", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "992", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 98, "STOP_DATE": 140.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Fluorouracil", "NUMBER_OF_CYCLES": "3", "PRESCRIBED_DOSE": "835", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "2505", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 161, "STOP_DATE": 161.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": "1", "PRESCRIBED_DOSE": "169", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "169", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 276, "STOP_DATE": 322.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "34", "RADIATION_DOSAGE": "6120", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-GM-A2DA": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "C07B122E-AC50-4DB2-ADD2-5617A5D0E976", "AGE": 46, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "4TH", "DAYS_LAST_FOLLOWUP": 5909.0, "DAYS_TO_BIRTH": -16854.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/28/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1B", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 216.753789, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 216.753789, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 99.08932505, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 99.08932505, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-GM-A2DA-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "GM", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 5.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2922, "MSI_SENSOR_SCORE": 0.08, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.066666667, "TISSUE_SOURCE_SITE": "MD Anderson", "TBL_SCORE": 66.0 }, "treatments": [ { "START_DATE": 74, "STOP_DATE": 147.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Fluorouracil", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 74, "STOP_DATE": 147.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 74, "STOP_DATE": 147.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 203, "STOP_DATE": 276.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Methotrexate", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 203, "STOP_DATE": 276.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Vinblastine", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 3061, "STOP_DATE": 3131.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Clinical Progressive Disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 3061, "STOP_DATE": 3131.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Exemestane", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Clinical Progressive Disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 3141, "STOP_DATE": 3415.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Stable Disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 3434, "STOP_DATE": 4307.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Letrozole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Clinical Progressive Disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 4347, "STOP_DATE": 4435.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Megestrol Acetate", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Clinical Progressive Disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 4470, "STOP_DATE": 4494.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Capecitabine", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Clinical Progressive Disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 4470, "STOP_DATE": 4494.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Trabectedin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Clinical Progressive Disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 4515, "STOP_DATE": 4720.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Capecitabine", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Stable Disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 4721, "STOP_DATE": 5015.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Exemestane", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Stable Disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 5021, "STOP_DATE": 5455.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Capecitabine", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Stable Disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 5455, "STOP_DATE": 5678.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Stable Disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 5684, "STOP_DATE": 5797.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Ixabepilone", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Clinical Progressive Disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 5797, "STOP_DATE": 6028.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Immunotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Trastuzumab", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Stable Disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 5909, "STOP_DATE": 6029.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Clinical Progressive Disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 6051, "STOP_DATE": 6213.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Capecitabine", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Stable Disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 6051, "STOP_DATE": 6536.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Lapatinib", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Stable Disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 6372, "STOP_DATE": 6422.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Vinorelbine", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Clinical Progressive Disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 6372, "STOP_DATE": 6536.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Immunotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Trastuzumab", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Stable Disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 284, "STOP_DATE": 326.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 5098, "STOP_DATE": 5111.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 2", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Stable Disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Distant Recurrence", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "10", "RADIATION_DOSAGE": "30", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "gy" }, { "START_DATE": 6048, "STOP_DATE": 6052.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 3", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Stable Disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Distant Recurrence", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "5", "RADIATION_DOSAGE": "20", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "gy" }, { "START_DATE": 6538, "STOP_DATE": 6552.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 4", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Stable Disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Distant Recurrence", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "10", "RADIATION_DOSAGE": "30", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "gy" } ] }, "TCGA-OL-A66O": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "A45833E1-7CC9-4273-B408-620F74679A12", "AGE": 39, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 528.0, "DAYS_TO_BIRTH": -14272.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "6/11/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 17.35871388, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 17.35871388, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 17.35871388, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 17.35871388, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-OL-A66O-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "OL", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 6.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3236, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.933333333, "TISSUE_SOURCE_SITE": "University of Chicago", "TBL_SCORE": 59.0 }, "treatments": [ { "START_DATE": 129, "STOP_DATE": 192.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 129, "STOP_DATE": 192.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 77, "STOP_DATE": 121.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": "6040", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-A2-A0YC": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "a1872011-b928-4189-ac02-e87506c20bca", "AGE": 59, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": 990.0, "DAYS_TO_BIRTH": -21685.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/8/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1MI", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 32.54758852, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 32.54758852, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 24.85452214, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A2-A0YC-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 4.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2793, "MSI_SENSOR_SCORE": 0.02, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.766666667, "TISSUE_SOURCE_SITE": "Walter Reed", "TBL_SCORE": 37.0 }, "treatments": [ { "START_DATE": 103, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 71, "STOP_DATE": 78.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "10", "RADIATION_DOSAGE": "3400", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Other", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-AR-A1AX": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "f72c1d69-da35-459f-8542-59bfd6c09c23", "AGE": 64, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE I", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 2629.0, "DAYS_TO_BIRTH": -23507.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "6/14/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T1", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 86.43192951, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 86.43192951, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 86.43192951, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 86.43192951, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AR-A1AX-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AR", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 7.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2683, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.866666667, "TISSUE_SOURCE_SITE": "Mayo", "TBL_SCORE": 20.0 }, "treatments": [ { "START_DATE": 54, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 117, "STOP_DATE": 482.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Immunotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Trastuzumab", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "2", "PRESCRIBED_DOSE_UNITS": "mg/kg", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 249, "STOP_DATE": 295.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Exemestane", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "25", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "3", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 341, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Letrozole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "2.5", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "4", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 54, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 194, "STOP_DATE": 242.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "33", "RADIATION_DOSAGE": "6060", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-BH-A0H3": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "6cdc0d53-f813-4101-81e5-9bee68270536", "AGE": 46, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE I", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 1928.0, "DAYS_TO_BIRTH": -17152.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "8/11/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 63.38560673, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 63.38560673, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 63.38560673, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 63.38560673, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A0H3-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 3.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2501, "MSI_SENSOR_SCORE": 0.01, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.433333333, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 3.0 }, "treatments": [ { "START_DATE": 77, "STOP_DATE": 115.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "28", "RADIATION_DOSAGE": "5040", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" }, { "START_DATE": 118, "STOP_DATE": 126.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 2", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "7", "RADIATION_DOSAGE": "14", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "gy" } ] }, "TCGA-PE-A5DC": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "76099BEB-0ABE-4B56-8B4E-E4485E0402E6", "AGE": 72, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": NaN, "DAYS_TO_BIRTH": -26514.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/30/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N2A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 47.01318342, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 47.01318342, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 47.01318342, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-PE-A5DC-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "PE", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": NaN, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3164, "MSI_SENSOR_SCORE": 0.06, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 3.166666667, "TISSUE_SOURCE_SITE": "Fox Chase", "TBL_SCORE": 183.0 }, "treatments": [] }, "TCGA-A2-A1FX": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "ac6d3ba9-f84f-4657-aa85-4d66fb7c09da", "AGE": 61, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 1847.0, "DAYS_TO_BIRTH": -22344.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/12/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N2A", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 60.72262222, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 60.72262222, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 60.72262222, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 60.72262222, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A2-A1FX-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 14.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3239, "MSI_SENSOR_SCORE": 0.3, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.8, "TISSUE_SOURCE_SITE": "Walter Reed", "TBL_SCORE": 63.0 }, "treatments": [ { "START_DATE": 74, "STOP_DATE": 155.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 198, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "3", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 74, "STOP_DATE": 155.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 186, "STOP_DATE": 231.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "31", "RADIATION_DOSAGE": "10560", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-A1-A0SO": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "6644fd4e-d2fe-4785-a73c-0f36fcc740e2", "AGE": 67, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 852.0, "DAYS_TO_BIRTH": -24826.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/6/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": null, "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 28.01065194, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 28.01065194, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 28.01065194, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 28.01065194, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A1-A0SO-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A1", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": NaN, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3308, "MSI_SENSOR_SCORE": 2.84, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 9.066666667, "TISSUE_SOURCE_SITE": "UCSF", "TBL_SCORE": 492.0 }, "treatments": [ { "START_DATE": 61, "STOP_DATE": 180.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": null, "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 205, "STOP_DATE": 266.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-A7-A6VY": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "E8EA576B-EB16-44F7-B241-DAEFC1375388", "AGE": 48, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 266.0, "DAYS_TO_BIRTH": -17640.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "10/25/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 8.745109643, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 8.745109643, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 8.745109643, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 8.745109643, "GENETIC_ANCESTRY_LABEL": "AFR_ADMIX" }, "sample": { "SAMPLE_ID": "TCGA-A7-A6VY-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "A7", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 7.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3463, "MSI_SENSOR_SCORE": 0.26, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 3.166666667, "TISSUE_SOURCE_SITE": "Christiana Healthcare", "TBL_SCORE": 218.0 }, "treatments": [ { "START_DATE": 68, "STOP_DATE": 111.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 68, "STOP_DATE": 111.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 126, "STOP_DATE": 167.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 211, "STOP_DATE": 247.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "25", "RADIATION_DOSAGE": "4500", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" }, { "START_DATE": 251, "STOP_DATE": 266.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 2", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "10", "RADIATION_DOSAGE": "2000", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-AC-A8OR": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "8CD1BA0B-EAD9-4661-A796-6C9DBF1C42CD", "AGE": 75, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 40.0, "DAYS_TO_BIRTH": -27605.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "2/26/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8480/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": null, "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 1.315054082, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 1.315054082, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 1.315054082, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 1.315054082, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AC-A8OR-01", "ONCOTREE_CODE": "IMMC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Mixed Mucinous Carcinoma", "TUMOR_TYPE": "Mucinous Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "AC", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 1.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3115, "MSI_SENSOR_SCORE": 0.06, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.933333333, "TISSUE_SOURCE_SITE": "International Genomics Consortium", "TBL_SCORE": 13.0 }, "treatments": [] }, "TCGA-A7-A0DB": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "f130f376-5801-40f9-975d-a7e2f7b5670d", "AGE": 56, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": 1007.0, "DAYS_TO_BIRTH": -20570.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "10/4/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 33.1064865, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 33.1064865, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 33.1064865, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A7-A0DB-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "A7", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 17.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.298, "MSI_SENSOR_SCORE": 0.64, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.033333333, "TISSUE_SOURCE_SITE": "Christiana Healthcare", "TBL_SCORE": 3.0 }, "treatments": [ { "START_DATE": 141, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": "216", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 92, "STOP_DATE": 138.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "33", "RADIATION_DOSAGE": "6100", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-A8-A0A2": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "34d5a193-85e5-4399-8a9b-e92858eafdfe", "AGE": 66, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 579.0, "DAYS_TO_BIRTH": -24380.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "5/27/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": null, "RADIATION_THERAPY": null, "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 19.03540783, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 19.03540783, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 19.03540783, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 19.03540783, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A8-A0A2-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 17.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2664, "MSI_SENSOR_SCORE": 0.12, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.933333333, "TISSUE_SOURCE_SITE": "Indivumed", "TBL_SCORE": 28.0 }, "treatments": [ { "START_DATE": 92, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 31, "STOP_DATE": 92.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": "60", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "gy" } ] }, "TCGA-A8-A06U": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "6bc4c56d-aac5-49a2-9913-9538d06d898f", "AGE": 80, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": NaN, "DAYS_TO_BIRTH": -29525.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "5/27/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "Yes", "RACE": null, "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 29.02981885, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 29.02981885, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 29.02981885, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 29.02981885, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A8-A06U-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 19.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2916, "MSI_SENSOR_SCORE": 1.75, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.1, "TISSUE_SOURCE_SITE": "Indivumed", "TBL_SCORE": 779.0 }, "treatments": [] }, "TCGA-LL-A5YP": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "6D24E675-2FA4-4102-861F-7516650B3049", "AGE": 49, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 450.0, "DAYS_TO_BIRTH": -18041.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/20/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "Yes", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 14.79435842, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 14.79435842, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 14.79435842, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 14.79435842, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-LL-A5YP-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "LL", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 16.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2939, "MSI_SENSOR_SCORE": 0.1, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.133333333, "TISSUE_SOURCE_SITE": "Candler", "TBL_SCORE": 250.0 }, "treatments": [ { "START_DATE": 50, "STOP_DATE": 92.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 50, "STOP_DATE": 92.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 113, "STOP_DATE": 457.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Immunotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Trastuzumab", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 302, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 225, "STOP_DATE": 266.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "30", "RADIATION_DOSAGE": "6000", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-B6-A0X0": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "1e68e760-a4cf-4100-bf9c-e50fa8d126f6", "AGE": 54, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE I", "AJCC_STAGING_EDITION": "4TH", "DAYS_LAST_FOLLOWUP": NaN, "DAYS_TO_BIRTH": -19802.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/15/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.919", "ICD_O_3_HISTOLOGY": "8201/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 129.6972088, "DSS_STATUS": null, "DSS_MONTHS": 129.6972088, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 129.6972088, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 129.6972088, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-B6-A0X0-01", "ONCOTREE_CODE": "BRCNOS", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Carcinoma (NOS)", "TUMOR_TYPE": "Other", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "B6", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 5.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.263, "MSI_SENSOR_SCORE": 0.05, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.633333333, "TISSUE_SOURCE_SITE": "Duke", "TBL_SCORE": 9.0 }, "treatments": [] }, "TCGA-GM-A2DF": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "D6F7AFC0-1558-43AD-ACB1-2B5311ED2264", "AGE": 53, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 2155.0, "DAYS_TO_BIRTH": -19614.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/29/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 70.84853865, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 70.84853865, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 70.84853865, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 70.84853865, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-GM-A2DF-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "GM", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 12.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.299, "MSI_SENSOR_SCORE": 0.04, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.233333333, "TISSUE_SOURCE_SITE": "MD Anderson", "TBL_SCORE": 205.0 }, "treatments": [ { "START_DATE": 82, "STOP_DATE": 159.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 166, "STOP_DATE": 229.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Fluorouracil", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 166, "STOP_DATE": 229.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Epirubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 166, "STOP_DATE": 229.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 250, "STOP_DATE": 294.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "32", "RADIATION_DOSAGE": "64", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "gy" } ] }, "TCGA-AN-A0FY": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "de75d0b9-0f47-4732-8df5-05c350cfcd32", "AGE": 55, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 10.0, "DAYS_TO_BIRTH": -20347.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/29/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 0.32876352, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 0.32876352, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 0.32876352, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 0.32876352, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AN-A0FY-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AN", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 19.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2826, "MSI_SENSOR_SCORE": 1.39, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.6, "TISSUE_SOURCE_SITE": "Cureline", "TBL_SCORE": 195.0 }, "treatments": [] }, "TCGA-BH-A0AW": { "demographics": { "SUBTYPE": "BRCA_Her2", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "c5891c7a-fd24-4891-8f51-373967e4a6dd", "AGE": 56, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": 622.0, "DAYS_TO_BIRTH": -20468.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "11/3/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 20.44909097, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 20.44909097, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 20.44909097, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 20.44909097, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A0AW-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 16.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2784, "MSI_SENSOR_SCORE": 0.21, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 4.6, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 264.0 }, "treatments": [ { "START_DATE": 53, "STOP_DATE": 150.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "6", "PRESCRIBED_DOSE_UNITS": "auc", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 53, "STOP_DATE": 150.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": "6", "PRESCRIBED_DOSE": "75", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 543, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Exemestane", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "50", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 53, "STOP_DATE": 410.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Trastuzumab", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "6", "PRESCRIBED_DOSE_UNITS": "mg/kg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 200, "STOP_DATE": 515.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 201, "STOP_DATE": 252.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "33", "RADIATION_DOSAGE": "6040", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-C8-A1HI": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "444374f8-9282-439c-af00-0f828edcbff3", "AGE": 40, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 343.0, "DAYS_TO_BIRTH": NaN, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "6/1/2011", "HISTORY_NEOADJUVANT_TRTYN": "Yes", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N2", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Asian", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 11.27658875, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 11.27658875, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 11.27658875, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 11.27658875, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-C8-A1HI-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "C8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 25.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2617, "MSI_SENSOR_SCORE": 0.09, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.533333333, "TISSUE_SOURCE_SITE": "ILSBio", "TBL_SCORE": 171.0 }, "treatments": [] }, "TCGA-BH-A0HW": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "29fdc464-f216-4828-b456-829f71436e27", "AGE": 62, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IA", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": 1561.0, "DAYS_TO_BIRTH": -22962.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "11/11/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Asian", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 51.31998553, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 51.31998553, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 51.31998553, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 51.31998553, "GENETIC_ANCESTRY_LABEL": "EAS" }, "sample": { "SAMPLE_ID": "TCGA-BH-A0HW-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 10.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2688, "MSI_SENSOR_SCORE": 0.32, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.133333333, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 51.0 }, "treatments": [ { "START_DATE": 223, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 72, "STOP_DATE": 135.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "900", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "3564", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 72, "STOP_DATE": 135.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "90", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "356", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 166, "STOP_DATE": 212.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "34", "RADIATION_DOSAGE": "6240", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-BH-A0GZ": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "27dfb9d4-3a2c-44bc-9acf-8f638d3f3004", "AGE": 62, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": 328.0, "DAYS_TO_BIRTH": -22714.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "11/10/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 10.78344347, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 10.78344347, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 10.78344347, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 10.78344347, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A0GZ-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 6.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2656, "MSI_SENSOR_SCORE": 0.07, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.133333333, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 71.0 }, "treatments": [ { "START_DATE": 157, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-BH-A0DG": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "0bc5744c-5fa3-45bb-87d0-70a02068b392", "AGE": 30, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 2041.0, "DAYS_TO_BIRTH": -11204.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "8/2/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 67.10063451, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 67.10063451, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 67.10063451, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 67.10063451, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A0DG-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 2.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2685, "MSI_SENSOR_SCORE": 0.12, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.133333333, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 202.0 }, "treatments": [ { "START_DATE": 48, "STOP_DATE": 166.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 48, "STOP_DATE": 166.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 48, "STOP_DATE": 166.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 166, "STOP_DATE": 181.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "30", "RADIATION_DOSAGE": "6000", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-OL-A66K": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "2AB1B35B-9E56-475C-AC9B-15ED0A422683", "AGE": 72, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 1021.0, "DAYS_TO_BIRTH": -26299.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "6/11/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 41.91734885, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 41.91734885, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 41.91734885, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 41.91734885, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-OL-A66K-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "OL", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 20.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3357, "MSI_SENSOR_SCORE": 0.08, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.933333333, "TISSUE_SOURCE_SITE": "University of Chicago", "TBL_SCORE": 5.0 }, "treatments": [] }, "TCGA-A8-A09T": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "0adf59c6-581a-475d-a2f4-40aa40060b5b", "AGE": 68, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE X", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 579.0, "DAYS_TO_BIRTH": -25110.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "5/27/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": null, "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 19.03540783, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 19.03540783, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 19.03540783, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 19.03540783, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A8-A09T-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 13.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.282, "MSI_SENSOR_SCORE": 0.26, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.733333333, "TISSUE_SOURCE_SITE": "Indivumed", "TBL_SCORE": 27.0 }, "treatments": [ { "START_DATE": 122, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 61, "STOP_DATE": 92.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-BH-A0GY": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "7d9d3522-ec3b-4efe-8c8e-c0e675276ef5", "AGE": 67, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": 923.0, "DAYS_TO_BIRTH": -24493.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "11/10/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 30.34487293, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 30.34487293, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 30.34487293, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 30.34487293, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A0GY-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 29.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2546, "MSI_SENSOR_SCORE": 0.4, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.133333333, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 105.0 }, "treatments": [ { "START_DATE": 351, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 202, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 202, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 317, "STOP_DATE": 365.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "33", "RADIATION_DOSAGE": "6040", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-E9-A1R3": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "4922cddc-575c-4b8a-8245-ce5f6876760c", "AGE": 70, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIC", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 78.0, "DAYS_TO_BIRTH": -25693.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/28/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N3", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 2.564355459, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 2.564355459, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 2.564355459, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 2.564355459, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E9-A1R3-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "E9", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 23.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2873, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.7, "TISSUE_SOURCE_SITE": "Asterand", "TBL_SCORE": 17.0 }, "treatments": [ { "START_DATE": 41, "STOP_DATE": 50.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "1", "PRESCRIBED_DOSE": "2000", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "2000", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 41, "STOP_DATE": 50.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Fluorouracil", "NUMBER_OF_CYCLES": "1", "PRESCRIBED_DOSE": "2000", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "2000", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 41, "STOP_DATE": 50.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Methotrexate", "NUMBER_OF_CYCLES": "1", "PRESCRIBED_DOSE": "100", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "100", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 45, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "20", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 55, "STOP_DATE": 78.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": "37400", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-OL-A5D6": { "demographics": { "SUBTYPE": "BRCA_Normal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "C3A981C7-F148-4252-BD50-AF8A49EC0DF8", "AGE": 71, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 385.0, "DAYS_TO_BIRTH": -26052.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/19/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 36.29549265, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 36.29549265, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 36.29549265, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 36.29549265, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-OL-A5D6-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "OL", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 4.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2858, "MSI_SENSOR_SCORE": 0.01, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.133333333, "TISSUE_SOURCE_SITE": "University of Chicago", "TBL_SCORE": 72.0 }, "treatments": [] }, "TCGA-A2-A0CZ": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "9f93ea0a-1687-44e0-9e8a-eeb4097d471c", "AGE": 46, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 1616.0, "DAYS_TO_BIRTH": -17026.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/14/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "0:LIVING", "OS_MONTHS": 53.1281849, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 53.1281849, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 53.1281849, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A2-A0CZ-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": NaN, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": NaN, "MSI_SENSOR_SCORE": 0.01, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.8, "TISSUE_SOURCE_SITE": "Walter Reed", "TBL_SCORE": 132.0 }, "treatments": [ { "START_DATE": 106, "STOP_DATE": 148.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "104-105", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "418", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 106, "STOP_DATE": 148.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "1045", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "4180", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 236, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "20", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "3", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-D8-A1X7": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "cdab777e-62de-4d51-92af-b6eb089c111f", "AGE": 40, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 509.0, "DAYS_TO_BIRTH": -14858.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "6/9/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8503/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 16.73406319, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 16.73406319, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 16.73406319, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 16.73406319, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D8-A1X7-01", "ONCOTREE_CODE": "BRCNOS", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Carcinoma (NOS)", "TUMOR_TYPE": "Other", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "D8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 4.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3339, "MSI_SENSOR_SCORE": 0.26, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.666666667, "TISSUE_SOURCE_SITE": "Greater Poland Cancer Center", "TBL_SCORE": 5.0 }, "treatments": [ { "START_DATE": 64, "STOP_DATE": 134.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin + Cyclophosphamide + Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-AO-A128": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "016caf42-4e19-4444-ab5d-6cf1e76c4afa", "AGE": 61, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": 3248.0, "DAYS_TO_BIRTH": -22340.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/7/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 106.7823914, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 106.7823914, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 106.7823914, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 106.7823914, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AO-A128-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AO", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 25.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3857, "MSI_SENSOR_SCORE": 1.03, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 27.96666667, "TISSUE_SOURCE_SITE": "MSKCC", "TBL_SCORE": 65.0 }, "treatments": [ { "START_DATE": 82, "STOP_DATE": 124.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "619", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "4800", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 82, "STOP_DATE": 124.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "62", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "480", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 160, "STOP_DATE": 222.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "175", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "1360", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 263, "STOP_DATE": 308.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "33", "RADIATION_DOSAGE": "6040", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-B6-A0RI": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "bfd55808-dddd-44c3-97d7-41600497b992", "AGE": 44, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIB", "AJCC_STAGING_EDITION": "3RD", "DAYS_LAST_FOLLOWUP": 7126.0, "DAYS_TO_BIRTH": -16138.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "11/2/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1B", "PATH_T_STAGE": "T4B", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 234.2768846, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 234.2768846, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 36.16398724, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 36.16398724, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-B6-A0RI-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "B6", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 3.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2565, "MSI_SENSOR_SCORE": 0.02, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.666666667, "TISSUE_SOURCE_SITE": "Duke", "TBL_SCORE": 19.0 }, "treatments": [] }, "TCGA-BH-A0DT": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "74f31744-0aed-4633-beec-4e203315f0b7", "AGE": 41, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 2403.0, "DAYS_TO_BIRTH": -15078.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "8/11/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 79.00187395, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 79.00187395, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 79.00187395, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 79.00187395, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A0DT-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 11.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2724, "MSI_SENSOR_SCORE": 0.02, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.5, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 1.0 }, "treatments": [ { "START_DATE": 118, "STOP_DATE": 287.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 118, "STOP_DATE": 287.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 118, "STOP_DATE": 287.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-E9-A1RH": { "demographics": { "SUBTYPE": "BRCA_Her2", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "408cb583-6dc3-4698-8bd2-e284042bd5ef", "AGE": 63, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 1417.0, "DAYS_TO_BIRTH": -23224.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "8/2/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 46.58579084, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 46.58579084, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 46.58579084, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 46.58579084, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E9-A1RH-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "E9", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 23.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3174, "MSI_SENSOR_SCORE": 0.33, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.933333333, "TISSUE_SOURCE_SITE": "Asterand", "TBL_SCORE": 342.0 }, "treatments": [ { "START_DATE": 11, "STOP_DATE": 205.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Fluorouracil", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "1500", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "6000", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 11, "STOP_DATE": 214.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Methotrexate", "NUMBER_OF_CYCLES": "6", "PRESCRIBED_DOSE": "100", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "600", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 11, "STOP_DATE": 214.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Fluorouracil", "NUMBER_OF_CYCLES": "2", "PRESCRIBED_DOSE": "2000", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "4000", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 11, "STOP_DATE": 214.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "6", "PRESCRIBED_DOSE": "1600", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "9600", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 63, "STOP_DATE": 107.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "22", "RADIATION_DOSAGE": "4400", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" }, { "START_DATE": 63, "STOP_DATE": 107.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 2", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "30", "RADIATION_DOSAGE": "60", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "gy" } ] }, "TCGA-A8-A06N": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "3a711140-1b89-4611-9992-3861e3d0e01a", "AGE": 66, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIB", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 0.0, "DAYS_TO_BIRTH": -24288.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "5/27/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T4B", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": null, "RADIATION_THERAPY": null, "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 0.0, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 0.0, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 0.0, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 0.0, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A8-A06N-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 21.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": NaN, "MSI_SENSOR_SCORE": 0.72, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.133333333, "TISSUE_SOURCE_SITE": "Indivumed", "TBL_SCORE": 49.0 }, "treatments": [] }, "TCGA-A2-A0T1": { "demographics": { "SUBTYPE": "BRCA_Her2", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "02bed00f-bef7-4fb7-b243-540354990e45", "AGE": 55, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIC", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": 521.0, "DAYS_TO_BIRTH": -20227.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "11/12/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N3", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "American Indian or Alaska Native", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 17.12857941, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 17.12857941, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 17.12857941, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 17.12857941, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-A2-A0T1-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 17.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2768, "MSI_SENSOR_SCORE": 0.02, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.8, "TISSUE_SOURCE_SITE": "Walter Reed", "TBL_SCORE": 339.0 }, "treatments": [ { "START_DATE": 46, "STOP_DATE": 187.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": "6", "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 46, "STOP_DATE": 187.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": "6", "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 46, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Targeted Molecular Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Trastuzumab", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": "3", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 189, "STOP_DATE": 252.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "30", "RADIATION_DOSAGE": "11840", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-E2-A15K": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "17c1d42c-cb84-4655-a4cd-b54bae17ecaf", "AGE": 58, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 275.0, "DAYS_TO_BIRTH": -21514.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/13/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 9.040996811, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 9.040996811, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 9.040996811, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 9.040996811, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E2-A15K-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "E2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 6.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2863, "MSI_SENSOR_SCORE": 0.24, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.233333333, "TISSUE_SOURCE_SITE": "Roswell Park", "TBL_SCORE": 81.0 }, "treatments": [ { "START_DATE": 146, "STOP_DATE": 208.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 61, "STOP_DATE": 131.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 61, "STOP_DATE": 131.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 232, "STOP_DATE": 273.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "30", "RADIATION_DOSAGE": "6000", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-D8-A1X9": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "34a74805-300c-4773-ab59-2085fcc2e6cc", "AGE": 66, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 727.0, "DAYS_TO_BIRTH": -24417.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/16/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 23.90110793, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 23.90110793, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 23.90110793, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D8-A1X9-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "D8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 4.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3887, "MSI_SENSOR_SCORE": 0.41, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.8, "TISSUE_SOURCE_SITE": "Greater Poland Cancer Center", "TBL_SCORE": 137.0 }, "treatments": [ { "START_DATE": 197, "STOP_DATE": 320.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin + Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "60+600", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 320, "STOP_DATE": 350.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "20", "RADIATION_DOSAGE": "4500", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-E2-A1LA": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "ce9e0309-9756-42d2-ae94-d91264a79498", "AGE": 59, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 748.0, "DAYS_TO_BIRTH": -21773.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "6/1/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": null, "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 24.59151133, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 24.59151133, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 24.59151133, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 24.59151133, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-E2-A1LA-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "E2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 3.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.33, "MSI_SENSOR_SCORE": 0.24, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.566666667, "TISSUE_SOURCE_SITE": "Roswell Park", "TBL_SCORE": 72.0 }, "treatments": [ { "START_DATE": 48, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": "1", "TOTAL_DOSE_UNITS": "Mg/Day", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-AR-A24Z": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "9fefbe7c-f66a-4940-843e-285cb7b392c1", "AGE": 57, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 3001.0, "DAYS_TO_BIRTH": -20900.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "8/30/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 98.66193247, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 98.66193247, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 98.66193247, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 98.66193247, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AR-A24Z-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AR", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 18.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3301, "MSI_SENSOR_SCORE": 1.07, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.433333333, "TISSUE_SOURCE_SITE": "Mayo", "TBL_SCORE": 480.0 }, "treatments": [ { "START_DATE": 49, "STOP_DATE": 91.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 49, "STOP_DATE": 91.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 133, "STOP_DATE": 1912.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-BH-A1FM": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "7eb18190-5a41-4637-9783-f81bbde499e4", "AGE": 44, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": "5TH", "DAYS_LAST_FOLLOWUP": NaN, "DAYS_TO_BIRTH": -16289.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/8/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N2", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": null, "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 45.63237663, "DSS_STATUS": null, "DSS_MONTHS": 45.63237663, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 45.63237663, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A1FM-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 21.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3445, "MSI_SENSOR_SCORE": 0.89, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.666666667, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 403.0 }, "treatments": [] }, "TCGA-GM-A3NY": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "BD5374C9-7F36-457F-B66B-7CC7FF64224E", "AGE": 72, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 1162.0, "DAYS_TO_BIRTH": -26642.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "1/3/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "0:LIVING", "OS_MONTHS": 38.20232107, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 38.20232107, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 38.20232107, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 38.20232107, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-GM-A3NY-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "GM", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 4.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3311, "MSI_SENSOR_SCORE": 0.01, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.0, "TISSUE_SOURCE_SITE": "MD Anderson", "TBL_SCORE": 21.0 }, "treatments": [ { "START_DATE": 160, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 82, "STOP_DATE": 124.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Stable Disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "30", "RADIATION_DOSAGE": "60", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "gy" } ] }, "TCGA-AO-A0JD": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "0a229f95-0ea1-4d63-953e-74f5ec2f3028", "AGE": 59, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": 2190.0, "DAYS_TO_BIRTH": -21831.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/20/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 71.99921097, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 71.99921097, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 71.99921097, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 71.99921097, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AO-A0JD-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AO", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 7.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2721, "MSI_SENSOR_SCORE": 0.18, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 3.366666667, "TISSUE_SOURCE_SITE": "MSKCC", "TBL_SCORE": 286.0 }, "treatments": [ { "START_DATE": 62, "STOP_DATE": 104.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "60", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "452", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 62, "STOP_DATE": 104.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "600", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "4536", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 118, "STOP_DATE": 160.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "175", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "1296", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 261, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 195, "STOP_DATE": 244.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "33", "RADIATION_DOSAGE": "10620", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-W8-A86G": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "90FF48C3-B14B-4A8B-94A1-98C0BAB0D27B", "AGE": 66, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 347.0, "DAYS_TO_BIRTH": -24125.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "1/29/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T2A", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 11.40809416, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 11.40809416, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 11.40809416, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 11.40809416, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-W8-A86G-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "W8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 14.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3056, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.5, "TISSUE_SOURCE_SITE": "Greenville Health System", "TBL_SCORE": 26.0 }, "treatments": [ { "START_DATE": 161, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-AR-A0TX": { "demographics": { "SUBTYPE": "BRCA_Her2", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "c364e81c-eb1e-4870-ab37-9c661f5f2e3d", "AGE": 64, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": 1972.0, "DAYS_TO_BIRTH": -23653.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "3/10/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T1", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": null, "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 64.83216622, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 64.83216622, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 64.83216622, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 64.83216622, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AR-A0TX-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AR", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 7.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2842, "MSI_SENSOR_SCORE": 0.08, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 9.3, "TISSUE_SOURCE_SITE": "Mayo", "TBL_SCORE": 193.0 }, "treatments": [] }, "TCGA-C8-A12W": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "6adca853-1b09-47ff-814c-47b732a76d96", "AGE": 49, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIB", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 385.0, "DAYS_TO_BIRTH": -18140.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/13/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T4", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Asian", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 12.65739554, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 12.65739554, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 12.65739554, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 12.65739554, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-C8-A12W-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "C8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 27.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2886, "MSI_SENSOR_SCORE": 0.65, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.733333333, "TISSUE_SOURCE_SITE": "ILSBio", "TBL_SCORE": 229.0 }, "treatments": [] }, "TCGA-AC-A62X": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "5B2A4F11-CA46-4974-9420-59B4820920BF", "AGE": 72, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 417.0, "DAYS_TO_BIRTH": -26627.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "10/21/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "Yes", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 13.7094388, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 13.7094388, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 13.7094388, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 13.7094388, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-AC-A62X-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "AC", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 29.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3234, "MSI_SENSOR_SCORE": 0.68, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.766666667, "TISSUE_SOURCE_SITE": "International Genomics Consortium", "TBL_SCORE": 58.0 }, "treatments": [] }, "TCGA-AO-A0J5": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "c1442467-d618-435f-8792-b1a18f696f1a", "AGE": 48, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": 705.0, "DAYS_TO_BIRTH": -17815.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/7/2010", "HISTORY_NEOADJUVANT_TRTYN": "Yes", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8523/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M1", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T4", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 26.03807082, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 26.03807082, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 26.03807082, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AO-A0J5-01", "ONCOTREE_CODE": "BRCNOS", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Carcinoma (NOS)", "TUMOR_TYPE": "Other", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AO", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 3.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.277, "MSI_SENSOR_SCORE": 0.12, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.766666667, "TISSUE_SOURCE_SITE": "MSKCC", "TBL_SCORE": 111.0 }, "treatments": [ { "START_DATE": 9, "STOP_DATE": 422.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Letrozole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "2.5", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Other", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 422, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Capecitabine", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1500", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Progression", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 618, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Fulvestrant", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "250", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "3", "REGIMEN_INDICATION": "Progression", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IM", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": -1, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Other", "TREATMENT_SUBTYPE": "Bisphosphonate Therapy", "AGENT": "Zoledronic Acid", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "4", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Other", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 336, "STOP_DATE": 371.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Palliative", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "25", "RADIATION_DOSAGE": "10625", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-BH-A1FD": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "3c8b5af9-c34d-43c2-b8c9-39ea11e44fa6", "AGE": 68, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE I", "AJCC_STAGING_EDITION": "5TH", "DAYS_LAST_FOLLOWUP": NaN, "DAYS_TO_BIRTH": -24940.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/8/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": null, "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 33.17223921, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 33.17223921, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 33.17223921, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A1FD-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 9.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2989, "MSI_SENSOR_SCORE": 0.29, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.966666667, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 393.0 }, "treatments": [] }, "TCGA-OL-A5RX": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "43C0BEC6-6FAC-47B1-83CB-200A15A932BE", "AGE": 51, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 878.0, "DAYS_TO_BIRTH": -18942.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "5/16/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 28.86543709, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 28.86543709, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 28.86543709, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 28.86543709, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-OL-A5RX-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "OL", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 5.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2925, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.766666667, "TISSUE_SOURCE_SITE": "University of Chicago", "TBL_SCORE": 1.0 }, "treatments": [] }, "TCGA-E2-A1B4": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "dbb2da92-99dd-400c-bc05-e87d7273656c", "AGE": 74, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 911.0, "DAYS_TO_BIRTH": -27241.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/25/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N2A", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 33.00785745, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 33.00785745, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 33.00785745, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 33.00785745, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E2-A1B4-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "E2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 2.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2568, "MSI_SENSOR_SCORE": 0.01, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.033333333, "TISSUE_SOURCE_SITE": "Roswell Park", "TBL_SCORE": 1.0 }, "treatments": [ { "START_DATE": 176, "STOP_DATE": 1004.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "828", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 83, "STOP_DATE": 187.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "33", "RADIATION_DOSAGE": "6040", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-BH-A18H": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "878f975b-94fd-4d69-b7e7-1ed3ac2ee438", "AGE": 63, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 652.0, "DAYS_TO_BIRTH": -23065.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "6/6/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T1B", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 21.43538153, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 21.43538153, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 21.43538153, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 21.43538153, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A18H-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 20.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2518, "MSI_SENSOR_SCORE": 0.04, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.366666667, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 125.0 }, "treatments": [ { "START_DATE": 34, "STOP_DATE": 118.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 34, "STOP_DATE": 118.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 118, "STOP_DATE": 219.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 219, "STOP_DATE": 259.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "28", "RADIATION_DOSAGE": "50.4", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "gy" }, { "START_DATE": 260, "STOP_DATE": 266.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 2", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "5", "RADIATION_DOSAGE": "10", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "gy" } ] }, "TCGA-EW-A1OW": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "f55dd73d-8c36-440b-84e5-9aae53107775", "AGE": 58, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 694.0, "DAYS_TO_BIRTH": -21465.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/18/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8090/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "0:LIVING", "OS_MONTHS": 22.81618832, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 22.81618832, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 22.81618832, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 22.81618832, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-EW-A1OW-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "EW", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 19.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": NaN, "MSI_SENSOR_SCORE": NaN, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.0, "TISSUE_SOURCE_SITE": "University of Miami", "TBL_SCORE": 82.0 }, "treatments": [ { "START_DATE": 108, "STOP_DATE": 213.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Fluorouracil", "NUMBER_OF_CYCLES": "3", "PRESCRIBED_DOSE": "965", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "fec then t", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "2895", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 108, "STOP_DATE": 213.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": "3", "PRESCRIBED_DOSE": "163", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "fec then t", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "489", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 108, "STOP_DATE": 213.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "3", "PRESCRIBED_DOSE": "965", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "fec then t", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "2895", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 108, "STOP_DATE": 213.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Epirubicin", "NUMBER_OF_CYCLES": "3", "PRESCRIBED_DOSE": "193", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "fec then t", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "579", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 294, "STOP_DATE": 338.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": "6000", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-BH-A0BD": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "b379bfb8-284e-4300-8325-85cfd6809cb8", "AGE": 47, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 554.0, "DAYS_TO_BIRTH": -17275.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "11/4/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 18.21349903, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 18.21349903, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 18.21349903, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 18.21349903, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A0BD-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 5.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2827, "MSI_SENSOR_SCORE": 0.18, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.966666667, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 25.0 }, "treatments": [ { "START_DATE": 61, "STOP_DATE": 166.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "6", "PRESCRIBED_DOSE": "86", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "522", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 244, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "20", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 61, "STOP_DATE": 166.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "6", "PRESCRIBED_DOSE": "865", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "5230", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 196, "STOP_DATE": 247.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "33", "RADIATION_DOSAGE": "6040", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-BH-A18P": { "demographics": { "SUBTYPE": "BRCA_Her2", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "557cb0a3-6f1b-4faf-8296-0a15c24158f9", "AGE": 60, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE I", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": NaN, "DAYS_TO_BIRTH": -22222.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "6/22/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.3", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.3", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T1", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": null, "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 30.27912023, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 30.27912023, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 30.27912023, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A18P-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 6.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2539, "MSI_SENSOR_SCORE": 0.06, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 9.2, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 40.0 }, "treatments": [] }, "TCGA-AO-A1KT": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "1f8f87cb-8a0b-474c-97fb-c71b4fd88d97", "AGE": 78, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 541.0, "DAYS_TO_BIRTH": -28660.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/1/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T1", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": null, "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 17.78610645, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 17.78610645, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 17.78610645, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 17.78610645, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AO-A1KT-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AO", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 11.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3339, "MSI_SENSOR_SCORE": 0.96, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.166666667, "TISSUE_SOURCE_SITE": "MSKCC", "TBL_SCORE": 69.0 }, "treatments": [ { "START_DATE": 62, "STOP_DATE": 209.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Methotrexate", "NUMBER_OF_CYCLES": "8", "PRESCRIBED_DOSE": "40", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "560", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 62, "STOP_DATE": 209.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Fluorouracil", "NUMBER_OF_CYCLES": "8", "PRESCRIBED_DOSE": "600", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "8448", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 323, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 62, "STOP_DATE": 209.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "8", "PRESCRIBED_DOSE": "600", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "8448", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 238, "STOP_DATE": 280.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "30", "RADIATION_DOSAGE": "6000", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-A7-A6VX": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "7EEA2B6E-771F-44C0-9350-38F45C8DBE87", "AGE": 68, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 317.0, "DAYS_TO_BIRTH": -25066.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "10/29/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 10.4218036, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 10.4218036, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 10.4218036, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 10.4218036, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-A7-A6VX-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "A7", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 17.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.355, "MSI_SENSOR_SCORE": 1.31, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 3.966666667, "TISSUE_SOURCE_SITE": "Christiana Healthcare", "TBL_SCORE": 264.0 }, "treatments": [ { "START_DATE": 79, "STOP_DATE": 142.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 79, "STOP_DATE": 142.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 230, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 170, "STOP_DATE": 204.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "25", "RADIATION_DOSAGE": "4500", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" }, { "START_DATE": 206, "STOP_DATE": 220.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 2", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "10", "RADIATION_DOSAGE": "2000", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-EW-A1J6": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "87281a89-91d2-44f7-9f80-668567ad5c72", "AGE": 70, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE I", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 875.0, "DAYS_TO_BIRTH": -25830.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/11/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 28.76680804, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 28.76680804, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 28.76680804, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 28.76680804, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-EW-A1J6-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "EW", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 16.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3472, "MSI_SENSOR_SCORE": 1.86, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.033333333, "TISSUE_SOURCE_SITE": "University of Miami", "TBL_SCORE": 172.0 }, "treatments": [ { "START_DATE": 111, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Letrozole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "2.5", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-BH-A0B1": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "b4e4fea2-b802-4a86-923e-3fcbd3c708fe", "AGE": 66, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": 1148.0, "DAYS_TO_BIRTH": -24315.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "11/3/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "0:LIVING", "OS_MONTHS": 37.74205214, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 37.74205214, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 37.74205214, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 37.74205214, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A0B1-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": NaN, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2667, "MSI_SENSOR_SCORE": 0.6, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.633333333, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 229.0 }, "treatments": [ { "START_DATE": 53, "STOP_DATE": 232.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 251, "STOP_DATE": 311.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 269, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 53, "STOP_DATE": 232.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 287, "STOP_DATE": 343.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "28", "RADIATION_DOSAGE": "6040", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-A7-A0CG": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "67eef990-5ff4-45d1-843d-d22d7848f130", "AGE": 78, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": 1043.0, "DAYS_TO_BIRTH": -28596.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "10/7/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8522/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 34.29003518, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 34.29003518, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 34.29003518, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A7-A0CG-01", "ONCOTREE_CODE": "BRCNOS", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Carcinoma (NOS)", "TUMOR_TYPE": "Mixed Histology (NOS)", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "A7", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 7.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2301, "MSI_SENSOR_SCORE": 0.16, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.566666667, "TISSUE_SOURCE_SITE": "Christiana Healthcare", "TBL_SCORE": 67.0 }, "treatments": [ { "START_DATE": 146, "STOP_DATE": 176.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "42", "RADIATION_DOSAGE": "10480", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-E2-A1BC": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "d8492ebd-3d94-4a4b-8de7-386526691cc2", "AGE": 63, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 501.0, "DAYS_TO_BIRTH": -23168.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "4/25/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8524/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "Yes", "RACE": null, "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 16.47105237, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 16.47105237, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 16.47105237, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E2-A1BC-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "E2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 7.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2645, "MSI_SENSOR_SCORE": 1.19, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.2, "TISSUE_SOURCE_SITE": "Roswell Park", "TBL_SCORE": 22.0 }, "treatments": [ { "START_DATE": 11, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": "1", "TOTAL_DOSE_UNITS": "Mg/Day", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-GM-A4E0": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "6397D7BC-9CB1-4A84-81AD-76954E0A8CEE", "AGE": 67, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIC", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 2191.0, "DAYS_TO_BIRTH": -24788.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "11/26/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N3A", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 72.03208732, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 72.03208732, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 72.03208732, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 72.03208732, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-GM-A4E0-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "GM", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 7.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2859, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.7, "TISSUE_SOURCE_SITE": "MD Anderson", "TBL_SCORE": 13.0 }, "treatments": [ { "START_DATE": 121, "STOP_DATE": 184.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Capecitabine", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 121, "STOP_DATE": 184.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 226, "STOP_DATE": 289.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Fluorouracil", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 226, "STOP_DATE": 289.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Epirubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 226, "STOP_DATE": 289.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 320, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 315, "STOP_DATE": 357.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "30", "RADIATION_DOSAGE": "60", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "gy" } ] }, "TCGA-B6-A0RS": { "demographics": { "SUBTYPE": "BRCA_Her2", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "9416ff9b-6f29-4554-b04d-b537a3ae3969", "AGE": 38, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "3RD", "DAYS_LAST_FOLLOWUP": NaN, "DAYS_TO_BIRTH": -14134.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "11/2/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 100.7002663, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 100.7002663, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 67.10063451, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 67.10063451, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-B6-A0RS-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "B6", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 13.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3095, "MSI_SENSOR_SCORE": 0.22, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 4.633333333, "TISSUE_SOURCE_SITE": "Duke", "TBL_SCORE": 247.0 }, "treatments": [] }, "TCGA-BH-A0DQ": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "a851ca14-7bbf-455b-a054-ec03979a4247", "AGE": 42, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": 98.0, "DAYS_TO_BIRTH": -15533.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "11/9/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 3.2218825, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 3.2218825, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 3.2218825, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 3.2218825, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A0DQ-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 7.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2911, "MSI_SENSOR_SCORE": 0.03, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.033333333, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 34.0 }, "treatments": [ { "START_DATE": 141, "STOP_DATE": 204.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 141, "STOP_DATE": 204.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 225, "STOP_DATE": 309.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": "12", "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 329, "STOP_DATE": 377.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": "6040", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-D8-A1JB": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "dd96a9c7-899c-47cd-a0f9-b149ed07a5d6", "AGE": 54, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 1688.0, "DAYS_TO_BIRTH": -19822.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/29/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 55.49528224, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 55.49528224, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 55.49528224, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 55.49528224, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D8-A1JB-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "D8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 8.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.324, "MSI_SENSOR_SCORE": 0.13, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.3, "TISSUE_SOURCE_SITE": "Greater Poland Cancer Center", "TBL_SCORE": 68.0 }, "treatments": [ { "START_DATE": 51, "STOP_DATE": 111.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "60", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "240", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 51, "STOP_DATE": 111.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 532, "STOP_DATE": 554.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": "4500", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-A2-A04V": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "64f67506-f2df-4f0a-b7be-29b4949e986a", "AGE": 39, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": NaN, "DAYS_TO_BIRTH": -14250.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "8/10/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 63.12259592, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 63.12259592, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 48.3282375, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 48.3282375, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A2-A04V-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 6.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.289, "MSI_SENSOR_SCORE": 0.04, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.9, "TISSUE_SOURCE_SITE": "Walter Reed", "TBL_SCORE": 98.0 }, "treatments": [ { "START_DATE": 50, "STOP_DATE": 92.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "1146", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "4584", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 107, "STOP_DATE": 1258.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "20", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "3", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 50, "STOP_DATE": 92.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "115", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "460", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 1269, "STOP_DATE": 1439.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Letrozole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "2.5", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "6", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 1452, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Exemestane", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "25", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "4", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 1577, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Capecitabine", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": "5", "REGIMEN_INDICATION": "Recurrence", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-AN-A0XR": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "f51af6db-2655-47fb-9ffc-83a503a728ea", "AGE": 55, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 10.0, "DAYS_TO_BIRTH": -20381.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/25/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N2", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 0.32876352, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 0.32876352, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 0.32876352, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 0.32876352, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AN-A0XR-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AN", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 6.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2961, "MSI_SENSOR_SCORE": 0.36, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.0, "TISSUE_SOURCE_SITE": "Cureline", "TBL_SCORE": 53.0 }, "treatments": [] }, "TCGA-BH-A1EO": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "4510295e-8aa7-4ef1-b2b7-91cc902f8200", "AGE": 68, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "5TH", "DAYS_LAST_FOLLOWUP": NaN, "DAYS_TO_BIRTH": -25136.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/6/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8522/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": null, "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 91.98803301, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 91.98803301, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 91.98803301, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A1EO-01", "ONCOTREE_CODE": "BRCNOS", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Carcinoma (NOS)", "TUMOR_TYPE": "Mixed Histology (NOS)", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 22.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2641, "MSI_SENSOR_SCORE": 0.2, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.366666667, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 76.0 }, "treatments": [] }, "TCGA-A2-A25E": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "ba89cb4f-cd63-47b1-9550-76fdaff89f2e", "AGE": 34, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 3204.0, "DAYS_TO_BIRTH": -12601.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/21/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N2A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 105.3358319, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 105.3358319, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 98.26741625, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 98.26741625, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-A2-A25E-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 5.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3265, "MSI_SENSOR_SCORE": 1.75, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.7, "TISSUE_SOURCE_SITE": "Walter Reed", "TBL_SCORE": 82.0 }, "treatments": [ { "START_DATE": 67, "STOP_DATE": 136.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "90", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "5", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "360", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 67, "STOP_DATE": 136.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "900", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "4", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "3600", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 2380, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Goserelin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "3.6", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "6", "REGIMEN_INDICATION": "Other", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "SC", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 250, "STOP_DATE": 601.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Immunotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Trastuzumab", "NUMBER_OF_CYCLES": "47", "PRESCRIBED_DOSE": "98-196", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "5142", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 158, "STOP_DATE": 242.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": "12", "PRESCRIBED_DOSE": "120", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "3", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "1440", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 334, "STOP_DATE": 2155.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "10", "PRESCRIBED_DOSE_UNITS": "mg/m2/day", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 3055, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 292, "STOP_DATE": 333.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "84", "RADIATION_DOSAGE": "10640", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-BH-A1FJ": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "f6581eee-61b9-43d4-ab0d-ce5ce3ba1c74", "AGE": 66, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": "5TH", "DAYS_LAST_FOLLOWUP": NaN, "DAYS_TO_BIRTH": -24262.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/8/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1B", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": null, "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 63.35273038, "DSS_STATUS": null, "DSS_MONTHS": 63.35273038, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 63.35273038, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A1FJ-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 3.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.4703, "MSI_SENSOR_SCORE": 1.53, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.833333333, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 21.0 }, "treatments": [] }, "TCGA-LD-A74U": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "38A4E9BD-93E9-432D-A756-3B1055B823BD", "AGE": 79, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIC", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 402.0, "DAYS_TO_BIRTH": -28981.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/30/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8524/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N3A", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 13.21629352, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 13.21629352, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 13.21629352, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 13.21629352, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-LD-A74U-01", "ONCOTREE_CODE": "BRCNOS", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Carcinoma (NOS)", "TUMOR_TYPE": "Other", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "LD", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 7.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3334, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 6.533333333, "TISSUE_SOURCE_SITE": "Hartford Hospital", "TBL_SCORE": 10.0 }, "treatments": [ { "START_DATE": 52, "STOP_DATE": 301.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Stable Disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-BH-A0HY": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "844ad251-3ee4-42f6-ad00-59a7a1670eea", "AGE": 60, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE I", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 1545.0, "DAYS_TO_BIRTH": -22179.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "8/2/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 50.7939639, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 50.7939639, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 50.7939639, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 50.7939639, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A0HY-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 18.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2802, "MSI_SENSOR_SCORE": 1.06, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.8, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 358.0 }, "treatments": [ { "START_DATE": 88, "STOP_DATE": 190.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 88, "STOP_DATE": 190.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 88, "STOP_DATE": 427.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Trastuzumab", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-E2-A2P5": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "F0DE67FF-8967-4FCE-9C12-0E07193285CD", "AGE": 78, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIC", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 515.0, "DAYS_TO_BIRTH": -28621.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/19/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N3", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "Yes", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 26.99148503, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 26.99148503, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 19.62718217, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 19.62718217, "GENETIC_ANCESTRY_LABEL": "ADMIX" }, "sample": { "SAMPLE_ID": "TCGA-E2-A2P5-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "E2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 26.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2955, "MSI_SENSOR_SCORE": 0.01, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.0, "TISSUE_SOURCE_SITE": "Roswell Park", "TBL_SCORE": 99.0 }, "treatments": [ { "START_DATE": 163, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 98, "STOP_DATE": 143.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "28", "RADIATION_DOSAGE": "60.4", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "gy" } ] }, "TCGA-BH-A0DO": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "d3d4d709-ab34-4617-aa8c-51a3d0a3efe6", "AGE": 78, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE I", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 1644.0, "DAYS_TO_BIRTH": -28529.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "8/11/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 54.04872275, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 54.04872275, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 54.04872275, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 54.04872275, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A0DO-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 9.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2675, "MSI_SENSOR_SCORE": 0.01, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.7, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 1.0 }, "treatments": [] }, "TCGA-D8-A1XL": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "2b19a6b4-7a17-4452-b4aa-6fc18adc0c3c", "AGE": 34, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 606.0, "DAYS_TO_BIRTH": -12668.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "6/9/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 19.92306934, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 19.92306934, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 19.92306934, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 19.92306934, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D8-A1XL-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "D8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 17.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3143, "MSI_SENSOR_SCORE": 0.33, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 3.1, "TISSUE_SOURCE_SITE": "Greater Poland Cancer Center", "TBL_SCORE": 181.0 }, "treatments": [ { "START_DATE": 65, "STOP_DATE": 128.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin + Cyclophosphamide + Tamoxifen", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "100.8+1000.8", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "403.2+4032", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 250, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen + Leuprolide + Goserelin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "20+11.25+10.8", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 211, "STOP_DATE": 249.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "55", "RADIATION_DOSAGE": "11000", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-LL-A5YO": { "demographics": { "SUBTYPE": "BRCA_Her2", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "B8AEFC48-4A6E-4254-A57F-5F688399B582", "AGE": 50, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 440.0, "DAYS_TO_BIRTH": -18354.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/8/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T1B", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 14.4655949, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 14.4655949, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 14.4655949, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 14.4655949, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-LL-A5YO-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "LL", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": NaN, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2957, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.366666667, "TISSUE_SOURCE_SITE": "Candler", "TBL_SCORE": 50.0 }, "treatments": [ { "START_DATE": 56, "STOP_DATE": 160.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 56, "STOP_DATE": 160.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 192, "STOP_DATE": 210.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "15", "RADIATION_DOSAGE": "40/48", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "gy" } ] }, "TCGA-A8-A075": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "7861a5f2-8910-4bcb-9c34-f79c5acd6e21", "AGE": 42, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 518.0, "DAYS_TO_BIRTH": -15369.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "5/27/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": null, "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 17.02995036, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 17.02995036, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 17.02995036, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 17.02995036, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A8-A075-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 19.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2806, "MSI_SENSOR_SCORE": 0.47, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.5, "TISSUE_SOURCE_SITE": "Indivumed", "TBL_SCORE": 137.0 }, "treatments": [ { "START_DATE": 31, "STOP_DATE": 122.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Epirubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 31, "STOP_DATE": 122.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 122, "STOP_DATE": 214.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 275, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 214, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Ancillary", "TREATMENT_SUBTYPE": null, "AGENT": "Zoledronic Acid", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 214, "STOP_DATE": 275.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "gy" } ] }, "TCGA-AC-A2QH": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "67C5F371-3FA9-47C5-8B15-C2DD9ACC8519", "AGE": 58, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 1005.0, "DAYS_TO_BIRTH": -21488.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "10/18/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8575/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 33.0407338, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 33.0407338, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 33.0407338, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 33.0407338, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AC-A2QH-01", "ONCOTREE_CODE": "MBC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Metaplastic Breast Cancer", "TUMOR_TYPE": "Metaplastic Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "AC", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 18.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3517, "MSI_SENSOR_SCORE": 1.54, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.9, "TISSUE_SOURCE_SITE": "International Genomics Consortium", "TBL_SCORE": 163.0 }, "treatments": [ { "START_DATE": 94, "STOP_DATE": 208.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 94, "STOP_DATE": 208.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 94, "STOP_DATE": 208.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Ancillary", "TREATMENT_SUBTYPE": null, "AGENT": "Palonosetron", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 246, "STOP_DATE": 305.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "33", "RADIATION_DOSAGE": "6040", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-AQ-A1H2": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "4d120899-9a80-4736-b097-285e9e261bcb", "AGE": 84, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 475.0, "DAYS_TO_BIRTH": -30958.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/20/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N2A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 15.61626722, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 15.61626722, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 15.61626722, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 15.61626722, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AQ-A1H2-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "AQ", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 10.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.306, "MSI_SENSOR_SCORE": 0.19, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.8, "TISSUE_SOURCE_SITE": "UNC", "TBL_SCORE": 89.0 }, "treatments": [ { "START_DATE": 98, "STOP_DATE": 462.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Trastuzumab", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "2", "PRESCRIBED_DOSE_UNITS": "mg/kg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 378, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 98, "STOP_DATE": 182.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": "12", "PRESCRIBED_DOSE": "80", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 208, "STOP_DATE": 243.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "25", "RADIATION_DOSAGE": "5000", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" }, { "START_DATE": 208, "STOP_DATE": 246.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 2", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "28", "RADIATION_DOSAGE": "5900", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-AR-A1AK": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "94b03e1d-50ec-4680-bffd-7086d1536ff2", "AGE": 70, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE I", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 3159.0, "DAYS_TO_BIRTH": -25825.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "6/15/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T1", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 103.8563961, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 103.8563961, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 103.8563961, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 103.8563961, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AR-A1AK-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AR", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 14.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2496, "MSI_SENSOR_SCORE": 0.07, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.933333333, "TISSUE_SOURCE_SITE": "Mayo", "TBL_SCORE": 34.0 }, "treatments": [ { "START_DATE": 33, "STOP_DATE": 1843.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-A7-A4SC": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "EC0AB947-9341-4FFF-BDA4-FDFB9434D508", "AGE": 62, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 446.0, "DAYS_TO_BIRTH": -23008.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "2/20/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "0:LIVING", "OS_MONTHS": 14.66285301, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 14.66285301, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 14.66285301, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 14.66285301, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A7-A4SC-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "A7", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": NaN, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3073, "MSI_SENSOR_SCORE": 0.01, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.8, "TISSUE_SOURCE_SITE": "Christiana Healthcare", "TBL_SCORE": 35.0 }, "treatments": [ { "START_DATE": 61, "STOP_DATE": 139.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 169, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 130, "STOP_DATE": 168.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "28", "RADIATION_DOSAGE": "5040", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" }, { "START_DATE": 130, "STOP_DATE": 166.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 2", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "26", "RADIATION_DOSAGE": "4680", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-C8-A273": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "5a5f0f48-2b13-4e78-b130-901b85d9a7f3", "AGE": 29, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 513.0, "DAYS_TO_BIRTH": NaN, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/21/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Asian", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 16.8655686, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 16.8655686, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 16.8655686, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 16.8655686, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-C8-A273-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "C8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 7.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2953, "MSI_SENSOR_SCORE": 0.26, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.533333333, "TISSUE_SOURCE_SITE": "ILSBio", "TBL_SCORE": 172.0 }, "treatments": [ { "START_DATE": 13, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-E9-A245": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "8218119a-f68b-4ea7-9ee4-5e2edc2ae342", "AGE": 47, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 26.0, "DAYS_TO_BIRTH": -17363.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/16/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 0.854785153, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 0.854785153, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 0.854785153, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 0.854785153, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E9-A245-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "E9", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 1.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3505, "MSI_SENSOR_SCORE": 0.01, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.633333333, "TISSUE_SOURCE_SITE": "Asterand", "TBL_SCORE": 5.0 }, "treatments": [ { "START_DATE": 20, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "20", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-LL-A73Y": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "EA645243-DF49-4466-A255-9F3D4321E357", "AGE": 67, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 477.0, "DAYS_TO_BIRTH": -24647.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "11/12/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 15.68201992, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 15.68201992, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 15.68201992, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 15.68201992, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-LL-A73Y-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "LL", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 24.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3583, "MSI_SENSOR_SCORE": 0.99, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 3.433333333, "TISSUE_SOURCE_SITE": "Candler", "TBL_SCORE": 96.0 }, "treatments": [ { "START_DATE": 42, "STOP_DATE": 126.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 42, "STOP_DATE": 126.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-E2-A1BD": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "0e1d0d46-7a7b-4538-95dd-b9fc20a15aec", "AGE": 53, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 1133.0, "DAYS_TO_BIRTH": -19627.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/25/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 37.24890686, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 37.24890686, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 37.24890686, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 37.24890686, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E2-A1BD-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "E2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 20.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2838, "MSI_SENSOR_SCORE": 0.24, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.266666667, "TISSUE_SOURCE_SITE": "Roswell Park", "TBL_SCORE": 15.0 }, "treatments": [ { "START_DATE": 170, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": "1", "TOTAL_DOSE_UNITS": "Mg/Day", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 55, "STOP_DATE": 108.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": "6600", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-A8-A08T": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "32bc7cc4-d185-4594-bbee-4b96410be512", "AGE": 64, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 2830.0, "DAYS_TO_BIRTH": -23560.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "5/27/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M1", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": null, "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 112.0754841, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 112.0754841, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 84.06483217, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A8-A08T-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 8.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2501, "MSI_SENSOR_SCORE": 0.24, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.3, "TISSUE_SOURCE_SITE": "Indivumed", "TBL_SCORE": 83.0 }, "treatments": [] }, "TCGA-B6-A0RG": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "9b13927c-7357-44fd-8385-92ae6a656b7d", "AGE": 26, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "4TH", "DAYS_LAST_FOLLOWUP": 2082.0, "DAYS_TO_BIRTH": -9840.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "11/2/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 68.44856495, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 68.44856495, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 68.44856495, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 68.44856495, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-B6-A0RG-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "B6", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 7.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2716, "MSI_SENSOR_SCORE": 0.49, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.266666667, "TISSUE_SOURCE_SITE": "Duke", "TBL_SCORE": 58.0 }, "treatments": [] }, "TCGA-A2-A0D1": { "demographics": { "SUBTYPE": "BRCA_Her2", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "084c6aec-94f7-4090-8f3f-59fa9e89721a", "AGE": 76, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 1051.0, "DAYS_TO_BIRTH": -28084.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/21/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 34.55304599, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 34.55304599, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 34.55304599, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 34.55304599, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A2-A0D1-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 10.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2684, "MSI_SENSOR_SCORE": 0.63, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.466666667, "TISSUE_SOURCE_SITE": "Walter Reed", "TBL_SCORE": 180.0 }, "treatments": [ { "START_DATE": 131, "STOP_DATE": 201.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": "3 cycles (9 doses)", "PRESCRIBED_DOSE": "176-180", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "4", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "1600", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 79, "STOP_DATE": 79.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": "1", "PRESCRIBED_DOSE": "140", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "140", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 79, "STOP_DATE": 428.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Targeted Molecular Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Trastuzumab", "NUMBER_OF_CYCLES": "23 doses", "PRESCRIBED_DOSE": "135-600", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "3", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "6575", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 79, "STOP_DATE": 79.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": "1", "PRESCRIBED_DOSE": "366", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "366", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 252, "STOP_DATE": 296.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "33", "RADIATION_DOSAGE": "6040", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-OL-A5D8": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "6D4860B2-21C6-4B7B-9093-2F32700D0612", "AGE": 40, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 973.0, "DAYS_TO_BIRTH": -14853.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/19/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 31.98869054, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 31.98869054, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 31.98869054, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-OL-A5D8-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "OL", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 5.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3078, "MSI_SENSOR_SCORE": 0.06, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.8, "TISSUE_SOURCE_SITE": "University of Chicago", "TBL_SCORE": 159.0 }, "treatments": [] }, "TCGA-E2-A1IL": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "b63391a0-73f8-4544-9e94-f6529245ca2a", "AGE": 78, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 118.0, "DAYS_TO_BIRTH": -28495.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/29/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 3.879409541, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 3.879409541, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 3.879409541, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 3.879409541, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E2-A1IL-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "E2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 6.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2965, "MSI_SENSOR_SCORE": 0.14, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.766666667, "TISSUE_SOURCE_SITE": "Roswell Park", "TBL_SCORE": 41.0 }, "treatments": [ { "START_DATE": 64, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": "1", "TOTAL_DOSE_UNITS": "Mg/Day", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 84, "STOP_DATE": 112.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "24", "RADIATION_DOSAGE": "5840", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-E2-A10E": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "dc15a8ae-991e-421c-bc70-70e94f79dd17", "AGE": 64, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 865.0, "DAYS_TO_BIRTH": -23684.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "2/11/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "0:LIVING", "OS_MONTHS": 28.43804452, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 28.43804452, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 28.43804452, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 28.43804452, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E2-A10E-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "E2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 5.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": NaN, "MSI_SENSOR_SCORE": 0.02, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.0, "TISSUE_SOURCE_SITE": "Roswell Park", "TBL_SCORE": 36.0 }, "treatments": [ { "START_DATE": 217, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": "1", "TOTAL_DOSE_UNITS": "Mg/Day", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 60, "STOP_DATE": 123.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide + Docetaxel", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 60, "STOP_DATE": 123.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "918", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "3672", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 60, "STOP_DATE": 123.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "115", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "460", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 173, "STOP_DATE": 218.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "30", "RADIATION_DOSAGE": "6000", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-BH-A1EU": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "a1093598-d3a8-4ffe-83fc-bc7d1faff7e5", "AGE": 83, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE I", "AJCC_STAGING_EDITION": "5TH", "DAYS_LAST_FOLLOWUP": NaN, "DAYS_TO_BIRTH": -30339.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/7/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T1", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "No", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": null, "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 42.27898872, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 42.27898872, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 42.27898872, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A1EU-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 23.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2553, "MSI_SENSOR_SCORE": 0.01, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.866666667, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 100.0 }, "treatments": [] }, "TCGA-AN-A0FJ": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "546248b0-22a0-4b70-a437-76fb0a238a0d", "AGE": 59, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": 242.0, "DAYS_TO_BIRTH": -21910.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/27/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M1", "PATH_N_STAGE": "N2", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 7.956077194, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 7.956077194, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 7.956077194, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AN-A0FJ-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AN", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 12.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2694, "MSI_SENSOR_SCORE": 1.15, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.633333333, "TISSUE_SOURCE_SITE": "Cureline", "TBL_SCORE": 557.0 }, "treatments": [] }, "TCGA-BH-A0HK": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "24334ac1-28a3-4b61-b590-3f51e375b247", "AGE": 81, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": 178.0, "DAYS_TO_BIRTH": -29751.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "11/10/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 5.851990663, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 5.851990663, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 5.851990663, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 5.851990663, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A0HK-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 5.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2649, "MSI_SENSOR_SCORE": 0.63, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 5.7, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 44.0 }, "treatments": [ { "START_DATE": 38, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-Z7-A8R6": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "B1D44C81-747D-471F-9093-AEB262A17975", "AGE": 46, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE I", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 3256.0, "DAYS_TO_BIRTH": -16955.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/9/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.8", "ICD_O_3_HISTOLOGY": "8022/3", "ICD_O_3_SITE": "C50.8", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 107.0454022, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 107.0454022, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 107.0454022, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 107.0454022, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-Z7-A8R6-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "Z7", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 14.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3434, "MSI_SENSOR_SCORE": 0.15, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.1, "TISSUE_SOURCE_SITE": "John Wayne Cancer Center", "TBL_SCORE": 72.0 }, "treatments": [ { "START_DATE": 31, "STOP_DATE": 153.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 31, "STOP_DATE": 153.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 31, "STOP_DATE": 153.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-BH-A1EW": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "9d166970-07c8-4ca3-9cfa-ed0049df9ecc", "AGE": 38, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "5TH", "DAYS_LAST_FOLLOWUP": NaN, "DAYS_TO_BIRTH": -14090.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/7/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1B", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": null, "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 55.69254036, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 55.69254036, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 55.69254036, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A1EW-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 15.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2654, "MSI_SENSOR_SCORE": 0.03, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.466666667, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 128.0 }, "treatments": [] }, "TCGA-C8-A8HP": { "demographics": { "SUBTYPE": "BRCA_Her2", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "8DB69F1D-72E2-40BA-AD8A-CF228499840D", "AGE": 59, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 396.0, "DAYS_TO_BIRTH": -21613.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/29/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8575/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N2", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Asian", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 13.01903541, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 13.01903541, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 13.01903541, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 13.01903541, "GENETIC_ANCESTRY_LABEL": "EAS" }, "sample": { "SAMPLE_ID": "TCGA-C8-A8HP-01", "ONCOTREE_CODE": "MBC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Metaplastic Breast Cancer", "TUMOR_TYPE": "Metaplastic Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "C8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 10.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3167, "MSI_SENSOR_SCORE": 0.01, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 4.866666667, "TISSUE_SOURCE_SITE": "ILSBio", "TBL_SCORE": 150.0 }, "treatments": [ { "START_DATE": 31, "STOP_DATE": 224.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Fluorouracil", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 31, "STOP_DATE": 224.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Epirubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 31, "STOP_DATE": 224.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-A8-A07J": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "316625b8-a217-4829-90d1-dfd9cb7e4bc3", "AGE": 35, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 365.0, "DAYS_TO_BIRTH": -12965.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "5/27/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": null, "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 11.9998685, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 11.9998685, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 11.9998685, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 11.9998685, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A8-A07J-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 6.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2569, "MSI_SENSOR_SCORE": 0.08, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.233333333, "TISSUE_SOURCE_SITE": "Indivumed", "TBL_SCORE": 20.0 }, "treatments": [ { "START_DATE": 31, "STOP_DATE": 92.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Fluorouracil", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 31, "STOP_DATE": 92.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Epirubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 31, "STOP_DATE": 92.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 92, "STOP_DATE": 153.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 184, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 153, "STOP_DATE": 184.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-A8-A08H": { "demographics": { "SUBTYPE": "BRCA_Normal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "db8d38ab-cc61-49ee-863d-40060112f2af", "AGE": 66, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 0.0, "DAYS_TO_BIRTH": -24137.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "5/27/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": null, "RADIATION_THERAPY": null, "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 0.0, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 0.0, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 0.0, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 0.0, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A8-A08H-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2613, "MSI_SENSOR_SCORE": 0.02, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 3.566666667, "TISSUE_SOURCE_SITE": "Indivumed", "TBL_SCORE": 4.0 }, "treatments": [] }, "TCGA-EW-A1P4": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "521e2140-ae5b-456f-8699-97398d009687", "AGE": 43, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 907.0, "DAYS_TO_BIRTH": -15989.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/11/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8510/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 29.8188513, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 29.8188513, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 29.8188513, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 29.8188513, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-EW-A1P4-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Medullary Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "EW", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 17.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3721, "MSI_SENSOR_SCORE": 0.97, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.966666667, "TISSUE_SOURCE_SITE": "University of Miami", "TBL_SCORE": 234.0 }, "treatments": [ { "START_DATE": 73, "STOP_DATE": 144.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "600", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "tc", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 73, "STOP_DATE": 144.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "75", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "tc", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 208, "STOP_DATE": 263.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": "15,900", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-BH-A0BR": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "3ecb0147-276d-486c-9af0-ce437c24ba83", "AGE": 59, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE I", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 2330.0, "DAYS_TO_BIRTH": -21622.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "8/10/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 76.60190025, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 76.60190025, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 76.60190025, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 76.60190025, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A0BR-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 12.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2842, "MSI_SENSOR_SCORE": 0.09, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.7, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 268.0 }, "treatments": [ { "START_DATE": 58, "STOP_DATE": 108.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "36", "RADIATION_DOSAGE": "64.8", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "gy" } ] }, "TCGA-BH-A1FB": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "ecab16bc-28d5-4c3a-8735-3c785bd047c4", "AGE": 60, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "5TH", "DAYS_LAST_FOLLOWUP": NaN, "DAYS_TO_BIRTH": -21933.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/7/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1B", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": null, "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 120.6233356, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 120.6233356, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 120.6233356, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A1FB-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": NaN, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": NaN, "MSI_SENSOR_SCORE": NaN, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.0, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 6.0 }, "treatments": [] }, "TCGA-BH-A204": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "05135396-df5c-49db-b34e-f4add5b65a2b", "AGE": 80, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "5TH", "DAYS_LAST_FOLLOWUP": NaN, "DAYS_TO_BIRTH": -29529.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/8/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1B", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": null, "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 83.30867607, "DSS_STATUS": null, "DSS_MONTHS": 83.30867607, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 83.30867607, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A204-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 7.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3005, "MSI_SENSOR_SCORE": 0.37, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.2, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 90.0 }, "treatments": [] }, "TCGA-D8-A27L": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "6020d1b4-ee20-4cc9-82a3-340b5e3122f1", "AGE": 49, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 499.0, "DAYS_TO_BIRTH": -18025.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/18/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N2A", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 16.40529967, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 16.40529967, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 16.40529967, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 16.40529967, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D8-A27L-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "D8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 7.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2929, "MSI_SENSOR_SCORE": 0.01, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.3, "TISSUE_SOURCE_SITE": "Greater Poland Cancer Center", "TBL_SCORE": 10.0 }, "treatments": [ { "START_DATE": 100, "STOP_DATE": 238.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin + Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "60+600", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "240+2400", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-AC-A3QQ": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "95CEF916-5545-455B-920C-773A54FC7676", "AGE": 54, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 734.0, "DAYS_TO_BIRTH": -19723.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/3/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 24.1312424, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 24.1312424, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 24.1312424, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AC-A3QQ-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "AC", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 6.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3129, "MSI_SENSOR_SCORE": 0.45, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.866666667, "TISSUE_SOURCE_SITE": "International Genomics Consortium", "TBL_SCORE": 53.0 }, "treatments": [] }, "TCGA-A2-A0T0": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "95c53f69-0f05-4348-822a-571f3d757001", "AGE": 59, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 533.0, "DAYS_TO_BIRTH": -21575.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "11/12/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 17.52309564, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 17.52309564, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 17.52309564, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 17.52309564, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A2-A0T0-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 4.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2795, "MSI_SENSOR_SCORE": 0.28, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 5.566666667, "TISSUE_SOURCE_SITE": "Walter Reed", "TBL_SCORE": 140.0 }, "treatments": [ { "START_DATE": 50, "STOP_DATE": 234.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "3", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 50, "STOP_DATE": 234.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 50, "STOP_DATE": 234.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 262, "STOP_DATE": 323.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "33", "RADIATION_DOSAGE": "6040", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-D8-A1JH": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "4d1bf9e6-5837-4aed-b568-92f014ed5a4b", "AGE": 56, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 426.0, "DAYS_TO_BIRTH": -20497.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/28/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 14.00532597, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 14.00532597, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 14.00532597, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 14.00532597, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D8-A1JH-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "D8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3268, "MSI_SENSOR_SCORE": 0.66, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.7, "TISSUE_SOURCE_SITE": "Greater Poland Cancer Center", "TBL_SCORE": 2.0 }, "treatments": [ { "START_DATE": 66, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "20", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": "Mg/Day", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 81, "STOP_DATE": 105.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "20", "RADIATION_DOSAGE": "45", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-A8-A085": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "3c08aabd-d5b5-4bbe-857c-38a7527b2163", "AGE": 44, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 1124.0, "DAYS_TO_BIRTH": -16377.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "5/27/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": null, "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "0:LIVING", "OS_MONTHS": 36.95301969, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 36.95301969, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 36.95301969, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 36.95301969, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A8-A085-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 4.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2599, "MSI_SENSOR_SCORE": 0.45, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.0, "TISSUE_SOURCE_SITE": "Indivumed", "TBL_SCORE": 87.0 }, "treatments": [ { "START_DATE": 394, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-AR-A24V": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "3cb06c7a-f2a8-448b-91a8-dd201bbf2ddd", "AGE": 52, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 3203.0, "DAYS_TO_BIRTH": -19027.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "8/29/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 105.3029556, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 105.3029556, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 105.3029556, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 105.3029556, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AR-A24V-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AR", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 23.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3138, "MSI_SENSOR_SCORE": 0.59, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.666666667, "TISSUE_SOURCE_SITE": "Mayo", "TBL_SCORE": 91.0 }, "treatments": [ { "START_DATE": 53, "STOP_DATE": 95.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 53, "STOP_DATE": 95.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 109, "STOP_DATE": 151.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 109, "STOP_DATE": 178.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Immunotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Bevacizumab", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 193, "STOP_DATE": 1027.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 1027, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 200, "STOP_DATE": 248.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "33", "RADIATION_DOSAGE": "6600", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-E2-A153": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "be9bf36a-12e1-4386-addf-1686dc8b49de", "AGE": 51, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 707.0, "DAYS_TO_BIRTH": -18875.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/7/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 23.24358089, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 23.24358089, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 23.24358089, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 23.24358089, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E2-A153-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "E2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 28.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2534, "MSI_SENSOR_SCORE": 0.08, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.466666667, "TISSUE_SOURCE_SITE": "Roswell Park", "TBL_SCORE": 3.0 }, "treatments": [ { "START_DATE": 229, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "20", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "3", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 42, "STOP_DATE": 98.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "1500", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "5700", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 42, "STOP_DATE": 98.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "120", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "480", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 112, "STOP_DATE": 196.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": "9", "PRESCRIBED_DOSE": "200", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "1722", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 237, "STOP_DATE": 294.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "33", "RADIATION_DOSAGE": "6040", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-D8-A1JL": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "aa4244a8-0454-4247-a1c3-357fd51746fa", "AGE": 72, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 611.0, "DAYS_TO_BIRTH": -26484.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/29/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 20.0874511, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 20.0874511, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 20.0874511, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 20.0874511, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D8-A1JL-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "D8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 23.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3016, "MSI_SENSOR_SCORE": 0.27, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.933333333, "TISSUE_SOURCE_SITE": "Greater Poland Cancer Center", "TBL_SCORE": 282.0 }, "treatments": [] }, "TCGA-BH-A8G0": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "59D60247-E549-4326-A672-50B05C13A291", "AGE": 54, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 662.0, "DAYS_TO_BIRTH": -19975.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/26/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 21.76414505, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 21.76414505, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 21.76414505, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 21.76414505, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A8G0-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 2.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3202, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.366666667, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 14.0 }, "treatments": [ { "START_DATE": 155, "STOP_DATE": 267.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 155, "STOP_DATE": 267.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-E2-A1IN": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "f43d622f-eed5-4933-adc6-ae9ad1e33028", "AGE": 60, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE I", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 675.0, "DAYS_TO_BIRTH": -22199.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/29/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 22.19153763, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 22.19153763, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 22.19153763, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 22.19153763, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E2-A1IN-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "E2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 20.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3233, "MSI_SENSOR_SCORE": 1.27, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 5.4, "TISSUE_SOURCE_SITE": "Roswell Park", "TBL_SCORE": 56.0 }, "treatments": [ { "START_DATE": 103, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": "1", "TOTAL_DOSE_UNITS": "Mg/Day", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 57, "STOP_DATE": 101.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "33", "RADIATION_DOSAGE": "6040", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-EW-A6SB": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "5C59028F-B8FA-4811-8314-BE3EAED5F364", "AGE": 62, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 760.0, "DAYS_TO_BIRTH": -22844.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/12/2015", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 24.98602755, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 24.98602755, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 24.98602755, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 24.98602755, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-EW-A6SB-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": null, "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": null, "TISSUE_SOURCE_SITE_CODE": "EW", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 23.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3424, "MSI_SENSOR_SCORE": 0.01, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.2, "TISSUE_SOURCE_SITE": "University of Miami", "TBL_SCORE": 104.0 }, "treatments": [] }, "TCGA-A7-A3RF": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "7451AF3C-ACC0-4D79-8429-6B8BE96911D8", "AGE": 79, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 408.0, "DAYS_TO_BIRTH": -29184.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/3/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8480/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 13.41355163, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 13.41355163, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 5.720485255, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 5.720485255, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A7-A3RF-01", "ONCOTREE_CODE": "IMMC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Mixed Mucinous Carcinoma", "TUMOR_TYPE": "Mucinous Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "A7", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3081, "MSI_SENSOR_SCORE": 0.01, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.066666667, "TISSUE_SOURCE_SITE": "Christiana Healthcare", "TBL_SCORE": 12.0 }, "treatments": [ { "START_DATE": 137, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Clinical Progressive Disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 88, "STOP_DATE": 136.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Radiographic Progressive Disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "34", "RADIATION_DOSAGE": "6280", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-A7-A0CJ": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "d69e59a8-b10b-46f5-b859-b6c178d90506", "AGE": 57, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": 931.0, "DAYS_TO_BIRTH": -21014.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "10/7/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 30.60788375, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 30.60788375, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 30.60788375, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A7-A0CJ-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "A7", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 22.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2683, "MSI_SENSOR_SCORE": 1.26, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.766666667, "TISSUE_SOURCE_SITE": "Christiana Healthcare", "TBL_SCORE": 293.0 }, "treatments": [ { "START_DATE": 61, "STOP_DATE": 124.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "1080", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "4320", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 61, "STOP_DATE": 124.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "140", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "560", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 203, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": "208", "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 152, "STOP_DATE": 202.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "33", "RADIATION_DOSAGE": "6100", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-C8-A12P": { "demographics": { "SUBTYPE": "BRCA_Her2", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "abdc76db-f85e-4337-a57e-6d098789da03", "AGE": 55, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 358.0, "DAYS_TO_BIRTH": -20332.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/13/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Asian", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 11.76973403, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 11.76973403, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 11.76973403, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 11.76973403, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-C8-A12P-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "C8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 17.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2886, "MSI_SENSOR_SCORE": 0.17, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 4.733333333, "TISSUE_SOURCE_SITE": "ILSBio", "TBL_SCORE": 538.0 }, "treatments": [] }, "TCGA-A7-A13G": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "6cd9baf5-bbe0-4c1e-a87f-c53b3af22890", "AGE": 79, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 718.0, "DAYS_TO_BIRTH": -28969.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/16/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 23.60522077, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 23.60522077, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 23.60522077, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 19.2655423, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A7-A13G-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "A7", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 4.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2762, "MSI_SENSOR_SCORE": 0.18, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.666666667, "TISSUE_SOURCE_SITE": "Christiana Healthcare", "TBL_SCORE": 40.0 }, "treatments": [ { "START_DATE": 33, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": "376", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 33, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-A2-A0EP": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "670F5022-5066-48F1-8472-5670129A1E0F", "AGE": 56, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE I", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 3603.0, "DAYS_TO_BIRTH": -20585.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "8/16/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I+)", "PATH_T_STAGE": "T1", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 118.4534964, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 118.4534964, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 118.4534964, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 118.4534964, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A2-A0EP-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": NaN, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2896, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.3, "TISSUE_SOURCE_SITE": "Walter Reed", "TBL_SCORE": 2.0 }, "treatments": [ { "START_DATE": 92, "STOP_DATE": 141.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 92, "STOP_DATE": 141.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 169, "STOP_DATE": 195.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 222, "STOP_DATE": 1781.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 1959, "STOP_DATE": 2461.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-B6-A0IH": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "2476dda9-da2a-4242-9642-b92b8b9b1c79", "AGE": 81, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": "4TH", "DAYS_LAST_FOLLOWUP": NaN, "DAYS_TO_BIRTH": -29907.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/15/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1B", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 112.3713713, "DSS_STATUS": null, "DSS_MONTHS": 112.3713713, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 112.3713713, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 112.3713713, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-B6-A0IH-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "B6", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 27.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2791, "MSI_SENSOR_SCORE": 0.02, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.233333333, "TISSUE_SOURCE_SITE": "Duke", "TBL_SCORE": 36.0 }, "treatments": [] }, "TCGA-A2-A25F": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "c836951b-3ffb-4e20-8504-0eccb7d50dd4", "AGE": 66, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 322.0, "DAYS_TO_BIRTH": -24319.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/26/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 10.58618536, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 10.58618536, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 10.58618536, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 10.58618536, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A2-A25F-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "A2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": NaN, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3314, "MSI_SENSOR_SCORE": 0.55, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.166666667, "TISSUE_SOURCE_SITE": "Walter Reed", "TBL_SCORE": 11.0 }, "treatments": [ { "START_DATE": 64, "STOP_DATE": 212.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 64, "STOP_DATE": 212.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 37, "STOP_DATE": 43.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "10", "RADIATION_DOSAGE": "3400", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-AN-A03X": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "88cd6ccc-70f7-436e-a99c-039b9d31e335", "AGE": 74, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": 10.0, "DAYS_TO_BIRTH": -27163.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/28/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 0.32876352, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 0.32876352, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 0.32876352, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 0.32876352, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AN-A03X-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AN", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 14.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.271, "MSI_SENSOR_SCORE": 0.22, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.166666667, "TISSUE_SOURCE_SITE": "Cureline", "TBL_SCORE": 56.0 }, "treatments": [] }, "TCGA-A2-A0EN": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "5e670fec-8992-44bf-8657-f7f9a272306b", "AGE": 70, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 2718.0, "DAYS_TO_BIRTH": -25771.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "2/27/2015", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I+)", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 134.3985271, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 134.3985271, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 134.3985271, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 134.3985271, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A2-A0EN-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 9.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2756, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.1, "TISSUE_SOURCE_SITE": "Walter Reed", "TBL_SCORE": 14.0 }, "treatments": [ { "START_DATE": 1985, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 64, "STOP_DATE": 1926.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "20", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 91, "STOP_DATE": 134.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "33", "RADIATION_DOSAGE": "6040", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-AO-A0JA": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "86b7b206-8e69-432d-acc9-bccce710955e", "AGE": 36, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIC", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": 655.0, "DAYS_TO_BIRTH": -13307.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/19/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N3", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 21.53401059, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 21.53401059, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 4.701318342, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 4.701318342, "GENETIC_ANCESTRY_LABEL": "AFR_ADMIX" }, "sample": { "SAMPLE_ID": "TCGA-AO-A0JA-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AO", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 10.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2673, "MSI_SENSOR_SCORE": 0.11, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.7, "TISSUE_SOURCE_SITE": "MSKCC", "TBL_SCORE": 60.0 }, "treatments": [ { "START_DATE": 166, "STOP_DATE": 242.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "20", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Recurrence", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 166, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Other", "TREATMENT_SUBTYPE": "Bisphosphonate Therapy", "AGENT": "Zoledronic Acid", "NUMBER_OF_CYCLES": "6", "PRESCRIBED_DOSE": "4", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Recurrence", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": "24", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 166, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Leuprolide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "7.5", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Recurrence", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IM", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 292, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": "7", "PRESCRIBED_DOSE": "80", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Progression", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": "980", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-E2-A15S": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "0f7ab21b-1fd0-45e0-9a47-17c4691eb84f", "AGE": 34, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 428.0, "DAYS_TO_BIRTH": -12671.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/14/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 14.07107867, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 14.07107867, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 14.07107867, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 14.07107867, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E2-A15S-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "E2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 10.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2644, "MSI_SENSOR_SCORE": 0.53, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.8, "TISSUE_SOURCE_SITE": "Roswell Park", "TBL_SCORE": 75.0 }, "treatments": [ { "START_DATE": 314, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "3", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": "1", "TOTAL_DOSE_UNITS": "Mg/Day", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 50, "STOP_DATE": 78.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "3", "PRESCRIBED_DOSE": "918", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "2754", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 50, "STOP_DATE": 78.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "3", "PRESCRIBED_DOSE": "92", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "276", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 191, "STOP_DATE": 247.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "30", "RADIATION_DOSAGE": "6000", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-BH-A18N": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "665dd3d3-779c-4abd-b5d7-13342340451d", "AGE": 88, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": NaN, "DAYS_TO_BIRTH": -32404.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "6/15/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1B", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 37.74205214, "DSS_STATUS": null, "DSS_MONTHS": 37.74205214, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 37.74205214, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 37.74205214, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A18N-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 23.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2785, "MSI_SENSOR_SCORE": 0.26, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.033333333, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 26.0 }, "treatments": [] }, "TCGA-AN-A0FT": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "baf5e81f-2322-41ec-9053-b9559a7993bc", "AGE": 63, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": 214.0, "DAYS_TO_BIRTH": -23300.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/28/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 7.035539337, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 7.035539337, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 7.035539337, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 7.035539337, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AN-A0FT-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AN", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 19.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2927, "MSI_SENSOR_SCORE": 0.5, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.8, "TISSUE_SOURCE_SITE": "Cureline", "TBL_SCORE": 400.0 }, "treatments": [] }, "TCGA-AN-A0XL": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "4649dee3-b668-44cd-ab97-3834de3ef8f8", "AGE": 61, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 163.0, "DAYS_TO_BIRTH": -22341.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/25/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 5.358845383, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 5.358845383, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 5.358845383, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 5.358845383, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AN-A0XL-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AN", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 13.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": NaN, "MSI_SENSOR_SCORE": 0.09, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.1, "TISSUE_SOURCE_SITE": "Cureline", "TBL_SCORE": 37.0 }, "treatments": [] }, "TCGA-BH-A8FY": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "5F4D16AA-9CC4-4EDB-B714-394E2661439A", "AGE": 87, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": NaN, "DAYS_TO_BIRTH": -31932.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/25/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I+)", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 9.698523852, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 9.698523852, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 9.698523852, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 9.698523852, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A8FY-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 5.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3253, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.3, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 35.0 }, "treatments": [] }, "TCGA-B6-A0IN": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "16a8d916-ad46-4690-b1a5-3b2b323f4336", "AGE": 45, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE X", "AJCC_STAGING_EDITION": "4TH", "DAYS_LAST_FOLLOWUP": NaN, "DAYS_TO_BIRTH": -16705.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "11/2/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8523/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "NX", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 84.5908538, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 84.5908538, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 46.42140908, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 46.42140908, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-B6-A0IN-01", "ONCOTREE_CODE": "BRCNOS", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Carcinoma (NOS)", "TUMOR_TYPE": "Other", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "B6", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 7.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2872, "MSI_SENSOR_SCORE": 0.12, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.966666667, "TISSUE_SOURCE_SITE": "Duke", "TBL_SCORE": 257.0 }, "treatments": [] }, "TCGA-AR-A1AQ": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "98e0b4de-52fc-4945-9bf5-11e29368f939", "AGE": 49, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 3021.0, "DAYS_TO_BIRTH": -18109.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "6/14/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 99.31945951, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 99.31945951, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 99.31945951, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 99.31945951, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AR-A1AQ-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AR", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 18.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.283, "MSI_SENSOR_SCORE": 0.39, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.266666667, "TISSUE_SOURCE_SITE": "Mayo", "TBL_SCORE": 90.0 }, "treatments": [ { "START_DATE": 32, "STOP_DATE": 74.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "60", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "480", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 32, "STOP_DATE": 74.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "600", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "4780", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 88, "STOP_DATE": 88.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": "1", "PRESCRIBED_DOSE": "175", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "340", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 121, "STOP_DATE": 163.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "30", "RADIATION_DOSAGE": "6000", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-XX-A89A": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "CA20249F-B7EA-4FD9-9ECB-34F74755AE35", "AGE": 68, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 488.0, "DAYS_TO_BIRTH": -25000.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "2/21/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 16.0436598, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 16.0436598, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 16.0436598, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 16.0436598, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-XX-A89A-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "XX", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 32.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3036, "MSI_SENSOR_SCORE": 0.01, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 5.033333333, "TISSUE_SOURCE_SITE": "Spectrum Health", "TBL_SCORE": 51.0 }, "treatments": [ { "START_DATE": 59, "STOP_DATE": 112.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "10", "RADIATION_DOSAGE": "1800", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" }, { "START_DATE": 59, "STOP_DATE": 112.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 2", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "18", "RADIATION_DOSAGE": "3240", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-E9-A1NA": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "af577366-0258-49e7-b6af-e70056c081a4", "AGE": 58, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 1112.0, "DAYS_TO_BIRTH": -21397.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "6/23/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8522/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 36.55850347, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 36.55850347, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 36.55850347, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 36.55850347, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E9-A1NA-01", "ONCOTREE_CODE": "BRCNOS", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Carcinoma (NOS)", "TUMOR_TYPE": "Mixed Histology (NOS)", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "E9", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 11.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3642, "MSI_SENSOR_SCORE": 2.28, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 3.0, "TISSUE_SOURCE_SITE": "Asterand", "TBL_SCORE": 1215.0 }, "treatments": [ { "START_DATE": 12, "STOP_DATE": 148.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 12, "STOP_DATE": 148.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 206, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Letrozole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 58, "STOP_DATE": 95.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "23", "RADIATION_DOSAGE": "4600", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-GM-A2DM": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "753D5D49-3B40-4737-9D4C-B1EC29CC2692", "AGE": 57, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 3226.0, "DAYS_TO_BIRTH": -21160.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/30/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 106.0591117, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 106.0591117, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 106.0591117, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 106.0591117, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-GM-A2DM-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "GM", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2914, "MSI_SENSOR_SCORE": 0.05, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.8, "TISSUE_SOURCE_SITE": "MD Anderson", "TBL_SCORE": 2.0 }, "treatments": [ { "START_DATE": 81, "STOP_DATE": 169.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 176, "STOP_DATE": 218.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Fluorouracil", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 176, "STOP_DATE": 218.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Epirubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 176, "STOP_DATE": 218.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 279, "STOP_DATE": 772.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 237, "STOP_DATE": 273.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "26", "RADIATION_DOSAGE": "52", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "gy" } ] }, "TCGA-B6-A0RO": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "0b172e29-6166-4863-803d-a0a010887c11", "AGE": 71, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIB", "AJCC_STAGING_EDITION": "4TH", "DAYS_LAST_FOLLOWUP": 4929.0, "DAYS_TO_BIRTH": -26269.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "11/2/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T4", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 162.0475392, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 162.0475392, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 162.0475392, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 162.0475392, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-B6-A0RO-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "B6", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 19.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2783, "MSI_SENSOR_SCORE": 0.13, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.166666667, "TISSUE_SOURCE_SITE": "Duke", "TBL_SCORE": 52.0 }, "treatments": [] }, "TCGA-AO-A1KP": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "3aaabc62-f5a4-4025-9b29-5adf82c86c84", "AGE": 77, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 2513.0, "DAYS_TO_BIRTH": -28247.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/1/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T1", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 97.08386757, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 97.08386757, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 97.08386757, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 97.08386757, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AO-A1KP-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AO", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 7.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2922, "MSI_SENSOR_SCORE": 0.23, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.533333333, "TISSUE_SOURCE_SITE": "MSKCC", "TBL_SCORE": 29.0 }, "treatments": [ { "START_DATE": 86, "STOP_DATE": 237.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Methotrexate", "NUMBER_OF_CYCLES": "8", "PRESCRIBED_DOSE": "40", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "320", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 86, "STOP_DATE": 237.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Fluorouracil", "NUMBER_OF_CYCLES": "8", "PRESCRIBED_DOSE": "600", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "8064", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 86, "STOP_DATE": 237.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "8", "PRESCRIBED_DOSE": "600", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "8064", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 335, "STOP_DATE": 2161.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-BH-A0BW": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "5d1d00c6-fcae-479e-ae1e-de76efd41d98", "AGE": 71, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE I", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 2371.0, "DAYS_TO_BIRTH": -25974.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "8/10/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 77.94983069, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 77.94983069, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 77.94983069, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 77.94983069, "GENETIC_ANCESTRY_LABEL": "AFR_ADMIX" }, "sample": { "SAMPLE_ID": "TCGA-BH-A0BW-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 10.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2932, "MSI_SENSOR_SCORE": 0.68, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 4.7, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 72.0 }, "treatments": [ { "START_DATE": 51, "STOP_DATE": 114.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 51, "STOP_DATE": 114.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 146, "STOP_DATE": 184.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "28", "RADIATION_DOSAGE": "50.4", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "gy" }, { "START_DATE": 187, "STOP_DATE": 196.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 2", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": "16", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "gy" } ] }, "TCGA-GM-A2DB": { "demographics": { "SUBTYPE": "BRCA_Her2", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "6E6B7742-A562-490B-BB72-04A5653852E4", "AGE": 62, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 2406.0, "DAYS_TO_BIRTH": -22883.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/28/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 79.10050301, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 79.10050301, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 79.10050301, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 79.10050301, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-GM-A2DB-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "GM", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 20.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3153, "MSI_SENSOR_SCORE": 0.08, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 4.166666667, "TISSUE_SOURCE_SITE": "MD Anderson", "TBL_SCORE": 261.0 }, "treatments": [ { "START_DATE": 91, "STOP_DATE": 167.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 181, "STOP_DATE": 248.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Fluorouracil", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 181, "STOP_DATE": 248.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Epirubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 181, "STOP_DATE": 248.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 271, "STOP_DATE": 317.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-AO-A12H": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "b5b99291-507e-4b68-a039-9a0f571f55df", "AGE": 69, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 1234.0, "DAYS_TO_BIRTH": -25515.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/8/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8523/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 40.56941842, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 40.56941842, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 40.56941842, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 40.56941842, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-AO-A12H-01", "ONCOTREE_CODE": "BRCNOS", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Carcinoma (NOS)", "TUMOR_TYPE": "Other", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AO", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2725, "MSI_SENSOR_SCORE": 0.02, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.7, "TISSUE_SOURCE_SITE": "MSKCC", "TBL_SCORE": 4.0 }, "treatments": [ { "START_DATE": 73, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-S3-AA12": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "2BCACFD1-6A45-4B96-9B80-2AD569B1AB45", "AGE": 82, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 574.0, "DAYS_TO_BIRTH": -30101.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/18/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "Yes", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 18.87102607, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 18.87102607, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 18.87102607, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 18.87102607, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-S3-AA12-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "S3", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 4.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.341, "MSI_SENSOR_SCORE": 0.34, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.2, "TISSUE_SOURCE_SITE": "Albert Einstein Medical Center", "TBL_SCORE": 71.0 }, "treatments": [ { "START_DATE": 58, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-A8-A08A": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "7fe4670d-4626-459d-869b-ab15f478c6a7", "AGE": 89, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE I", "AJCC_STAGING_EDITION": "5TH", "DAYS_LAST_FOLLOWUP": 30.0, "DAYS_TO_BIRTH": -32750.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "5/27/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": null, "RADIATION_THERAPY": null, "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 0.986290561, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 0.986290561, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 0.986290561, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 0.986290561, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A8-A08A-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 3.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": NaN, "MSI_SENSOR_SCORE": 0.06, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.8, "TISSUE_SOURCE_SITE": "Indivumed", "TBL_SCORE": 12.0 }, "treatments": [] }, "TCGA-B6-A0RV": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "cd3faa15-743c-476f-ab0d-f205b14126b6", "AGE": 42, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": "4TH", "DAYS_LAST_FOLLOWUP": 5156.0, "DAYS_TO_BIRTH": -15507.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "11/2/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8522/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N2", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 169.5104711, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 169.5104711, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 169.5104711, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 169.5104711, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-B6-A0RV-01", "ONCOTREE_CODE": "BRCNOS", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Carcinoma (NOS)", "TUMOR_TYPE": "Mixed Histology (NOS)", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "B6", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 7.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2622, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.266666667, "TISSUE_SOURCE_SITE": "Duke", "TBL_SCORE": 110.0 }, "treatments": [] }, "TCGA-GM-A3XL": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "65CAC997-4D39-4501-85EC-4FCB328A8EB5", "AGE": 49, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 2108.0, "DAYS_TO_BIRTH": -18171.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "10/1/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 69.3033501, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 69.3033501, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 69.3033501, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 69.3033501, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-GM-A3XL-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "GM", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 4.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.296, "MSI_SENSOR_SCORE": 0.06, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.933333333, "TISSUE_SOURCE_SITE": "MD Anderson", "TBL_SCORE": 172.0 }, "treatments": [ { "START_DATE": 100, "STOP_DATE": 163.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Fluorouracil", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 100, "STOP_DATE": 163.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 100, "STOP_DATE": 163.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 191, "STOP_DATE": 248.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 274, "STOP_DATE": 315.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "30", "RADIATION_DOSAGE": "60", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "gy" } ] }, "TCGA-A2-A0EY": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "d67cd793-2931-429a-9084-2f3c4c8be7ad", "AGE": 62, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 1925.0, "DAYS_TO_BIRTH": -22872.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/21/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 63.28697768, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 63.28697768, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 63.28697768, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 63.28697768, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A2-A0EY-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 23.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3273, "MSI_SENSOR_SCORE": 0.24, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 6.133333333, "TISSUE_SOURCE_SITE": "Walter Reed", "TBL_SCORE": 256.0 }, "treatments": [ { "START_DATE": 105, "STOP_DATE": 154.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "104-105", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "418", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 105, "STOP_DATE": 154.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "1038-1050", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "4176", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 329, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1 mg daily", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "6", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 183, "STOP_DATE": 245.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "129", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "3", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "516", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 183, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Targeted Molecular Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Lapatinib", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1000 mg daily", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "4", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 183, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Targeted Molecular Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Trastuzumab", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "134.4-406", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "5", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 279, "STOP_DATE": 316.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "28", "RADIATION_DOSAGE": "5040", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" }, { "START_DATE": 317, "STOP_DATE": 328.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 2", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "5", "RADIATION_DOSAGE": "1000", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" }, { "START_DATE": 279, "STOP_DATE": 316.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 3", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "28", "RADIATION_DOSAGE": "5040", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-BH-A1F6": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "ad18820b-a804-49c0-ba8a-86c09fa6bce2", "AGE": 51, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": NaN, "DAYS_TO_BIRTH": -18691.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/7/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N2A", "PATH_T_STAGE": "T4D", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": null, "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 97.4783838, "DSS_STATUS": null, "DSS_MONTHS": 97.4783838, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 97.4783838, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A1F6-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 21.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3071, "MSI_SENSOR_SCORE": 0.46, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.1, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 326.0 }, "treatments": [] }, "TCGA-E2-A15H": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "5580b21a-2cdb-4777-ad79-6e06654144f5", "AGE": 38, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 393.0, "DAYS_TO_BIRTH": -13985.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/13/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1MI", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 12.92040635, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 12.92040635, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 12.92040635, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 12.92040635, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E2-A15H-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "E2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 17.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2652, "MSI_SENSOR_SCORE": 0.14, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.933333333, "TISSUE_SOURCE_SITE": "Roswell Park", "TBL_SCORE": 231.0 }, "treatments": [ { "START_DATE": 83, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Trastuzumab", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-AC-A62Y": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "05AF737D-89AA-49B6-97B2-28B8AC8BD2CF", "AGE": 79, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 530.0, "DAYS_TO_BIRTH": -28876.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/19/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 17.42446658, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 17.42446658, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 17.42446658, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AC-A62Y-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "AC", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 22.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2991, "MSI_SENSOR_SCORE": 0.02, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.9, "TISSUE_SOURCE_SITE": "International Genomics Consortium", "TBL_SCORE": 51.0 }, "treatments": [] }, "TCGA-EW-A1J3": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "bb1de798-0c02-437e-b539-33cb556d3993", "AGE": 61, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 504.0, "DAYS_TO_BIRTH": -22332.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/18/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 16.56968143, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 16.56968143, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 16.56968143, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 16.56968143, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-EW-A1J3-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "EW", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 9.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.294, "MSI_SENSOR_SCORE": 0.18, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.733333333, "TISSUE_SOURCE_SITE": "University of Miami", "TBL_SCORE": 54.0 }, "treatments": [ { "START_DATE": 189, "STOP_DATE": 294.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": "6", "PRESCRIBED_DOSE": "6", "PRESCRIBED_DOSE_UNITS": "auc", "REGIMEN_NUMBER": "tch", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 336, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 189, "STOP_DATE": 294.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": "6", "PRESCRIBED_DOSE": "100", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "tch", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 189, "STOP_DATE": 294.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Trastuzumab", "NUMBER_OF_CYCLES": "6", "PRESCRIBED_DOSE": "6", "PRESCRIBED_DOSE_UNITS": "mg/kg", "REGIMEN_NUMBER": "tch", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-B6-A0X7": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "5b9a5cd2-5ec8-48a0-b9f2-da9bede0b089", "AGE": 62, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE X", "AJCC_STAGING_EDITION": "4TH", "DAYS_LAST_FOLLOWUP": NaN, "DAYS_TO_BIRTH": -22723.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/14/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "NX", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 58.55278298, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 58.55278298, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 36.29549265, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-B6-A0X7-01", "ONCOTREE_CODE": "BRCNOS", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Carcinoma (NOS)", "TUMOR_TYPE": "Mixed Histology (NOS)", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "B6", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 5.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": NaN, "MSI_SENSOR_SCORE": 0.16, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.533333333, "TISSUE_SOURCE_SITE": "Duke", "TBL_SCORE": 51.0 }, "treatments": [] }, "TCGA-GI-A2C9": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "9F6BE944-83DE-42AB-8738-F0022F475E61", "AGE": 58, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 3342.0, "DAYS_TO_BIRTH": -21534.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "10/21/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "0:LIVING", "OS_MONTHS": 109.8727685, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 109.8727685, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 109.8727685, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 109.8727685, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-GI-A2C9-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "GI", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 8.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3253, "MSI_SENSOR_SCORE": 0.13, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.0, "TISSUE_SOURCE_SITE": "ABS - IUPUI", "TBL_SCORE": 228.0 }, "treatments": [ { "START_DATE": 3349, "STOP_DATE": 3349.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": null, "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 3349, "STOP_DATE": 3342.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-E9-A22D": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "cf0a3f38-5850-44e1-8574-808bd37d84a3", "AGE": 38, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 1248.0, "DAYS_TO_BIRTH": -14115.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "8/2/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 41.02968735, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 41.02968735, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 41.02968735, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 41.02968735, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E9-A22D-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "E9", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 16.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3096, "MSI_SENSOR_SCORE": 0.18, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.966666667, "TISSUE_SOURCE_SITE": "Asterand", "TBL_SCORE": 402.0 }, "treatments": [ { "START_DATE": 16, "STOP_DATE": 189.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "6", "PRESCRIBED_DOSE": "90", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "360", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 193, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "20", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": "3160", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 16, "STOP_DATE": 189.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Fluorouracil", "NUMBER_OF_CYCLES": "6", "PRESCRIBED_DOSE": "900", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "3600", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 16, "STOP_DATE": 189.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "6", "PRESCRIBED_DOSE": "900", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "3600", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-AN-A049": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "2e1e3bf0-1708-4b65-936c-48b89eb8966a", "AGE": 62, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": 19.0, "DAYS_TO_BIRTH": -22710.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/29/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": null, "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 0.624650689, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 0.624650689, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 0.624650689, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AN-A049-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AN", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 10.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2375, "MSI_SENSOR_SCORE": 0.37, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.966666667, "TISSUE_SOURCE_SITE": "Cureline", "TBL_SCORE": 127.0 }, "treatments": [] }, "TCGA-AR-A24R": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "db62d9c7-8343-4771-84fc-146d2e307bb8", "AGE": 45, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 3430.0, "DAYS_TO_BIRTH": -16642.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "8/26/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N2", "PATH_T_STAGE": "T1", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 112.7658875, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 112.7658875, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 112.7658875, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 112.7658875, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AR-A24R-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AR", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 17.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3522, "MSI_SENSOR_SCORE": 0.72, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.733333333, "TISSUE_SOURCE_SITE": "Mayo", "TBL_SCORE": 145.0 }, "treatments": [ { "START_DATE": 1969, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Letrozole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 53, "STOP_DATE": 157.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "5", "PRESCRIBED_DOSE": "60", "PRESCRIBED_DOSE_UNITS": "mg/m2/day", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "10500", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 53, "STOP_DATE": 151.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "5", "PRESCRIBED_DOSE": "24", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "600", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 172, "STOP_DATE": 214.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "175", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "1200", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 228, "STOP_DATE": 1904.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "20", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 249, "STOP_DATE": 295.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "34", "RADIATION_DOSAGE": "6240", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-LL-A7T0": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "D8F8064F-02EF-4FED-942B-714CBE5E8455", "AGE": 70, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 376.0, "DAYS_TO_BIRTH": -25867.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "1/3/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 12.36150837, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 12.36150837, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 12.36150837, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 12.36150837, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-LL-A7T0-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "LL", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 24.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3499, "MSI_SENSOR_SCORE": 0.23, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.333333333, "TISSUE_SOURCE_SITE": "Candler", "TBL_SCORE": 163.0 }, "treatments": [] }, "TCGA-E2-A576": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "F04DCA9E-409B-4300-B11D-12243E5D361D", "AGE": 69, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 1043.0, "DAYS_TO_BIRTH": -25350.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/10/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 34.29003518, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 34.29003518, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 34.29003518, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 34.29003518, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-E2-A576-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "E2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 10.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3386, "MSI_SENSOR_SCORE": 0.16, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.466666667, "TISSUE_SOURCE_SITE": "Roswell Park", "TBL_SCORE": 72.0 }, "treatments": [ { "START_DATE": 252, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 88, "STOP_DATE": 151.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 88, "STOP_DATE": 151.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 236, "STOP_DATE": 239.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "5", "RADIATION_DOSAGE": "1000", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" }, { "START_DATE": 196, "STOP_DATE": 235.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 2", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "28", "RADIATION_DOSAGE": "5040", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-E9-A295": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "fec0da58-1047-44d2-b6d1-c18cceed43dc", "AGE": 71, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 375.0, "DAYS_TO_BIRTH": -25957.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/12/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 12.32863202, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 12.32863202, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 12.32863202, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 12.32863202, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E9-A295-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "E9", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 23.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3216, "MSI_SENSOR_SCORE": 0.32, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.933333333, "TISSUE_SOURCE_SITE": "Asterand", "TBL_SCORE": 69.0 }, "treatments": [ { "START_DATE": 152, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 46, "STOP_DATE": 74.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "65", "RADIATION_DOSAGE": "130", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "gy" } ] }, "TCGA-B6-A0WX": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "a482fc4c-ff1d-46a0-a968-7df06422cc4b", "AGE": 40, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": "5TH", "DAYS_LAST_FOLLOWUP": NaN, "DAYS_TO_BIRTH": -14784.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/14/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1B", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 21.00798895, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 21.00798895, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 18.5093862, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 18.5093862, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-B6-A0WX-01", "ONCOTREE_CODE": "BRCNOS", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Carcinoma (NOS)", "TUMOR_TYPE": "Other", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "B6", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 16.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3032, "MSI_SENSOR_SCORE": 0.18, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.9, "TISSUE_SOURCE_SITE": "Duke", "TBL_SCORE": 110.0 }, "treatments": [] }, "TCGA-GM-A3XN": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "0930E97A-72EA-4BD5-B2F0-50C76AF695F3", "AGE": 44, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 2019.0, "DAYS_TO_BIRTH": -16109.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "10/1/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N2A", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "0:LIVING", "OS_MONTHS": 66.37735477, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 66.37735477, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 66.37735477, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 66.37735477, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-GM-A3XN-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "GM", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 9.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3013, "MSI_SENSOR_SCORE": 0.01, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": NaN, "TISSUE_SOURCE_SITE": "MD Anderson", "TBL_SCORE": 15.0 }, "treatments": [ { "START_DATE": 134, "STOP_DATE": 211.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 218, "STOP_DATE": 282.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Fluorouracil", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 218, "STOP_DATE": 282.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 218, "STOP_DATE": 282.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 416, "STOP_DATE": 1591.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 1592, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 359, "STOP_DATE": 394.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "30", "RADIATION_DOSAGE": "60", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "gy" } ] }, "TCGA-A2-A0YT": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "14b95463-2108-4921-afc2-e29eef52b18f", "AGE": 56, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIB", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": NaN, "DAYS_TO_BIRTH": -20482.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/10/2010", "HISTORY_NEOADJUVANT_TRTYN": "Yes", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N2A", "PATH_T_STAGE": "T4B", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 23.76960253, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 23.76960253, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 23.76960253, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 23.76960253, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A2-A0YT-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 25.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3009, "MSI_SENSOR_SCORE": 0.84, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.933333333, "TISSUE_SOURCE_SITE": "Walter Reed", "TBL_SCORE": 232.0 }, "treatments": [ { "START_DATE": 286, "STOP_DATE": 723.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "4", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 231, "STOP_DATE": 280.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "61", "RADIATION_DOSAGE": "11080", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-E9-A1RE": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "24046547-d038-4616-b190-52ac93f4965f", "AGE": 74, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 1419.0, "DAYS_TO_BIRTH": -27392.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/28/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N2", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 46.65154355, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 46.65154355, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 46.65154355, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 46.65154355, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E9-A1RE-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "E9", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 18.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3168, "MSI_SENSOR_SCORE": 1.16, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.633333333, "TISSUE_SOURCE_SITE": "Asterand", "TBL_SCORE": 205.0 }, "treatments": [ { "START_DATE": 50, "STOP_DATE": 145.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "2", "PRESCRIBED_DOSE": "60", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "120", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 50, "STOP_DATE": 145.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "1", "PRESCRIBED_DOSE": "100", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "100", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 50, "STOP_DATE": 145.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Fluorouracil", "NUMBER_OF_CYCLES": "3", "PRESCRIBED_DOSE": "2000", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "6000", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 50, "STOP_DATE": 145.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Fluorouracil", "NUMBER_OF_CYCLES": "1", "PRESCRIBED_DOSE": "1500", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "1500", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 50, "STOP_DATE": 145.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "1", "PRESCRIBED_DOSE": "80", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "80", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 39, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "20", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 50, "STOP_DATE": 145.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "1600", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "6400", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 183, "STOP_DATE": 209.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "20", "RADIATION_DOSAGE": "4000", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-BH-A0B4": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "c710f4ab-fbd9-42ed-95d4-4e6d51207f38", "AGE": 65, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": 1191.0, "DAYS_TO_BIRTH": -23980.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "11/4/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N2", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "0:LIVING", "OS_MONTHS": 39.15573528, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 39.15573528, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 39.15573528, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 39.15573528, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A0B4-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 4.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2519, "MSI_SENSOR_SCORE": 0.08, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.166666667, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 123.0 }, "treatments": [ { "START_DATE": 692, "STOP_DATE": 797.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": "6", "PRESCRIBED_DOSE": "130", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "785", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 211, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "20", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-BH-A0HP": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "fcef8cb5-fb2c-4bfb-82cd-6b9f3145182c", "AGE": 65, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": 414.0, "DAYS_TO_BIRTH": -23883.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "11/11/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N2A", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 13.61080975, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 13.61080975, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 13.61080975, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 13.61080975, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A0HP-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 6.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2572, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 7.933333333, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 34.0 }, "treatments": [ { "START_DATE": 63, "STOP_DATE": 126.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "130", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "533", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 63, "STOP_DATE": 126.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "1308", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "5347", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 147, "STOP_DATE": 238.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": "12", "PRESCRIBED_DOSE": "180", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "2141", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 347, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 275, "STOP_DATE": 330.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "33", "RADIATION_DOSAGE": "6040", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-D8-A27V": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "AD6D26AB-6568-40DB-BFB0-394D40E801CF", "AGE": 62, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 381.0, "DAYS_TO_BIRTH": -22958.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/21/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 12.52589013, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 12.52589013, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 12.52589013, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 12.52589013, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D8-A27V-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "D8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 13.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3265, "MSI_SENSOR_SCORE": 0.97, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 103.0666667, "TISSUE_SOURCE_SITE": "Greater Poland Cancer Center", "TBL_SCORE": 106.0 }, "treatments": [ { "START_DATE": 48, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "20", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-A8-A07W": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "01263518-5f7c-49dc-8d7e-84b0c03a6a63", "AGE": 76, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 304.0, "DAYS_TO_BIRTH": -27942.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "5/25/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M1", "PATH_N_STAGE": "NX", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": null, "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 9.99441102, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 9.99441102, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 9.99441102, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A8-A07W-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 26.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2628, "MSI_SENSOR_SCORE": 0.97, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 4.3, "TISSUE_SOURCE_SITE": "Indivumed", "TBL_SCORE": 227.0 }, "treatments": [ { "START_DATE": 212, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Exemestane", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-E9-A1RG": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "8744733a-7b46-43aa-bdef-64876816adbb", "AGE": 62, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 647.0, "DAYS_TO_BIRTH": -22788.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "8/2/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N2", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 21.27099977, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 21.27099977, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 21.27099977, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 21.27099977, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E9-A1RG-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "E9", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 20.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3466, "MSI_SENSOR_SCORE": 2.11, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.1, "TISSUE_SOURCE_SITE": "Asterand", "TBL_SCORE": 252.0 }, "treatments": [ { "START_DATE": 32, "STOP_DATE": 200.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "1", "PRESCRIBED_DOSE": "2000", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "2000", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 31, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "20", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 32, "STOP_DATE": 200.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "1000", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "4000", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 32, "STOP_DATE": 200.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Fluorouracil", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "1000", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "4000", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 32, "STOP_DATE": 200.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Fluorouracil", "NUMBER_OF_CYCLES": "2", "PRESCRIBED_DOSE": "2000", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "4000", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 32, "STOP_DATE": 200.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Methotrexate", "NUMBER_OF_CYCLES": "2", "PRESCRIBED_DOSE": "100", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "200", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 32, "STOP_DATE": 200.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "1", "PRESCRIBED_DOSE": "1600", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "1600", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 32, "STOP_DATE": 200.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Methotrexate", "NUMBER_OF_CYCLES": "2", "PRESCRIBED_DOSE": "50", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "100", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 32, "STOP_DATE": 200.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Methotrexate", "NUMBER_OF_CYCLES": "2", "PRESCRIBED_DOSE": "70", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "140", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 149, "STOP_DATE": 177.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "45", "RADIATION_DOSAGE": "9000", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-D8-A3Z5": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "77E25AE8-82EC-4DEA-8E62-1176F27E47BA", "AGE": 54, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIC", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 1015.0, "DAYS_TO_BIRTH": -19846.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/3/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N3A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "0:LIVING", "OS_MONTHS": 33.36949732, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 33.36949732, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 33.36949732, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 33.36949732, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D8-A3Z5-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "D8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 6.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3186, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.0, "TISSUE_SOURCE_SITE": "Greater Poland Cancer Center", "TBL_SCORE": 3.0 }, "treatments": [] }, "TCGA-D8-A1XW": { "demographics": { "SUBTYPE": "BRCA_Normal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "887b9e5b-99db-44ac-9c30-c0dc6877b41c", "AGE": 53, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 1309.0, "DAYS_TO_BIRTH": -19478.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/16/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 43.03514482, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 43.03514482, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 43.03514482, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 43.03514482, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D8-A1XW-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "D8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 18.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3111, "MSI_SENSOR_SCORE": 0.62, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.866666667, "TISSUE_SOURCE_SITE": "Greater Poland Cancer Center", "TBL_SCORE": 63.0 }, "treatments": [ { "START_DATE": 76, "STOP_DATE": 181.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin + Cyclophosphamide", "NUMBER_OF_CYCLES": "6", "PRESCRIBED_DOSE": "60+600", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "360+3600", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-E2-A14O": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "fb356957-f620-4d99-b675-1355a1d9f932", "AGE": 76, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 1359.0, "DAYS_TO_BIRTH": -27837.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/31/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 44.67896242, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 44.67896242, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 44.67896242, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 44.67896242, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E2-A14O-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "E2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 32.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2735, "MSI_SENSOR_SCORE": 0.97, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.066666667, "TISSUE_SOURCE_SITE": "Roswell Park", "TBL_SCORE": 28.0 }, "treatments": [ { "START_DATE": 53, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": "1", "TOTAL_DOSE_UNITS": "Mg/Day", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 68, "STOP_DATE": 105.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": "5000", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-E9-A3HO": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "807B62ED-D3F7-4211-83BE-754386FF2C96", "AGE": 49, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 1158.0, "DAYS_TO_BIRTH": -18046.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "2/20/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 38.07081566, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 38.07081566, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 38.07081566, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 38.07081566, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E9-A3HO-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "E9", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 11.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2903, "MSI_SENSOR_SCORE": 0.04, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.833333333, "TISSUE_SOURCE_SITE": "Asterand", "TBL_SCORE": 105.0 }, "treatments": [ { "START_DATE": 26, "STOP_DATE": 26.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 26, "STOP_DATE": 26.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Fluorouracil", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 26, "STOP_DATE": 26.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Methotrexate", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 28, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 313, "STOP_DATE": 337.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Leuprolide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 61, "STOP_DATE": 64.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Goserelin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-A2-A3XV": { "demographics": { "SUBTYPE": "BRCA_Her2", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "189E1F27-7738-413A-A4D4-97D41D592A13", "AGE": 46, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 996.0, "DAYS_TO_BIRTH": -16971.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "8/24/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 32.74484663, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 32.74484663, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 32.74484663, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 32.74484663, "GENETIC_ANCESTRY_LABEL": "AFR_ADMIX" }, "sample": { "SAMPLE_ID": "TCGA-A2-A3XV-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "A2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 6.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2941, "MSI_SENSOR_SCORE": 0.01, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.3, "TISSUE_SOURCE_SITE": "Walter Reed", "TBL_SCORE": 16.0 }, "treatments": [ { "START_DATE": 62, "STOP_DATE": 175.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 62, "STOP_DATE": 175.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 62, "STOP_DATE": 428.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Targeted Molecular Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Trastuzumab", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 429, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 211, "STOP_DATE": 246.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "25", "RADIATION_DOSAGE": "50", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "gy" }, { "START_DATE": 247, "STOP_DATE": 258.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 2", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "5", "RADIATION_DOSAGE": "10", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "gy" } ] }, "TCGA-AR-A24O": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "125b0a9a-6cbe-4207-9178-e7ff03487e87", "AGE": 43, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 3607.0, "DAYS_TO_BIRTH": -15977.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "8/16/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8522/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N2", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 118.5850018, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 118.5850018, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 84.19633757, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 84.19633757, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AR-A24O-01", "ONCOTREE_CODE": "BRCNOS", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Carcinoma (NOS)", "TUMOR_TYPE": "Mixed Histology (NOS)", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AR", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 5.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3187, "MSI_SENSOR_SCORE": 0.08, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.666666667, "TISSUE_SOURCE_SITE": "Mayo", "TBL_SCORE": 21.0 }, "treatments": [ { "START_DATE": 44, "STOP_DATE": 93.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "60", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "390", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 1998, "STOP_DATE": 2283.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Letrozole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "2.5", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "3", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 153, "STOP_DATE": 1994.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "20", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 107, "STOP_DATE": 149.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "175", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "1200", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 44, "STOP_DATE": 93.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "600", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "3820", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 174, "STOP_DATE": 218.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "33", "RADIATION_DOSAGE": "6040", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-BH-A0HU": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "dc657ca8-98e8-4ec4-a513-1b848be0e85d", "AGE": 52, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IA", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": 392.0, "DAYS_TO_BIRTH": -19216.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "11/11/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 12.88753, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 12.88753, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 12.88753, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 12.88753, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A0HU-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 9.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2787, "MSI_SENSOR_SCORE": 0.47, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.066666667, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 77.0 }, "treatments": [ { "START_DATE": 110, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "20", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 47, "STOP_DATE": 110.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "1362", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "5472", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 47, "STOP_DATE": 110.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "170", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "684", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 155, "STOP_DATE": 196.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "30", "RADIATION_DOSAGE": "5750", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-A8-A09W": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "452672e8-b6d9-45b5-bb02-e88e03e2dd66", "AGE": 70, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIB", "AJCC_STAGING_EDITION": "5TH", "DAYS_LAST_FOLLOWUP": 30.0, "DAYS_TO_BIRTH": -25659.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "5/27/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N3", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": null, "RADIATION_THERAPY": null, "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 0.986290561, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 0.986290561, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 0.986290561, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A8-A09W-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 7.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2509, "MSI_SENSOR_SCORE": 0.52, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.7, "TISSUE_SOURCE_SITE": "Indivumed", "TBL_SCORE": 111.0 }, "treatments": [] }, "TCGA-BH-A1EY": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "0741b5db-4405-42ba-b63a-c6ee4f341480", "AGE": 79, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "5TH", "DAYS_LAST_FOLLOWUP": NaN, "DAYS_TO_BIRTH": -28940.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/7/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 17.6874774, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 17.6874774, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 13.01903541, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A1EY-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 11.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3148, "MSI_SENSOR_SCORE": 0.05, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.233333333, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 229.0 }, "treatments": [] }, "TCGA-AO-A03O": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "1111fb30-46ce-4722-98da-ec9ba2323d90", "AGE": 69, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": NaN, "DAYS_TO_BIRTH": -25362.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/19/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 81.63198212, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 81.63198212, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 81.63198212, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 81.63198212, "GENETIC_ANCESTRY_LABEL": "AFR_ADMIX" }, "sample": { "SAMPLE_ID": "TCGA-AO-A03O-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AO", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 24.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2729, "MSI_SENSOR_SCORE": 0.88, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.466666667, "TISSUE_SOURCE_SITE": "MSKCC", "TBL_SCORE": 499.0 }, "treatments": [ { "START_DATE": 112, "STOP_DATE": 158.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "300", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "1276", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 54, "STOP_DATE": 98.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "300", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "4380", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 54, "STOP_DATE": 98.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "300", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "436", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 182, "STOP_DATE": 993.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-C8-A1HK": { "demographics": { "SUBTYPE": "BRCA_Her2", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "52c35691-efca-42f5-a03e-02c9f872275c", "AGE": 53, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 366.0, "DAYS_TO_BIRTH": NaN, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "6/1/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Asian", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 12.03274485, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 12.03274485, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 12.03274485, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 12.03274485, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-C8-A1HK-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "C8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 25.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3767, "MSI_SENSOR_SCORE": 0.75, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.733333333, "TISSUE_SOURCE_SITE": "ILSBio", "TBL_SCORE": 236.0 }, "treatments": [] }, "TCGA-BH-A18Q": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "db4bc6aa-2e7d-4bcb-8519-a455f624d33b", "AGE": 56, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": NaN, "DAYS_TO_BIRTH": -20675.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "6/24/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.8", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.8", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1B", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": null, "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 55.62678765, "DSS_STATUS": null, "DSS_MONTHS": 55.62678765, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 55.62678765, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 55.62678765, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A18Q-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 18.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2711, "MSI_SENSOR_SCORE": 1.55, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.5, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 89.0 }, "treatments": [] }, "TCGA-E2-A1LK": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "1d27253f-b036-44e7-a04d-8da5bbf57419", "AGE": 84, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIC", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": NaN, "DAYS_TO_BIRTH": -30757.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "6/3/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N3A", "PATH_T_STAGE": "T4B", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 8.745109643, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 8.745109643, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 5.095834566, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 5.095834566, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-E2-A1LK-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "E2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 16.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3073, "MSI_SENSOR_SCORE": 2.89, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.2, "TISSUE_SOURCE_SITE": "Roswell Park", "TBL_SCORE": 168.0 }, "treatments": [] }, "TCGA-A7-A3J0": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "DA70CF7E-0E61-4C72-B4C5-C408569D11B8", "AGE": 62, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 313.0, "DAYS_TO_BIRTH": -22672.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/13/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8480/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "0:LIVING", "OS_MONTHS": 10.29029819, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 10.29029819, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 10.29029819, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 10.29029819, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A7-A3J0-01", "ONCOTREE_CODE": "IMMC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Mixed Mucinous Carcinoma", "TUMOR_TYPE": "Mucinous Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "A7", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 11.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2958, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.0, "TISSUE_SOURCE_SITE": "Christiana Healthcare", "TBL_SCORE": 4.0 }, "treatments": [ { "START_DATE": 72, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 57, "STOP_DATE": 63.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "10", "RADIATION_DOSAGE": "3400", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Other", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-E9-A1N6": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "955d4263-61f7-42e8-8a6e-772a0d6c209d", "AGE": 52, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 410.0, "DAYS_TO_BIRTH": -19327.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "6/23/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 22.29016668, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 22.29016668, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 14.56422395, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 14.56422395, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E9-A1N6-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "E9", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 15.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": NaN, "MSI_SENSOR_SCORE": NaN, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.0, "TISSUE_SOURCE_SITE": "Asterand", "TBL_SCORE": 241.0 }, "treatments": [ { "START_DATE": 128, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 447, "STOP_DATE": 574.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Stable Disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 447, "STOP_DATE": 574.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Stable Disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 575, "STOP_DATE": 678.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Letrozole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Clinical Progressive Disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 82, "STOP_DATE": 117.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "19", "RADIATION_DOSAGE": "3800", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-A2-A0EU": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "c0427237-b476-4af4-b664-7bd479922ea5", "AGE": 79, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 1043.0, "DAYS_TO_BIRTH": -29144.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "8/11/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 34.29003518, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 34.29003518, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 34.29003518, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 34.29003518, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A2-A0EU-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 26.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2729, "MSI_SENSOR_SCORE": 0.1, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.466666667, "TISSUE_SOURCE_SITE": "Walter Reed", "TBL_SCORE": 11.0 }, "treatments": [ { "START_DATE": 116, "STOP_DATE": 193.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "33", "RADIATION_DOSAGE": "6040", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-A2-A0CU": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "332423a7-8866-4ee3-b08f-3c8d7c16af80", "AGE": 73, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": NaN, "DAYS_TO_BIRTH": -26823.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/9/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I+)", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 5.194463622, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 5.194463622, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 5.194463622, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A2-A0CU-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 20.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2981, "MSI_SENSOR_SCORE": 0.06, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.433333333, "TISSUE_SOURCE_SITE": "Walter Reed", "TBL_SCORE": 99.0 }, "treatments": [ { "START_DATE": 98, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "10", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-AN-A0AR": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "ebc460c2-df88-4dc0-a2c0-aca8072b75ad", "AGE": 55, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": 10.0, "DAYS_TO_BIRTH": -20152.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/28/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 0.32876352, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 0.32876352, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 0.32876352, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 0.32876352, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AN-A0AR-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AN", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 10.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2932, "MSI_SENSOR_SCORE": 2.5, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 3.666666667, "TISSUE_SOURCE_SITE": "Cureline", "TBL_SCORE": 394.0 }, "treatments": [] }, "TCGA-C8-A278": { "demographics": { "SUBTYPE": "BRCA_Her2", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "65077db7-dd59-4362-9d28-d5a9154e9be0", "AGE": 61, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 297.0, "DAYS_TO_BIRTH": -22598.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/21/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N2", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "No", "PRIOR_DX": "No", "RACE": "Asian", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 9.764276556, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 9.764276556, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 9.764276556, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 9.764276556, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-C8-A278-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "C8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 17.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3104, "MSI_SENSOR_SCORE": 0.09, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.433333333, "TISSUE_SOURCE_SITE": "ILSBio", "TBL_SCORE": 175.0 }, "treatments": [ { "START_DATE": 23, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-E2-A1AZ": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "89128dba-403f-4a96-bb3b-23ed0d5e2147", "AGE": 63, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 2329.0, "DAYS_TO_BIRTH": -23230.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/25/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 76.5690239, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 76.5690239, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 76.5690239, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 76.5690239, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-E2-A1AZ-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "E2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 22.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2761, "MSI_SENSOR_SCORE": 0.41, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.666666667, "TISSUE_SOURCE_SITE": "Roswell Park", "TBL_SCORE": 221.0 }, "treatments": [ { "START_DATE": 61, "STOP_DATE": 121.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "1125", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "4500", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 61, "STOP_DATE": 121.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "115", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "460", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 167, "STOP_DATE": 211.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "33", "RADIATION_DOSAGE": "6040", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-E2-A1LI": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "3558dec7-eae3-4a41-a217-266c6a4535fb", "AGE": 57, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 3121.0, "DAYS_TO_BIRTH": -21064.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "6/3/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 102.6070947, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 102.6070947, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 102.6070947, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E2-A1LI-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "E2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 26.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3573, "MSI_SENSOR_SCORE": 0.45, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.9, "TISSUE_SOURCE_SITE": "Roswell Park", "TBL_SCORE": 93.0 }, "treatments": [ { "START_DATE": 42, "STOP_DATE": 112.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "600", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": "2400", "TOTAL_DOSE_UNITS": "Mg/M2", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 42, "STOP_DATE": 112.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "60", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": "240", "TOTAL_DOSE_UNITS": "Mg/M2", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 152, "STOP_DATE": 194.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-D8-A143": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "1c40b84e-a0e3-429f-a48c-21566cf881c0", "AGE": 51, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 431.0, "DAYS_TO_BIRTH": -18984.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "2/25/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 14.16970773, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 14.16970773, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 14.16970773, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 14.16970773, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D8-A143-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "D8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 20.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3145, "MSI_SENSOR_SCORE": 1.28, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.633333333, "TISSUE_SOURCE_SITE": "Greater Poland Cancer Center", "TBL_SCORE": 91.0 }, "treatments": [ { "START_DATE": 67, "STOP_DATE": 172.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "6", "PRESCRIBED_DOSE": "60", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "ac", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": "Mg/M2", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 67, "STOP_DATE": 172.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-OL-A6VR": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "DB3E1CE8-4A05-4BFC-B5AE-13CF789369E1", "AGE": 48, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 1220.0, "DAYS_TO_BIRTH": -17702.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/5/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T1B", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 40.10914949, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 40.10914949, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 40.10914949, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 40.10914949, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-OL-A6VR-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "OL", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 2.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3456, "MSI_SENSOR_SCORE": 0.12, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.766666667, "TISSUE_SOURCE_SITE": "University of Chicago", "TBL_SCORE": 12.0 }, "treatments": [] }, "TCGA-E2-A10F": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "8e159b50-8136-42d4-b9c7-d579a74e4931", "AGE": 47, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 878.0, "DAYS_TO_BIRTH": -17257.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "2/11/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 28.86543709, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 28.86543709, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 28.86543709, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 28.86543709, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E2-A10F-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "E2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 6.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": NaN, "MSI_SENSOR_SCORE": 0.04, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.7, "TISSUE_SOURCE_SITE": "Roswell Park", "TBL_SCORE": 16.0 }, "treatments": [ { "START_DATE": 223, "STOP_DATE": 337.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "20", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "20", "TOTAL_DOSE_UNITS": "Mg/Day", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 69, "STOP_DATE": 132.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "1284", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "5136", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 69, "STOP_DATE": 132.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "160", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "640", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 170, "STOP_DATE": 216.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "33", "RADIATION_DOSAGE": "6040", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-EW-A2FS": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "D34471A1-B367-4F8A-B35A-C5901C4F5503", "AGE": 41, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 1604.0, "DAYS_TO_BIRTH": -15302.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "10/12/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N1MI", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 52.73366867, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 52.73366867, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 52.73366867, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 52.73366867, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-EW-A2FS-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "EW", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 4.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3517, "MSI_SENSOR_SCORE": 0.97, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.9, "TISSUE_SOURCE_SITE": "University of Miami", "TBL_SCORE": 155.0 }, "treatments": [ { "START_DATE": 343, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 140, "STOP_DATE": 1166.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Goserelin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Stable Disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 164, "STOP_DATE": 227.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 164, "STOP_DATE": 227.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 164, "STOP_DATE": 318.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Bevacizumab", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 248, "STOP_DATE": 332.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 394, "STOP_DATE": 439.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": "6400", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-BH-A5J0": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "DB55D9D9-DD56-4CA9-B1F1-0D929697B280", "AGE": 63, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 715.0, "DAYS_TO_BIRTH": -23072.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "2/13/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 23.50659171, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 23.50659171, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 23.50659171, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 23.50659171, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-BH-A5J0-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 21.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3109, "MSI_SENSOR_SCORE": 0.01, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.033333333, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 187.0 }, "treatments": [] }, "TCGA-BH-A201": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "3bf81a9f-abb4-4495-a514-fd3865e13a03", "AGE": 64, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 856.0, "DAYS_TO_BIRTH": -23423.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/8/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T1", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 28.14215735, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 28.14215735, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 28.14215735, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A201-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 4.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2668, "MSI_SENSOR_SCORE": 0.01, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.7, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 71.0 }, "treatments": [ { "START_DATE": 56, "STOP_DATE": 108.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "28", "RADIATION_DOSAGE": "6640", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-A2-A25D": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "3b963d72-ba5c-467b-83c9-fbdb462510a3", "AGE": 90, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIC", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 552.0, "DAYS_TO_BIRTH": -32872.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "6/21/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N3A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 18.14774633, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 18.14774633, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 18.14774633, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A2-A25D-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "A2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 7.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3005, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.7, "TISSUE_SOURCE_SITE": "Walter Reed", "TBL_SCORE": 134.0 }, "treatments": [ { "START_DATE": 113, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "20", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 79, "STOP_DATE": 90.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Exemestane", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "25", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 49, "STOP_DATE": 78.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "3", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 90, "STOP_DATE": 147.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "36", "RADIATION_DOSAGE": "6640", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-A7-A3J1": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "8F9AD301-6699-4078-A80D-886E40894AF7", "AGE": 63, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 343.0, "DAYS_TO_BIRTH": -23209.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/12/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "0:LIVING", "OS_MONTHS": 11.27658875, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 11.27658875, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 11.27658875, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 11.27658875, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A7-A3J1-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "A7", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 6.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2891, "MSI_SENSOR_SCORE": 0.01, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.0, "TISSUE_SOURCE_SITE": "Christiana Healthcare", "TBL_SCORE": 26.0 }, "treatments": [ { "START_DATE": 137, "STOP_DATE": 175.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 189, "STOP_DATE": 251.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 300, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Exemestane", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 89, "STOP_DATE": 134.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "33", "RADIATION_DOSAGE": "6100", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-BH-A18J": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "cc074b7f-d3b2-4880-902e-bf10e667b665", "AGE": 56, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "5TH", "DAYS_LAST_FOLLOWUP": NaN, "DAYS_TO_BIRTH": -20678.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "6/8/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M1", "PATH_N_STAGE": "N2", "PATH_T_STAGE": "T4B", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": null, "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 20.12032745, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 20.12032745, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 20.12032745, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A18J-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 5.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2602, "MSI_SENSOR_SCORE": 0.08, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.5, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 307.0 }, "treatments": [] }, "TCGA-D8-A13Y": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "17f275c1-a0d4-487d-8f02-ea279584b4cd", "AGE": 52, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IA", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": 1728.0, "DAYS_TO_BIRTH": -19028.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "2/23/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 56.81033633, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 56.81033633, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 56.81033633, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 56.81033633, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D8-A13Y-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "D8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 13.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3032, "MSI_SENSOR_SCORE": 1.06, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.233333333, "TISSUE_SOURCE_SITE": "Greater Poland Cancer Center", "TBL_SCORE": 137.0 }, "treatments": [ { "START_DATE": 7, "STOP_DATE": 161.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "60", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "4x chemotherapy+hormonotherapy", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "60", "TOTAL_DOSE_UNITS": "Mg/M2", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 7, "STOP_DATE": 161.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-B6-A0WW": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "f02931f8-d72a-481d-b532-8b141dab115f", "AGE": 58, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE X", "AJCC_STAGING_EDITION": "4TH", "DAYS_LAST_FOLLOWUP": NaN, "DAYS_TO_BIRTH": -21479.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/14/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N1B", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 18.34500444, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 18.34500444, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 14.69572936, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 14.69572936, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-B6-A0WW-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "B6", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 9.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2824, "MSI_SENSOR_SCORE": 0.67, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.133333333, "TISSUE_SOURCE_SITE": "Duke", "TBL_SCORE": 70.0 }, "treatments": [] }, "TCGA-C8-A12O": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "83f26720-007c-42c9-a7de-7484bf8afa89", "AGE": 50, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 385.0, "DAYS_TO_BIRTH": -18506.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/13/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Asian", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 12.65739554, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 12.65739554, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 12.65739554, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 12.65739554, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-C8-A12O-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "C8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 27.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2718, "MSI_SENSOR_SCORE": 0.11, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.2, "TISSUE_SOURCE_SITE": "ILSBio", "TBL_SCORE": 104.0 }, "treatments": [] }, "TCGA-A2-A0SX": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "18d35983-ea6a-4b70-a209-9bef37595956", "AGE": 48, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 1534.0, "DAYS_TO_BIRTH": -17774.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "11/9/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 50.43232403, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 50.43232403, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 40.73380018, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 40.73380018, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A2-A0SX-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 11.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2956, "MSI_SENSOR_SCORE": 0.31, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.766666667, "TISSUE_SOURCE_SITE": "Walter Reed", "TBL_SCORE": 122.0 }, "treatments": [ { "START_DATE": 62, "STOP_DATE": 132.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "6", "PRESCRIBED_DOSE": "100", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "600", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 62, "STOP_DATE": 132.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "6", "PRESCRIBED_DOSE": "1000", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "6000", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 1289, "STOP_DATE": 1359.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Gemcitabine", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "1800", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "4", "REGIMEN_INDICATION": "Recurrence", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "7200", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 1289, "STOP_DATE": 1359.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "610", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "3", "REGIMEN_INDICATION": "Recurrence", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "2203", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 1429, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Capecitabine", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1500-2000", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "5", "REGIMEN_INDICATION": "Progression", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-A2-A0CT": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "378778d2-b331-4867-a93b-c64028c8b4c7", "AGE": 71, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 2289.0, "DAYS_TO_BIRTH": -25959.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/9/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 75.25396982, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 75.25396982, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 75.25396982, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 75.25396982, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A2-A0CT-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 25.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2932, "MSI_SENSOR_SCORE": 1.11, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.666666667, "TISSUE_SOURCE_SITE": "Walter Reed", "TBL_SCORE": 90.0 }, "treatments": [ { "START_DATE": 75, "STOP_DATE": 138.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "900", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "3600", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 75, "STOP_DATE": 138.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "90", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "360", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 160, "STOP_DATE": 433.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "3", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 559, "STOP_DATE": 1537.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "20", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "4", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-AN-A0FZ": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "8240c4ae-f878-4882-aa07-7857c7ac52cf", "AGE": 45, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": 10.0, "DAYS_TO_BIRTH": -16533.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/29/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N2", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 0.32876352, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 0.32876352, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 0.32876352, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 0.32876352, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AN-A0FZ-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AN", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 16.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2641, "MSI_SENSOR_SCORE": 0.5, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.233333333, "TISSUE_SOURCE_SITE": "Cureline", "TBL_SCORE": 446.0 }, "treatments": [] }, "TCGA-AR-A2LE": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "E3FCBF94-D3EF-4A37-AA45-5297F96AF9EB", "AGE": 69, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE I", "AJCC_STAGING_EDITION": "5TH", "DAYS_LAST_FOLLOWUP": 5062.0, "DAYS_TO_BIRTH": -25499.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "1/12/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T1", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 166.420094, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 166.420094, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 166.420094, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 138.1793076, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AR-A2LE-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AR", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 4.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3011, "MSI_SENSOR_SCORE": 0.03, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 8.633333333, "TISSUE_SOURCE_SITE": "Mayo", "TBL_SCORE": 8.0 }, "treatments": [ { "START_DATE": 17, "STOP_DATE": 1869.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 42, "STOP_DATE": 84.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "30", "RADIATION_DOSAGE": "6000", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-LD-A9QF": { "demographics": { "SUBTYPE": "BRCA_Normal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "95C53ECF-D8F1-4BCB-9B1A-C9A0542939F0", "AGE": 73, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 323.0, "DAYS_TO_BIRTH": -26869.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/7/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 10.61906171, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 10.61906171, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 10.61906171, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 10.61906171, "GENETIC_ANCESTRY_LABEL": "AFR_ADMIX" }, "sample": { "SAMPLE_ID": "TCGA-LD-A9QF-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "LD", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": NaN, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3232, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.633333333, "TISSUE_SOURCE_SITE": "Hartford Hospital", "TBL_SCORE": 68.0 }, "treatments": [ { "START_DATE": 190, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 190, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Trastuzumab", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-D8-A1XJ": { "demographics": { "SUBTYPE": "BRCA_Her2", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "cc510968-fe52-4109-a79f-74f216b48c78", "AGE": 76, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 663.0, "DAYS_TO_BIRTH": -27967.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "6/9/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8523/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 21.82989776, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 21.82989776, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 21.82989776, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 21.82989776, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D8-A1XJ-01", "ONCOTREE_CODE": "BRCNOS", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Carcinoma (NOS)", "TUMOR_TYPE": "Other", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "D8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 14.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3111, "MSI_SENSOR_SCORE": 0.28, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.7, "TISSUE_SOURCE_SITE": "Greater Poland Cancer Center", "TBL_SCORE": 194.0 }, "treatments": [ { "START_DATE": 85, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "20", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": "Mg/Day", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-B6-A408": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "9964F447-92AD-4D1E-AF20-11CF84FAB7B0", "AGE": 55, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIC", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 2072.0, "DAYS_TO_BIRTH": -20102.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/20/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8522/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N3A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "0:LIVING", "OS_MONTHS": 68.11980143, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 68.11980143, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 68.11980143, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 68.11980143, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-B6-A408-01", "ONCOTREE_CODE": "BRCNOS", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Carcinoma (NOS)", "TUMOR_TYPE": "Mixed Histology (NOS)", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "B6", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 21.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3131, "MSI_SENSOR_SCORE": 0.05, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.0, "TISSUE_SOURCE_SITE": "Duke", "TBL_SCORE": 66.0 }, "treatments": [ { "START_DATE": 55, "STOP_DATE": 163.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 58, "STOP_DATE": 163.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 58, "STOP_DATE": 163.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 208, "STOP_DATE": 244.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "24", "RADIATION_DOSAGE": "4800", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-A8-A09R": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "cb0a2055-2168-4454-8755-47dd613db36f", "AGE": 82, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 273.0, "DAYS_TO_BIRTH": -30196.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "5/27/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": null, "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 8.975244107, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 8.975244107, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 8.975244107, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 8.975244107, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A8-A09R-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 20.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": NaN, "MSI_SENSOR_SCORE": 0.41, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.166666667, "TISSUE_SOURCE_SITE": "Indivumed", "TBL_SCORE": 105.0 }, "treatments": [ { "START_DATE": 0, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Letrozole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 61, "STOP_DATE": 120.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "gy" } ] }, "TCGA-A2-A1FV": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "cd0c96a4-6414-4efb-879b-7408b62ed5b6", "AGE": 74, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 714.0, "DAYS_TO_BIRTH": -27287.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/26/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I+)", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 23.47371536, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 23.47371536, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 23.47371536, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 23.47371536, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A2-A1FV-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "A2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 12.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3124, "MSI_SENSOR_SCORE": 0.21, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.3, "TISSUE_SOURCE_SITE": "Walter Reed", "TBL_SCORE": 108.0 }, "treatments": [ { "START_DATE": 141, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "3", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 70, "STOP_DATE": 133.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "1032", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "4128", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 70, "STOP_DATE": 133.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "129", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "516", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 169, "STOP_DATE": 216.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "33", "RADIATION_DOSAGE": "6040", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-AR-A2LO": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "AD0FA961-C085-4F38-B3DB-5FC0CBF6B64F", "AGE": 46, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 1198.0, "DAYS_TO_BIRTH": -17080.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "1/12/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 39.38586974, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 39.38586974, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 39.38586974, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 39.38586974, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AR-A2LO-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AR", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 11.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3064, "MSI_SENSOR_SCORE": 0.09, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.533333333, "TISSUE_SOURCE_SITE": "Mayo", "TBL_SCORE": 44.0 }, "treatments": [ { "START_DATE": 44, "STOP_DATE": 84.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 44, "STOP_DATE": 84.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 98, "STOP_DATE": 175.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 44, "STOP_DATE": 161.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Immunotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Bevacizumab", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 199, "STOP_DATE": 903.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 903, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 196, "STOP_DATE": 228.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "25", "RADIATION_DOSAGE": "5000", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-AR-A2LQ": { "demographics": { "SUBTYPE": "BRCA_Normal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "4229E432-6AC5-49D2-B58A-E8713DDB79BD", "AGE": 59, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 1233.0, "DAYS_TO_BIRTH": -21865.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "1/12/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 40.53654207, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 40.53654207, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 40.53654207, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 40.53654207, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AR-A2LQ-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AR", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 1.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3312, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.333333333, "TISSUE_SOURCE_SITE": "Mayo", "TBL_SCORE": 1.0 }, "treatments": [ { "START_DATE": 89, "STOP_DATE": 152.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 89, "STOP_DATE": 152.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 176, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 201, "STOP_DATE": 240.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "28", "RADIATION_DOSAGE": "5040", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-OL-A5RW": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "A82D0A57-4383-473D-B334-D13B278404B1", "AGE": 40, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 1106.0, "DAYS_TO_BIRTH": -14638.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "5/16/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 36.36124536, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 36.36124536, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 36.36124536, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 36.36124536, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-OL-A5RW-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "OL", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 17.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3301, "MSI_SENSOR_SCORE": 0.97, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 4.866666667, "TISSUE_SOURCE_SITE": "University of Chicago", "TBL_SCORE": 397.0 }, "treatments": [ { "START_DATE": 69, "STOP_DATE": 234.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 69, "STOP_DATE": 234.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 69, "STOP_DATE": 234.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 184, "STOP_DATE": 234.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": "5040", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-GM-A2DH": { "demographics": { "SUBTYPE": "BRCA_Her2", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "5700C1B3-922A-4401-8AB8-89028908D696", "AGE": 58, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE I", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 2193.0, "DAYS_TO_BIRTH": -21344.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/29/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I+)", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 72.09784002, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 72.09784002, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 72.09784002, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 72.09784002, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-GM-A2DH-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "GM", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 16.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2942, "MSI_SENSOR_SCORE": 0.05, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 5.766666667, "TISSUE_SOURCE_SITE": "MD Anderson", "TBL_SCORE": 234.0 }, "treatments": [ { "START_DATE": 86, "STOP_DATE": 163.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 170, "STOP_DATE": 233.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Fluorouracil", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 170, "STOP_DATE": 233.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 170, "STOP_DATE": 233.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-D8-A27F": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "1549dc64-3dab-43fc-96e9-b07d520957e1", "AGE": 40, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 488.0, "DAYS_TO_BIRTH": -14731.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/18/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 16.0436598, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 16.0436598, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 16.0436598, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 16.0436598, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D8-A27F-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "D8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 7.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3123, "MSI_SENSOR_SCORE": 0.94, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.033333333, "TISSUE_SOURCE_SITE": "Greater Poland Cancer Center", "TBL_SCORE": 129.0 }, "treatments": [ { "START_DATE": 379, "STOP_DATE": 488.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin + Cyclophosphamide", "NUMBER_OF_CYCLES": "6", "PRESCRIBED_DOSE": "60+600", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "360+3600", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 158, "STOP_DATE": 182.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "25", "RADIATION_DOSAGE": "5000", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-AR-A254": { "demographics": { "SUBTYPE": "BRCA_Her2", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "6014a582-d22e-46e1-9000-c8e2fbad7acf", "AGE": 50, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 2605.0, "DAYS_TO_BIRTH": -18270.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "8/31/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N2", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 85.64289706, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 85.64289706, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 85.64289706, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 85.64289706, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AR-A254-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AR", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 11.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3291, "MSI_SENSOR_SCORE": 0.52, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.1, "TISSUE_SOURCE_SITE": "Mayo", "TBL_SCORE": 269.0 }, "treatments": [ { "START_DATE": 22, "STOP_DATE": 43.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 50, "STOP_DATE": 99.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 106, "STOP_DATE": 173.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Fluorouracil", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 106, "STOP_DATE": 170.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Epirubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 106, "STOP_DATE": 170.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 22, "STOP_DATE": 22.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Immunotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Trastuzumab", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 29, "STOP_DATE": 184.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Immunotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Trastuzumab", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 232, "STOP_DATE": 344.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Immunotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Trastuzumab", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 262, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 252, "STOP_DATE": 291.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "30", "RADIATION_DOSAGE": "6000", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-AN-A0FF": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "d5cab7f5-e4f1-40ee-a0c8-4c8004c1c9a0", "AGE": 32, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IA", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": 172.0, "DAYS_TO_BIRTH": -11929.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/27/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T1B", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 5.654732551, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 5.654732551, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 5.654732551, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 5.654732551, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AN-A0FF-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AN", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 4.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2735, "MSI_SENSOR_SCORE": 0.05, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.666666667, "TISSUE_SOURCE_SITE": "Cureline", "TBL_SCORE": 25.0 }, "treatments": [] }, "TCGA-A1-A0SG": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "0ed9ad26-7fdc-4d75-93f9-d029eee94993", "AGE": 61, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 434.0, "DAYS_TO_BIRTH": -22380.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/31/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8507/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": null, "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 14.26833679, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 14.26833679, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 14.26833679, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 14.26833679, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A1-A0SG-01", "ONCOTREE_CODE": "BRCNOS", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Carcinoma (NOS)", "TUMOR_TYPE": "Other", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A1", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 4.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.311, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.9, "TISSUE_SOURCE_SITE": "UCSF", "TBL_SCORE": 30.0 }, "treatments": [ { "START_DATE": 111, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": null, "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-BH-A0BL": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "92b5de82-0221-4df1-8094-80f40c0bb4fa", "AGE": 35, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE I", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 2278.0, "DAYS_TO_BIRTH": -12841.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "8/8/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 74.89232995, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 74.89232995, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 74.89232995, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 74.89232995, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A0BL-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 17.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2584, "MSI_SENSOR_SCORE": 0.08, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 3.6, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 113.0 }, "treatments": [ { "START_DATE": 72, "STOP_DATE": 142.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 72, "STOP_DATE": 142.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 163, "STOP_DATE": 240.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-AC-A2FE": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "F6EEBD4B-B63A-4A9C-92D3-0D954A8A6655", "AGE": 62, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIC", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 2240.0, "DAYS_TO_BIRTH": -22746.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/3/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N3A", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 86.66206398, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 86.66206398, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 25.18328566, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 25.18328566, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AC-A2FE-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AC", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 5.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.259, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.0, "TISSUE_SOURCE_SITE": "International Genomics Consortium", "TBL_SCORE": 60.0 }, "treatments": [ { "START_DATE": 67, "STOP_DATE": 173.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Partial Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 67, "STOP_DATE": 173.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Partial Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 273, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 67, "STOP_DATE": 173.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 2516, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Capecitabine", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Clinical Progressive Disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 2516, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Clinical Progressive Disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 178, "STOP_DATE": 219.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Partial Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "28", "RADIATION_DOSAGE": "5040", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" }, { "START_DATE": 791, "STOP_DATE": 813.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 2", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Partial Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Distant Site", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-D8-A1JK": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "56203436-8634-4fd0-96b5-ba6be9d87857", "AGE": 90, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 612.0, "DAYS_TO_BIRTH": -32872.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/29/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 20.12032745, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 20.12032745, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 20.12032745, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 20.12032745, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D8-A1JK-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "D8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 21.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3022, "MSI_SENSOR_SCORE": 0.33, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 6.5, "TISSUE_SOURCE_SITE": "Greater Poland Cancer Center", "TBL_SCORE": 422.0 }, "treatments": [] }, "TCGA-AC-A2FO": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "F5D4C2D3-CC69-4B38-8551-0917E3622A68", "AGE": 65, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 2255.0, "DAYS_TO_BIRTH": -23928.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/21/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 74.13617385, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 74.13617385, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 74.13617385, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 74.13617385, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AC-A2FO-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AC", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 2.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3027, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.8, "TISSUE_SOURCE_SITE": "International Genomics Consortium", "TBL_SCORE": 49.0 }, "treatments": [ { "START_DATE": 105, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Chemo, NOS", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 225, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Hormone, NOS", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-C8-A8HR": { "demographics": { "SUBTYPE": "BRCA_Normal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "DCB68327-1537-4CA6-81DE-3910D0663CB8", "AGE": 49, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 408.0, "DAYS_TO_BIRTH": -17921.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/29/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N2", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Asian", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 13.41355163, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 13.41355163, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 13.41355163, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 13.41355163, "GENETIC_ANCESTRY_LABEL": "EAS" }, "sample": { "SAMPLE_ID": "TCGA-C8-A8HR-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "C8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 10.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3233, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.333333333, "TISSUE_SOURCE_SITE": "ILSBio", "TBL_SCORE": 57.0 }, "treatments": [ { "START_DATE": 43, "STOP_DATE": 237.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Fluorouracil", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 43, "STOP_DATE": 237.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Epirubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 43, "STOP_DATE": 237.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-E9-A1N4": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "69a68fbc-e43d-4652-85ee-693211bded47", "AGE": 41, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 1000.0, "DAYS_TO_BIRTH": -15055.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/26/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N2", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 32.87635204, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 32.87635204, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 32.87635204, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 32.87635204, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E9-A1N4-01", "ONCOTREE_CODE": "BRCNOS", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Carcinoma (NOS)", "TUMOR_TYPE": "Mixed Histology (NOS)", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "E9", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 6.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2834, "MSI_SENSOR_SCORE": 0.03, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.666666667, "TISSUE_SOURCE_SITE": "Asterand", "TBL_SCORE": 51.0 }, "treatments": [ { "START_DATE": 118, "STOP_DATE": 194.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "6", "PRESCRIBED_DOSE": "80", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "480", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 118, "STOP_DATE": 194.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "6", "PRESCRIBED_DOSE": "800", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "4800", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 118, "STOP_DATE": 194.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Fluorouracil", "NUMBER_OF_CYCLES": "6", "PRESCRIBED_DOSE": "800", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "4800", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 230, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 69, "STOP_DATE": 96.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "20", "RADIATION_DOSAGE": "400", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-BH-A42T": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "10C829EC-FD66-49C4-8AFE-AD3AE567372C", "AGE": 75, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 30.0, "DAYS_TO_BIRTH": -27731.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/28/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I+)", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 10.52043265, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 10.52043265, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 10.52043265, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 10.52043265, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-BH-A42T-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 11.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2992, "MSI_SENSOR_SCORE": 0.23, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": NaN, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 97.0 }, "treatments": [] }, "TCGA-BH-A0BS": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "2b22db1d-54a1-4b9e-a86e-a174cf51d95c", "AGE": 55, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 2612.0, "DAYS_TO_BIRTH": -20374.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "8/18/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1C", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 85.87303153, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 85.87303153, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 85.87303153, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 85.87303153, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A0BS-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 2.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2639, "MSI_SENSOR_SCORE": 0.06, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.433333333, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 2.0 }, "treatments": [ { "START_DATE": 44, "STOP_DATE": 207.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 44, "STOP_DATE": 207.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 245, "STOP_DATE": 302.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "25", "RADIATION_DOSAGE": "6040", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" }, { "START_DATE": 245, "STOP_DATE": 302.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 2", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "26", "RADIATION_DOSAGE": "46.8", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "gy" } ] }, "TCGA-LL-A5YM": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "E9A12DF9-024E-4CBC-B6BF-E4E87485FA90", "AGE": 88, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIB", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 466.0, "DAYS_TO_BIRTH": -32478.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "6/3/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8541/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "NX", "PATH_T_STAGE": "T4B", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "No", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 15.32038005, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 15.32038005, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 8.482098826, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 8.482098826, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-LL-A5YM-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "LL", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 16.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3208, "MSI_SENSOR_SCORE": 0.2, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.766666667, "TISSUE_SOURCE_SITE": "Candler", "TBL_SCORE": 114.0 }, "treatments": [ { "START_DATE": 307, "STOP_DATE": 339.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Partial Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Local Recurrence", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "20", "RADIATION_DOSAGE": "50", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "gy" } ] }, "TCGA-C8-A131": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "c49e3b18-fd88-48f4-8b01-300692ceb367", "AGE": 82, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 411.0, "DAYS_TO_BIRTH": -29966.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/15/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N2", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Asian", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 13.51218069, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 13.51218069, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 13.51218069, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 13.51218069, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-C8-A131-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "C8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 21.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2745, "MSI_SENSOR_SCORE": 0.05, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.933333333, "TISSUE_SOURCE_SITE": "ILSBio", "TBL_SCORE": 67.0 }, "treatments": [ { "START_DATE": 34, "STOP_DATE": 57.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Fluorouracil", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 34, "STOP_DATE": 57.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 34, "STOP_DATE": 57.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-B6-A0WV": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "7588a286-6935-424a-bc5f-92e24c83eb37", "AGE": 67, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "4TH", "DAYS_LAST_FOLLOWUP": NaN, "DAYS_TO_BIRTH": -24803.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/14/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1B", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 79.46214288, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 79.46214288, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 79.46214288, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 79.46214288, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-B6-A0WV-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "B6", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 24.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2725, "MSI_SENSOR_SCORE": 0.52, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.966666667, "TISSUE_SOURCE_SITE": "Duke", "TBL_SCORE": 45.0 }, "treatments": [] }, "TCGA-AR-A1AN": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "43029932-feb0-4658-97fa-645c1e775009", "AGE": 46, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 2920.0, "DAYS_TO_BIRTH": -16974.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Hispanic Or Latino", "FORM_COMPLETION_DATE": "6/14/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 95.99894796, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 95.99894796, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 95.99894796, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 95.99894796, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AR-A1AN-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AR", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 9.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2497, "MSI_SENSOR_SCORE": 0.23, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.833333333, "TISSUE_SOURCE_SITE": "Mayo", "TBL_SCORE": 229.0 }, "treatments": [ { "START_DATE": 301, "STOP_DATE": 441.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "20", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "3", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 442, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "4", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 47, "STOP_DATE": 91.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "60", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "435", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 162, "STOP_DATE": 300.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 47, "STOP_DATE": 91.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "600", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "4310", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 105, "STOP_DATE": 154.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "175", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "1250", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 169, "STOP_DATE": 211.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "30", "RADIATION_DOSAGE": "6000", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-E9-A54Y": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "182C4BDF-2C58-4303-B034-459DA86B9D90", "AGE": 63, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 725.0, "DAYS_TO_BIRTH": -23057.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "6/21/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N2", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 23.83535523, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 23.83535523, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 23.83535523, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 23.83535523, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E9-A54Y-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "E9", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 9.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3073, "MSI_SENSOR_SCORE": 0.71, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.2, "TISSUE_SOURCE_SITE": "Asterand", "TBL_SCORE": 93.0 }, "treatments": [] }, "TCGA-A2-A4RW": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "0D146997-CFDC-4587-888C-E876FC455C80", "AGE": 49, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIC", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 222.0, "DAYS_TO_BIRTH": -18060.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "2/27/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N3A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": null, "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "0:LIVING", "OS_MONTHS": 7.298550153, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 7.298550153, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 7.298550153, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 7.298550153, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A2-A4RW-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "A2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 5.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2918, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.0, "TISSUE_SOURCE_SITE": "Walter Reed", "TBL_SCORE": 111.0 }, "treatments": [] }, "TCGA-E2-A109": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "f0787165-6f58-4d67-b510-928eea2c4882", "AGE": 64, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 1417.0, "DAYS_TO_BIRTH": -23521.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "2/11/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 46.58579084, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 46.58579084, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 46.58579084, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 46.58579084, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E2-A109-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "E2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 16.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": NaN, "MSI_SENSOR_SCORE": 0.77, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.1, "TISSUE_SOURCE_SITE": "Roswell Park", "TBL_SCORE": 347.0 }, "treatments": [ { "START_DATE": 734, "STOP_DATE": 807.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "20", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "5", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "20", "TOTAL_DOSE_UNITS": "Mg/Day", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 230, "STOP_DATE": 300.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": "6", "PRESCRIBED_DOSE": "367", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "2202", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 111, "STOP_DATE": 209.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "15", "PRESCRIBED_DOSE": "24", "PRESCRIBED_DOSE_UNITS": "mg/m2/day", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "52", "TOTAL_DOSE_UNITS": "Mg/Wk", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 111, "STOP_DATE": 215.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "15", "PRESCRIBED_DOSE": "60", "PRESCRIBED_DOSE_UNITS": "mg/m2/day", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "125", "TOTAL_DOSE_UNITS": "Mg/Day", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 318, "STOP_DATE": 608.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "1", "TOTAL_DOSE_UNITS": "Mg/Day", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 857, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Letrozole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "2.5", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "6", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": "2.5", "TOTAL_DOSE_UNITS": "Mg/Day", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 643, "STOP_DATE": 685.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Exemestane", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "25", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "3", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "25", "TOTAL_DOSE_UNITS": "Mg/Day", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 699, "STOP_DATE": 734.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Letrozole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "2.5", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "4", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "2.5", "TOTAL_DOSE_UNITS": "Mg/Day", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-A8-A099": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "e98b69bc-766a-485f-b5e8-9166b8d457b3", "AGE": 76, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE X", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 304.0, "DAYS_TO_BIRTH": -28063.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "5/27/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N3A", "PATH_T_STAGE": "T4B", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": null, "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 9.99441102, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 9.99441102, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 9.99441102, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A8-A099-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 5.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2753, "MSI_SENSOR_SCORE": 0.62, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.9, "TISSUE_SOURCE_SITE": "Indivumed", "TBL_SCORE": 27.0 }, "treatments": [ { "START_DATE": 61, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Exemestane", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 92, "STOP_DATE": 123.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "gy" } ] }, "TCGA-E9-A24A": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "9f3cc92b-fa22-478e-a2e4-6b4c8afb93d6", "AGE": 69, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 747.0, "DAYS_TO_BIRTH": -25370.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/22/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 24.55863497, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 24.55863497, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 24.55863497, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 24.55863497, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E9-A24A-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "E9", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 6.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3188, "MSI_SENSOR_SCORE": 0.27, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.733333333, "TISSUE_SOURCE_SITE": "Asterand", "TBL_SCORE": 4.0 }, "treatments": [ { "START_DATE": 9, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "20", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 35, "STOP_DATE": 65.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "20", "RADIATION_DOSAGE": "4000", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-A2-A0EO": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "bf88ddf5-a6d4-498c-bf7f-db9bfabff72d", "AGE": 54, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 2442.0, "DAYS_TO_BIRTH": -19880.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "8/10/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T1", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 80.28405168, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 80.28405168, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 80.28405168, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A2-A0EO-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 22.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2627, "MSI_SENSOR_SCORE": 0.08, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.933333333, "TISSUE_SOURCE_SITE": "Walter Reed", "TBL_SCORE": 14.0 }, "treatments": [ { "START_DATE": 876, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Exemestane", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "25", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 158, "STOP_DATE": 876.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "10 mg twice daily", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 244, "STOP_DATE": 361.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Immunotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Nelipepimut-S", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "500", "PRESCRIBED_DOSE_UNITS": "ug", "REGIMEN_NUMBER": "3", "REGIMEN_INDICATION": "Other", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": "2000", "TOTAL_DOSE_UNITS": "Ug", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 91, "STOP_DATE": 137.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "33", "RADIATION_DOSAGE": "6040", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-AR-A255": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "e8f3cc64-5e15-4f4d-b73e-5c9b250a664c", "AGE": 62, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE I", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 2161.0, "DAYS_TO_BIRTH": -22809.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "8/31/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T1", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 71.04579676, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 71.04579676, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 71.04579676, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 71.04579676, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AR-A255-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AR", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 25.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3501, "MSI_SENSOR_SCORE": 1.78, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.233333333, "TISSUE_SOURCE_SITE": "Mayo", "TBL_SCORE": 135.0 }, "treatments": [ { "START_DATE": 54, "STOP_DATE": 54.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Immunotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Trastuzumab", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 75, "STOP_DATE": 419.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Immunotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Trastuzumab", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 96, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 47, "STOP_DATE": 89.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "30", "RADIATION_DOSAGE": "6000", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-D8-A27H": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "0dca98b0-f43e-45b6-9a02-00092c78678c", "AGE": 72, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 397.0, "DAYS_TO_BIRTH": -26588.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/18/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 13.05191176, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 13.05191176, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 13.05191176, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 13.05191176, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D8-A27H-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "D8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 5.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": NaN, "MSI_SENSOR_SCORE": 1.08, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 4.1, "TISSUE_SOURCE_SITE": "Greater Poland Cancer Center", "TBL_SCORE": 302.0 }, "treatments": [ { "START_DATE": 36, "STOP_DATE": 141.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin + Cyclophosphamide", "NUMBER_OF_CYCLES": "6", "PRESCRIBED_DOSE": "60+600", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "360+3600", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-D8-A27E": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "680f23a9-fcce-493e-b908-27c1ad202e4c", "AGE": 66, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 530.0, "DAYS_TO_BIRTH": -24315.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/21/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8523/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 17.42446658, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 17.42446658, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 17.42446658, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 17.42446658, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D8-A27E-01", "ONCOTREE_CODE": "BRCNOS", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Carcinoma (NOS)", "TUMOR_TYPE": "Other", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "D8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3095, "MSI_SENSOR_SCORE": 0.01, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.333333333, "TISSUE_SOURCE_SITE": "Greater Poland Cancer Center", "TBL_SCORE": 2.0 }, "treatments": [ { "START_DATE": 125, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen + Anastrozole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "20+1", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 90, "STOP_DATE": 95.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "10", "RADIATION_DOSAGE": "3400", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Radioisotope", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-A2-A0T4": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "b0f8d698-a30e-4d8d-b0a2-a5a01fac8406", "AGE": 62, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": 624.0, "DAYS_TO_BIRTH": -22849.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "11/17/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 20.51484367, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 20.51484367, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 20.51484367, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 20.51484367, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A2-A0T4-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 7.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3097, "MSI_SENSOR_SCORE": 0.01, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.033333333, "TISSUE_SOURCE_SITE": "Walter Reed", "TBL_SCORE": 65.0 }, "treatments": [ { "START_DATE": 85, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Letrozole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "2.5", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-AO-A1KO": { "demographics": { "SUBTYPE": "BRCA_Normal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "c25898b4-eb33-42f4-bf3f-bf532a929e7d", "AGE": 46, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 448.0, "DAYS_TO_BIRTH": -16817.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/1/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I+)", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 20.44909097, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 20.44909097, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 20.44909097, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 20.44909097, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AO-A1KO-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AO", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": NaN, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3223, "MSI_SENSOR_SCORE": 0.53, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.166666667, "TISSUE_SOURCE_SITE": "MSKCC", "TBL_SCORE": 2.0 }, "treatments": [ { "START_DATE": 70, "STOP_DATE": 160.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "600", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 70, "STOP_DATE": 160.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "60", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 231, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "20", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 70, "STOP_DATE": 160.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "175", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-GM-A3XG": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "6F0FD68F-ED6A-4C9E-BE02-C97BA4950F76", "AGE": 46, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 1330.0, "DAYS_TO_BIRTH": -16948.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "10/1/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "0:LIVING", "OS_MONTHS": 43.72554821, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 43.72554821, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 43.72554821, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 43.72554821, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-GM-A3XG-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "GM", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": NaN, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2829, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": NaN, "TISSUE_SOURCE_SITE": "MD Anderson", "TBL_SCORE": 0.0 }, "treatments": [ { "START_DATE": 163, "STOP_DATE": 247.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 261, "STOP_DATE": 324.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Fluorouracil", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 261, "STOP_DATE": 324.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 261, "STOP_DATE": 324.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 434, "STOP_DATE": 473.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 813, "STOP_DATE": 843.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 372, "STOP_DATE": 415.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "30", "RADIATION_DOSAGE": "60", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "gy" } ] }, "TCGA-A2-A0YJ": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "796b593f-5886-4a27-bf94-7ea8df325e1a", "AGE": 39, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": 566.0, "DAYS_TO_BIRTH": -14448.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/28/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N2A", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 18.60801526, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 18.60801526, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 18.37788079, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 18.37788079, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A2-A0YJ-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 25.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2988, "MSI_SENSOR_SCORE": 0.47, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.5, "TISSUE_SOURCE_SITE": "Walter Reed", "TBL_SCORE": 211.0 }, "treatments": [ { "START_DATE": 46, "STOP_DATE": 150.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "6", "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 46, "STOP_DATE": 150.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": "6", "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 180, "STOP_DATE": 223.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": "6000", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-BH-A28Q": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "32861b48-83f5-43a3-bb54-45215ad2c5d6", "AGE": 46, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 1119.0, "DAYS_TO_BIRTH": -16882.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/29/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 36.78863793, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 36.78863793, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 36.78863793, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A28Q-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 7.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.311, "MSI_SENSOR_SCORE": 0.4, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.633333333, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 21.0 }, "treatments": [] }, "TCGA-D8-A27T": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "27c1c094-690b-4973-8900-a797ad88f98c", "AGE": 53, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIC", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 398.0, "DAYS_TO_BIRTH": -19591.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/21/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N3A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 13.08478811, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 13.08478811, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 13.08478811, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 13.08478811, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D8-A27T-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "D8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 29.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3234, "MSI_SENSOR_SCORE": 0.02, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.7, "TISSUE_SOURCE_SITE": "Greater Poland Cancer Center", "TBL_SCORE": 34.0 }, "treatments": [ { "START_DATE": 227, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "20", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 115, "STOP_DATE": 220.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin + Cyclophosphamide", "NUMBER_OF_CYCLES": "6", "PRESCRIBED_DOSE": "101.4+1014", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "405.6+4056", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 272, "STOP_DATE": 301.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "25", "RADIATION_DOSAGE": "5000", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-A8-A07P": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "8cccf160-93e9-48a5-9b8b-54aa50153142", "AGE": 68, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 334.0, "DAYS_TO_BIRTH": -24929.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "5/27/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": null, "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 10.98070158, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 10.98070158, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 10.98070158, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 10.98070158, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A8-A07P-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 5.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2679, "MSI_SENSOR_SCORE": 0.54, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.533333333, "TISSUE_SOURCE_SITE": "Indivumed", "TBL_SCORE": 62.0 }, "treatments": [ { "START_DATE": 61, "STOP_DATE": 181.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Fluorouracil", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 61, "STOP_DATE": 181.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 61, "STOP_DATE": 181.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 61, "STOP_DATE": 181.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 273, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 181, "STOP_DATE": 212.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-AO-A12A": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "99927651-34be-4795-893a-128d8a1fdb30", "AGE": 47, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 2755.0, "DAYS_TO_BIRTH": -17420.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/8/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I+)", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 102.3112076, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 102.3112076, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 102.3112076, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AO-A12A-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AO", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 25.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2771, "MSI_SENSOR_SCORE": 0.02, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.466666667, "TISSUE_SOURCE_SITE": "MSKCC", "TBL_SCORE": 3.0 }, "treatments": [ { "START_DATE": 186, "STOP_DATE": 830.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "20", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 67, "STOP_DATE": 112.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "600", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 831, "STOP_DATE": 1918.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Exemestane", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "25", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 126, "STOP_DATE": 168.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "175", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 67, "STOP_DATE": 112.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "60", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-B6-A409": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "5362CBC4-CD28-4AFD-A8AC-1A4C2C33CAD2", "AGE": 44, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": NaN, "DAYS_TO_BIRTH": -16178.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/20/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N2A", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 18.83814972, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 18.83814972, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 14.99161653, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 14.99161653, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-B6-A409-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "B6", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 30.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3125, "MSI_SENSOR_SCORE": 0.07, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.966666667, "TISSUE_SOURCE_SITE": "Duke", "TBL_SCORE": 72.0 }, "treatments": [ { "START_DATE": 51, "STOP_DATE": 93.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 51, "STOP_DATE": 93.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 107, "STOP_DATE": 149.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-E2-A2P6": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "F83B866B-0B2E-4BBA-9367-BE6DCCF56232", "AGE": 77, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 1051.0, "DAYS_TO_BIRTH": -28411.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/19/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": null, "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 34.55304599, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 34.55304599, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 34.55304599, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 34.55304599, "GENETIC_ANCESTRY_LABEL": "AMR" }, "sample": { "SAMPLE_ID": "TCGA-E2-A2P6-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "E2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 6.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2847, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 3.5, "TISSUE_SOURCE_SITE": "Roswell Park", "TBL_SCORE": 72.0 }, "treatments": [ { "START_DATE": 106, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-BH-A0DI": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "27ba717a-5cd8-440a-9345-4ae086f6efca", "AGE": 63, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 912.0, "DAYS_TO_BIRTH": -23327.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "8/11/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 29.98323306, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 29.98323306, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 29.98323306, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 29.98323306, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A0DI-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 8.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2654, "MSI_SENSOR_SCORE": 0.01, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.3, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 198.0 }, "treatments": [ { "START_DATE": 131, "STOP_DATE": 194.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 131, "STOP_DATE": 194.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 215, "STOP_DATE": 319.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 362, "STOP_DATE": 402.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "28", "RADIATION_DOSAGE": "50", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "gy" }, { "START_DATE": 322, "STOP_DATE": 357.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 2", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "25", "RADIATION_DOSAGE": "45", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "gy" }, { "START_DATE": 363, "STOP_DATE": 369.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 3", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "5", "RADIATION_DOSAGE": "10", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "gy" } ] }, "TCGA-A2-A0EM": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "2fdfd287-d13c-4910-9788-73987d45908a", "AGE": 73, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IA", "AJCC_STAGING_EDITION": "5TH", "DAYS_LAST_FOLLOWUP": 3094.0, "DAYS_TO_BIRTH": -26845.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/6/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T1", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 101.7194332, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 101.7194332, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 101.7194332, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 101.7194332, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A2-A0EM-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 5.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2606, "MSI_SENSOR_SCORE": 0.06, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.033333333, "TISSUE_SOURCE_SITE": "Walter Reed", "TBL_SCORE": 3.0 }, "treatments": [ { "START_DATE": 75, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "10 mg bid", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 72, "STOP_DATE": 119.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "33", "RADIATION_DOSAGE": "6060", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-E2-A1IK": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "becedbfd-b2aa-4dde-b7f4-29e6f59ec32c", "AGE": 71, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 1800.0, "DAYS_TO_BIRTH": -26052.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/17/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1MI", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 59.17743367, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 59.17743367, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 59.17743367, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 59.17743367, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E2-A1IK-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "E2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2987, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.5, "TISSUE_SOURCE_SITE": "Roswell Park", "TBL_SCORE": 0.0 }, "treatments": [ { "START_DATE": 92, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": "1", "TOTAL_DOSE_UNITS": "Mg/Day", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-BH-A1ES": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "51ccbf1b-7cae-44ba-991a-11eda8b8c404", "AGE": 35, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "5TH", "DAYS_LAST_FOLLOWUP": NaN, "DAYS_TO_BIRTH": -13138.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/6/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": null, "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 113.8179308, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 113.8179308, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 113.8179308, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A1ES-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 7.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2593, "MSI_SENSOR_SCORE": 0.25, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.0, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 132.0 }, "treatments": [] }, "TCGA-A8-A0A7": { "demographics": { "SUBTYPE": "BRCA_Her2", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "995fdab7-7284-4d33-befa-ec22aa7c6479", "AGE": 57, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 30.0, "DAYS_TO_BIRTH": -20940.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "5/27/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": null, "RADIATION_THERAPY": null, "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 0.986290561, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 0.986290561, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 0.986290561, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 0.986290561, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A8-A0A7-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 15.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.217, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 6.5, "TISSUE_SOURCE_SITE": "Indivumed", "TBL_SCORE": 58.0 }, "treatments": [] }, "TCGA-BH-A0DP": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "14267783-5624-4fe5-ba81-9d67f1017474", "AGE": 60, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": 476.0, "DAYS_TO_BIRTH": -22199.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "11/9/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 15.64914357, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 15.64914357, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 15.64914357, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 15.64914357, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A0DP-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 19.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2522, "MSI_SENSOR_SCORE": 0.14, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.766666667, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 5.0 }, "treatments": [ { "START_DATE": 97, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 136, "STOP_DATE": 180.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "30", "RADIATION_DOSAGE": "6000", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-C8-A138": { "demographics": { "SUBTYPE": "BRCA_Her2", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "b6c286c6-2755-419b-87d3-59c7feda9653", "AGE": 54, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 380.0, "DAYS_TO_BIRTH": -20053.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/15/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N2", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Asian", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 12.49301378, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 12.49301378, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 12.49301378, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 12.49301378, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-C8-A138-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "C8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 19.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2797, "MSI_SENSOR_SCORE": 0.02, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.466666667, "TISSUE_SOURCE_SITE": "ILSBio", "TBL_SCORE": 178.0 }, "treatments": [] }, "TCGA-D8-A1Y3": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "632984bd-dc81-42b6-b024-476cfd0bb2ae", "AGE": 61, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 430.0, "DAYS_TO_BIRTH": -22317.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "6/9/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N2A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 14.13683138, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 14.13683138, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 14.13683138, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 14.13683138, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D8-A1Y3-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "D8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 22.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3234, "MSI_SENSOR_SCORE": 1.46, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.666666667, "TISSUE_SOURCE_SITE": "Greater Poland Cancer Center", "TBL_SCORE": 108.0 }, "treatments": [ { "START_DATE": 62, "STOP_DATE": 125.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin + Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "106.8+1068", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "427.2+4272", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 133, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "20", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 145, "STOP_DATE": 169.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "40", "RADIATION_DOSAGE": "9000", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-OL-A66N": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "E9002F4E-BA0B-4738-9368-DD9614A5DA8A", "AGE": 59, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIC", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 792.0, "DAYS_TO_BIRTH": -21608.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "6/11/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N3", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 26.03807082, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 26.03807082, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 26.03807082, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 26.03807082, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-OL-A66N-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "OL", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 21.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3342, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.2, "TISSUE_SOURCE_SITE": "University of Chicago", "TBL_SCORE": 22.0 }, "treatments": [ { "START_DATE": 374, "STOP_DATE": 412.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": "5040", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-BH-A0AU": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "360d1d6d-cf3e-4c78-b36f-ef5e3160aa6b", "AGE": 45, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 1914.0, "DAYS_TO_BIRTH": -16688.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/27/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 62.92533781, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 62.92533781, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 62.92533781, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 62.92533781, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A0AU-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 25.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.284, "MSI_SENSOR_SCORE": 0.16, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.566666667, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 162.0 }, "treatments": [ { "START_DATE": 65, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-LL-A9Q3": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "6AF6D256-A753-46D2-B611-E4094FF265AA", "AGE": 69, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIC", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 532.0, "DAYS_TO_BIRTH": -25477.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/21/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N3A", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 17.49021929, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 17.49021929, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 17.49021929, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 17.49021929, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-LL-A9Q3-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "LL", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 13.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3216, "MSI_SENSOR_SCORE": 0.07, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.566666667, "TISSUE_SOURCE_SITE": "Candler", "TBL_SCORE": 83.0 }, "treatments": [ { "START_DATE": 118, "STOP_DATE": 531.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Immunotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Trastuzumab", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 118, "STOP_DATE": 216.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 273, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 251, "STOP_DATE": 290.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "28", "RADIATION_DOSAGE": "50.4", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "gy" } ] }, "TCGA-BH-A6R8": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "91B09291-5944-4691-A0D8-7D1CCC649B9B", "AGE": 46, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 293.0, "DAYS_TO_BIRTH": -16829.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "2/13/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 9.632771148, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 9.632771148, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 9.632771148, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 9.632771148, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A6R8-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 14.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3586, "MSI_SENSOR_SCORE": 0.2, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.0, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 14.0 }, "treatments": [ { "START_DATE": 194, "STOP_DATE": 253.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": "61", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "gy" } ] }, "TCGA-A8-A081": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "9d876f05-5080-4c4e-9bf5-45f631d381e5", "AGE": 80, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 0.0, "DAYS_TO_BIRTH": -29555.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "5/27/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": null, "RADIATION_THERAPY": null, "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 0.0, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 0.0, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 0.0, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 0.0, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A8-A081-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 22.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2701, "MSI_SENSOR_SCORE": 0.84, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 3.666666667, "TISSUE_SOURCE_SITE": "Indivumed", "TBL_SCORE": 181.0 }, "treatments": [] }, "TCGA-C8-A26W": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "ff0f875f-113a-4c0f-8c0a-4259cd496e6d", "AGE": 58, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 381.0, "DAYS_TO_BIRTH": -21391.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/21/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "No", "PRIOR_DX": "No", "RACE": "Asian", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 12.52589013, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 12.52589013, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 12.52589013, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 12.52589013, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-C8-A26W-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "C8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 7.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3066, "MSI_SENSOR_SCORE": 0.25, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.6, "TISSUE_SOURCE_SITE": "ILSBio", "TBL_SCORE": 150.0 }, "treatments": [ { "START_DATE": 23, "STOP_DATE": 193.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 23, "STOP_DATE": 193.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-A7-A26H": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "dddd8e2f-e540-418a-b02e-698d18a12c14", "AGE": 72, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 724.0, "DAYS_TO_BIRTH": -26423.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "8/4/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T1", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 23.80247888, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 23.80247888, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 9.567018444, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 9.567018444, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A7-A26H-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "A7", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 8.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.301, "MSI_SENSOR_SCORE": 0.18, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 3.666666667, "TISSUE_SOURCE_SITE": "Christiana Healthcare", "TBL_SCORE": 66.0 }, "treatments": [ { "START_DATE": 44, "STOP_DATE": 296.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "253", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 311, "STOP_DATE": 486.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": "8", "PRESCRIBED_DOSE": "139-141", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Recurrence", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "1535", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-C8-A8HQ": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "6951FE6A-D7D1-4F41-85AF-76655B5D1F62", "AGE": 53, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 380.0, "DAYS_TO_BIRTH": -19432.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/29/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8480/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Asian", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 12.49301378, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 12.49301378, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 12.49301378, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 12.49301378, "GENETIC_ANCESTRY_LABEL": "EAS" }, "sample": { "SAMPLE_ID": "TCGA-C8-A8HQ-01", "ONCOTREE_CODE": "IMMC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Mixed Mucinous Carcinoma", "TUMOR_TYPE": "Mucinous Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "C8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 5.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3121, "MSI_SENSOR_SCORE": 0.01, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 7.266666667, "TISSUE_SOURCE_SITE": "ILSBio", "TBL_SCORE": 95.0 }, "treatments": [] }, "TCGA-A2-A0SW": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "991e1427-3c01-423d-abfd-4584302ca72c", "AGE": 82, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": NaN, "DAYS_TO_BIRTH": -30085.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "11/8/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M1", "PATH_N_STAGE": "N2", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 44.87622054, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 44.87622054, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 21.46825788, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A2-A0SW-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 13.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2874, "MSI_SENSOR_SCORE": 1.59, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.733333333, "TISSUE_SOURCE_SITE": "Walter Reed", "TBL_SCORE": 102.0 }, "treatments": [ { "START_DATE": 85, "STOP_DATE": 479.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 479, "STOP_DATE": 1365.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "20", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 54, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": "10680", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-D8-A27I": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "9c55032f-4db7-4026-ae83-8d060dd8e3fe", "AGE": 58, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 439.0, "DAYS_TO_BIRTH": -21327.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/18/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N2A", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 14.43271855, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 14.43271855, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 14.43271855, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 14.43271855, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D8-A27I-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "D8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 12.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3554, "MSI_SENSOR_SCORE": 0.09, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.966666667, "TISSUE_SOURCE_SITE": "Greater Poland Cancer Center", "TBL_SCORE": 24.0 }, "treatments": [ { "START_DATE": 76, "STOP_DATE": 160.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin + Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "60+600", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "240+2400", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 188, "STOP_DATE": 212.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "20", "RADIATION_DOSAGE": "4500", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-AO-A0J3": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "39cde586-df95-435f-b9a6-73b0c0ee5e92", "AGE": 67, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": 651.0, "DAYS_TO_BIRTH": -24519.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/19/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8523/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1B", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 21.40250518, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 21.40250518, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 21.40250518, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 21.40250518, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AO-A0J3-01", "ONCOTREE_CODE": "BRCNOS", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Carcinoma (NOS)", "TUMOR_TYPE": "Other", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AO", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 12.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.288, "MSI_SENSOR_SCORE": 0.77, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.533333333, "TISSUE_SOURCE_SITE": "MSKCC", "TBL_SCORE": 220.0 }, "treatments": [ { "START_DATE": 245, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 66, "STOP_DATE": 107.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "60", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "470", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 66, "STOP_DATE": 107.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "600", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "4700", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 149, "STOP_DATE": 191.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Fluorouracil", "NUMBER_OF_CYCLES": "3", "PRESCRIBED_DOSE": "600", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "3600", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 149, "STOP_DATE": 191.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Methotrexate", "NUMBER_OF_CYCLES": "3", "PRESCRIBED_DOSE": "40", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "240", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 121, "STOP_DATE": 121.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": "1", "PRESCRIBED_DOSE": "175", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "340", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 149, "STOP_DATE": 191.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "3", "PRESCRIBED_DOSE": "600", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "3600", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 223, "STOP_DATE": 263.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "28", "RADIATION_DOSAGE": "10080", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-E2-A1LG": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "ef4cbd38-bc79-4d60-a715-647edd2ebe9e", "AGE": 50, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 1523.0, "DAYS_TO_BIRTH": -18492.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "6/3/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "Yes", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 50.07068416, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 50.07068416, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 50.07068416, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 50.07068416, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-E2-A1LG-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "E2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 19.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3061, "MSI_SENSOR_SCORE": 0.8, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 4.8, "TISSUE_SOURCE_SITE": "Roswell Park", "TBL_SCORE": 113.0 }, "treatments": [ { "START_DATE": 70, "STOP_DATE": 112.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "1212", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "4848", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 70, "STOP_DATE": 179.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Other", "TREATMENT_SUBTYPE": "Phase III Clinical Trial", "AGENT": "Bevacizumab", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "880", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "8860", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 70, "STOP_DATE": 112.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "121", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "484", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 126, "STOP_DATE": 203.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": "10", "PRESCRIBED_DOSE": "162", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "1554", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-BH-A0DZ": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "478eb8aa-50b8-4ce5-98e4-d518ede4b174", "AGE": 43, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": 495.0, "DAYS_TO_BIRTH": -15980.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "11/9/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 16.27379426, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 16.27379426, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 16.27379426, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 16.27379426, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A0DZ-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 4.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2596, "MSI_SENSOR_SCORE": 0.32, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 14.66666667, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 141.0 }, "treatments": [ { "START_DATE": 234, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "20", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 89, "STOP_DATE": 217.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": "6", "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 89, "STOP_DATE": 224.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Trastuzumab", "NUMBER_OF_CYCLES": "12", "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 89, "STOP_DATE": 217.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": "6", "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-S3-A6ZG": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "1A679332-30A3-4495-A2E5-39D299E14333", "AGE": 71, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 562.0, "DAYS_TO_BIRTH": -26141.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "11/12/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 18.47650985, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 18.47650985, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 18.47650985, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 18.47650985, "GENETIC_ANCESTRY_LABEL": "AFR_ADMIX" }, "sample": { "SAMPLE_ID": "TCGA-S3-A6ZG-01", "ONCOTREE_CODE": "BRCNOS", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Carcinoma (NOS)", "TUMOR_TYPE": "Mixed Histology (NOS)", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "S3", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 17.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3316, "MSI_SENSOR_SCORE": 0.05, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.233333333, "TISSUE_SOURCE_SITE": "Albert Einstein Medical Center", "TBL_SCORE": 24.0 }, "treatments": [ { "START_DATE": 52, "STOP_DATE": 100.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 116, "STOP_DATE": 221.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 52, "STOP_DATE": 100.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 256, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 52, "STOP_DATE": 100.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Ancillary", "TREATMENT_SUBTYPE": null, "AGENT": "Pegfilgrastim", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 269, "STOP_DATE": 326.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "33", "RADIATION_DOSAGE": "6040", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-A2-A3KD": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "BB026999-0AAB-4232-96D7-2C93B6C9691D", "AGE": 47, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 1206.0, "DAYS_TO_BIRTH": -17372.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/2/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8480/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1MI", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 39.64888056, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 39.64888056, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 39.64888056, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A2-A3KD-01", "ONCOTREE_CODE": "IMMC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Mixed Mucinous Carcinoma", "TUMOR_TYPE": "Mucinous Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "A2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 5.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2961, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.233333333, "TISSUE_SOURCE_SITE": "Walter Reed", "TBL_SCORE": 23.0 }, "treatments": [ { "START_DATE": 127, "STOP_DATE": 190.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "962", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "3848", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 282, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "20", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "3", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 127, "STOP_DATE": 190.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "120", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "480", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 222, "STOP_DATE": 272.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-A8-A08X": { "demographics": { "SUBTYPE": "BRCA_Her2", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "f5539207-6534-4edc-a5a5-7666b5d16ba4", "AGE": 43, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIC", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 1308.0, "DAYS_TO_BIRTH": -15705.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "5/27/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N3A", "PATH_T_STAGE": "T4D", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": null, "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 43.00226847, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 43.00226847, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 12.03274485, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 12.03274485, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A8-A08X-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 23.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.266, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.1, "TISSUE_SOURCE_SITE": "Indivumed", "TBL_SCORE": 190.0 }, "treatments": [ { "START_DATE": 0, "STOP_DATE": 61.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 0, "STOP_DATE": 61.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 91, "STOP_DATE": 153.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 182, "STOP_DATE": 1249.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Targeted Molecular Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Trastuzumab", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 669, "STOP_DATE": 884.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Vincristine", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 366, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 153, "STOP_DATE": 182.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": "60", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "gy" } ] }, "TCGA-LL-A6FQ": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "92B842C5-F71B-4EF7-BA86-358D28E0966F", "AGE": 77, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 80.0, "DAYS_TO_BIRTH": -28375.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "8/30/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N2A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": null, "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 2.630108163, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 2.630108163, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 2.630108163, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 2.630108163, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-LL-A6FQ-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "LL", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 21.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3469, "MSI_SENSOR_SCORE": 0.06, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.266666667, "TISSUE_SOURCE_SITE": "Candler", "TBL_SCORE": 180.0 }, "treatments": [] }, "TCGA-AO-A03V": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "a6cb373a-1604-4e25-bd81-da6c3e4f06ee", "AGE": 41, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE I", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 886.0, "DAYS_TO_BIRTH": -15284.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "1/9/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 44.41595161, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 44.41595161, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 44.41595161, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 44.41595161, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AO-A03V-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AO", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 7.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2742, "MSI_SENSOR_SCORE": 0.23, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.7, "TISSUE_SOURCE_SITE": "MSKCC", "TBL_SCORE": 302.0 }, "treatments": [ { "START_DATE": 200, "STOP_DATE": 735.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "20", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 753, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 102, "STOP_DATE": 200.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Methotrexate", "NUMBER_OF_CYCLES": "8", "PRESCRIBED_DOSE": "40", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "600", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 102, "STOP_DATE": 200.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Fluorouracil", "NUMBER_OF_CYCLES": "8", "PRESCRIBED_DOSE": "600", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "8800", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 102, "STOP_DATE": 200.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "8", "PRESCRIBED_DOSE": "600", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "8800", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-AR-A1AT": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "4d26dada-5eb7-4d4e-8eb8-f5465c5c3428", "AGE": 62, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": NaN, "DAYS_TO_BIRTH": -22942.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "6/14/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 41.8187198, "DSS_STATUS": null, "DSS_MONTHS": 41.8187198, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 41.8187198, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 41.8187198, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AR-A1AT-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AR", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": NaN, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2816, "MSI_SENSOR_SCORE": 0.07, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.9, "TISSUE_SOURCE_SITE": "Mayo", "TBL_SCORE": NaN }, "treatments": [ { "START_DATE": 174, "STOP_DATE": 1272.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "3", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-A2-A0YL": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "b205c89f-af62-4186-acad-ed23d243fa98", "AGE": 48, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": 1474.0, "DAYS_TO_BIRTH": -17702.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/27/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N2A", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 48.45974291, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 48.45974291, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 48.45974291, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 48.45974291, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A2-A0YL-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 4.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3028, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.933333333, "TISSUE_SOURCE_SITE": "Walter Reed", "TBL_SCORE": 32.0 }, "treatments": [ { "START_DATE": 50, "STOP_DATE": 154.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": "6", "PRESCRIBED_DOSE": "140", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "3", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "840", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 50, "STOP_DATE": 154.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "6", "PRESCRIBED_DOSE": "940", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "5640", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 177, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "4", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 50, "STOP_DATE": 154.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "6", "PRESCRIBED_DOSE": "94", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "564", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 177, "STOP_DATE": 224.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "33", "RADIATION_DOSAGE": "6040", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-LL-A5YL": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "1D75E89D-4B01-443C-BE54-749C7A667BF4", "AGE": 64, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 519.0, "DAYS_TO_BIRTH": -23395.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "6/3/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 17.06282671, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 17.06282671, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 17.06282671, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 17.06282671, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-LL-A5YL-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "LL", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 5.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3113, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.866666667, "TISSUE_SOURCE_SITE": "Candler", "TBL_SCORE": 14.0 }, "treatments": [ { "START_DATE": 78, "STOP_DATE": 150.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 78, "STOP_DATE": 150.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 169, "STOP_DATE": 246.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 169, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Trastuzumab", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 341, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 273, "STOP_DATE": 315.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "28", "RADIATION_DOSAGE": "50.4", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "gy" }, { "START_DATE": 273, "STOP_DATE": 315.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 2", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "28", "RADIATION_DOSAGE": "50.4", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "gy" } ] }, "TCGA-AR-A0TT": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "13ca97a1-75bb-4a49-b8c3-181e5b2c9e86", "AGE": 53, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 3316.0, "DAYS_TO_BIRTH": -19679.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "3/8/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N2", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 109.0179834, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 109.0179834, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 109.0179834, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 109.0179834, "GENETIC_ANCESTRY_LABEL": "AFR_ADMIX" }, "sample": { "SAMPLE_ID": "TCGA-AR-A0TT-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AR", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 12.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2872, "MSI_SENSOR_SCORE": 0.22, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.833333333, "TISSUE_SOURCE_SITE": "Mayo", "TBL_SCORE": 485.0 }, "treatments": [ { "START_DATE": 48, "STOP_DATE": 91.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "600", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "4680", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 385, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "20", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "3", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 105, "STOP_DATE": 147.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "175", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "1360", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 48, "STOP_DATE": 91.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "60", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "465", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 230, "STOP_DATE": 376.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-BH-A0WA": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "786e8dbe-442e-4551-87b3-b4c333b04dd4", "AGE": 82, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE I", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 701.0, "DAYS_TO_BIRTH": -30025.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "2/16/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8575/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 23.04632278, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 23.04632278, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 23.04632278, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 23.04632278, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A0WA-01", "ONCOTREE_CODE": "BRCA", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Invasive Breast Carcinoma", "TUMOR_TYPE": "Breast Invasive Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 13.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3023, "MSI_SENSOR_SCORE": 0.54, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.966666667, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 155.0 }, "treatments": [] }, "TCGA-AO-A12G": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "58c56d4b-3f85-4aad-a779-5f9e1791677d", "AGE": 75, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 1266.0, "DAYS_TO_BIRTH": -27705.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/8/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8022/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I+)", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 53.88434099, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 53.88434099, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 53.88434099, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 53.88434099, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AO-A12G-01", "ONCOTREE_CODE": "BRCNOS", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Carcinoma (NOS)", "TUMOR_TYPE": "Other", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AO", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 6.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": NaN, "MSI_SENSOR_SCORE": 0.16, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.133333333, "TISSUE_SOURCE_SITE": "MSKCC", "TBL_SCORE": 83.0 }, "treatments": [ { "START_DATE": 177, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-AR-A0TU": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "dfe6db17-cf45-488e-bd3c-b8433d7343ca", "AGE": 35, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 709.0, "DAYS_TO_BIRTH": -13039.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "3/10/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": null, "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "0:LIVING", "OS_MONTHS": 23.3093336, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 23.3093336, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 23.3093336, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 23.3093336, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AR-A0TU-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AR", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": NaN, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3095, "MSI_SENSOR_SCORE": 1.08, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.066666667, "TISSUE_SOURCE_SITE": "Mayo", "TBL_SCORE": 211.0 }, "treatments": [] }, "TCGA-AR-A24H": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "6f89509c-f802-482e-b4da-94553aa76fe9", "AGE": 65, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "5TH", "DAYS_LAST_FOLLOWUP": 4894.0, "DAYS_TO_BIRTH": -24046.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "8/29/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 160.8968669, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 160.8968669, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 160.8968669, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 160.8968669, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AR-A24H-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AR", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 15.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2995, "MSI_SENSOR_SCORE": 0.61, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 4.166666667, "TISSUE_SOURCE_SITE": "Mayo", "TBL_SCORE": 164.0 }, "treatments": [ { "START_DATE": 23, "STOP_DATE": 1042.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "20", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 1042, "STOP_DATE": 3094.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 37, "STOP_DATE": 111.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": "6300", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-C8-A27A": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "3b1f7e48-216d-47de-ba79-db350f52bff0", "AGE": 48, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 747.0, "DAYS_TO_BIRTH": -17779.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/21/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "No", "PRIOR_DX": "No", "RACE": "Asian", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 24.55863497, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 24.55863497, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 24.55863497, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 24.55863497, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-C8-A27A-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "C8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 16.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3255, "MSI_SENSOR_SCORE": 0.81, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.8, "TISSUE_SOURCE_SITE": "ILSBio", "TBL_SCORE": 329.0 }, "treatments": [ { "START_DATE": 411, "STOP_DATE": 434.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Fluorouracil", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 411, "STOP_DATE": 434.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 411, "STOP_DATE": 434.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 411, "STOP_DATE": 434.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-E9-A5UP": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "A412B374-4D25-491F-B76F-DDAA989ACF59", "AGE": 63, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 803.0, "DAYS_TO_BIRTH": -23371.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/23/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8503/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "0:LIVING", "OS_MONTHS": 26.39971069, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 26.39971069, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 26.39971069, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 26.39971069, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E9-A5UP-01", "ONCOTREE_CODE": "BRCNOS", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Carcinoma (NOS)", "TUMOR_TYPE": "Other", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "E9", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 23.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2997, "MSI_SENSOR_SCORE": 0.24, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.0, "TISSUE_SOURCE_SITE": "Asterand", "TBL_SCORE": 43.0 }, "treatments": [ { "START_DATE": 8, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 44, "STOP_DATE": 78.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": "46", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "gy" }, { "START_DATE": 44, "STOP_DATE": 78.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 2", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": "44", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "gy" }, { "START_DATE": 44, "STOP_DATE": 78.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 3", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": "40", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "gy" }, { "START_DATE": 80, "STOP_DATE": 101.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 4", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": "33", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "gy" }, { "START_DATE": 80, "STOP_DATE": 101.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 5", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": "30", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "gy" } ] }, "TCGA-A8-A0A9": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "7b605fb6-d077-401e-b870-b87ddf505f82", "AGE": 80, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 822.0, "DAYS_TO_BIRTH": -29370.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "5/27/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": null, "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 27.02436138, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 27.02436138, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 27.02436138, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 27.02436138, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A8-A0A9-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 33.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2626, "MSI_SENSOR_SCORE": 0.3, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.733333333, "TISSUE_SOURCE_SITE": "Indivumed", "TBL_SCORE": 55.0 }, "treatments": [ { "START_DATE": 31, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 123, "STOP_DATE": 153.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-BH-A0BZ": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "4a032bad-e726-48f2-8f39-e3acc109cc91", "AGE": 59, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 2255.0, "DAYS_TO_BIRTH": -21856.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "8/10/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 74.13617385, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 74.13617385, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 74.13617385, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 74.13617385, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A0BZ-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 20.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2835, "MSI_SENSOR_SCORE": 0.32, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 8.2, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 114.0 }, "treatments": [ { "START_DATE": 76, "STOP_DATE": 167.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 76, "STOP_DATE": 167.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 167, "STOP_DATE": 197.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 257, "STOP_DATE": 293.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "25", "RADIATION_DOSAGE": "50", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "gy" }, { "START_DATE": 257, "STOP_DATE": 293.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 2", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "25", "RADIATION_DOSAGE": "50", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "gy" }, { "START_DATE": 257, "STOP_DATE": 293.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 3", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "25", "RADIATION_DOSAGE": "45", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "gy" }, { "START_DATE": 294, "STOP_DATE": 300.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 4", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": "10", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "gy" } ] }, "TCGA-D8-A73W": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "EA8DBC7A-54C6-469C-865E-F49D00B0223D", "AGE": 79, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 244.0, "DAYS_TO_BIRTH": -29125.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/28/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8480/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 12.65739554, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 12.65739554, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 0.690403393, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 0.690403393, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D8-A73W-01", "ONCOTREE_CODE": "IMMC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Mixed Mucinous Carcinoma", "TUMOR_TYPE": "Mucinous Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "D8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 5.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.332, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.3, "TISSUE_SOURCE_SITE": "Greater Poland Cancer Center", "TBL_SCORE": 19.0 }, "treatments": [ { "START_DATE": -709, "STOP_DATE": -620.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Clinical Progressive Disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": -652, "STOP_DATE": -652.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Stable Disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Distant Site", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "1", "RADIATION_DOSAGE": "800", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-D8-A1JS": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "0d03055c-186b-418a-b614-e2035757bc3b", "AGE": 77, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 371.0, "DAYS_TO_BIRTH": -28178.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/28/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8503/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 12.19712661, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 12.19712661, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 12.19712661, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 12.19712661, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D8-A1JS-01", "ONCOTREE_CODE": "BRCNOS", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Carcinoma (NOS)", "TUMOR_TYPE": "Other", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "D8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 2.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2879, "MSI_SENSOR_SCORE": 0.02, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.633333333, "TISSUE_SOURCE_SITE": "Greater Poland Cancer Center", "TBL_SCORE": 3.0 }, "treatments": [ { "START_DATE": 14, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "20", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "hormone therapy", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": "Mg/Day", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-AR-A1AH": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "a6e11b30-3ae8-4dd1-b04c-a730c6a79746", "AGE": 51, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 3807.0, "DAYS_TO_BIRTH": -18991.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "6/13/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 125.1602722, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 125.1602722, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 125.1602722, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 37.34753592, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AR-A1AH-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AR", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 12.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2878, "MSI_SENSOR_SCORE": 1.35, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.666666667, "TISSUE_SOURCE_SITE": "Mayo", "TBL_SCORE": 229.0 }, "treatments": [] }, "TCGA-MS-A51U": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "910655DA-2C12-4572-96B7-DED616E69B4B", "AGE": 44, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 681.0, "DAYS_TO_BIRTH": -16213.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/12/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "0:LIVING", "OS_MONTHS": 22.38879574, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 22.38879574, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 22.38879574, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 22.38879574, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-MS-A51U-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "MS", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 18.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.284, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.0, "TISSUE_SOURCE_SITE": "University of Minnesota", "TBL_SCORE": 48.0 }, "treatments": [ { "START_DATE": 57, "STOP_DATE": 116.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Stable Disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 57, "STOP_DATE": 116.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Stable Disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 130, "STOP_DATE": 178.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Stable Disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 218, "STOP_DATE": 266.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Radiographic Progressive Disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-AR-A2LM": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "0BF6E772-1AA1-4F54-9A50-C1414E2F22F3", "AGE": 49, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 1935.0, "DAYS_TO_BIRTH": -18053.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "1/12/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T1", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 63.6157412, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 63.6157412, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 63.6157412, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 63.6157412, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AR-A2LM-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AR", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 4.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2864, "MSI_SENSOR_SCORE": 0.13, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.366666667, "TISSUE_SOURCE_SITE": "Mayo", "TBL_SCORE": 45.0 }, "treatments": [ { "START_DATE": 78, "STOP_DATE": 99.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 78, "STOP_DATE": 141.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 120, "STOP_DATE": 141.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 170, "STOP_DATE": 967.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-AR-A251": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "8c51bbcb-7c8d-47ad-9193-70ca157c6900", "AGE": 51, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 3030.0, "DAYS_TO_BIRTH": -18771.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "8/30/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N2", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 99.61534668, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 99.61534668, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 99.61534668, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 99.61534668, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AR-A251-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AR", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 13.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3554, "MSI_SENSOR_SCORE": 1.79, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 5.3, "TISSUE_SOURCE_SITE": "Mayo", "TBL_SCORE": 393.0 }, "treatments": [ { "START_DATE": 44, "STOP_DATE": 87.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 44, "STOP_DATE": 87.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 100, "STOP_DATE": 141.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 175, "STOP_DATE": 1969.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 160, "STOP_DATE": 195.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "25", "RADIATION_DOSAGE": "5000", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-B6-A2IU": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "9857BE0C-AECA-4A43-90B1-0535BD08E086", "AGE": 62, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "5TH", "DAYS_LAST_FOLLOWUP": 5176.0, "DAYS_TO_BIRTH": -22905.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Hispanic Or Latino", "FORM_COMPLETION_DATE": "1/11/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 170.1679982, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 170.1679982, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 170.1679982, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 138.869711, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-B6-A2IU-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "B6", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 9.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3032, "MSI_SENSOR_SCORE": 0.03, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.233333333, "TISSUE_SOURCE_SITE": "Duke", "TBL_SCORE": 17.0 }, "treatments": [] }, "TCGA-E2-A1IJ": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "b09643c2-ded5-4346-b3c5-90a48f88a02e", "AGE": 57, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE I", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 865.0, "DAYS_TO_BIRTH": -20956.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/29/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 28.43804452, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 28.43804452, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 28.43804452, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 28.43804452, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E2-A1IJ-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "E2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 6.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3479, "MSI_SENSOR_SCORE": 0.54, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.5, "TISSUE_SOURCE_SITE": "Roswell Park", "TBL_SCORE": 35.0 }, "treatments": [ { "START_DATE": 48, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": "1", "TOTAL_DOSE_UNITS": "Mg/Day", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 53, "STOP_DATE": 102.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "33", "RADIATION_DOSAGE": "6440", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-BH-A1F8": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "ee554215-bea2-4268-aaf9-784e68cdb969", "AGE": 90, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIB", "AJCC_STAGING_EDITION": "5TH", "DAYS_LAST_FOLLOWUP": NaN, "DAYS_TO_BIRTH": -32871.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/7/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N2", "PATH_T_STAGE": "T4B", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": null, "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 25.08465661, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 25.08465661, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 25.08465661, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A1F8-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 16.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3189, "MSI_SENSOR_SCORE": 0.62, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 4.333333333, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 131.0 }, "treatments": [] }, "TCGA-BH-A18R": { "demographics": { "SUBTYPE": "BRCA_Her2", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "f6e1ec78-5ad9-4879-9b7e-262d17b166ad", "AGE": 50, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": NaN, "DAYS_TO_BIRTH": -18524.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/3/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T2B", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": null, "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 37.54479403, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 37.54479403, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 37.54479403, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 37.54479403, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A18R-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 4.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2519, "MSI_SENSOR_SCORE": 0.22, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.966666667, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 214.0 }, "treatments": [] }, "TCGA-E2-A14T": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "e0929c47-cff3-4518-a188-8764af01073a", "AGE": 52, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 2311.0, "DAYS_TO_BIRTH": -19237.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/6/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 75.97724956, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 75.97724956, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 75.97724956, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 75.97724956, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E2-A14T-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "E2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 16.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2796, "MSI_SENSOR_SCORE": 0.19, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.2, "TISSUE_SOURCE_SITE": "Roswell Park", "TBL_SCORE": 235.0 }, "treatments": [ { "START_DATE": 47, "STOP_DATE": 89.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "124", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "496", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 103, "STOP_DATE": 145.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "357", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "1428", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 159, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "3", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": "1", "TOTAL_DOSE_UNITS": "Mg/Day", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 47, "STOP_DATE": 89.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "1242", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "4968", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-AC-A3BB": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "048549CF-D0A5-4743-A0A1-2004F7CC2B08", "AGE": 46, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 987.0, "DAYS_TO_BIRTH": -16983.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "2/3/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N2A", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "No", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "0:LIVING", "OS_MONTHS": 32.44895946, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 32.44895946, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 32.44895946, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 32.44895946, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-AC-A3BB-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "AC", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 13.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3178, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": NaN, "TISSUE_SOURCE_SITE": "International Genomics Consortium", "TBL_SCORE": 8.0 }, "treatments": [ { "START_DATE": 92, "STOP_DATE": 197.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 92, "STOP_DATE": 197.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 92, "STOP_DATE": 197.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 217, "STOP_DATE": 261.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "28", "RADIATION_DOSAGE": "6040", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-A8-A09V": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "cc348a26-ee11-47a4-8b51-de922967e175", "AGE": 51, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 457.0, "DAYS_TO_BIRTH": -18628.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "5/27/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": null, "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 15.02449288, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 15.02449288, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 15.02449288, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 15.02449288, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A8-A09V-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 3.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2656, "MSI_SENSOR_SCORE": 0.18, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.033333333, "TISSUE_SOURCE_SITE": "Indivumed", "TBL_SCORE": 25.0 }, "treatments": [ { "START_DATE": 123, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 31, "STOP_DATE": 92.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-A8-A08L": { "demographics": { "SUBTYPE": "BRCA_Her2", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "8bd68696-5eeb-46d7-9dc6-c39c849029a4", "AGE": 89, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": NaN, "DAYS_TO_BIRTH": -32842.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "5/27/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N2A", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": null, "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 9.99441102, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 9.99441102, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 9.99441102, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 9.99441102, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A8-A08L-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 9.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2911, "MSI_SENSOR_SCORE": 1.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 6.533333333, "TISSUE_SOURCE_SITE": "Indivumed", "TBL_SCORE": 149.0 }, "treatments": [ { "START_DATE": 31, "STOP_DATE": 61.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": "45", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "gy" } ] }, "TCGA-AR-A24X": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "491d5ebb-e9ab-4b17-acb8-630ff9fef0f2", "AGE": 52, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 3004.0, "DAYS_TO_BIRTH": -19030.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "8/30/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8522/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 98.76056153, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 98.76056153, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 98.76056153, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 98.76056153, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AR-A24X-01", "ONCOTREE_CODE": "BRCNOS", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Carcinoma (NOS)", "TUMOR_TYPE": "Mixed Histology (NOS)", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AR", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 4.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3918, "MSI_SENSOR_SCORE": 1.71, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.9, "TISSUE_SOURCE_SITE": "Mayo", "TBL_SCORE": 2.0 }, "treatments": [ { "START_DATE": 130, "STOP_DATE": 1926.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-A7-A26F": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "3b7b9c1e-a84c-47ed-983c-9e4b00cbf01a", "AGE": 55, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 738.0, "DAYS_TO_BIRTH": -20210.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "8/8/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8575/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T1", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 24.26274781, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 24.26274781, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 24.26274781, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 24.26274781, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A7-A26F-01", "ONCOTREE_CODE": "BRCNOS", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Carcinoma (NOS)", "TUMOR_TYPE": "Other", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "A7", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 9.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3293, "MSI_SENSOR_SCORE": 1.3, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.233333333, "TISSUE_SOURCE_SITE": "Christiana Healthcare", "TBL_SCORE": 54.0 }, "treatments": [ { "START_DATE": 77, "STOP_DATE": 140.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "150", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "600", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 77, "STOP_DATE": 140.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "1200", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "4800", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 178, "STOP_DATE": 224.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "33", "RADIATION_DOSAGE": "6100", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-AC-A2FM": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "B6B1DC9A-91F4-4B0A-AFD5-62C9A90C0D5E", "AGE": 87, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": NaN, "DAYS_TO_BIRTH": -31805.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "2/22/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1MI", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 26.03807082, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 26.03807082, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 25.64355459, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 25.64355459, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AC-A2FM-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AC", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 11.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3114, "MSI_SENSOR_SCORE": 0.07, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.0, "TISSUE_SOURCE_SITE": "International Genomics Consortium", "TBL_SCORE": 124.0 }, "treatments": [] }, "TCGA-E9-A1NG": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "659b0170-e914-45ff-aa55-fcb8d3dc7b8a", "AGE": 62, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 656.0, "DAYS_TO_BIRTH": -22896.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "6/23/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 25.8408127, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 25.8408127, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 25.8408127, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 25.8408127, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E9-A1NG-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "E9", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 5.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3399, "MSI_SENSOR_SCORE": 0.05, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.566666667, "TISSUE_SOURCE_SITE": "Asterand", "TBL_SCORE": 57.0 }, "treatments": [ { "START_DATE": 34, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Letrozole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 34, "STOP_DATE": 786.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-EW-A1OY": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "53ff5893-7d5e-4bcb-be9c-665fa34b7824", "AGE": 63, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 908.0, "DAYS_TO_BIRTH": -23266.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Hispanic Or Latino", "FORM_COMPLETION_DATE": "6/10/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 29.85172765, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 29.85172765, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 29.85172765, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 29.85172765, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-EW-A1OY-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "EW", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 18.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3431, "MSI_SENSOR_SCORE": 1.39, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.9, "TISSUE_SOURCE_SITE": "University of Miami", "TBL_SCORE": 195.0 }, "treatments": [ { "START_DATE": 478, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Letrozole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 109, "STOP_DATE": 161.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 109, "STOP_DATE": 161.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 180, "STOP_DATE": 308.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Stable Disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 341, "STOP_DATE": 376.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "29", "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-B6-A0IQ": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "01eef340-598c-4205-a990-cec190ac2ca5", "AGE": 40, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": "4TH", "DAYS_LAST_FOLLOWUP": 4285.0, "DAYS_TO_BIRTH": -14669.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "11/2/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1B", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 140.8751685, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 140.8751685, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 140.8751685, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 140.8751685, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-B6-A0IQ-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "B6", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 14.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": NaN, "MSI_SENSOR_SCORE": 0.53, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.166666667, "TISSUE_SOURCE_SITE": "Duke", "TBL_SCORE": 290.0 }, "treatments": [] }, "TCGA-AC-A3W5": { "demographics": { "SUBTYPE": "BRCA_Her2", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "4C313E5B-4DC3-408E-8E92-22427F74743E", "AGE": 65, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 504.0, "DAYS_TO_BIRTH": -24029.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/24/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "Yes", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 16.56968143, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 16.56968143, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 16.56968143, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-AC-A3W5-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "AC", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 23.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3228, "MSI_SENSOR_SCORE": 0.05, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 4.033333333, "TISSUE_SOURCE_SITE": "International Genomics Consortium", "TBL_SCORE": 154.0 }, "treatments": [ { "START_DATE": 56, "STOP_DATE": 139.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 56, "STOP_DATE": 139.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 56, "STOP_DATE": 392.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Targeted Molecular Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Trastuzumab", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 170, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Letrozole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 154, "STOP_DATE": 182.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "21", "RADIATION_DOSAGE": "5256", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-BH-A202": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "e7a00d67-2c26-4d1f-bd17-35f659e88bc1", "AGE": 60, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 795.0, "DAYS_TO_BIRTH": -22052.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/8/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 26.13669987, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 26.13669987, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 26.13669987, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A202-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 21.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2744, "MSI_SENSOR_SCORE": 0.07, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.866666667, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 65.0 }, "treatments": [ { "START_DATE": 47, "STOP_DATE": 169.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 47, "STOP_DATE": 169.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 182, "STOP_DATE": 231.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "25", "RADIATION_DOSAGE": "6100", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-A8-A09I": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "1557183c-aedd-4df6-b98a-3654667f7b69", "AGE": 84, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 1371.0, "DAYS_TO_BIRTH": -30711.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "5/27/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "Yes", "RACE": null, "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 45.07347865, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 45.07347865, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 45.07347865, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 45.07347865, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A8-A09I-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 16.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.275, "MSI_SENSOR_SCORE": 0.21, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 4.3, "TISSUE_SOURCE_SITE": "Indivumed", "TBL_SCORE": 231.0 }, "treatments": [ { "START_DATE": 31, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-A8-A0AB": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "22eaba28-be67-4730-9846-860bc1fca29a", "AGE": 54, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 518.0, "DAYS_TO_BIRTH": -19814.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "5/27/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": null, "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 17.02995036, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 17.02995036, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 17.02995036, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 17.02995036, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A8-A0AB-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 17.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2865, "MSI_SENSOR_SCORE": 0.22, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.0, "TISSUE_SOURCE_SITE": "Indivumed", "TBL_SCORE": 40.0 }, "treatments": [ { "START_DATE": 61, "STOP_DATE": 184.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Fluorouracil", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 61, "STOP_DATE": 184.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 61, "STOP_DATE": 184.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 214, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-B6-A0I2": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "328dfcb0-b5ae-43f2-bc87-dad0ab3df9e7", "AGE": 45, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IA", "AJCC_STAGING_EDITION": "4TH", "DAYS_LAST_FOLLOWUP": 4361.0, "DAYS_TO_BIRTH": -16702.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "11/2/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 143.3737713, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 143.3737713, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 143.3737713, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-B6-A0I2-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "B6", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 23.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2733, "MSI_SENSOR_SCORE": 0.46, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.8, "TISSUE_SOURCE_SITE": "Duke", "TBL_SCORE": 73.0 }, "treatments": [] }, "TCGA-A8-A08Z": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "d7808cbc-4b8c-467b-b2c3-f48d05b9ecab", "AGE": 76, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIB", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 1217.0, "DAYS_TO_BIRTH": -28003.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "5/27/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N3A", "PATH_T_STAGE": "T4B", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": null, "RADIATION_THERAPY": null, "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 40.01052043, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 40.01052043, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 40.01052043, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 40.01052043, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A8-A08Z-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 6.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.251, "MSI_SENSOR_SCORE": 0.16, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.966666667, "TISSUE_SOURCE_SITE": "Indivumed", "TBL_SCORE": 31.0 }, "treatments": [] }, "TCGA-E9-A2JS": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "4A831893-F4CA-4357-A756-B5E954E35DD7", "AGE": 72, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 540.0, "DAYS_TO_BIRTH": -26407.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/20/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 29.72022224, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 29.72022224, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 17.22720847, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 17.22720847, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E9-A2JS-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "E9", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 15.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3135, "MSI_SENSOR_SCORE": 0.81, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.933333333, "TISSUE_SOURCE_SITE": "Asterand", "TBL_SCORE": 149.0 }, "treatments": [ { "START_DATE": 21, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 17, "STOP_DATE": 191.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 17, "STOP_DATE": 191.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Methotrexate", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 17, "STOP_DATE": 191.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Fluorouracil", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 524, "STOP_DATE": 846.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Ancillary", "TREATMENT_SUBTYPE": null, "AGENT": "Pamidronic Acid", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 677, "STOP_DATE": 713.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Goserelin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Clinical Progressive Disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 105, "STOP_DATE": 133.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": "45", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "gy" }, { "START_DATE": 105, "STOP_DATE": 133.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 2", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": "41", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "gy" }, { "START_DATE": 105, "STOP_DATE": 133.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 3", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": "38", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "gy" } ] }, "TCGA-AO-A0JJ": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "bef7b135-a727-45e8-850a-cc4cd56c49aa", "AGE": 54, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": 1887.0, "DAYS_TO_BIRTH": -19758.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/20/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 62.0376763, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 62.0376763, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 62.0376763, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 62.0376763, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AO-A0JJ-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AO", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 4.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2537, "MSI_SENSOR_SCORE": 0.03, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.5, "TISSUE_SOURCE_SITE": "MSKCC", "TBL_SCORE": 13.0 }, "treatments": [ { "START_DATE": 56, "STOP_DATE": 98.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "60", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "480", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 154, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Letrozole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "2.5", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 112, "STOP_DATE": 112.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": "1", "PRESCRIBED_DOSE": "175", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "350", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 126, "STOP_DATE": 154.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": "3", "PRESCRIBED_DOSE": "200", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "1280", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 56, "STOP_DATE": 98.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "600", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "4800", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 217, "STOP_DATE": 256.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "25", "RADIATION_DOSAGE": "10000", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-LL-A442": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "3F56D67F-5A9C-4353-9408-E7F60EB6477B", "AGE": 56, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 889.0, "DAYS_TO_BIRTH": -20495.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "10/26/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "Yes", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "0:LIVING", "OS_MONTHS": 29.22707696, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 29.22707696, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 29.22707696, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 29.22707696, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-LL-A442-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "LL", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": NaN, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": NaN, "TISSUE_SOURCE_SITE": "Candler", "TBL_SCORE": 2.0 }, "treatments": [ { "START_DATE": 111, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-GM-A2DK": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "3A0775A0-61AE-43F2-B5F6-629A44355C2F", "AGE": 58, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE I", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 2645.0, "DAYS_TO_BIRTH": -21198.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/29/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 86.95795115, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 86.95795115, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 86.95795115, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 86.95795115, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-GM-A2DK-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "GM", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 6.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2912, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.666666667, "TISSUE_SOURCE_SITE": "MD Anderson", "TBL_SCORE": 104.0 }, "treatments": [ { "START_DATE": 79, "STOP_DATE": 1893.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 93, "STOP_DATE": 135.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "30", "RADIATION_DOSAGE": "60", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "gy" } ] }, "TCGA-BH-A1FE": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "4aa68586-6331-4795-b40c-859386640df6", "AGE": 31, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "5TH", "DAYS_LAST_FOLLOWUP": NaN, "DAYS_TO_BIRTH": -11650.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/8/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": null, "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 74.72794819, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 74.72794819, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 74.72794819, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A1FE-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 6.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3192, "MSI_SENSOR_SCORE": 0.03, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.633333333, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 277.0 }, "treatments": [] }, "TCGA-B6-A3ZX": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "9434687A-197C-4959-B6B8-9C05F1DD7F53", "AGE": 50, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 1132.0, "DAYS_TO_BIRTH": -18434.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/20/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8522/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M1", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 37.87355755, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 37.87355755, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 32.67909393, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-B6-A3ZX-01", "ONCOTREE_CODE": "BRCNOS", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Carcinoma (NOS)", "TUMOR_TYPE": "Mixed Histology (NOS)", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "B6", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 19.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3137, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.0, "TISSUE_SOURCE_SITE": "Duke", "TBL_SCORE": 60.0 }, "treatments": [ { "START_DATE": 91, "STOP_DATE": 147.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 91, "STOP_DATE": 147.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 148, "STOP_DATE": 225.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 354, "STOP_DATE": 386.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "25", "RADIATION_DOSAGE": "200", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-D8-A1XD": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "c4699748-f01d-4b30-9c74-1ca77fb84ac1", "AGE": 36, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 522.0, "DAYS_TO_BIRTH": -13510.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/16/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N2A", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "0:LIVING", "OS_MONTHS": 17.16145577, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 17.16145577, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 17.16145577, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 17.16145577, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D8-A1XD-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "D8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 6.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": NaN, "MSI_SENSOR_SCORE": NaN, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.0, "TISSUE_SOURCE_SITE": "Greater Poland Cancer Center", "TBL_SCORE": 161.0 }, "treatments": [ { "START_DATE": 109, "STOP_DATE": 138.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "25", "RADIATION_DOSAGE": "4500", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-E9-A1NH": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "b2aac45b-2073-4c7a-adb9-769a4fdcc111", "AGE": 71, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 576.0, "DAYS_TO_BIRTH": -26221.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "6/23/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 18.93677878, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 18.93677878, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 18.93677878, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 18.93677878, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E9-A1NH-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "E9", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 19.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3135, "MSI_SENSOR_SCORE": 0.38, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.833333333, "TISSUE_SOURCE_SITE": "Asterand", "TBL_SCORE": 12.0 }, "treatments": [ { "START_DATE": 33, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-E9-A22G": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "56033839-35d5-4d72-8b8c-400cb345263d", "AGE": 47, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 1239.0, "DAYS_TO_BIRTH": -17300.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "8/2/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 40.73380018, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 40.73380018, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 40.73380018, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 40.73380018, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E9-A22G-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "E9", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 11.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3397, "MSI_SENSOR_SCORE": 1.64, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.7, "TISSUE_SOURCE_SITE": "Asterand", "TBL_SCORE": 235.0 }, "treatments": [ { "START_DATE": 31, "STOP_DATE": 170.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "6", "PRESCRIBED_DOSE": "800", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "3200", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 14, "STOP_DATE": 136.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "6", "PRESCRIBED_DOSE": "80", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "320", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-BH-A42U": { "demographics": { "SUBTYPE": "BRCA_Normal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "2DC1CEC9-925A-417F-9E21-3C2143E711B4", "AGE": 80, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 3364.0, "DAYS_TO_BIRTH": -29330.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "10/1/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 110.5960483, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 110.5960483, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 110.5960483, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 110.5960483, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-BH-A42U-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": NaN, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2876, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.633333333, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 1.0 }, "treatments": [] }, "TCGA-BH-A0E2": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "8ace3b8c-f23e-48a9-a137-9e046bd9549b", "AGE": 49, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": 435.0, "DAYS_TO_BIRTH": -18152.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "11/9/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N2A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 14.30121314, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 14.30121314, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 14.30121314, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 14.30121314, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-BH-A0E2-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 6.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2493, "MSI_SENSOR_SCORE": 0.64, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.433333333, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 221.0 }, "treatments": [ { "START_DATE": 256, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "20", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 81, "STOP_DATE": 151.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "1104", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "4392", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 81, "STOP_DATE": 151.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "110", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "438", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 172, "STOP_DATE": 221.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": "11", "PRESCRIBED_DOSE": "146", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "1589", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-AR-A2LK": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "1B703058-E596-45BC-80FE-8B98D545C2E2", "AGE": 62, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 1304.0, "DAYS_TO_BIRTH": -22800.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "1/25/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N2", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 54.21310451, "DSS_STATUS": null, "DSS_MONTHS": 54.21310451, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 42.87076306, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 42.87076306, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AR-A2LK-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AR", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 26.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3271, "MSI_SENSOR_SCORE": 1.05, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.066666667, "TISSUE_SOURCE_SITE": "Mayo", "TBL_SCORE": 32.0 }, "treatments": [ { "START_DATE": 263, "STOP_DATE": 1310.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 218, "STOP_DATE": 262.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "33", "RADIATION_DOSAGE": "6100", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-E2-A14N": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "752ad011-79e0-494f-9868-98bf6feb28f8", "AGE": 37, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 1434.0, "DAYS_TO_BIRTH": -13743.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/31/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 47.14468883, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 47.14468883, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 47.14468883, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 47.14468883, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E2-A14N-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "E2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 19.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2559, "MSI_SENSOR_SCORE": 0.05, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.566666667, "TISSUE_SOURCE_SITE": "Roswell Park", "TBL_SCORE": 127.0 }, "treatments": [ { "START_DATE": 64, "STOP_DATE": 64.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "1", "PRESCRIBED_DOSE": "110", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "110", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 64, "STOP_DATE": 148.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "5", "PRESCRIBED_DOSE": "1100", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "5444", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 87, "STOP_DATE": 148.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "135", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "540", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 181, "STOP_DATE": 236.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "28", "RADIATION_DOSAGE": "5040", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-A2-A0ES": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "a2934508-3daf-49e2-b14f-ed9b7693f96f", "AGE": 52, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 2190.0, "DAYS_TO_BIRTH": -19160.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "1/25/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 71.99921097, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 71.99921097, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 71.99921097, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 71.99921097, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A2-A0ES-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2529, "MSI_SENSOR_SCORE": 0.04, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.433333333, "TISSUE_SOURCE_SITE": "Walter Reed", "TBL_SCORE": 34.0 }, "treatments": [ { "START_DATE": 77, "STOP_DATE": 141.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "1180-1280", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "5018", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 77, "STOP_DATE": 141.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "160", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "640", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 203, "STOP_DATE": 458.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "3", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 459, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Exemestane", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "25", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "4", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-BH-A0DS": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "fb57c598-b45b-478a-9d34-ca1f050d5b7c", "AGE": 71, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 78.0, "DAYS_TO_BIRTH": -25944.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "11/9/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N2A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 2.564355459, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 2.564355459, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 2.564355459, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 2.564355459, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A0DS-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 26.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2815, "MSI_SENSOR_SCORE": 0.58, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.166666667, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 25.0 }, "treatments": [ { "START_DATE": 47, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 78, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 245, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": "Yes", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-AO-A03M": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "095c7985-3842-494f-b591-706ad1cd2133", "AGE": 29, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE I", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 1866.0, "DAYS_TO_BIRTH": -10616.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "1/9/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 61.34727291, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 61.34727291, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 61.34727291, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 61.34727291, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AO-A03M-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AO", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 14.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": NaN, "MSI_SENSOR_SCORE": 0.07, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 25.26666667, "TISSUE_SOURCE_SITE": "MSKCC", "TBL_SCORE": 131.0 }, "treatments": [ { "START_DATE": 63, "STOP_DATE": 105.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "60", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "376", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 119, "STOP_DATE": 161.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "175", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "1100", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 161, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "20", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 63, "STOP_DATE": 105.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "600", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "3768", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-D8-A1XT": { "demographics": { "SUBTYPE": "BRCA_Her2", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "64975923-d032-4182-8565-59fc37127d8d", "AGE": 61, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 506.0, "DAYS_TO_BIRTH": -22448.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/16/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 16.63543413, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 16.63543413, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 16.63543413, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 16.63543413, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D8-A1XT-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "D8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 12.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2853, "MSI_SENSOR_SCORE": 0.57, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.166666667, "TISSUE_SOURCE_SITE": "Greater Poland Cancer Center", "TBL_SCORE": 243.0 }, "treatments": [ { "START_DATE": 74, "STOP_DATE": 228.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin + Cyclophosphamide", "NUMBER_OF_CYCLES": "6", "PRESCRIBED_DOSE": "60+600", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "360+3600", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-AR-A24U": { "demographics": { "SUBTYPE": "BRCA_Her2", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "241fffc8-4250-4cfa-b2e7-e68c33ae07dc", "AGE": 47, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 2363.0, "DAYS_TO_BIRTH": -17523.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "8/26/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T1", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 102.8372292, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 102.8372292, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 102.8372292, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 102.8372292, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AR-A24U-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AR", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 8.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3456, "MSI_SENSOR_SCORE": 0.49, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.133333333, "TISSUE_SOURCE_SITE": "Mayo", "TBL_SCORE": 178.0 }, "treatments": [ { "START_DATE": 55, "STOP_DATE": 97.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 55, "STOP_DATE": 97.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 111, "STOP_DATE": 188.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 111, "STOP_DATE": 111.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Immunotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Trastuzumab", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 118, "STOP_DATE": 476.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Immunotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Trastuzumab", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 118, "STOP_DATE": 476.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Immunotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Trastuzumab", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 207, "STOP_DATE": 246.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "30", "RADIATION_DOSAGE": "6000", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-C8-A1HF": { "demographics": { "SUBTYPE": "BRCA_Her2", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "a2453bcb-90f2-4505-949d-a89cf4bfc9b8", "AGE": 48, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 332.0, "DAYS_TO_BIRTH": NaN, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/24/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Asian", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 10.91494888, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 10.91494888, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 10.91494888, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 10.91494888, "GENETIC_ANCESTRY_LABEL": "EAS" }, "sample": { "SAMPLE_ID": "TCGA-C8-A1HF-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "C8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 24.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2797, "MSI_SENSOR_SCORE": 0.41, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.9, "TISSUE_SOURCE_SITE": "ILSBio", "TBL_SCORE": 93.0 }, "treatments": [] }, "TCGA-AR-A1AO": { "demographics": { "SUBTYPE": "BRCA_Normal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "623befd6-0ca4-4a6c-9cf5-d9385c3b718f", "AGE": 47, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 2618.0, "DAYS_TO_BIRTH": -17332.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "6/13/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T1", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 86.07028964, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 86.07028964, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 86.07028964, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 86.07028964, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AR-A1AO-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AR", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.261, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 3.0, "TISSUE_SOURCE_SITE": "Mayo", "TBL_SCORE": 7.0 }, "treatments": [ { "START_DATE": 160, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "20", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 139, "STOP_DATE": 139.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": "1", "PRESCRIBED_DOSE": "175", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "310", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 76, "STOP_DATE": 118.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "600", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "4250", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 76, "STOP_DATE": 118.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "60", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "425", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 168, "STOP_DATE": 210.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "30", "RADIATION_DOSAGE": "6000", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-BH-A0HI": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "e0375a8b-a135-4103-a59d-39063fcf4a6f", "AGE": 78, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IA", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": 620.0, "DAYS_TO_BIRTH": -28644.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "11/10/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 20.38333827, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 20.38333827, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 20.38333827, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 20.38333827, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A0HI-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 2.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.272, "MSI_SENSOR_SCORE": 0.01, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.033333333, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 17.0 }, "treatments": [ { "START_DATE": 88, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 96, "STOP_DATE": 141.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "33", "RADIATION_DOSAGE": "6040", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-A1-A0SJ": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "a2db9dd1-44d5-48b5-817c-a21a85fadb21", "AGE": 39, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 416.0, "DAYS_TO_BIRTH": -14383.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/6/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": null, "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 13.67656245, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 13.67656245, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 13.67656245, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 13.67656245, "GENETIC_ANCESTRY_LABEL": "AFR_ADMIX" }, "sample": { "SAMPLE_ID": "TCGA-A1-A0SJ-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A1", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 24.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.292, "MSI_SENSOR_SCORE": 0.37, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.033333333, "TISSUE_SOURCE_SITE": "UCSF", "TBL_SCORE": 297.0 }, "treatments": [] }, "TCGA-E9-A1RC": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "5cdae21d-eee5-478f-932a-0f51fcf5f031", "AGE": 56, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIC", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 1224.0, "DAYS_TO_BIRTH": -20795.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/28/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8522/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N3", "PATH_T_STAGE": "T4B", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 40.2406549, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 40.2406549, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 40.2406549, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 40.2406549, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E9-A1RC-01", "ONCOTREE_CODE": "BRCNOS", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Carcinoma (NOS)", "TUMOR_TYPE": "Mixed Histology (NOS)", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "E9", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 28.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3181, "MSI_SENSOR_SCORE": 0.86, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.266666667, "TISSUE_SOURCE_SITE": "Asterand", "TBL_SCORE": 92.0 }, "treatments": [ { "START_DATE": 1220, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "20", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Palliative", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 1222, "STOP_DATE": 1222.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Mitomycin", "NUMBER_OF_CYCLES": "1", "PRESCRIBED_DOSE": "20", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Palliative", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "20", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 1222, "STOP_DATE": 1222.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Mitoxantrone", "NUMBER_OF_CYCLES": "1", "PRESCRIBED_DOSE": "20", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Palliative", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "20", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 1222, "STOP_DATE": 1222.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Methotrexate", "NUMBER_OF_CYCLES": "1", "PRESCRIBED_DOSE": "70", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Palliative", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "70", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-AN-A0XW": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "39de7761-e762-4811-b95c-8216b79ae06b", "AGE": 36, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 170.0, "DAYS_TO_BIRTH": -13208.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/29/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N2", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 5.588979847, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 5.588979847, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 5.588979847, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 5.588979847, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AN-A0XW-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AN", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 6.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2638, "MSI_SENSOR_SCORE": 0.21, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 9.6, "TISSUE_SOURCE_SITE": "Cureline", "TBL_SCORE": 158.0 }, "treatments": [] }, "TCGA-E9-A1N8": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "ac075bc0-1b59-4557-beea-541694faee03", "AGE": 48, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 1039.0, "DAYS_TO_BIRTH": -17652.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "6/23/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 34.15852977, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 34.15852977, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 34.15852977, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 34.15852977, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E9-A1N8-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "E9", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 10.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.361, "MSI_SENSOR_SCORE": 2.08, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.066666667, "TISSUE_SOURCE_SITE": "Asterand", "TBL_SCORE": 133.0 }, "treatments": [ { "START_DATE": 22, "STOP_DATE": 107.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "800", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "3200", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 22, "STOP_DATE": 107.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Fluorouracil", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "800", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "3200", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 22, "STOP_DATE": 107.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "80", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "320", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-AO-A0J7": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "9536bec0-dae0-4d63-a1b3-956741835243", "AGE": 71, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": 618.0, "DAYS_TO_BIRTH": -26281.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/19/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8523/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 20.31758556, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 20.31758556, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 20.31758556, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 20.31758556, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AO-A0J7-01", "ONCOTREE_CODE": "BRCNOS", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Carcinoma (NOS)", "TUMOR_TYPE": "Other", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AO", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 15.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2727, "MSI_SENSOR_SCORE": 1.24, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.6, "TISSUE_SOURCE_SITE": "MSKCC", "TBL_SCORE": 5.0 }, "treatments": [ { "START_DATE": 97, "STOP_DATE": 140.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "60", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "440", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 97, "STOP_DATE": 140.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "600", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "4400", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 154, "STOP_DATE": 195.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "175", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "1280", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 202, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 258, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "17", "RADIATION_DOSAGE": "3060", "RADIATION_TREATMENT_ONGOING": "Yes", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-EW-A6SC": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "97862B8E-9F76-4B19-A865-156A9C00FB1E", "AGE": 60, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 952.0, "DAYS_TO_BIRTH": -21918.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/12/2015", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 31.29828714, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 31.29828714, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 31.29828714, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 31.29828714, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-EW-A6SC-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": null, "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": null, "TISSUE_SOURCE_SITE_CODE": "EW", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 5.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3447, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.866666667, "TISSUE_SOURCE_SITE": "University of Miami", "TBL_SCORE": 91.0 }, "treatments": [ { "START_DATE": 114, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Exemestane", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 162, "STOP_DATE": 169.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "10", "RADIATION_DOSAGE": "38.5", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-A2-A0CW": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "32efa6e8-6b19-480a-9d04-ace02e93318a", "AGE": 67, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 3283.0, "DAYS_TO_BIRTH": -24541.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "1/28/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 107.9330638, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 107.9330638, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 107.9330638, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 107.9330638, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A2-A0CW-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 15.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2846, "MSI_SENSOR_SCORE": 0.32, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.166666667, "TISSUE_SOURCE_SITE": "Walter Reed", "TBL_SCORE": 343.0 }, "treatments": [ { "START_DATE": 156, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-AR-A5QN": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "077506EA-8F11-405D-BB8E-3C9924FE54D0", "AGE": 68, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIC", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 1013.0, "DAYS_TO_BIRTH": -25089.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/15/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N3", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 33.30374462, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 33.30374462, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 33.30374462, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AR-A5QN-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AR", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 6.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2848, "MSI_SENSOR_SCORE": 0.03, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.0, "TISSUE_SOURCE_SITE": "Mayo", "TBL_SCORE": 61.0 }, "treatments": [ { "START_DATE": 39, "STOP_DATE": 102.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 39, "STOP_DATE": 102.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 128, "STOP_DATE": 388.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 388, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Exemestane", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 136, "STOP_DATE": 173.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "28", "RADIATION_DOSAGE": "5040", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-D8-A147": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "fc18d029-9be2-4fa0-9aef-6d647dc55f0b", "AGE": 45, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 584.0, "DAYS_TO_BIRTH": -16736.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "2/27/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 19.19978959, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 19.19978959, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 19.19978959, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 19.19978959, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D8-A147-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "D8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 11.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2934, "MSI_SENSOR_SCORE": 0.62, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 4.9, "TISSUE_SOURCE_SITE": "Greater Poland Cancer Center", "TBL_SCORE": 252.0 }, "treatments": [ { "START_DATE": 21, "STOP_DATE": 135.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "5", "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 21, "STOP_DATE": 135.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 21, "STOP_DATE": 135.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 21, "STOP_DATE": 135.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 188, "STOP_DATE": 223.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "1 brachy+25", "RADIATION_DOSAGE": "6000", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-E2-A1L7": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "791c5768-f0f5-4ab6-86eb-998e5c4b49e3", "AGE": 40, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 1836.0, "DAYS_TO_BIRTH": -14854.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "6/1/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N2", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 60.36098235, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 60.36098235, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 53.22681395, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 53.22681395, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E2-A1L7-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "E2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 6.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3365, "MSI_SENSOR_SCORE": 0.93, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.066666667, "TISSUE_SOURCE_SITE": "Roswell Park", "TBL_SCORE": 192.0 }, "treatments": [ { "START_DATE": 97, "STOP_DATE": 153.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "359", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "1436", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 170, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Other", "TREATMENT_SUBTYPE": "Phase III Clinical Trial", "AGENT": "Clodronic Acid", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1600", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "3", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": "1600", "TOTAL_DOSE_UNITS": "Mg/Day", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 41, "STOP_DATE": 83.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "120", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "480", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 41, "STOP_DATE": 83.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "1200", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "4800", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 240, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "4", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": "1", "TOTAL_DOSE_UNITS": "Mg/Day", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 191, "STOP_DATE": 237.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "33", "RADIATION_DOSAGE": "6040", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" }, { "START_DATE": 1694, "STOP_DATE": 1735.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 2", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "30", "RADIATION_DOSAGE": "60", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "gy" } ] }, "TCGA-BH-A18F": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "bfd49783-1767-469b-9d79-7822301c5efc", "AGE": 50, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 1001.0, "DAYS_TO_BIRTH": -18594.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "6/1/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 32.90922839, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 32.90922839, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 32.90922839, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 32.90922839, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A18F-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 21.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2742, "MSI_SENSOR_SCORE": 0.02, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.566666667, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 12.0 }, "treatments": [ { "START_DATE": 101, "STOP_DATE": 189.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 101, "STOP_DATE": 189.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 189, "STOP_DATE": 223.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "25", "RADIATION_DOSAGE": "5000", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" }, { "START_DATE": 224, "STOP_DATE": 233.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 2", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "8", "RADIATION_DOSAGE": "1600", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-E2-A1IF": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "718db047-9f32-48c4-98c9-515218441bca", "AGE": 74, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE I", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 1138.0, "DAYS_TO_BIRTH": -27341.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/28/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 37.41328862, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 37.41328862, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 37.41328862, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 37.41328862, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E2-A1IF-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "E2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 6.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3328, "MSI_SENSOR_SCORE": 0.11, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.633333333, "TISSUE_SOURCE_SITE": "Roswell Park", "TBL_SCORE": 4.0 }, "treatments": [ { "START_DATE": 41, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": "1", "TOTAL_DOSE_UNITS": "Mg/Day", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-C8-A12L": { "demographics": { "SUBTYPE": "BRCA_Her2", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "441919eb-8c9f-478c-bda3-8de4f8295e8a", "AGE": 67, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 363.0, "DAYS_TO_BIRTH": -24710.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/12/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Asian", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 11.93411579, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 11.93411579, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 11.93411579, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 11.93411579, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-C8-A12L-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "C8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 16.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2814, "MSI_SENSOR_SCORE": 0.81, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.433333333, "TISSUE_SOURCE_SITE": "ILSBio", "TBL_SCORE": 292.0 }, "treatments": [] }, "TCGA-AR-A1AR": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "eda6d2d5-4199-4f76-a45b-1d0401b4e54c", "AGE": 50, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": NaN, "DAYS_TO_BIRTH": -18482.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "6/28/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N2", "PATH_T_STAGE": "T1", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 17.22720847, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 17.22720847, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 8.810862347, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 8.810862347, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AR-A1AR-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AR", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 17.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2662, "MSI_SENSOR_SCORE": 0.03, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.566666667, "TISSUE_SOURCE_SITE": "Mayo", "TBL_SCORE": 179.0 }, "treatments": [] }, "TCGA-D8-A4Z1": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "80419545-4E5D-4BAF-8948-F84589B5EF3E", "AGE": 68, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 659.0, "DAYS_TO_BIRTH": -25097.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "2/1/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 21.66551599, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 21.66551599, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 21.66551599, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 21.66551599, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D8-A4Z1-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "D8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 1.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2876, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.0, "TISSUE_SOURCE_SITE": "Greater Poland Cancer Center", "TBL_SCORE": 7.0 }, "treatments": [ { "START_DATE": 104, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-A8-A09N": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "33919e92-4ea9-47e5-a6f4-36e51845d50f", "AGE": 57, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIC", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 31.0, "DAYS_TO_BIRTH": -21002.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "5/27/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N3A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": null, "RADIATION_THERAPY": null, "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 1.019166913, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 1.019166913, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 1.019166913, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 1.019166913, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A8-A09N-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 14.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2927, "MSI_SENSOR_SCORE": 0.97, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.966666667, "TISSUE_SOURCE_SITE": "Indivumed", "TBL_SCORE": 327.0 }, "treatments": [] }, "TCGA-A7-A6VV": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "57AF5C72-0D60-4A6B-B1B4-EC6DAB90F80F", "AGE": 51, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 313.0, "DAYS_TO_BIRTH": -18695.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "10/22/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 10.29029819, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 10.29029819, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 10.29029819, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 10.29029819, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-A7-A6VV-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "A7", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 23.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3488, "MSI_SENSOR_SCORE": 0.17, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.433333333, "TISSUE_SOURCE_SITE": "Christiana Healthcare", "TBL_SCORE": 346.0 }, "treatments": [ { "START_DATE": 160, "STOP_DATE": 266.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 160, "STOP_DATE": 266.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-BH-A0E7": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "d3b9d925-ae04-4721-8bfc-50b41225bc74", "AGE": 79, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": 1363.0, "DAYS_TO_BIRTH": -29115.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "11/9/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 44.81046783, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 44.81046783, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 44.81046783, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 44.81046783, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A0E7-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 4.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.267, "MSI_SENSOR_SCORE": 0.01, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.366666667, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 6.0 }, "treatments": [ { "START_DATE": 26, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 74, "STOP_DATE": 124.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "33", "RADIATION_DOSAGE": "5940", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-AN-A041": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "316e021c-5175-4ab3-bdb6-2bf9683f657a", "AGE": 29, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 7.0, "DAYS_TO_BIRTH": -10812.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/1/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 0.230134464, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 0.230134464, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 0.230134464, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 0.230134464, "GENETIC_ANCESTRY_LABEL": "EUR_ADMIX" }, "sample": { "SAMPLE_ID": "TCGA-AN-A041-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AN", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 14.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2731, "MSI_SENSOR_SCORE": 0.32, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.933333333, "TISSUE_SOURCE_SITE": "Cureline", "TBL_SCORE": 117.0 }, "treatments": [] }, "TCGA-A8-A09Q": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "09c2bc35-c21f-4aa4-ac30-0d8db02ad811", "AGE": 83, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIB", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 761.0, "DAYS_TO_BIRTH": -30528.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "5/27/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N2A", "PATH_T_STAGE": "T4B", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": null, "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 25.0189039, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 25.0189039, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 25.0189039, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A8-A09Q-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 24.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2681, "MSI_SENSOR_SCORE": 0.94, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 4.3, "TISSUE_SOURCE_SITE": "Indivumed", "TBL_SCORE": 598.0 }, "treatments": [ { "START_DATE": 31, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-B6-A0I6": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "045c13ef-3db7-4adf-b0a3-23338f0479f3", "AGE": 49, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "3RD", "DAYS_LAST_FOLLOWUP": NaN, "DAYS_TO_BIRTH": -18014.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "11/2/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 32.58046487, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 32.58046487, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 28.2407864, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 28.2407864, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-B6-A0I6-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "B6", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": NaN, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2894, "MSI_SENSOR_SCORE": 2.69, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.0, "TISSUE_SOURCE_SITE": "Duke", "TBL_SCORE": 402.0 }, "treatments": [] }, "TCGA-E2-A1LS": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "91a2f2af-e4b1-4a0b-ab20-6a36ce63c533", "AGE": 46, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 1604.0, "DAYS_TO_BIRTH": -16887.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "6/3/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "0:LIVING", "OS_MONTHS": 52.73366867, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 52.73366867, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 52.73366867, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 52.73366867, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E2-A1LS-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "E2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": NaN, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3313, "MSI_SENSOR_SCORE": 2.68, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.1, "TISSUE_SOURCE_SITE": "Roswell Park", "TBL_SCORE": NaN }, "treatments": [] }, "TCGA-A8-A07C": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "b6633c36-7ce4-4b69-9bf6-30b64d46c66f", "AGE": 57, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 1034.0, "DAYS_TO_BIRTH": -20820.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "5/27/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": null, "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "0:LIVING", "OS_MONTHS": 33.99414801, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 33.99414801, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 33.99414801, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 33.99414801, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A8-A07C-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": NaN, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": NaN, "MSI_SENSOR_SCORE": 1.74, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 4.566666667, "TISSUE_SOURCE_SITE": "Indivumed", "TBL_SCORE": 312.0 }, "treatments": [ { "START_DATE": 0, "STOP_DATE": 62.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Fluorouracil", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 0, "STOP_DATE": 62.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Epirubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 0, "STOP_DATE": 62.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 92, "STOP_DATE": 123.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 153, "STOP_DATE": 184.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "gy" } ] }, "TCGA-PE-A5DE": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "89C128B9-1C6B-4C04-A4AF-7066772E783C", "AGE": 41, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 2645.0, "DAYS_TO_BIRTH": -15216.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "4/24/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 86.95795115, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 86.95795115, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 86.95795115, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-PE-A5DE-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "PE", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 23.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2918, "MSI_SENSOR_SCORE": 0.01, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 13.06666667, "TISSUE_SOURCE_SITE": "Fox Chase", "TBL_SCORE": 16.0 }, "treatments": [ { "START_DATE": 42, "STOP_DATE": 105.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 42, "STOP_DATE": 105.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 182, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 124, "STOP_DATE": 167.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "32", "RADIATION_DOSAGE": "4600", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-E2-A15I": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "64089c20-939f-48b4-ae8b-904ad0597145", "AGE": 44, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 1692.0, "DAYS_TO_BIRTH": -16163.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/13/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 55.62678765, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 55.62678765, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 55.62678765, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 55.62678765, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E2-A15I-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "E2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 7.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2653, "MSI_SENSOR_SCORE": 0.48, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.9, "TISSUE_SOURCE_SITE": "Roswell Park", "TBL_SCORE": 13.0 }, "treatments": [ { "START_DATE": 41, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "20", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": "20", "TOTAL_DOSE_UNITS": "Mg/Day", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-A8-A0A6": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "4b0d295c-e185-4b52-9752-178e5bc1d47d", "AGE": 64, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIC", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 640.0, "DAYS_TO_BIRTH": -23404.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "5/27/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N3A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": null, "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 21.04086531, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 21.04086531, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 21.04086531, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 21.04086531, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A8-A0A6-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 17.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2919, "MSI_SENSOR_SCORE": 0.12, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.866666667, "TISSUE_SOURCE_SITE": "Indivumed", "TBL_SCORE": 56.0 }, "treatments": [ { "START_DATE": 61, "STOP_DATE": 184.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Epirubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 61, "STOP_DATE": 184.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 214, "STOP_DATE": 245.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Exemestane", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 245, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 306, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Ancillary", "TREATMENT_SUBTYPE": null, "AGENT": "Zoledronic Acid", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 214, "STOP_DATE": 275.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "gy" } ] }, "TCGA-HN-A2OB": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "61204CDF-3B1C-44A1-BDA6-0FEF1AC4A333", "AGE": 45, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 1883.0, "DAYS_TO_BIRTH": -16672.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "9/26/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": null, "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 62.46506888, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 62.46506888, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 50.7282112, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 50.7282112, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-HN-A2OB-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "HN", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 2.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2932, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.633333333, "TISSUE_SOURCE_SITE": "Ontario Institute for Cancer Research (OICR)", "TBL_SCORE": 30.0 }, "treatments": [ { "START_DATE": 105, "STOP_DATE": 147.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Fluorouracil", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 105, "STOP_DATE": 147.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Epirubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 105, "STOP_DATE": 147.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 168, "STOP_DATE": 210.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 242, "STOP_DATE": 276.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "25", "RADIATION_DOSAGE": "50", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "gy" } ] }, "TCGA-A2-A0YI": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "72cd1b17-d349-4551-83f7-3062ce9db865", "AGE": 62, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE I", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 1505.0, "DAYS_TO_BIRTH": -22961.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/14/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8522/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I+)", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 49.47890982, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 49.47890982, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 49.47890982, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 49.47890982, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A2-A0YI-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 4.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2845, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.4, "TISSUE_SOURCE_SITE": "Walter Reed", "TBL_SCORE": 46.0 }, "treatments": [ { "START_DATE": 77, "STOP_DATE": 116.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "30", "RADIATION_DOSAGE": "6000", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-A2-A04T": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "b58ad350-5140-4fa8-bc2c-24bca8395f3a", "AGE": 62, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 2246.0, "DAYS_TO_BIRTH": -22707.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "8/9/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 73.84028668, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 73.84028668, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 73.84028668, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 73.84028668, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A2-A04T-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 14.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2887, "MSI_SENSOR_SCORE": 1.39, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.933333333, "TISSUE_SOURCE_SITE": "Walter Reed", "TBL_SCORE": 206.0 }, "treatments": [ { "START_DATE": 75, "STOP_DATE": 117.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "1150", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "4600", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 75, "STOP_DATE": 117.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "58", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "232", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 131, "STOP_DATE": 173.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": "3", "PRESCRIBED_DOSE": "250-338", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "838", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 206, "STOP_DATE": 249.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": "6040", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-AR-A252": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "4d0fec97-e024-4608-a0cc-426a3decc7b1", "AGE": 50, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE I", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 2838.0, "DAYS_TO_BIRTH": -18611.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "8/30/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T1", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 93.30308709, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 93.30308709, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 93.30308709, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 93.30308709, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AR-A252-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AR", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 16.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3281, "MSI_SENSOR_SCORE": 0.21, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.466666667, "TISSUE_SOURCE_SITE": "Mayo", "TBL_SCORE": 99.0 }, "treatments": [ { "START_DATE": 55, "STOP_DATE": 97.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 55, "STOP_DATE": 97.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 116, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 118, "STOP_DATE": 159.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "30", "RADIATION_DOSAGE": "6000", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-BH-A0HF": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "17ca61a2-607a-45ff-88fa-ef72e80bf891", "AGE": 77, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IA", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": 727.0, "DAYS_TO_BIRTH": -28233.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "11/10/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "0:LIVING", "OS_MONTHS": 23.90110793, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 23.90110793, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 23.90110793, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 23.90110793, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A0HF-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": NaN, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2482, "MSI_SENSOR_SCORE": 0.19, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 28.0, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 31.0 }, "treatments": [ { "START_DATE": 34, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 64, "STOP_DATE": 111.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "33", "RADIATION_DOSAGE": "6040", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-E2-A1B0": { "demographics": { "SUBTYPE": "BRCA_Her2", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "996bd3f0-d767-4eff-9c82-99fcb5a3006a", "AGE": 50, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 1631.0, "DAYS_TO_BIRTH": -18346.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/25/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N2", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 53.62133018, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 53.62133018, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 53.62133018, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 53.62133018, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E2-A1B0-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "E2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 27.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2831, "MSI_SENSOR_SCORE": 0.58, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.4, "TISSUE_SOURCE_SITE": "Roswell Park", "TBL_SCORE": 272.0 }, "treatments": [ { "START_DATE": 140, "STOP_DATE": 217.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": "6", "PRESCRIBED_DOSE": "160", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "1920", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 231, "STOP_DATE": 557.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Trastuzumab", "NUMBER_OF_CYCLES": "16", "PRESCRIBED_DOSE": "545", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "3", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "8720", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 35, "STOP_DATE": 119.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "6", "PRESCRIBED_DOSE": "1260", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "7560", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 35, "STOP_DATE": 119.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "6", "PRESCRIBED_DOSE": "126", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "756", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 257, "STOP_DATE": 300.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "30", "RADIATION_DOSAGE": "6000", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-5L-AAT0": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "86C6F993-327F-4525-9983-29C55625593A", "AGE": 42, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 1477.0, "DAYS_TO_BIRTH": -15393.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Hispanic Or Latino", "FORM_COMPLETION_DATE": "8/15/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 48.55837196, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 48.55837196, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 48.55837196, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-5L-AAT0-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "5L", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 3.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3208, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 4.6, "TISSUE_SOURCE_SITE": "University of Sao Paulo", "TBL_SCORE": 28.0 }, "treatments": [ { "START_DATE": 322, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 371, "STOP_DATE": 411.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "25", "RADIATION_DOSAGE": "5000", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-E2-A15D": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "c85f080a-1075-41df-959f-1b514a11b3c4", "AGE": 47, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 526.0, "DAYS_TO_BIRTH": -17224.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/13/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 17.29296117, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 17.29296117, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 17.29296117, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 17.29296117, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E2-A15D-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "E2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 10.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2677, "MSI_SENSOR_SCORE": 0.11, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.1, "TISSUE_SOURCE_SITE": "Roswell Park", "TBL_SCORE": 9.0 }, "treatments": [ { "START_DATE": 111, "STOP_DATE": 316.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "20", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "4100", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 61, "STOP_DATE": 106.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "33", "RADIATION_DOSAGE": "6040", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-A7-A26E": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "011b9b2d-ebe5-42bf-9662-d922faccc7a1", "AGE": 71, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 954.0, "DAYS_TO_BIRTH": -26274.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/28/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 31.36403985, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 31.36403985, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 31.36403985, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 31.36403985, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A7-A26E-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "A7", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 5.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2833, "MSI_SENSOR_SCORE": 3.15, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.3, "TISSUE_SOURCE_SITE": "Christiana Healthcare", "TBL_SCORE": 3.0 }, "treatments": [ { "START_DATE": 101, "STOP_DATE": 164.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "130", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "520", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 247, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": "174", "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 101, "STOP_DATE": 164.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "1000", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "4000", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 205, "STOP_DATE": 246.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "54", "RADIATION_DOSAGE": "9720", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-BH-A8FZ": { "demographics": { "SUBTYPE": "BRCA_Normal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "1CC30842-4A5B-4F07-B36F-5B84CEAA5662", "AGE": 58, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 574.0, "DAYS_TO_BIRTH": -21343.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/25/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T1B", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 18.87102607, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 18.87102607, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 18.87102607, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 18.87102607, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A8FZ-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 9.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3117, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.9, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 62.0 }, "treatments": [ { "START_DATE": 81, "STOP_DATE": 125.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "33", "RADIATION_DOSAGE": "10", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "gy" } ] }, "TCGA-AR-A0TS": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "972447aa-4332-47e7-bddd-2eb699dbb664", "AGE": 46, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 2558.0, "DAYS_TO_BIRTH": -17141.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/8/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 84.09770852, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 84.09770852, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 84.09770852, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 84.09770852, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AR-A0TS-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AR", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 14.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2793, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.3, "TISSUE_SOURCE_SITE": "Mayo", "TBL_SCORE": 103.0 }, "treatments": [ { "START_DATE": 61, "STOP_DATE": 100.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "600", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "4600", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 114, "STOP_DATE": 156.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "175", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "1320", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 61, "STOP_DATE": 100.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "60", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "460", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 185, "STOP_DATE": 228.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "30", "RADIATION_DOSAGE": "6000", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-E9-A1NI": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "c65b835a-2d38-4250-a173-0780d2c2cf58", "AGE": 51, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 300.0, "DAYS_TO_BIRTH": -18985.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "6/23/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8522/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 9.862905612, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 9.862905612, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 9.862905612, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 9.862905612, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E9-A1NI-01", "ONCOTREE_CODE": "BRCNOS", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Carcinoma (NOS)", "TUMOR_TYPE": "Mixed Histology (NOS)", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "E9", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 22.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3235, "MSI_SENSOR_SCORE": 0.65, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.066666667, "TISSUE_SOURCE_SITE": "Asterand", "TBL_SCORE": 59.0 }, "treatments": [ { "START_DATE": 0, "STOP_DATE": 80.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 0, "STOP_DATE": 80.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 0, "STOP_DATE": 80.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Fluorouracil", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 86, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-E2-A107": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "eff2360e-399a-4167-ab2b-798e27bef739", "AGE": 54, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 1047.0, "DAYS_TO_BIRTH": -20065.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "2/11/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N2A", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 34.42154059, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 34.42154059, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 34.42154059, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 34.42154059, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E2-A107-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "E2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 22.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": NaN, "MSI_SENSOR_SCORE": 0.03, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.9, "TISSUE_SOURCE_SITE": "Roswell Park", "TBL_SCORE": 25.0 }, "treatments": [ { "START_DATE": 165, "STOP_DATE": 333.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Bevacizumab", "NUMBER_OF_CYCLES": "13", "PRESCRIBED_DOSE": "1065", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "13845", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 109, "STOP_DATE": 151.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin + Cytoxan + Avastin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 165, "STOP_DATE": 242.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": "12", "PRESCRIBED_DOSE": "80", "PRESCRIBED_DOSE_UNITS": "mg/m2/wk", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "140", "TOTAL_DOSE_UNITS": "Mg/Wk", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 459, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": "4", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 305, "STOP_DATE": 355.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": "3", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 109, "STOP_DATE": 151.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "105", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "420", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 109, "STOP_DATE": 151.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "1050", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "4200", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 165, "STOP_DATE": 242.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": "12", "PRESCRIBED_DOSE": "140", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "1680", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 397, "STOP_DATE": 417.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Exemestane", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": "5", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 249, "STOP_DATE": 333.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Bevacizumab", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "1049", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "3", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "4196", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 459, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "20", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "6", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 279, "STOP_DATE": 326.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "33", "RADIATION_DOSAGE": "6040", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-BH-A5IZ": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "A8A33BA9-0976-4E19-B0E9-FA5BA4D4EAA8", "AGE": 51, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 567.0, "DAYS_TO_BIRTH": -18927.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "2/13/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "CM0 (I+)", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 18.64089161, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 18.64089161, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 18.64089161, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 18.64089161, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-BH-A5IZ-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 11.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2992, "MSI_SENSOR_SCORE": 0.18, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 3.766666667, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 44.0 }, "treatments": [ { "START_DATE": 77, "STOP_DATE": 140.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 161, "STOP_DATE": 161.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 77, "STOP_DATE": 140.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 280, "STOP_DATE": 323.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-D8-A1Y1": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "38a631a1-6875-4216-a335-ee93c90a86d6", "AGE": 80, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 116.0, "DAYS_TO_BIRTH": -29474.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "6/9/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 9.928658316, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 9.928658316, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 9.928658316, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D8-A1Y1-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "D8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 21.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.4692, "MSI_SENSOR_SCORE": 6.24, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 6.8, "TISSUE_SOURCE_SITE": "Greater Poland Cancer Center", "TBL_SCORE": 8.0 }, "treatments": [ { "START_DATE": 58, "STOP_DATE": 302.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "20", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-AN-A0AT": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "05506f4c-e701-4a9d-ae06-97f066aade43", "AGE": 62, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": 10.0, "DAYS_TO_BIRTH": -22798.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/28/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 0.32876352, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 0.32876352, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 0.32876352, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 0.32876352, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AN-A0AT-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AN", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 8.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2819, "MSI_SENSOR_SCORE": 1.3, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 3.933333333, "TISSUE_SOURCE_SITE": "Cureline", "TBL_SCORE": 270.0 }, "treatments": [] }, "TCGA-OL-A97C": { "demographics": { "SUBTYPE": "BRCA_Normal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "6FFD1B8C-6F0B-456A-9160-E0C8021E5897", "AGE": 67, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 271.0, "DAYS_TO_BIRTH": -24735.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/18/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "9020/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 8.909491403, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 8.909491403, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 9.040996811, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-OL-A97C-01", "ONCOTREE_CODE": "BRCNOS", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Carcinoma (NOS)", "TUMOR_TYPE": "Other", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "OL", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 8.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3453, "MSI_SENSOR_SCORE": 0.05, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.0, "TISSUE_SOURCE_SITE": "University of Chicago", "TBL_SCORE": 29.0 }, "treatments": [] }, "TCGA-A2-A0YM": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "5cbf0aea-ebb4-4005-bdd5-14ef2dc6826c", "AGE": 67, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": 965.0, "DAYS_TO_BIRTH": -24831.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/8/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 31.72567972, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 31.72567972, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 31.72567972, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 31.72567972, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A2-A0YM-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 27.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3077, "MSI_SENSOR_SCORE": 1.2, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.566666667, "TISSUE_SOURCE_SITE": "Walter Reed", "TBL_SCORE": 272.0 }, "treatments": [ { "START_DATE": 80, "STOP_DATE": 126.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "31", "RADIATION_DOSAGE": "5520", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-E9-A3Q9": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "E36E985D-2C44-4E14-854A-7DBCA4BB0304", "AGE": 78, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIC", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 1001.0, "DAYS_TO_BIRTH": -28715.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/30/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N3", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "0:LIVING", "OS_MONTHS": 32.90922839, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 32.90922839, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 32.90922839, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 32.90922839, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E9-A3Q9-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "E9", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3186, "MSI_SENSOR_SCORE": 0.01, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.0, "TISSUE_SOURCE_SITE": "Asterand", "TBL_SCORE": 12.0 }, "treatments": [ { "START_DATE": 28, "STOP_DATE": 51.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 28, "STOP_DATE": 51.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Mitoxantrone", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 28, "STOP_DATE": 51.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Fluorouracil", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 108, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-A2-A4S1": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "843C8F16-5E59-40D4-9ECC-8A75375156F6", "AGE": 66, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 820.0, "DAYS_TO_BIRTH": -24353.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "2/26/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8575/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 26.95860867, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 26.95860867, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 26.95860867, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 26.95860867, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A2-A4S1-01", "ONCOTREE_CODE": "MBC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Metaplastic Breast Cancer", "TUMOR_TYPE": "Metaplastic Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "A2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 26.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2898, "MSI_SENSOR_SCORE": 0.04, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.366666667, "TISSUE_SOURCE_SITE": "Walter Reed", "TBL_SCORE": 187.0 }, "treatments": [ { "START_DATE": 91, "STOP_DATE": 123.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "25", "RADIATION_DOSAGE": "5000", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" }, { "START_DATE": 126, "STOP_DATE": 130.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 2", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "5", "RADIATION_DOSAGE": "1000", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-C8-A132": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "89e867de-d30e-4bfc-a453-0a76309dabd5", "AGE": 56, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 383.0, "DAYS_TO_BIRTH": -20471.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/15/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Asian", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 12.59164283, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 12.59164283, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 12.59164283, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 12.59164283, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-C8-A132-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "C8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 14.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.287, "MSI_SENSOR_SCORE": 0.02, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.133333333, "TISSUE_SOURCE_SITE": "ILSBio", "TBL_SCORE": 203.0 }, "treatments": [] }, "TCGA-E2-A1L9": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "5ea18514-51ad-4844-abea-15e82f0b10c9", "AGE": 40, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 598.0, "DAYS_TO_BIRTH": -14868.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "6/7/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1MI", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 19.66005852, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 19.66005852, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 19.66005852, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 19.66005852, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E2-A1L9-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "E2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 4.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3394, "MSI_SENSOR_SCORE": 0.38, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.8, "TISSUE_SOURCE_SITE": "Roswell Park", "TBL_SCORE": 4.0 }, "treatments": [ { "START_DATE": 55, "STOP_DATE": 122.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 56, "STOP_DATE": 122.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 187, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "20", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": "20", "TOTAL_DOSE_UNITS": "Mg/Day", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 140, "STOP_DATE": 177.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "33", "RADIATION_DOSAGE": "6040", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-E2-A56Z": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "45C3975C-D333-4237-93F7-E12DC2451C38", "AGE": 69, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 252.0, "DAYS_TO_BIRTH": -25282.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "6/20/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 8.284840714, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 8.284840714, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 8.284840714, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 8.284840714, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-E2-A56Z-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "E2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 17.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3253, "MSI_SENSOR_SCORE": 0.18, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.5, "TISSUE_SOURCE_SITE": "Roswell Park", "TBL_SCORE": 152.0 }, "treatments": [ { "START_DATE": 130, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 84, "STOP_DATE": 129.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "33", "RADIATION_DOSAGE": "60.4", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "gy" } ] }, "TCGA-GM-A5PV": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "67C8DC41-EDCB-4563-96B3-3F93F9EDCBE9", "AGE": 63, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 412.0, "DAYS_TO_BIRTH": -23215.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/12/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 13.54505704, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 13.54505704, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 13.54505704, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 13.54505704, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-GM-A5PV-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "GM", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 2.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2809, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.933333333, "TISSUE_SOURCE_SITE": "MD Anderson", "TBL_SCORE": 20.0 }, "treatments": [ { "START_DATE": 107, "STOP_DATE": 174.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 107, "STOP_DATE": 174.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-EW-A3U0": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "D9DC3B59-613D-469E-8B4F-6C5A557EB26A", "AGE": 61, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 532.0, "DAYS_TO_BIRTH": -22520.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/24/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "0:LIVING", "OS_MONTHS": 17.49021929, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 17.49021929, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 17.49021929, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 17.49021929, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-EW-A3U0-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "EW", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 12.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3219, "MSI_SENSOR_SCORE": 0.07, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.0, "TISSUE_SOURCE_SITE": "University of Miami", "TBL_SCORE": 610.0 }, "treatments": [ { "START_DATE": 85, "STOP_DATE": 127.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cisplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 85, "STOP_DATE": 127.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 148, "STOP_DATE": 197.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 148, "STOP_DATE": 197.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 229, "STOP_DATE": 281.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": "109", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "gy" } ] }, "TCGA-BH-A0AY": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "93ed6066-b567-4e1c-ab81-23370f9d3452", "AGE": 62, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": 777.0, "DAYS_TO_BIRTH": -22703.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "11/3/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 25.54492554, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 25.54492554, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 25.54492554, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 25.54492554, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A0AY-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 25.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.263, "MSI_SENSOR_SCORE": 0.73, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 3.4, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 62.0 }, "treatments": [ { "START_DATE": 209, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Exemestane", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "50", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 131, "STOP_DATE": 192.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": null, "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-AC-A3OD": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "F2622CDB-AC92-42B3-A1CA-67E133C3DD4A", "AGE": 68, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 451.0, "DAYS_TO_BIRTH": -25186.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/19/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N1MI", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 14.82723477, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 14.82723477, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 14.82723477, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 14.82723477, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AC-A3OD-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "AC", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 6.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2962, "MSI_SENSOR_SCORE": 0.05, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.933333333, "TISSUE_SOURCE_SITE": "International Genomics Consortium", "TBL_SCORE": 111.5 }, "treatments": [ { "START_DATE": 76, "STOP_DATE": 120.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "25", "RADIATION_DOSAGE": "6040", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-D8-A1X6": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "42e47f3a-dff7-41e4-8f84-146d97e8ab72", "AGE": 80, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 541.0, "DAYS_TO_BIRTH": -29256.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "6/9/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N2A", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 17.78610645, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 17.78610645, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 17.78610645, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 17.78610645, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D8-A1X6-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "D8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 13.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2839, "MSI_SENSOR_SCORE": 0.03, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.233333333, "TISSUE_SOURCE_SITE": "Greater Poland Cancer Center", "TBL_SCORE": 17.0 }, "treatments": [ { "START_DATE": 65, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "20", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-AN-A046": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "dcd5860c-7e3a-44f3-a732-fe92fe3fe300", "AGE": 68, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": 10.0, "DAYS_TO_BIRTH": -25158.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/28/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 0.32876352, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 0.32876352, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 0.32876352, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 0.32876352, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AN-A046-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AN", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 7.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2695, "MSI_SENSOR_SCORE": 0.04, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 180.8333333, "TISSUE_SOURCE_SITE": "Cureline", "TBL_SCORE": 23.0 }, "treatments": [] }, "TCGA-D8-A141": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "42f6f503-4cf6-4a8e-b5fe-b44bccf6b38b", "AGE": 40, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 626.0, "DAYS_TO_BIRTH": -14626.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "2/27/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 20.58059638, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 20.58059638, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 20.58059638, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 20.58059638, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D8-A141-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "D8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 9.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2838, "MSI_SENSOR_SCORE": 0.04, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.633333333, "TISSUE_SOURCE_SITE": "Greater Poland Cancer Center", "TBL_SCORE": 4.0 }, "treatments": [ { "START_DATE": 50, "STOP_DATE": 113.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "101.4", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "405.6", "TOTAL_DOSE_UNITS": "Mg/M2", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 50, "STOP_DATE": 113.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 50, "STOP_DATE": 113.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-A8-A08B": { "demographics": { "SUBTYPE": "BRCA_Her2", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "d8d7a6c2-6427-4f47-968c-6c3affba4617", "AGE": 52, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 1156.0, "DAYS_TO_BIRTH": -19114.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "5/27/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": null, "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 38.00506296, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 38.00506296, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 38.00506296, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 38.00506296, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A8-A08B-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 19.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2653, "MSI_SENSOR_SCORE": 0.63, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.566666667, "TISSUE_SOURCE_SITE": "Indivumed", "TBL_SCORE": 229.0 }, "treatments": [ { "START_DATE": 31, "STOP_DATE": 122.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Fluorouracil", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 31, "STOP_DATE": 122.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Epirubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 31, "STOP_DATE": 122.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 214, "STOP_DATE": 883.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 214, "STOP_DATE": 579.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Targeted Molecular Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Trastuzumab", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 914, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Letrozole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 122, "STOP_DATE": 184.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "gy" } ] }, "TCGA-AO-A0JL": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "d5d8e76e-2f2a-49bc-ba0a-d51283611b16", "AGE": 59, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": 1683.0, "DAYS_TO_BIRTH": -21895.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/20/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N2A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "0:LIVING", "OS_MONTHS": 55.33090048, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 55.33090048, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 55.33090048, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 55.33090048, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AO-A0JL-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AO", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 25.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": NaN, "MSI_SENSOR_SCORE": 1.34, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.0, "TISSUE_SOURCE_SITE": "MSKCC", "TBL_SCORE": 243.0 }, "treatments": [ { "START_DATE": 136, "STOP_DATE": 178.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "175", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "1372", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 136, "STOP_DATE": 493.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Targeted Molecular Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Trastuzumab", "NUMBER_OF_CYCLES": "22", "PRESCRIBED_DOSE": "6", "PRESCRIBED_DOSE_UNITS": "mg/kg", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "9476", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 80, "STOP_DATE": 122.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "600", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "4872", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 80, "STOP_DATE": 122.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "60", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "488", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 192, "STOP_DATE": 240.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "45", "RADIATION_DOSAGE": "10776", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-AN-A0FS": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "10c9be1e-2cc0-45e4-8d2c-c013ea63ef05", "AGE": 55, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 210.0, "DAYS_TO_BIRTH": -20352.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/20/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 6.904033928, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 6.904033928, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 6.904033928, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 6.904033928, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AN-A0FS-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AN", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 3.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3024, "MSI_SENSOR_SCORE": 0.1, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.033333333, "TISSUE_SOURCE_SITE": "Cureline", "TBL_SCORE": 49.0 }, "treatments": [] }, "TCGA-AC-A23H": { "demographics": { "SUBTYPE": "BRCA_Her2", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "7dcf550c-90ce-4f63-aecd-0e46897e2a3e", "AGE": 90, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 81.0, "DAYS_TO_BIRTH": -32873.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/13/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "NX", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "No", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 5.720485255, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 5.720485255, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 5.720485255, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AC-A23H-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AC", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 16.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3208, "MSI_SENSOR_SCORE": 0.54, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 142.6666667, "TISSUE_SOURCE_SITE": "International Genomics Consortium", "TBL_SCORE": 215.0 }, "treatments": [] }, "TCGA-A7-A4SA": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "A2EFE7E1-ACA3-440F-825F-ED621EDCA69F", "AGE": 40, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 454.0, "DAYS_TO_BIRTH": -14906.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "2/19/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "0:LIVING", "OS_MONTHS": 14.92586383, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 14.92586383, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 14.92586383, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 14.92586383, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A7-A4SA-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "A7", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 10.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2899, "MSI_SENSOR_SCORE": 0.03, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.0, "TISSUE_SOURCE_SITE": "Christiana Healthcare", "TBL_SCORE": 110.0 }, "treatments": [ { "START_DATE": 73, "STOP_DATE": 115.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 73, "STOP_DATE": 115.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 136, "STOP_DATE": 213.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 217, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-E2-A573": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "6429C443-8AC3-407F-BB9C-66420B904BBF", "AGE": 48, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 1062.0, "DAYS_TO_BIRTH": -17689.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "6/20/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 34.91468587, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 34.91468587, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 34.91468587, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 34.91468587, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-E2-A573-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "E2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 27.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3234, "MSI_SENSOR_SCORE": 0.05, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.566666667, "TISSUE_SOURCE_SITE": "Roswell Park", "TBL_SCORE": 54.0 }, "treatments": [ { "START_DATE": 104, "STOP_DATE": 167.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 104, "STOP_DATE": 167.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 201, "STOP_DATE": 251.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "36", "RADIATION_DOSAGE": "66.4", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "gy" } ] }, "TCGA-AN-A0FX": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "13b860c3-8048-4dc9-9eb0-7480bc660837", "AGE": 52, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": 10.0, "DAYS_TO_BIRTH": -19309.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "11/28/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 0.32876352, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 0.32876352, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 0.32876352, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 0.32876352, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AN-A0FX-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AN", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 14.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3678, "MSI_SENSOR_SCORE": 0.53, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 4.0, "TISSUE_SOURCE_SITE": "Cureline", "TBL_SCORE": 193.0 }, "treatments": [] }, "TCGA-AR-A2LN": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "A076F135-BE82-40FA-8516-285ED355C965", "AGE": 65, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 1161.0, "DAYS_TO_BIRTH": -23992.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "1/12/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 38.16944472, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 38.16944472, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 38.16944472, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 38.16944472, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AR-A2LN-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AR", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 2.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2847, "MSI_SENSOR_SCORE": 0.03, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.266666667, "TISSUE_SOURCE_SITE": "Mayo", "TBL_SCORE": 44.0 }, "treatments": [ { "START_DATE": 15, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Letrozole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-A2-A3XZ": { "demographics": { "SUBTYPE": "BRCA_Her2", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "FE7F74B8-20F4-4471-91DC-4CCA8C68E5C0", "AGE": 46, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE I", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 1532.0, "DAYS_TO_BIRTH": -16978.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "8/21/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 50.36657133, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 50.36657133, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 50.36657133, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 50.36657133, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-A2-A3XZ-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 9.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.292, "MSI_SENSOR_SCORE": 0.03, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.066666667, "TISSUE_SOURCE_SITE": "Walter Reed", "TBL_SCORE": 125.0 }, "treatments": [ { "START_DATE": 97, "STOP_DATE": 202.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 97, "STOP_DATE": 202.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 97, "STOP_DATE": 423.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Targeted Molecular Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Trastuzumab", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-A8-A06Q": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "281f70c5-876f-44b3-84fb-f2302f85e74c", "AGE": 63, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": "5TH", "DAYS_LAST_FOLLOWUP": 31.0, "DAYS_TO_BIRTH": -23164.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "5/27/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N2", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": null, "RADIATION_THERAPY": null, "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 1.019166913, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 1.019166913, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 1.019166913, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 1.019166913, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A8-A06Q-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 20.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3039, "MSI_SENSOR_SCORE": 0.37, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 7.2, "TISSUE_SOURCE_SITE": "Indivumed", "TBL_SCORE": 446.0 }, "treatments": [] }, "TCGA-BH-A203": { "demographics": { "SUBTYPE": "BRCA_Her2", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "b3264748-947a-43aa-b227-b294fbcc8447", "AGE": 78, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "5TH", "DAYS_LAST_FOLLOWUP": NaN, "DAYS_TO_BIRTH": -28609.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/8/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1B", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": null, "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 38.5968373, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 38.5968373, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 38.5968373, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A203-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 15.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3141, "MSI_SENSOR_SCORE": 0.31, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.033333333, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 434.0 }, "treatments": [] }, "TCGA-E9-A22A": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "4aacbc42-5ac5-4339-b9fa-c6e812084837", "AGE": 74, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 1189.0, "DAYS_TO_BIRTH": -27288.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "8/2/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 39.08998258, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 39.08998258, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 39.08998258, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 39.08998258, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E9-A22A-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "E9", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 9.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3325, "MSI_SENSOR_SCORE": 0.15, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.9, "TISSUE_SOURCE_SITE": "Asterand", "TBL_SCORE": 122.0 }, "treatments": [ { "START_DATE": 111, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "20", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": "7240", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-AC-A2BK": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "6FA2A667-9C36-4526-8A58-1975E863A806", "AGE": 78, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 2222.0, "DAYS_TO_BIRTH": -28625.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "9/16/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N2A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 73.05125423, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 73.05125423, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 73.05125423, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 73.05125423, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-AC-A2BK-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AC", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 14.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3604, "MSI_SENSOR_SCORE": 2.61, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.633333333, "TISSUE_SOURCE_SITE": "International Genomics Consortium", "TBL_SCORE": 199.0 }, "treatments": [ { "START_DATE": 73, "STOP_DATE": 136.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 73, "STOP_DATE": 136.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 149, "STOP_DATE": 164.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 149, "STOP_DATE": 164.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Bevacizumab", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 203, "STOP_DATE": 254.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "25", "RADIATION_DOSAGE": "6000", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-AN-A04C": { "demographics": { "SUBTYPE": "BRCA_Her2", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "66072c06-f251-4f0b-b6ae-12b407c52cc6", "AGE": 51, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": 54.0, "DAYS_TO_BIRTH": -18851.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/29/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": null, "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 1.77532301, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 1.77532301, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 1.77532301, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AN-A04C-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AN", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 19.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2757, "MSI_SENSOR_SCORE": 0.75, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.233333333, "TISSUE_SOURCE_SITE": "Cureline", "TBL_SCORE": 260.0 }, "treatments": [] }, "TCGA-E9-A1R4": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "b7a4df9a-4e25-4550-9c10-338ca1921c2f", "AGE": 66, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 186.0, "DAYS_TO_BIRTH": -24181.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/28/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 6.115001479, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 6.115001479, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 6.115001479, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 6.115001479, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E9-A1R4-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "E9", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 17.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3146, "MSI_SENSOR_SCORE": 0.37, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 3.7, "TISSUE_SOURCE_SITE": "Asterand", "TBL_SCORE": 135.0 }, "treatments": [ { "START_DATE": 9, "STOP_DATE": 45.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Methotrexate", "NUMBER_OF_CYCLES": "2", "PRESCRIBED_DOSE": "100", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "200", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 9, "STOP_DATE": 45.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "2", "PRESCRIBED_DOSE": "2000", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "4000", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 9, "STOP_DATE": 45.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Fluorouracil", "NUMBER_OF_CYCLES": "2", "PRESCRIBED_DOSE": "2000", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "4000", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 12, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "20", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 125, "STOP_DATE": 155.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "23", "RADIATION_DOSAGE": "4600", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-BH-A0W7": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "9f80649b-a249-4fb5-97ad-059a30e13fea", "AGE": 49, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE I", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 1363.0, "DAYS_TO_BIRTH": -17996.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "2/15/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 44.81046783, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 44.81046783, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 44.81046783, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 44.81046783, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A0W7-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 12.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2752, "MSI_SENSOR_SCORE": 0.05, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 5.5, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 99.0 }, "treatments": [ { "START_DATE": 76, "STOP_DATE": 138.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 76, "STOP_DATE": 138.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 168, "STOP_DATE": 1233.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 1171, "STOP_DATE": 1324.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 168, "STOP_DATE": 229.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "36", "RADIATION_DOSAGE": "1600", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-E2-A14X": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "60df7543-6da5-4c75-943b-5800c1e08234", "AGE": 55, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 972.0, "DAYS_TO_BIRTH": -20105.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/6/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N2", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 31.95581418, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 31.95581418, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 31.95581418, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 31.95581418, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-E2-A14X-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "E2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 27.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2726, "MSI_SENSOR_SCORE": 0.34, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.866666667, "TISSUE_SOURCE_SITE": "Roswell Park", "TBL_SCORE": 87.0 }, "treatments": [ { "START_DATE": 182, "STOP_DATE": 280.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Other", "TREATMENT_SUBTYPE": "Clinical Trial - Bisphosphonates As Adjuvant Therapy", "AGENT": "Clodronic Acid", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "75200", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "75200", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 55, "STOP_DATE": 97.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "2", "PRESCRIBED_DOSE": "128", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "512", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 55, "STOP_DATE": 188.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Bevacizumab", "NUMBER_OF_CYCLES": "7", "PRESCRIBED_DOSE": "1470", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "9310", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 55, "STOP_DATE": 97.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "2", "PRESCRIBED_DOSE": "1284", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "5136", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 111, "STOP_DATE": 199.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": "5", "PRESCRIBED_DOSE": "171", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "1642", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 218, "STOP_DATE": 271.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "36", "RADIATION_DOSAGE": "6640", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-A2-A0YF": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "ae8c77fe-e6c8-44d5-8265-4a38c637bbef", "AGE": 67, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE I", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 1535.0, "DAYS_TO_BIRTH": -24660.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/2/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I+)", "PATH_T_STAGE": "T1B", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 50.46520038, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 50.46520038, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 50.46520038, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 50.46520038, "GENETIC_ANCESTRY_LABEL": "AFR_ADMIX" }, "sample": { "SAMPLE_ID": "TCGA-A2-A0YF-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 4.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2855, "MSI_SENSOR_SCORE": 0.17, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.866666667, "TISSUE_SOURCE_SITE": "Walter Reed", "TBL_SCORE": 54.0 }, "treatments": [] }, "TCGA-E2-A9RU": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "6F18F96E-C0C9-4CC4-9FB2-CBA8949D5402", "AGE": 90, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIC", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 538.0, "DAYS_TO_BIRTH": -32873.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "6/16/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N3A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 17.6874774, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 17.6874774, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 17.6874774, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 17.6874774, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-E2-A9RU-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "E2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 27.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3405, "MSI_SENSOR_SCORE": 0.78, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.2, "TISSUE_SOURCE_SITE": "Roswell Park", "TBL_SCORE": 587.0 }, "treatments": [ { "START_DATE": 112, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 126, "STOP_DATE": 166.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": "50.4", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "gy" }, { "START_DATE": 166, "STOP_DATE": 173.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 2", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "5", "RADIATION_DOSAGE": "10", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "gy" } ] }, "TCGA-S3-AA11": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "0DD8DBC1-C48B-4E7C-B401-57101F724967", "AGE": 67, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 421.0, "DAYS_TO_BIRTH": -24813.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/18/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 13.84094421, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 13.84094421, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 13.84094421, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 13.84094421, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-S3-AA11-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "S3", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 1.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3311, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.0, "TISSUE_SOURCE_SITE": "Albert Einstein Medical Center", "TBL_SCORE": 15.0 }, "treatments": [ { "START_DATE": 53, "STOP_DATE": 169.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Letrozole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 169, "STOP_DATE": 309.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Exemestane", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 309, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 77, "STOP_DATE": 123.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "30", "RADIATION_DOSAGE": "60", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "gy" } ] }, "TCGA-A2-A0T2": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "128d198e-9b22-427c-90db-3714455f3a17", "AGE": 66, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": NaN, "DAYS_TO_BIRTH": -24235.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "11/12/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M1", "PATH_N_STAGE": "N3", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 8.38346977, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 8.38346977, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 8.38346977, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A2-A0T2-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 34.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3164, "MSI_SENSOR_SCORE": 1.48, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.933333333, "TISSUE_SOURCE_SITE": "Walter Reed", "TBL_SCORE": 66.0 }, "treatments": [ { "START_DATE": 105, "STOP_DATE": 225.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Capecitabine", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "3", "PRESCRIBED_DOSE_UNITS": "g/day", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": "G/Day", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 179, "STOP_DATE": 199.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "12", "RADIATION_DOSAGE": "3000", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-D8-A1JA": { "demographics": { "SUBTYPE": "BRCA_Her2", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "9ced0c70-c46c-4f98-8f48-840defe4b8b1", "AGE": 60, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 502.0, "DAYS_TO_BIRTH": -21918.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/29/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "NX", "PATH_T_STAGE": "T4B", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "No", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 16.50392872, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 16.50392872, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 14.16970773, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 14.16970773, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D8-A1JA-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "D8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 6.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.31, "MSI_SENSOR_SCORE": 0.38, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 26.6, "TISSUE_SOURCE_SITE": "Greater Poland Cancer Center", "TBL_SCORE": 136.0 }, "treatments": [ { "START_DATE": 340, "STOP_DATE": 403.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "60", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "240", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 340, "STOP_DATE": 403.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 431, "STOP_DATE": 472.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Recurrence", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Local Recurrence", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": "5000", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-OL-A66P": { "demographics": { "SUBTYPE": "BRCA_Her2", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "F81AC8A2-4CE6-439E-B027-1C0BFC88CEAA", "AGE": 75, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 428.0, "DAYS_TO_BIRTH": -27489.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "6/11/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 14.07107867, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 14.07107867, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 14.07107867, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 14.07107867, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-OL-A66P-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "OL", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 3.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3535, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 3.166666667, "TISSUE_SOURCE_SITE": "University of Chicago", "TBL_SCORE": 314.0 }, "treatments": [ { "START_DATE": 71, "STOP_DATE": 162.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 71, "STOP_DATE": 162.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-C8-A137": { "demographics": { "SUBTYPE": "BRCA_Her2", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "03ab1e9f-4918-404d-b178-3a4fd929c5e8", "AGE": 34, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 379.0, "DAYS_TO_BIRTH": -12729.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/15/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Asian", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 12.46013742, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 12.46013742, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 4.471183877, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 4.471183877, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-C8-A137-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "C8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 5.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2714, "MSI_SENSOR_SCORE": 0.24, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.433333333, "TISSUE_SOURCE_SITE": "ILSBio", "TBL_SCORE": 218.0 }, "treatments": [ { "START_DATE": 137, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Stable Disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Local Recurrence", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "30", "RADIATION_DOSAGE": "60", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "gy" } ] }, "TCGA-D8-A27K": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "7f97971b-2818-4e4b-9c9e-7c0246f9484c", "AGE": 47, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 1461.0, "DAYS_TO_BIRTH": -17426.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/18/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 48.03235033, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 48.03235033, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 48.03235033, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 48.03235033, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D8-A27K-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "D8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 5.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2936, "MSI_SENSOR_SCORE": 0.05, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.7, "TISSUE_SOURCE_SITE": "Greater Poland Cancer Center", "TBL_SCORE": 1.0 }, "treatments": [ { "START_DATE": 49, "STOP_DATE": 117.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin + Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "60+600", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "240+2400", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 49, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-AR-A24N": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "30047d32-0833-4aca-98d1-3b9ab7122863", "AGE": 54, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE I", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 3035.0, "DAYS_TO_BIRTH": -19989.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "8/16/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T1", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 99.77972844, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 99.77972844, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 99.77972844, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 99.77972844, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AR-A24N-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AR", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 3.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3066, "MSI_SENSOR_SCORE": 0.05, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.066666667, "TISSUE_SOURCE_SITE": "Mayo", "TBL_SCORE": 5.0 }, "treatments": [] }, "TCGA-AC-A8OP": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "B9C6C069-2A2B-4CC7-A398-DC45C132D979", "AGE": 72, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 614.0, "DAYS_TO_BIRTH": -26550.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "2/26/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 20.18608015, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 20.18608015, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 20.18608015, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 20.18608015, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-AC-A8OP-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "AC", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 20.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3014, "MSI_SENSOR_SCORE": 0.05, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 4.633333333, "TISSUE_SOURCE_SITE": "International Genomics Consortium", "TBL_SCORE": 186.0 }, "treatments": [] }, "TCGA-AC-A2QJ": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "D9FD2724-7DB0-4AF3-AC14-217BDFA5203F", "AGE": 48, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIB", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 69.0, "DAYS_TO_BIRTH": -17569.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Hispanic Or Latino", "FORM_COMPLETION_DATE": "10/18/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8575/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T4B", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 14.66285301, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 14.66285301, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 7.791695434, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 7.791695434, "GENETIC_ANCESTRY_LABEL": "AMR" }, "sample": { "SAMPLE_ID": "TCGA-AC-A2QJ-01", "ONCOTREE_CODE": "MBC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Metaplastic Breast Cancer", "TUMOR_TYPE": "Metaplastic Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "AC", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 23.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3069, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.0, "TISSUE_SOURCE_SITE": "International Genomics Consortium", "TBL_SCORE": 25.0 }, "treatments": [ { "START_DATE": 69, "STOP_DATE": 111.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Clinical Progressive Disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 69, "STOP_DATE": 111.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Clinical Progressive Disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 125, "STOP_DATE": 202.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Clinical Progressive Disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 322, "STOP_DATE": 385.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Gemcitabine", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Clinical Progressive Disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 386, "STOP_DATE": 407.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Clinical Progressive Disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 349, "STOP_DATE": 418.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Fulvestrant", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Clinical Progressive Disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 241, "STOP_DATE": 279.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Radiographic Progressive Disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "20", "RADIATION_DOSAGE": "5000", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" }, { "START_DATE": 299, "STOP_DATE": 312.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 2", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Radiographic Progressive Disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "10", "RADIATION_DOSAGE": "1800", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-A7-A13F": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "2cf68894-168b-458b-af4f-53cad72989a8", "AGE": 44, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": 765.0, "DAYS_TO_BIRTH": -16363.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/2/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 25.15040931, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 25.15040931, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 25.15040931, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 25.15040931, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A7-A13F-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "A7", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 25.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.28, "MSI_SENSOR_SCORE": 0.27, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.433333333, "TISSUE_SOURCE_SITE": "Christiana Healthcare", "TBL_SCORE": 90.0 }, "treatments": [ { "START_DATE": 105, "STOP_DATE": 175.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "198-200", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "798", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 49, "STOP_DATE": 91.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "121-123", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "487", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 49, "STOP_DATE": 91.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "1200-1230", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "4854", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 179, "STOP_DATE": 210.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "20", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 358, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": "106", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 211, "STOP_DATE": 248.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "28", "RADIATION_DOSAGE": "5040", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" }, { "START_DATE": 211, "STOP_DATE": 246.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 2", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "26", "RADIATION_DOSAGE": "4680", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-S3-AA10": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "23C31C2E-336C-4878-A476-CF8D811B4875", "AGE": 65, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 586.0, "DAYS_TO_BIRTH": -24075.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/18/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 19.2655423, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 19.2655423, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 19.2655423, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 19.2655423, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-S3-AA10-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "S3", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 22.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3339, "MSI_SENSOR_SCORE": 0.53, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 4.533333333, "TISSUE_SOURCE_SITE": "Albert Einstein Medical Center", "TBL_SCORE": 133.0 }, "treatments": [ { "START_DATE": 75, "STOP_DATE": 199.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 75, "STOP_DATE": 199.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 75, "STOP_DATE": 199.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Ancillary", "TREATMENT_SUBTYPE": null, "AGENT": "Pegfilgrastim", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 265, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-BH-A0E9": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "76ace6aa-0505-442c-978a-f889cf2d44bb", "AGE": 53, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 2489.0, "DAYS_TO_BIRTH": -19415.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "8/11/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 81.82924023, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 81.82924023, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 81.82924023, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 81.82924023, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A0E9-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 24.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2735, "MSI_SENSOR_SCORE": 0.01, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.1, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 29.0 }, "treatments": [ { "START_DATE": 96, "STOP_DATE": 503.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 96, "STOP_DATE": 503.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 96, "STOP_DATE": 503.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 150, "STOP_DATE": 189.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "28", "RADIATION_DOSAGE": "5040", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" }, { "START_DATE": 192, "STOP_DATE": 201.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 2", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "7", "RADIATION_DOSAGE": "1400", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-AO-A0J9": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "a4903de8-6cf5-4541-8ec7-065beace8b44", "AGE": 61, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIC", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": 1613.0, "DAYS_TO_BIRTH": -22642.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/19/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N3", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 53.02955584, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 53.02955584, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 35.04619128, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 35.04619128, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AO-A0J9-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AO", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 17.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2677, "MSI_SENSOR_SCORE": 0.05, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 3.566666667, "TISSUE_SOURCE_SITE": "MSKCC", "TBL_SCORE": 16.0 }, "treatments": [ { "START_DATE": 161, "STOP_DATE": 204.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": "3", "PRESCRIBED_DOSE": "100", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "630", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 1072, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Other", "TREATMENT_SUBTYPE": "Bisphosphonate Therapy", "AGENT": "Zoledronic Acid", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "4", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Recurrence", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": "16", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 85, "STOP_DATE": 128.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "600", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "5040", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 141, "STOP_DATE": 141.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": "1", "PRESCRIBED_DOSE": "175", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "370", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 239, "STOP_DATE": 1023.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 1072, "STOP_DATE": 1207.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Exemestane", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "25", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Recurrence", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 1207, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "20", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Progression", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 85, "STOP_DATE": 128.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "60", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "500", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 226, "STOP_DATE": 263.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "28", "RADIATION_DOSAGE": "11117", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-B6-A0RN": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "2199b7a1-bd47-4bb5-b36a-a3e291e3e259", "AGE": 60, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IA", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": 8008.0, "DAYS_TO_BIRTH": -22077.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "11/2/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 263.2738271, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 263.2738271, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 263.2738271, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 263.2738271, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-B6-A0RN-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "B6", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 4.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.264, "MSI_SENSOR_SCORE": 0.04, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.833333333, "TISSUE_SOURCE_SITE": "Duke", "TBL_SCORE": 5.0 }, "treatments": [] }, "TCGA-D8-A1JD": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "530ad151-703d-4638-851f-0b5111ff318b", "AGE": 41, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 552.0, "DAYS_TO_BIRTH": -15166.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/29/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "No", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 18.14774633, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 18.14774633, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 18.14774633, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 18.14774633, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D8-A1JD-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "D8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 18.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3017, "MSI_SENSOR_SCORE": 0.08, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 3.3, "TISSUE_SOURCE_SITE": "Greater Poland Cancer Center", "TBL_SCORE": 154.0 }, "treatments": [ { "START_DATE": 50, "STOP_DATE": 113.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "60", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "240", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 50, "STOP_DATE": 113.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 151, "STOP_DATE": 183.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "20", "RADIATION_DOSAGE": "4500", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-E9-A1RA": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "4b4e4ea8-6eb9-49ad-b880-c5065fe6517f", "AGE": 48, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 1369.0, "DAYS_TO_BIRTH": -17699.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/28/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 45.00772594, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 45.00772594, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 45.00772594, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 45.00772594, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E9-A1RA-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "E9", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 25.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3227, "MSI_SENSOR_SCORE": 0.28, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.5, "TISSUE_SOURCE_SITE": "Asterand", "TBL_SCORE": 1.0 }, "treatments": [ { "START_DATE": 10, "STOP_DATE": 80.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "100", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "380", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 9, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "20", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 10, "STOP_DATE": 80.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "1000", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "4000", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 93, "STOP_DATE": 134.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "25", "RADIATION_DOSAGE": "5000", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-3C-AALI": { "demographics": { "SUBTYPE": "BRCA_Her2", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "55262FCB-1B01-4480-B322-36570430C917", "AGE": 50, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 4005.0, "DAYS_TO_BIRTH": -18538.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/28/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 131.6697899, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 131.6697899, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 131.6697899, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 131.6697899, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-3C-AALI-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "3C", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 22.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3449, "MSI_SENSOR_SCORE": 0.74, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 15.26666667, "TISSUE_SOURCE_SITE": "Columbia University", "TBL_SCORE": 190.0 }, "treatments": [ { "START_DATE": 43, "STOP_DATE": 117.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Other", "TREATMENT_SUBTYPE": null, "AGENT": "Poly E", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 320, "STOP_DATE": 352.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "25", "RADIATION_DOSAGE": "5000", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-E2-A14Y": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "a0576d44-9add-429b-9eeb-f7b234b7385f", "AGE": 35, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 2109.0, "DAYS_TO_BIRTH": -13004.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/6/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 69.33622645, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 69.33622645, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 69.33622645, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 69.33622645, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E2-A14Y-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "E2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 6.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2568, "MSI_SENSOR_SCORE": 0.29, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.533333333, "TISSUE_SOURCE_SITE": "Roswell Park", "TBL_SCORE": 111.0 }, "treatments": [ { "START_DATE": 44, "STOP_DATE": 384.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Trastuzumab", "NUMBER_OF_CYCLES": "17", "PRESCRIBED_DOSE": "536", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "7168", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 548, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Toremifene", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "60", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "5", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": "60", "TOTAL_DOSE_UNITS": "Mg/Day", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 190, "STOP_DATE": 547.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "20", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "3", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "20", "TOTAL_DOSE_UNITS": "Mg/Day", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 212, "STOP_DATE": 1185.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Zoledronic Acid", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "4", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "4", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "48", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 44, "STOP_DATE": 149.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": "6", "PRESCRIBED_DOSE": "600", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "4092", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 44, "STOP_DATE": 149.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": "6", "PRESCRIBED_DOSE": "137", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "829", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-A1-A0SB": { "demographics": { "SUBTYPE": "BRCA_Normal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "0045349c-69d9-4306-a403-c9c1fa836644", "AGE": 70, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE I", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 259.0, "DAYS_TO_BIRTH": -25833.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "6/30/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8200/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": null, "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 8.514975178, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 8.514975178, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 8.514975178, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 8.514975178, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A1-A0SB-01", "ONCOTREE_CODE": "BRCNOS", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Carcinoma (NOS)", "TUMOR_TYPE": "Other", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A1", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": NaN, "MSI_SENSOR_SCORE": 0.2, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.5, "TISSUE_SOURCE_SITE": "UCSF", "TBL_SCORE": 2.0 }, "treatments": [] }, "TCGA-A8-A07B": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "b43e41af-1d82-4b5f-b8f1-add0510e6b86", "AGE": 69, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 1308.0, "DAYS_TO_BIRTH": -25475.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "5/27/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": null, "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 43.00226847, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 43.00226847, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 43.00226847, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 43.00226847, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A8-A07B-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 16.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2543, "MSI_SENSOR_SCORE": 0.68, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.133333333, "TISSUE_SOURCE_SITE": "Indivumed", "TBL_SCORE": 207.0 }, "treatments": [] }, "TCGA-A8-A094": { "demographics": { "SUBTYPE": "BRCA_Her2", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "993103b1-e5a1-4c33-8629-be53ebc41d64", "AGE": 75, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 0.0, "DAYS_TO_BIRTH": -27729.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "5/27/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": null, "RADIATION_THERAPY": null, "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 0.0, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 0.0, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 0.0, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 0.0, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A8-A094-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 11.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2589, "MSI_SENSOR_SCORE": 0.36, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 5.766666667, "TISSUE_SOURCE_SITE": "Indivumed", "TBL_SCORE": 216.0 }, "treatments": [] }, "TCGA-EW-A1PB": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "88db1340-e4bf-451a-87c0-6e9168296f5e", "AGE": 70, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 608.0, "DAYS_TO_BIRTH": -25770.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/18/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 19.98882204, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 19.98882204, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 19.98882204, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 19.98882204, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-EW-A1PB-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "EW", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 14.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3663, "MSI_SENSOR_SCORE": 1.08, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 4.366666667, "TISSUE_SOURCE_SITE": "University of Miami", "TBL_SCORE": 195.0 }, "treatments": [] }, "TCGA-C8-A274": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "dbcad60f-86c7-41e3-b0ae-baa39c9f83dd", "AGE": 63, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 508.0, "DAYS_TO_BIRTH": -23337.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/21/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "No", "PRIOR_DX": "No", "RACE": "Asian", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 16.70118684, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 16.70118684, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 16.70118684, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 16.70118684, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-C8-A274-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "C8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 16.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3504, "MSI_SENSOR_SCORE": 0.41, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 6.4, "TISSUE_SOURCE_SITE": "ILSBio", "TBL_SCORE": 42.0 }, "treatments": [ { "START_DATE": 8, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-AN-A0XN": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "4e3699da-4367-4a43-9d66-a117d3ad460d", "AGE": 68, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 10.0, "DAYS_TO_BIRTH": -25029.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/25/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N2", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 0.32876352, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 0.32876352, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 0.32876352, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 0.32876352, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AN-A0XN-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AN", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 12.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3135, "MSI_SENSOR_SCORE": 0.45, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 4.866666667, "TISSUE_SOURCE_SITE": "Cureline", "TBL_SCORE": 443.0 }, "treatments": [] }, "TCGA-UU-A93S": { "demographics": { "SUBTYPE": "BRCA_Her2", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "45013972-2DFD-4F82-A076-E3E4AF1B43B8", "AGE": 63, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": NaN, "DAYS_TO_BIRTH": -23278.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "11/11/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M1", "PATH_N_STAGE": "N3B", "PATH_T_STAGE": "T4D", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "No", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 3.813656837, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 3.813656837, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 3.813656837, "GENETIC_ANCESTRY_LABEL": "AFR_ADMIX" }, "sample": { "SAMPLE_ID": "TCGA-UU-A93S-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "UU", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 15.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3562, "MSI_SENSOR_SCORE": 0.48, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 4.633333333, "TISSUE_SOURCE_SITE": "Mary Bird Perkins Cancer Center - Our Lady of the Lake", "TBL_SCORE": 416.0 }, "treatments": [] }, "TCGA-AC-A3W6": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "1B4CFAD1-E353-4411-97B6-2B7B9309E95E", "AGE": 90, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 602.0, "DAYS_TO_BIRTH": -32872.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/24/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "0:LIVING", "OS_MONTHS": 19.79156393, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 19.79156393, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 19.79156393, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 19.79156393, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AC-A3W6-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "AC", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 6.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3196, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": NaN, "TISSUE_SOURCE_SITE": "International Genomics Consortium", "TBL_SCORE": 5.0 }, "treatments": [] }, "TCGA-A2-A0CP": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "fe15c48b-116d-461e-9b40-68514730fd18", "AGE": 60, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 2813.0, "DAYS_TO_BIRTH": -22133.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/8/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 92.48117829, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 92.48117829, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 92.48117829, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 92.48117829, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A2-A0CP-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 5.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.273, "MSI_SENSOR_SCORE": 0.04, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.233333333, "TISSUE_SOURCE_SITE": "Walter Reed", "TBL_SCORE": 3.0 }, "treatments": [ { "START_DATE": 70, "STOP_DATE": 134.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "106", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "424", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 70, "STOP_DATE": 134.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "1056-1062", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "4236", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 206, "STOP_DATE": 2043.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1 mg daily", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "3", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 163, "STOP_DATE": 210.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "33", "RADIATION_DOSAGE": "6040", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-EW-A424": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "A6502F17-6BEE-4D5A-8520-06364593D39C", "AGE": 51, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 715.0, "DAYS_TO_BIRTH": -18850.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/26/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "0:LIVING", "OS_MONTHS": 23.50659171, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 23.50659171, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 23.50659171, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 23.50659171, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-EW-A424-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "EW", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 4.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": NaN, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.0, "TISSUE_SOURCE_SITE": "University of Miami", "TBL_SCORE": 45.0 }, "treatments": [ { "START_DATE": 118, "STOP_DATE": 181.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 118, "STOP_DATE": 181.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 154, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 231, "STOP_DATE": 281.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "25", "RADIATION_DOSAGE": "60", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "gy" } ] }, "TCGA-LL-A740": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "AA60FA8D-C374-40E0-AF2D-B007701E67E3", "AGE": 61, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 441.0, "DAYS_TO_BIRTH": -22416.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "11/12/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 14.49847125, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 14.49847125, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 14.49847125, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 14.49847125, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-LL-A740-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "LL", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 6.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3365, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.433333333, "TISSUE_SOURCE_SITE": "Candler", "TBL_SCORE": 116.0 }, "treatments": [ { "START_DATE": 122, "STOP_DATE": 164.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 122, "STOP_DATE": 164.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 178, "STOP_DATE": 255.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-BH-A0DL": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "ba39bfbc-5cac-4f6c-b55c-4eee3466ee93", "AGE": 64, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 2381.0, "DAYS_TO_BIRTH": -23628.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "8/11/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8575/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 78.27859421, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 78.27859421, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 78.27859421, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 78.27859421, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A0DL-01", "ONCOTREE_CODE": "BRCNOS", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Carcinoma (NOS)", "TUMOR_TYPE": "Other", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 10.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2967, "MSI_SENSOR_SCORE": 0.18, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 3.3, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 118.0 }, "treatments": [ { "START_DATE": 58, "STOP_DATE": 121.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 58, "STOP_DATE": 205.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 154, "STOP_DATE": 205.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "36", "RADIATION_DOSAGE": "6640", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-A2-A4S3": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "418C11E8-2670-48D5-BBF5-95B46BFF1201", "AGE": 59, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 666.0, "DAYS_TO_BIRTH": -21762.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "2/28/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": null, "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 21.89565046, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 21.89565046, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 21.89565046, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 21.89565046, "GENETIC_ANCESTRY_LABEL": "AFR_ADMIX" }, "sample": { "SAMPLE_ID": "TCGA-A2-A4S3-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "A2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 11.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3033, "MSI_SENSOR_SCORE": 0.13, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.8, "TISSUE_SOURCE_SITE": "Walter Reed", "TBL_SCORE": 203.0 }, "treatments": [] }, "TCGA-AR-A24W": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "67526f5a-3a30-45b2-aeab-2b21a855063e", "AGE": 55, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 991.0, "DAYS_TO_BIRTH": -20123.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "11/10/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 50.95834566, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 50.95834566, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 50.95834566, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 50.95834566, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AR-A24W-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AR", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 28.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3248, "MSI_SENSOR_SCORE": 0.03, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.466666667, "TISSUE_SOURCE_SITE": "Mayo", "TBL_SCORE": 60.0 }, "treatments": [ { "START_DATE": 164, "STOP_DATE": 345.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Letrozole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 345, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-A7-A13E": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "8c7e74e0-71ef-49b8-9217-94b8ef740ef9", "AGE": 62, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": 326.0, "DAYS_TO_BIRTH": -22690.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "2/28/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 20.18608015, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 20.18608015, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 18.27925173, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 18.27925173, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A7-A13E-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "A7", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 22.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.321, "MSI_SENSOR_SCORE": 4.87, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 3.1, "TISSUE_SOURCE_SITE": "Christiana Healthcare", "TBL_SCORE": 88.0 }, "treatments": [ { "START_DATE": 211, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 67, "STOP_DATE": 108.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "120-122", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "486", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 67, "STOP_DATE": 108.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "1200-1230", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "4848", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 123, "STOP_DATE": 207.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "158-160", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "1908", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 67, "STOP_DATE": 193.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Targeted Molecular Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Bevacizumab", "NUMBER_OF_CYCLES": "8", "PRESCRIBED_DOSE": "914-1364", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "9136", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 574, "STOP_DATE": 574.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": "1", "PRESCRIBED_DOSE": "157", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Palliative", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "157", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 211, "STOP_DATE": 589.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "379", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 238, "STOP_DATE": 287.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "33", "RADIATION_DOSAGE": "6100", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" }, { "START_DATE": 584, "STOP_DATE": 598.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 2", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Palliative", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Distant Site", "COURSE_NUMBER": 3.0, "NUMBER_OF_FRACTIONS": "10", "RADIATION_DOSAGE": "3000", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" }, { "START_DATE": 557, "STOP_DATE": 563.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 3", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Palliative", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Distant Site", "COURSE_NUMBER": 2.0, "NUMBER_OF_FRACTIONS": "5", "RADIATION_DOSAGE": "2000", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-AO-A0J6": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "e9f4f373-37a5-48ad-a1a0-b0d47820111a", "AGE": 61, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": 1140.0, "DAYS_TO_BIRTH": -22462.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/19/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 37.47904133, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 37.47904133, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 37.47904133, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 37.47904133, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AO-A0J6-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AO", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 5.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2929, "MSI_SENSOR_SCORE": 0.67, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 3.333333333, "TISSUE_SOURCE_SITE": "MSKCC", "TBL_SCORE": 164.0 }, "treatments": [ { "START_DATE": 130, "STOP_DATE": 172.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "175", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "1320", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 74, "STOP_DATE": 116.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "600", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "4400", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 74, "STOP_DATE": 116.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "60", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "440", "TOTAL_DOSE_UNITS": "Meq", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 241, "STOP_DATE": 273.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "21", "RADIATION_DOSAGE": "5240", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-BH-A0E1": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "606fbc6a-b41b-441d-9401-51e54912bf5e", "AGE": 52, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": 477.0, "DAYS_TO_BIRTH": -19192.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "11/9/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 15.68201992, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 15.68201992, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 15.68201992, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 15.68201992, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A0E1-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 3.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2507, "MSI_SENSOR_SCORE": 0.36, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.466666667, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 3.0 }, "treatments": [ { "START_DATE": 140, "STOP_DATE": 203.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 308, "STOP_DATE": 596.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": "12", "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 140, "STOP_DATE": 203.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 349, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-A8-A06R": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "f3ba71f9-25f3-4784-bf2d-3aa522a0cba8", "AGE": 69, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "5TH", "DAYS_LAST_FOLLOWUP": 547.0, "DAYS_TO_BIRTH": -25477.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "5/27/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": null, "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 17.98336457, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 17.98336457, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 17.98336457, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 17.98336457, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A8-A06R-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 20.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3035, "MSI_SENSOR_SCORE": 1.23, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.933333333, "TISSUE_SOURCE_SITE": "Indivumed", "TBL_SCORE": 1101.0 }, "treatments": [ { "START_DATE": 59, "STOP_DATE": 151.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Fluorouracil", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 59, "STOP_DATE": 151.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 59, "STOP_DATE": 151.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 243, "STOP_DATE": 334.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 181, "STOP_DATE": 212.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": "60", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "gy" } ] }, "TCGA-B6-A0IO": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "04af44fc-c487-4005-b3cb-cb64815824a2", "AGE": 66, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": 5042.0, "DAYS_TO_BIRTH": -24322.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "11/2/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 165.762567, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 165.762567, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 165.762567, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 165.762567, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-B6-A0IO-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "B6", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 21.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": NaN, "MSI_SENSOR_SCORE": 0.24, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.933333333, "TISSUE_SOURCE_SITE": "Duke", "TBL_SCORE": 194.0 }, "treatments": [] }, "TCGA-WT-AB44": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "5CD79093-1571-4F71-8136-0D84CCABDCAC", "AGE": 77, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 883.0, "DAYS_TO_BIRTH": NaN, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/16/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 29.02981885, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 29.02981885, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 29.02981885, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 29.02981885, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-WT-AB44-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "WT", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 18.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3186, "MSI_SENSOR_SCORE": 0.24, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.033333333, "TISSUE_SOURCE_SITE": "University of Kansas", "TBL_SCORE": 12.0 }, "treatments": [ { "START_DATE": 31, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 92, "STOP_DATE": 153.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "33", "RADIATION_DOSAGE": "6040", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-D8-A3Z6": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "A6E5F869-1182-4F81-B4BB-CF55261C8F3F", "AGE": 56, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIC", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 563.0, "DAYS_TO_BIRTH": -20629.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/3/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N3A", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 18.5093862, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 18.5093862, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 18.5093862, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 18.5093862, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D8-A3Z6-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "D8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 10.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2925, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.833333333, "TISSUE_SOURCE_SITE": "Greater Poland Cancer Center", "TBL_SCORE": 46.0 }, "treatments": [ { "START_DATE": 22, "STOP_DATE": 86.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Stable Disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 108, "STOP_DATE": 185.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Stable Disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 260, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 22, "STOP_DATE": 86.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Stable Disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 234, "STOP_DATE": 260.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Stable Disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "22", "RADIATION_DOSAGE": "45", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "gy" } ] }, "TCGA-A2-A1G4": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "e3b555aa-7f0a-49c6-9b13-182c61a144c1", "AGE": 71, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 595.0, "DAYS_TO_BIRTH": -25966.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/22/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 19.56142946, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 19.56142946, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 19.56142946, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 19.56142946, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A2-A1G4-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "A2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 4.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2954, "MSI_SENSOR_SCORE": 0.24, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.933333333, "TISSUE_SOURCE_SITE": "Walter Reed", "TBL_SCORE": 77.0 }, "treatments": [ { "START_DATE": 207, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Letrozole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "2.5", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "4", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 80, "STOP_DATE": 185.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "6", "PRESCRIBED_DOSE": "80", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "480", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 80, "STOP_DATE": 185.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": "6", "PRESCRIBED_DOSE": "120", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "3", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "720", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 80, "STOP_DATE": 185.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "6", "PRESCRIBED_DOSE": "795", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "4770", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-GM-A2DN": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "56BBD282-B88D-4730-9242-AB97D08DC83A", "AGE": 58, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 3091.0, "DAYS_TO_BIRTH": -21288.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/30/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 101.6208042, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 101.6208042, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 101.6208042, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 101.6208042, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-GM-A2DN-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "GM", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 3.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2965, "MSI_SENSOR_SCORE": 0.07, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.8, "TISSUE_SOURCE_SITE": "MD Anderson", "TBL_SCORE": 3.0 }, "treatments": [ { "START_DATE": 167, "STOP_DATE": 244.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 251, "STOP_DATE": 314.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Fluorouracil", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 251, "STOP_DATE": 314.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Epirubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 251, "STOP_DATE": 314.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 335, "STOP_DATE": 1063.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-LL-A6FR": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "1347C23D-8D6E-4C15-9461-640249838C96", "AGE": 50, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 489.0, "DAYS_TO_BIRTH": -18520.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "8/30/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 16.07653615, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 16.07653615, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 16.07653615, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 16.07653615, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-LL-A6FR-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "LL", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 15.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3539, "MSI_SENSOR_SCORE": 0.28, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.233333333, "TISSUE_SOURCE_SITE": "Candler", "TBL_SCORE": 195.0 }, "treatments": [ { "START_DATE": 62, "STOP_DATE": 104.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 62, "STOP_DATE": 104.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 118, "STOP_DATE": 489.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Immunotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Trastuzumab", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 118, "STOP_DATE": 195.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 230, "STOP_DATE": 262.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "22", "RADIATION_DOSAGE": "54.72", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "gy" } ] }, "TCGA-A2-A0SV": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "ad01259b-d858-40bc-a6ba-0bb06e996afb", "AGE": 63, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": NaN, "DAYS_TO_BIRTH": -23126.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "11/15/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M1", "PATH_N_STAGE": "N2A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 27.12299043, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 27.12299043, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 27.12299043, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A2-A0SV-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 13.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3032, "MSI_SENSOR_SCORE": 0.59, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.1, "TISSUE_SOURCE_SITE": "Walter Reed", "TBL_SCORE": 80.0 }, "treatments": [ { "START_DATE": 304, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Capecitabine", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "3000", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "4", "REGIMEN_INDICATION": "Progression", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 65, "STOP_DATE": 253.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Other", "TREATMENT_SUBTYPE": "Bisphosphonate Therapy", "AGENT": "Zoledronic Acid", "NUMBER_OF_CYCLES": "7", "PRESCRIBED_DOSE": "4", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "16", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 79, "STOP_DATE": 168.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 170, "STOP_DATE": 223.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Fulvestrant", "NUMBER_OF_CYCLES": "5", "PRESCRIBED_DOSE": "250-500", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "3", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IM", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "1250", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 108, "STOP_DATE": 141.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-EW-A1P0": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "81e32f39-3aa0-468b-87ed-dd2eb6165ddf", "AGE": 55, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 1251.0, "DAYS_TO_BIRTH": -20107.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/10/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8523/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N1B", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 41.1283164, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 41.1283164, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 35.96672913, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 35.96672913, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-EW-A1P0-01", "ONCOTREE_CODE": "BRCNOS", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Carcinoma (NOS)", "TUMOR_TYPE": "Other", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "EW", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 5.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3252, "MSI_SENSOR_SCORE": 0.37, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.666666667, "TISSUE_SOURCE_SITE": "University of Miami", "TBL_SCORE": 90.0 }, "treatments": [ { "START_DATE": 1033, "STOP_DATE": 1245.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-BH-A28O": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "84B7CCF2-8AB3-4B21-96DE-800D231BC072", "AGE": 50, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIC", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 1120.0, "DAYS_TO_BIRTH": -18501.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/2/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N3", "PATH_T_STAGE": "T3A", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "0:LIVING", "OS_MONTHS": 36.82151429, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 36.82151429, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 36.82151429, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 36.82151429, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A28O-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 2.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3017, "MSI_SENSOR_SCORE": 0.01, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": NaN, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 0.0 }, "treatments": [ { "START_DATE": 338, "STOP_DATE": 430.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 338, "STOP_DATE": 430.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-AN-A04A": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "e5aae05a-478e-4a55-a27c-12b2b4be302a", "AGE": 36, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 90.0, "DAYS_TO_BIRTH": -13445.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/29/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N2", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": null, "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 2.958871684, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 2.958871684, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 2.958871684, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AN-A04A-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AN", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 14.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2812, "MSI_SENSOR_SCORE": 0.34, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.366666667, "TISSUE_SOURCE_SITE": "Cureline", "TBL_SCORE": 163.0 }, "treatments": [] }, "TCGA-AN-A0AJ": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "9646160a-f1f9-437b-8c7d-efb0b57bfb97", "AGE": 79, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": 303.0, "DAYS_TO_BIRTH": -29131.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/20/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8522/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 9.961534668, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 9.961534668, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 9.961534668, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 9.961534668, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AN-A0AJ-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AN", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 16.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.252, "MSI_SENSOR_SCORE": 1.25, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.566666667, "TISSUE_SOURCE_SITE": "Cureline", "TBL_SCORE": 438.0 }, "treatments": [] }, "TCGA-A2-A4RX": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "D111C4AB-B39A-4A7C-8D8E-CB342BC10627", "AGE": 67, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 742.0, "DAYS_TO_BIRTH": -24779.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "2/28/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8575/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": null, "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "0:LIVING", "OS_MONTHS": 24.39425321, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 24.39425321, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 24.39425321, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 24.39425321, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-A2-A4RX-01", "ONCOTREE_CODE": "MBC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Metaplastic Breast Cancer", "TUMOR_TYPE": "Metaplastic Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "A2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 20.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3083, "MSI_SENSOR_SCORE": 0.03, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": NaN, "TISSUE_SOURCE_SITE": "Walter Reed", "TBL_SCORE": 8.0 }, "treatments": [] }, "TCGA-BH-A0DV": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "96b9c7db-1be1-4b60-b47c-26b654c3d64c", "AGE": 54, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 2064.0, "DAYS_TO_BIRTH": -19781.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "8/2/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N2A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 67.85679061, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 67.85679061, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 67.85679061, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 67.85679061, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A0DV-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 4.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2638, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.566666667, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 3.0 }, "treatments": [ { "START_DATE": 48, "STOP_DATE": 176.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 48, "STOP_DATE": 177.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 48, "STOP_DATE": 177.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 177, "STOP_DATE": 223.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "33", "RADIATION_DOSAGE": "6040", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-AO-A03P": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "2d4c778c-7f77-4f0a-8261-2086accf15fd", "AGE": 54, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 2576.0, "DAYS_TO_BIRTH": -19724.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/19/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 95.70306079, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 95.70306079, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 63.18834862, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-AO-A03P-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AO", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 11.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.239, "MSI_SENSOR_SCORE": 1.02, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.333333333, "TISSUE_SOURCE_SITE": "MSKCC", "TBL_SCORE": 392.0 }, "treatments": [ { "START_DATE": 2451, "STOP_DATE": 2822.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Immunotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Bevacizumab", "NUMBER_OF_CYCLES": "27", "PRESCRIBED_DOSE": "10", "PRESCRIBED_DOSE_UNITS": "mg/kg", "REGIMEN_NUMBER": "3", "REGIMEN_INDICATION": "Recurrence", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "20050", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 1918, "STOP_DATE": 2331.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Letrozole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "2.5", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Recurrence", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 2332, "STOP_DATE": 2422.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Exemestane", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "25", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Recurrence", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 2422, "STOP_DATE": 2839.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Capecitabine", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1500", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "3", "REGIMEN_INDICATION": "Recurrence", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 2853, "STOP_DATE": 2881.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Fulvestrant", "NUMBER_OF_CYCLES": "3", "PRESCRIBED_DOSE": "500", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "5", "REGIMEN_INDICATION": "Other", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IM", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "1500", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 98, "STOP_DATE": 141.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "30", "RADIATION_DOSAGE": "6000", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-BH-A0C3": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "7bcf6d42-eb8f-4aa2-825b-38671d4f9e3a", "AGE": 47, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE I", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 2709.0, "DAYS_TO_BIRTH": -17221.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "8/11/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8522/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 89.06203768, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 89.06203768, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 87.91136536, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 87.91136536, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A0C3-01", "ONCOTREE_CODE": "BRCNOS", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Carcinoma (NOS)", "TUMOR_TYPE": "Mixed Histology (NOS)", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 11.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2808, "MSI_SENSOR_SCORE": 0.05, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.366666667, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 33.0 }, "treatments": [ { "START_DATE": 109, "STOP_DATE": 209.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Clinical Progressive Disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 109, "STOP_DATE": 209.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Clinical Progressive Disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 209, "STOP_DATE": 262.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Radiographic Progressive Disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "34", "RADIATION_DOSAGE": "6640", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-EW-A1PE": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "f3b86c02-09a5-4e97-aa7a-86f13f7cda4b", "AGE": 56, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 320.0, "DAYS_TO_BIRTH": -20694.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/27/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8507/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 10.52043265, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 10.52043265, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 10.52043265, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 10.52043265, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-EW-A1PE-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "EW", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 6.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3418, "MSI_SENSOR_SCORE": 0.44, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.933333333, "TISSUE_SOURCE_SITE": "University of Miami", "TBL_SCORE": 11.0 }, "treatments": [ { "START_DATE": 269, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Exemestane", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "25", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 71, "STOP_DATE": 111.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Epirubicin", "NUMBER_OF_CYCLES": "3", "PRESCRIBED_DOSE": "1000", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "fec then t", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "2990", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 132, "STOP_DATE": 174.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": "3", "PRESCRIBED_DOSE": "200", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "fec then t", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "603", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 71, "STOP_DATE": 111.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "3", "PRESCRIBED_DOSE": "1000", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "fec then t", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "2990", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 71, "STOP_DATE": 111.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Fluorouracil", "NUMBER_OF_CYCLES": "3", "PRESCRIBED_DOSE": "200", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "fec then t", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "598", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 208, "STOP_DATE": 269.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "25", "RADIATION_DOSAGE": "10,500", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-D8-A1JM": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "3e775c99-ceda-4246-8d6f-0f58ca5097c8", "AGE": 59, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 590.0, "DAYS_TO_BIRTH": -21602.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/29/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 19.3970477, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 19.3970477, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 19.3970477, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 19.3970477, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D8-A1JM-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "D8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 14.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3527, "MSI_SENSOR_SCORE": 1.09, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.3, "TISSUE_SOURCE_SITE": "Greater Poland Cancer Center", "TBL_SCORE": 197.0 }, "treatments": [ { "START_DATE": 39, "STOP_DATE": 144.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin + Cyclophosphamide + Tamoxifen", "NUMBER_OF_CYCLES": "6", "PRESCRIBED_DOSE": "1200+120+20", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "7200+720+20", "TOTAL_DOSE_UNITS": "Mg/M2", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 171, "STOP_DATE": 196.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "45", "RADIATION_DOSAGE": "9000", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-A2-A1G1": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "75b5529b-565a-4eba-918a-910b2f441d32", "AGE": 85, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 584.0, "DAYS_TO_BIRTH": -31223.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/12/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 19.19978959, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 19.19978959, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 19.19978959, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 19.19978959, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A2-A1G1-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "A2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 20.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3368, "MSI_SENSOR_SCORE": 1.11, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.966666667, "TISSUE_SOURCE_SITE": "Walter Reed", "TBL_SCORE": 149.0 }, "treatments": [ { "START_DATE": 92, "STOP_DATE": 143.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "28", "RADIATION_DOSAGE": "6000", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-AQ-A04H": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "83f943c7-3975-4b4f-985d-9c057741793b", "AGE": 61, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 754.0, "DAYS_TO_BIRTH": -22539.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/15/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N2A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 24.78876944, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 24.78876944, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 24.78876944, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 24.78876944, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AQ-A04H-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AQ", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 15.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2685, "MSI_SENSOR_SCORE": 0.73, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.0, "TISSUE_SOURCE_SITE": "UNC", "TBL_SCORE": 240.0 }, "treatments": [ { "START_DATE": 29, "STOP_DATE": 133.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": "6", "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 175, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Letrozole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "2.5", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 29, "STOP_DATE": 133.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 29, "STOP_DATE": 133.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Trastuzumab", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 138, "STOP_DATE": 166.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-EW-A1P7": { "demographics": { "SUBTYPE": "BRCA_Normal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "01674b2c-5cf2-478f-84a1-f69c39f47bd4", "AGE": 59, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 915.0, "DAYS_TO_BIRTH": -21750.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/18/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 30.08186212, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 30.08186212, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 23.96686064, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 23.96686064, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-EW-A1P7-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "EW", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 1.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3686, "MSI_SENSOR_SCORE": 1.05, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.666666667, "TISSUE_SOURCE_SITE": "University of Miami", "TBL_SCORE": 16.0 }, "treatments": [ { "START_DATE": 93, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": "12", "PRESCRIBED_DOSE": "550", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "carboplatin/taxol", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 93, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": "12", "PRESCRIBED_DOSE": "234", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "carboplatin/taxol", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-E2-A15O": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "eafa45a4-2fd1-4fa3-860c-9d52ed382b7d", "AGE": 89, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE I", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 1545.0, "DAYS_TO_BIRTH": -32583.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/14/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "NX", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "No", "PRIOR_DX": "Yes", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 50.7939639, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 50.7939639, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 39.78038597, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 39.78038597, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-E2-A15O-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "E2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 11.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2816, "MSI_SENSOR_SCORE": 0.19, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.9, "TISSUE_SOURCE_SITE": "Roswell Park", "TBL_SCORE": 60.0 }, "treatments": [ { "START_DATE": 396, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Letrozole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "3", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 96, "STOP_DATE": 396.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Exemestane", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "20", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "6000", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 48, "STOP_DATE": 104.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "56", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 1245, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Letrozole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-E9-A22B": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "b956df1b-bc77-4bdb-a5bd-5dda7b4c8da7", "AGE": 71, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 1167.0, "DAYS_TO_BIRTH": -26278.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "8/2/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8522/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 38.36670283, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 38.36670283, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 38.36670283, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 38.36670283, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E9-A22B-01", "ONCOTREE_CODE": "BRCNOS", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Carcinoma (NOS)", "TUMOR_TYPE": "Mixed Histology (NOS)", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "E9", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 9.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3157, "MSI_SENSOR_SCORE": 0.1, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.766666667, "TISSUE_SOURCE_SITE": "Asterand", "TBL_SCORE": 91.0 }, "treatments": [ { "START_DATE": 50, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "20", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": "7240", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-BH-A209": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "5258294f-ef5b-4091-9183-6bcc545d54b2", "AGE": 77, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE I", "AJCC_STAGING_EDITION": "5TH", "DAYS_LAST_FOLLOWUP": NaN, "DAYS_TO_BIRTH": -28403.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/8/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8510/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": null, "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 130.1574777, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 130.1574777, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 130.1574777, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-BH-A209-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Medullary Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 19.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3711, "MSI_SENSOR_SCORE": 0.33, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.933333333, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 176.0 }, "treatments": [] }, "TCGA-EW-A1J5": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "5d8ed961-a012-4b6b-bffb-9468d3953646", "AGE": 59, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 477.0, "DAYS_TO_BIRTH": -21559.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "6/10/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 15.68201992, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 15.68201992, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 15.68201992, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 15.68201992, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-EW-A1J5-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "EW", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 8.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.312, "MSI_SENSOR_SCORE": 0.24, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 12.26666667, "TISSUE_SOURCE_SITE": "University of Miami", "TBL_SCORE": 34.0 }, "treatments": [ { "START_DATE": 94, "STOP_DATE": 247.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "98", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "ac then th", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "392", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 94, "STOP_DATE": 247.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "984", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "ac then th", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "3936", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 94, "STOP_DATE": 247.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": "12", "PRESCRIBED_DOSE": "127", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "ac then th", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "1524", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 94, "STOP_DATE": 247.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Trastuzumab", "NUMBER_OF_CYCLES": "12", "PRESCRIBED_DOSE": "236", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "ac then th", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "2832", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-BH-A0DH": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "491b6364-1223-474f-816f-e248c8c841e2", "AGE": 63, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": 1156.0, "DAYS_TO_BIRTH": -23366.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "11/8/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 38.00506296, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 38.00506296, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 38.00506296, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 38.00506296, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A0DH-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 9.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2783, "MSI_SENSOR_SCORE": 0.03, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.3, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 23.0 }, "treatments": [ { "START_DATE": 164, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Letrozole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "2.5", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 71, "STOP_DATE": 143.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 71, "STOP_DATE": 143.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 71, "STOP_DATE": 143.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 189, "STOP_DATE": 233.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "30", "RADIATION_DOSAGE": "6000", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-EW-A6SA": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "ABA5F46A-E67A-4CD2-9C52-C0686968FF04", "AGE": 59, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE II", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 510.0, "DAYS_TO_BIRTH": -21623.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "2/27/2015", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0 (I+)", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "0:LIVING", "OS_MONTHS": 16.76693954, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 16.76693954, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 16.76693954, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 16.76693954, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-EW-A6SA-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "EW", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 16.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3435, "MSI_SENSOR_SCORE": 0.78, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.233333333, "TISSUE_SOURCE_SITE": "University of Miami", "TBL_SCORE": 172.0 }, "treatments": [] }, "TCGA-A8-A06Y": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "515b1400-e896-4f2a-81bd-70895441a0bd", "AGE": 66, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 791.0, "DAYS_TO_BIRTH": -24442.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "5/27/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": null, "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 26.00519446, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 26.00519446, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 26.00519446, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 26.00519446, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A8-A06Y-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 12.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2632, "MSI_SENSOR_SCORE": 0.87, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.966666667, "TISSUE_SOURCE_SITE": "Indivumed", "TBL_SCORE": 20.0 }, "treatments": [ { "START_DATE": 92, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 61, "STOP_DATE": 122.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "gy" } ] }, "TCGA-E2-A14Z": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "d7ce6b79-f7c0-481e-9dbd-6273f01c9786", "AGE": 64, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE I", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 518.0, "DAYS_TO_BIRTH": -23682.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/6/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 18.5093862, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 18.5093862, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 6.180754184, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 6.180754184, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E2-A14Z-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "E2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 22.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2884, "MSI_SENSOR_SCORE": 0.13, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.033333333, "TISSUE_SOURCE_SITE": "Roswell Park", "TBL_SCORE": 228.0 }, "treatments": [ { "START_DATE": 196, "STOP_DATE": 266.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Recurrence", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 196, "STOP_DATE": 266.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Recurrence", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 110, "STOP_DATE": 188.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "78", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 236, "STOP_DATE": 359.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Palliative", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Distant Recurrence", "COURSE_NUMBER": 2.0, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": "5500", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Implants", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" }, { "START_DATE": 64, "STOP_DATE": 110.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 2", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "33", "RADIATION_DOSAGE": "6040", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-AO-A0JF": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "f357fe19-5359-4662-8ce9-aa996132283b", "AGE": 68, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": 1980.0, "DAYS_TO_BIRTH": -24923.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/20/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 65.09517704, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 65.09517704, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 65.09517704, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 65.09517704, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AO-A0JF-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AO", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 2.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2755, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.866666667, "TISSUE_SOURCE_SITE": "MSKCC", "TBL_SCORE": 3.0 }, "treatments": [ { "START_DATE": 336, "STOP_DATE": 353.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 172, "STOP_DATE": 256.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": "12", "PRESCRIBED_DOSE": "80", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "1920", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 105, "STOP_DATE": 155.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "60", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "480", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 105, "STOP_DATE": 155.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "600", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "4800", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 356, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Letrozole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "2.5", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 299, "STOP_DATE": 328.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "21", "RADIATION_DOSAGE": "5272", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-GM-A2D9": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "1133B8A9-6B11-4511-B70A-F200E3B8B5DB", "AGE": 69, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE I", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": NaN, "DAYS_TO_BIRTH": -25490.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/28/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 59.5719499, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 59.5719499, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 17.62172469, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 17.62172469, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-GM-A2D9-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "GM", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 5.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3107, "MSI_SENSOR_SCORE": 0.07, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 14.56666667, "TISSUE_SOURCE_SITE": "MD Anderson", "TBL_SCORE": 57.0 }, "treatments": [ { "START_DATE": 559, "STOP_DATE": 1265.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Stable Disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 1266, "STOP_DATE": 1354.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Stable Disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 1362, "STOP_DATE": 1455.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Capecitabine", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Clinical Progressive Disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 1470, "STOP_DATE": 1567.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Gemcitabine", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Clinical Progressive Disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 68, "STOP_DATE": 96.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "30", "RADIATION_DOSAGE": "60", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "gy" }, { "START_DATE": 1413, "STOP_DATE": 1434.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 2", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Stable Disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Distant Recurrence", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "10", "RADIATION_DOSAGE": "30", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "gy" } ] }, "TCGA-AO-A125": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "8577ffcb-242e-40e2-98d4-2831d952be34", "AGE": 72, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "5TH", "DAYS_LAST_FOLLOWUP": 3019.0, "DAYS_TO_BIRTH": -26466.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/7/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8050/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 113.6206727, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 113.6206727, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 113.6206727, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 113.6206727, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-AO-A125-01", "ONCOTREE_CODE": "BRCNOS", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Carcinoma (NOS)", "TUMOR_TYPE": "Other", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AO", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 5.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": NaN, "MSI_SENSOR_SCORE": 0.2, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.033333333, "TISSUE_SOURCE_SITE": "MSKCC", "TBL_SCORE": 2.0 }, "treatments": [ { "START_DATE": 799, "STOP_DATE": 2535.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Exemestane", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "25", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 129, "STOP_DATE": 799.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "20", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-B6-A0X5": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "4e6edfe6-adcb-4c12-8ff4-38a79f5887e8", "AGE": 61, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "4TH", "DAYS_LAST_FOLLOWUP": NaN, "DAYS_TO_BIRTH": -22380.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/14/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1B", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 68.94171023, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 68.94171023, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 44.15294079, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 44.15294079, "GENETIC_ANCESTRY_LABEL": "AFR_ADMIX" }, "sample": { "SAMPLE_ID": "TCGA-B6-A0X5-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "B6", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 3.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2756, "MSI_SENSOR_SCORE": 0.01, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.2, "TISSUE_SOURCE_SITE": "Duke", "TBL_SCORE": 6.0 }, "treatments": [] }, "TCGA-AR-A1AM": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "EBD1512A-4865-4193-97B3-F599D555759A", "AGE": 52, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 2991.0, "DAYS_TO_BIRTH": -19123.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "11/20/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "0:LIVING", "OS_MONTHS": 98.33316895, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 98.33316895, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 98.33316895, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 98.33316895, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AR-A1AM-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AR", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 3.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.306, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": NaN, "TISSUE_SOURCE_SITE": "Mayo", "TBL_SCORE": 14.0 }, "treatments": [ { "START_DATE": 55, "STOP_DATE": 97.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 127, "STOP_DATE": 314.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 314, "STOP_DATE": 336.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 55, "STOP_DATE": 97.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-BH-A0DK": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "f2bbfa9d-9a9d-4f46-9fde-378e4c44e2ad", "AGE": 49, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": 423.0, "DAYS_TO_BIRTH": -18237.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "11/8/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 13.90669691, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 13.90669691, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 13.90669691, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 13.90669691, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A0DK-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 7.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2437, "MSI_SENSOR_SCORE": 0.32, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 5.733333333, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 71.0 }, "treatments": [ { "START_DATE": 112, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "20", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-C8-A135": { "demographics": { "SUBTYPE": "BRCA_Her2", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "33cea538-4c3f-470a-972d-257c43241ab4", "AGE": 64, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 393.0, "DAYS_TO_BIRTH": -23667.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/15/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Asian", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 12.92040635, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 12.92040635, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 12.92040635, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 12.92040635, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-C8-A135-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "C8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 20.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2924, "MSI_SENSOR_SCORE": 0.13, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.9, "TISSUE_SOURCE_SITE": "ILSBio", "TBL_SCORE": 248.0 }, "treatments": [ { "START_DATE": 40, "STOP_DATE": 51.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Fluorouracil", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 40, "STOP_DATE": 51.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 40, "STOP_DATE": 51.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 40, "STOP_DATE": 51.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-BH-A0BM": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "c2aeee6c-ba10-4cf9-b560-c739580f7bf3", "AGE": 54, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 1876.0, "DAYS_TO_BIRTH": -20049.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "11/8/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 61.67603643, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 61.67603643, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 61.67603643, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 61.67603643, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A0BM-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 4.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2664, "MSI_SENSOR_SCORE": 0.04, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.733333333, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 6.0 }, "treatments": [ { "START_DATE": 80, "STOP_DATE": 138.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 80, "STOP_DATE": 138.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 164, "STOP_DATE": 229.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": "12", "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-E9-A1N3": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "03c143e0-d8a1-4d60-a4a3-df0501fc6b6e", "AGE": 70, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 1059.0, "DAYS_TO_BIRTH": -25714.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/26/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8522/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N2", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 34.81605681, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 34.81605681, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 34.81605681, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 34.81605681, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E9-A1N3-01", "ONCOTREE_CODE": "BRCNOS", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Carcinoma (NOS)", "TUMOR_TYPE": "Mixed Histology (NOS)", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "E9", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 1.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3674, "MSI_SENSOR_SCORE": 0.03, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.766666667, "TISSUE_SOURCE_SITE": "Asterand", "TBL_SCORE": 22.0 }, "treatments": [ { "START_DATE": 15, "STOP_DATE": 68.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Fluorouracil", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 15, "STOP_DATE": 68.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 15, "STOP_DATE": 68.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 130, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "20", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-E9-A1RB": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "94b95984-b2fb-4e42-8887-45e7086c3179", "AGE": 40, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 633.0, "DAYS_TO_BIRTH": -14755.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/28/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 32.08731959, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 32.08731959, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 32.08731959, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 32.08731959, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E9-A1RB-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "E9", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 27.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.315, "MSI_SENSOR_SCORE": 0.76, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.866666667, "TISSUE_SOURCE_SITE": "Asterand", "TBL_SCORE": 131.0 }, "treatments": [ { "START_DATE": 11, "STOP_DATE": 107.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Methotrexate", "NUMBER_OF_CYCLES": "5", "PRESCRIBED_DOSE": "100", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "500", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 15, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "20", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 11, "STOP_DATE": 107.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "5", "PRESCRIBED_DOSE": "2000", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "10000", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 11, "STOP_DATE": 107.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Fluorouracil", "NUMBER_OF_CYCLES": "5", "PRESCRIBED_DOSE": "2000", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "10000", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-A8-A07F": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "5d688049-f271-40ef-813a-d37240ffe21c", "AGE": 65, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 577.0, "DAYS_TO_BIRTH": -23742.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "5/27/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": null, "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 18.96965513, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 18.96965513, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 18.96965513, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 18.96965513, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A8-A07F-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 22.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2604, "MSI_SENSOR_SCORE": 0.11, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.933333333, "TISSUE_SOURCE_SITE": "Indivumed", "TBL_SCORE": 9.0 }, "treatments": [ { "START_DATE": 365, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 181, "STOP_DATE": 212.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-E2-A10C": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "9ac44381-5d43-4f63-aa3f-7703bfc923c9", "AGE": 54, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 1220.0, "DAYS_TO_BIRTH": -19849.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "2/11/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 40.10914949, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 40.10914949, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 40.10914949, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 40.10914949, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E2-A10C-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "E2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 21.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2886, "MSI_SENSOR_SCORE": 0.08, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 11.23333333, "TISSUE_SOURCE_SITE": "Roswell Park", "TBL_SCORE": 135.0 }, "treatments": [ { "START_DATE": 95, "STOP_DATE": 139.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 282, "STOP_DATE": 343.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "3", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "1", "TOTAL_DOSE_UNITS": "Mg/Day", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 343, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Letrozole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "2.5", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "4", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 160, "STOP_DATE": 252.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": "12", "PRESCRIBED_DOSE": "80", "PRESCRIBED_DOSE_UNITS": "mg/m2/wk", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "160", "TOTAL_DOSE_UNITS": "Mg/Wk", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 95, "STOP_DATE": 139.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 279, "STOP_DATE": 328.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "29", "RADIATION_DOSAGE": "6040", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-BH-A0HL": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "602083f0-18d9-48b6-a529-31e165c54b37", "AGE": 56, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": 72.0, "DAYS_TO_BIRTH": -20804.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "11/10/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8503/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "0:LIVING", "OS_MONTHS": 2.367097347, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 2.367097347, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 2.367097347, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 2.367097347, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A0HL-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": NaN, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2969, "MSI_SENSOR_SCORE": 0.56, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.1, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 632.0 }, "treatments": [ { "START_DATE": 72, "STOP_DATE": 135.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "120", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "480", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 72, "STOP_DATE": 135.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "1200", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "4800", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 156, "STOP_DATE": 237.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 492, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-D8-A27M": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "ae65baeb-6b78-492a-8c63-bb7e93e83dc2", "AGE": 59, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 410.0, "DAYS_TO_BIRTH": -21910.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/17/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 13.47930434, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 13.47930434, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 13.47930434, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 13.47930434, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D8-A27M-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "D8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 8.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3232, "MSI_SENSOR_SCORE": 0.06, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.366666667, "TISSUE_SOURCE_SITE": "Greater Poland Cancer Center", "TBL_SCORE": 140.0 }, "treatments": [ { "START_DATE": 84, "STOP_DATE": 238.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide + Methotrexate + Fluorouracil", "NUMBER_OF_CYCLES": "6", "PRESCRIBED_DOSE": "40+600+100", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "240+3600+600", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-AC-A2QI": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "C57835BE-77AB-4CF5-9B23-62C11A7B2EAF", "AGE": 76, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 588.0, "DAYS_TO_BIRTH": -27865.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "10/18/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "0:LIVING", "OS_MONTHS": 19.331295, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 19.331295, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 19.331295, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 19.331295, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AC-A2QI-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "AC", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 5.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3177, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": NaN, "TISSUE_SOURCE_SITE": "International Genomics Consortium", "TBL_SCORE": 12.0 }, "treatments": [ { "START_DATE": 100, "STOP_DATE": 275.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 100, "STOP_DATE": 275.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Fluorouracil", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 100, "STOP_DATE": 275.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Methotrexate", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 309, "STOP_DATE": 355.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "33", "RADIATION_DOSAGE": "6040", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-A2-A25B": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "eadf8482-e60e-4307-adb7-d5c3b9fa6cae", "AGE": 39, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 1291.0, "DAYS_TO_BIRTH": -14454.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/15/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 42.44337048, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 42.44337048, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 42.41049413, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-A2-A25B-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "A2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": NaN, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.314, "MSI_SENSOR_SCORE": 0.61, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 3.266666667, "TISSUE_SOURCE_SITE": "Walter Reed", "TBL_SCORE": 395.0 }, "treatments": [ { "START_DATE": 64, "STOP_DATE": 148.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": "5", "PRESCRIBED_DOSE": "148-150", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "745", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 64, "STOP_DATE": 148.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "5", "PRESCRIBED_DOSE": "99-100", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "498", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 64, "STOP_DATE": 148.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "5", "PRESCRIBED_DOSE": "985-1000", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "3", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "4965", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 293, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "20", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "4", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 188, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": "Yes", "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-A2-A04P": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "ccd4a24b-d8cc-4686-9dee-c98b0c5a8d21", "AGE": 36, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIC", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": NaN, "DAYS_TO_BIRTH": -13238.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "8/26/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N3C", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 18.01624092, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 18.01624092, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 3.353387908, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-A2-A04P-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 9.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3046, "MSI_SENSOR_SCORE": 1.12, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 4.266666667, "TISSUE_SOURCE_SITE": "Walter Reed", "TBL_SCORE": 298.0 }, "treatments": [ { "START_DATE": 242, "STOP_DATE": 303.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Gemcitabine", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": "4", "REGIMEN_INDICATION": "Progression", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 424, "STOP_DATE": 424.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Vinorelbine", "NUMBER_OF_CYCLES": "1", "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": "7", "REGIMEN_INDICATION": "Progression", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 69, "STOP_DATE": 180.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": "12", "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 180, "STOP_DATE": 242.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Capecitabine", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Recurrence", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 424, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Exemestane", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "25", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "8", "REGIMEN_INDICATION": "Progression", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 303, "STOP_DATE": 424.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": "5", "REGIMEN_INDICATION": "Progression", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 424, "STOP_DATE": 424.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cisplatin", "NUMBER_OF_CYCLES": "1", "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": "6", "REGIMEN_INDICATION": "Progression", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 242, "STOP_DATE": 303.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": "3", "REGIMEN_INDICATION": "Progression", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 193, "STOP_DATE": 237.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Progression", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Distant Recurrence", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "23", "RADIATION_DOSAGE": "4393", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" }, { "START_DATE": 193, "STOP_DATE": 237.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 2", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "59", "RADIATION_DOSAGE": "10620", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-AN-A0AK": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "9e894662-b718-40f8-8899-b5e036cfbd76", "AGE": 76, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": 224.0, "DAYS_TO_BIRTH": -27977.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/21/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 7.364302857, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 7.364302857, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 7.364302857, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 7.364302857, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AN-A0AK-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AN", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 12.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.8283, "MSI_SENSOR_SCORE": 32.92, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 37.36666667, "TISSUE_SOURCE_SITE": "Cureline", "TBL_SCORE": 32.0 }, "treatments": [] }, "TCGA-B6-A0IM": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "5a4b7098-1f6a-49e9-b364-29d6d34f5bd5", "AGE": 75, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "4TH", "DAYS_LAST_FOLLOWUP": 3836.0, "DAYS_TO_BIRTH": -27557.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "11/2/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8523/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 127.3301115, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 127.3301115, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 127.3301115, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 127.3301115, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-B6-A0IM-01", "ONCOTREE_CODE": "BRCNOS", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Carcinoma (NOS)", "TUMOR_TYPE": "Other", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "B6", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 9.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2982, "MSI_SENSOR_SCORE": 0.17, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.933333333, "TISSUE_SOURCE_SITE": "Duke", "TBL_SCORE": 53.0 }, "treatments": [] }, "TCGA-A8-A079": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "31c31cce-1b4d-4f12-922f-84f389403170", "AGE": 69, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIB", "AJCC_STAGING_EDITION": "5TH", "DAYS_LAST_FOLLOWUP": 274.0, "DAYS_TO_BIRTH": -25294.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "5/27/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N3", "PATH_T_STAGE": "T4B", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": null, "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 9.008120459, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 9.008120459, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 9.008120459, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 9.008120459, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A8-A079-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 14.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.267, "MSI_SENSOR_SCORE": 0.95, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.133333333, "TISSUE_SOURCE_SITE": "Indivumed", "TBL_SCORE": 283.0 }, "treatments": [ { "START_DATE": 30, "STOP_DATE": 183.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Fluorouracil", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 30, "STOP_DATE": 183.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Epirubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 30, "STOP_DATE": 183.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 214, "STOP_DATE": 274.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": "50", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "gy" } ] }, "TCGA-AC-A3QP": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "6F4C8D30-47FB-47DF-9EB7-4E5881E3711E", "AGE": 79, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 675.0, "DAYS_TO_BIRTH": -29113.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/5/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N1MI", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 22.19153763, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 22.19153763, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 22.19153763, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 22.19153763, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AC-A3QP-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "AC", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 2.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2972, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.733333333, "TISSUE_SOURCE_SITE": "International Genomics Consortium", "TBL_SCORE": 15.0 }, "treatments": [ { "START_DATE": 115, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Letrozole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 62, "STOP_DATE": 108.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "33", "RADIATION_DOSAGE": "6040", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-AO-A1KR": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "b7f74ae1-6f58-447c-be50-a7666eb19d9a", "AGE": 51, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 2513.0, "DAYS_TO_BIRTH": -18900.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/15/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 82.61827268, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 82.61827268, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 82.61827268, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 82.61827268, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AO-A1KR-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AO", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 13.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.313, "MSI_SENSOR_SCORE": 0.18, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.133333333, "TISSUE_SOURCE_SITE": "MSKCC", "TBL_SCORE": 326.0 }, "treatments": [ { "START_DATE": 76, "STOP_DATE": 118.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "60", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "452", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 132, "STOP_DATE": 174.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "175", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "3", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "658", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 76, "STOP_DATE": 118.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "600", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "4512", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-E2-A14Q": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "303a1d77-a37a-4966-a4a4-9981d99ba1b4", "AGE": 50, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 1163.0, "DAYS_TO_BIRTH": -18507.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/31/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1MI", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 38.23519742, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 38.23519742, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 38.23519742, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 38.23519742, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E2-A14Q-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "E2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 8.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.305, "MSI_SENSOR_SCORE": 0.07, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.866666667, "TISSUE_SOURCE_SITE": "Roswell Park", "TBL_SCORE": 72.0 }, "treatments": [ { "START_DATE": 53, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "20", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": "20", "TOTAL_DOSE_UNITS": "Mg/Day", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-AQ-A04J": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "9938ce5c-e74e-446e-a932-f096f85cc3b1", "AGE": 45, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": 819.0, "DAYS_TO_BIRTH": -16615.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "10/15/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I+)", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 26.92573232, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 26.92573232, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 26.92573232, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 26.92573232, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AQ-A04J-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AQ", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 5.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2782, "MSI_SENSOR_SCORE": 0.01, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.3, "TISSUE_SOURCE_SITE": "UNC", "TBL_SCORE": 118.0 }, "treatments": [ { "START_DATE": 118, "STOP_DATE": 160.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "175", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "700", "TOTAL_DOSE_UNITS": "Mg/M2", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 61, "STOP_DATE": 104.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "60", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "240", "TOTAL_DOSE_UNITS": "Mg/M2", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 61, "STOP_DATE": 104.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "600", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "2400", "TOTAL_DOSE_UNITS": "Mg/M2", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-E9-A3QA": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "F3CB557D-23E4-4FD1-81CA-DB1A3F56D56E", "AGE": 33, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 918.0, "DAYS_TO_BIRTH": -12142.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/30/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8510/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 30.18049117, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 30.18049117, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 30.18049117, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 30.18049117, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E9-A3QA-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Medullary Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "E9", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 6.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2997, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.333333333, "TISSUE_SOURCE_SITE": "Asterand", "TBL_SCORE": 108.0 }, "treatments": [] }, "TCGA-AR-A2LH": { "demographics": { "SUBTYPE": "BRCA_Normal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "376FFE63-EFD7-42AF-90E1-261255B28BB7", "AGE": 55, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE III", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": NaN, "DAYS_TO_BIRTH": -20288.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "1/12/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N3", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 20.25183286, "DSS_STATUS": null, "DSS_MONTHS": 20.25183286, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 14.26833679, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 14.26833679, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AR-A2LH-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AR", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 3.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3086, "MSI_SENSOR_SCORE": 0.01, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.0, "TISSUE_SOURCE_SITE": "Mayo", "TBL_SCORE": 3.0 }, "treatments": [ { "START_DATE": 42, "STOP_DATE": 84.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 42, "STOP_DATE": 84.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 98, "STOP_DATE": 140.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-B6-A0I1": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "5DD423E8-FEAA-4568-A750-500948C41D6C", "AGE": 73, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "5TH", "DAYS_LAST_FOLLOWUP": NaN, "DAYS_TO_BIRTH": -26902.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "1/11/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 77.62106717, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 77.62106717, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 36.82151429, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 36.82151429, "GENETIC_ANCESTRY_LABEL": "AFR_ADMIX" }, "sample": { "SAMPLE_ID": "TCGA-B6-A0I1-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "B6", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 9.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2998, "MSI_SENSOR_SCORE": 0.82, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.7, "TISSUE_SOURCE_SITE": "Duke", "TBL_SCORE": 236.0 }, "treatments": [] }, "TCGA-A2-A0CK": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "5ACA16CA-4516-4E27-8249-6914029A7EBF", "AGE": 60, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": "5TH", "DAYS_LAST_FOLLOWUP": 4159.0, "DAYS_TO_BIRTH": -22094.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/21/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N2A", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 136.7327481, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 136.7327481, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 44.84334418, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 44.84334418, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A2-A0CK-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 4.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3074, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.433333333, "TISSUE_SOURCE_SITE": "Walter Reed", "TBL_SCORE": 30.0 }, "treatments": [ { "START_DATE": 1451, "STOP_DATE": 1518.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 1569, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 243, "STOP_DATE": 280.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": "5040", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" }, { "START_DATE": 243, "STOP_DATE": 280.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 2", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": "5040", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-B6-A0IB": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "157ec9e0-ca6e-4da1-9233-f976cf0db433", "AGE": 64, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IV", "AJCC_STAGING_EDITION": "3RD", "DAYS_LAST_FOLLOWUP": NaN, "DAYS_TO_BIRTH": -23646.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "11/2/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M1", "PATH_N_STAGE": "N3", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 129.5657034, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 129.5657034, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 89.32504849, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-B6-A0IB-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "B6", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 21.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.278, "MSI_SENSOR_SCORE": 0.25, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.2, "TISSUE_SOURCE_SITE": "Duke", "TBL_SCORE": 32.0 }, "treatments": [] }, "TCGA-A8-A08P": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "f947d67f-4aa2-4eb9-977e-21a5ae563613", "AGE": 70, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 943.0, "DAYS_TO_BIRTH": -25598.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "5/27/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N2A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": null, "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 31.00239997, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 31.00239997, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 31.00239997, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 31.00239997, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A8-A08P-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": NaN, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.26, "MSI_SENSOR_SCORE": 0.19, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.2, "TISSUE_SOURCE_SITE": "Indivumed", "TBL_SCORE": 517.0 }, "treatments": [ { "START_DATE": 60, "STOP_DATE": 182.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Fluorouracil", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 60, "STOP_DATE": 182.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 60, "STOP_DATE": 182.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 60, "STOP_DATE": 182.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 244, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Exemestane", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 213, "STOP_DATE": 578.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Targeted Molecular Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Trastuzumab", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 182, "STOP_DATE": 244.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "gy" } ] }, "TCGA-AR-A0TR": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "d1703dbd-5c93-4cf2-a4d1-0d90640882bd", "AGE": 68, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": NaN, "DAYS_TO_BIRTH": -25190.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/8/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 5.260216326, "DSS_STATUS": null, "DSS_MONTHS": 5.260216326, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 5.260216326, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 5.260216326, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AR-A0TR-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AR", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 19.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2857, "MSI_SENSOR_SCORE": 0.26, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.033333333, "TISSUE_SOURCE_SITE": "Mayo", "TBL_SCORE": 23.0 }, "treatments": [ { "START_DATE": 25, "STOP_DATE": 160.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "20", "PRESCRIBED_DOSE_UNITS": "mg/dl", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-BH-A0E0": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "20e8106b-1290-4735-abe4-7621e08e3dc8", "AGE": 38, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIC", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": 134.0, "DAYS_TO_BIRTH": -14175.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "11/9/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N3A", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 4.405431173, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 4.405431173, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 4.405431173, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 4.405431173, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A0E0-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 22.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2819, "MSI_SENSOR_SCORE": 0.73, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.966666667, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 77.0 }, "treatments": [ { "START_DATE": 38, "STOP_DATE": 143.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "6", "PRESCRIBED_DOSE": "87", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "503", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 38, "STOP_DATE": 143.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "6", "PRESCRIBED_DOSE": "820", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "5034", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 38, "STOP_DATE": 143.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": "6", "PRESCRIBED_DOSE": "130", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "763", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 198, "STOP_DATE": 255.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": "6040", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-A1-A0SI": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "16368c32-2118-4fcf-8693-6c89995e49d8", "AGE": 52, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 635.0, "DAYS_TO_BIRTH": -19250.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "6/30/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": null, "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 20.87648355, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 20.87648355, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 20.87648355, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 20.87648355, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A1-A0SI-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A1", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 15.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3411, "MSI_SENSOR_SCORE": 0.63, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 6.033333333, "TISSUE_SOURCE_SITE": "UCSF", "TBL_SCORE": 22.0 }, "treatments": [] }, "TCGA-UL-AAZ6": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "4B54E06E-A280-4981-A4E1-9AEA154341B4", "AGE": 73, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 518.0, "DAYS_TO_BIRTH": -26999.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "8/28/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 17.02995036, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 17.02995036, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 17.02995036, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-UL-AAZ6-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "UL", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 19.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3254, "MSI_SENSOR_SCORE": 0.98, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.7, "TISSUE_SOURCE_SITE": "Boston Medical Center", "TBL_SCORE": 406.0 }, "treatments": [ { "START_DATE": 122, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Trastuzumab", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-B6-A0RT": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "4bf50455-9ab7-4521-a791-089f66d3b877", "AGE": 39, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": "4TH", "DAYS_LAST_FOLLOWUP": 2721.0, "DAYS_TO_BIRTH": -14374.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "11/3/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 89.4565539, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 89.4565539, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 89.4565539, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-B6-A0RT-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "B6", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 2.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2897, "MSI_SENSOR_SCORE": 0.01, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.866666667, "TISSUE_SOURCE_SITE": "Duke", "TBL_SCORE": 48.0 }, "treatments": [] }, "TCGA-D8-A1XU": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "332148f5-f070-4c20-8eb1-4d8c0673aa52", "AGE": 56, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 395.0, "DAYS_TO_BIRTH": -20715.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/16/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 12.98615906, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 12.98615906, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 12.98615906, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 12.98615906, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D8-A1XU-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "D8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 19.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.302, "MSI_SENSOR_SCORE": 0.03, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.8, "TISSUE_SOURCE_SITE": "Greater Poland Cancer Center", "TBL_SCORE": 67.0 }, "treatments": [] }, "TCGA-XX-A899": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "F89588E9-CA73-4465-A7FB-7246EDB45E3A", "AGE": 46, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 467.0, "DAYS_TO_BIRTH": -17022.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "2/21/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N2A", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 15.3532564, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 15.3532564, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 15.3532564, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 15.3532564, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-XX-A899-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "XX", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 4.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.31, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.466666667, "TISSUE_SOURCE_SITE": "Spectrum Health", "TBL_SCORE": 59.0 }, "treatments": [ { "START_DATE": 96, "STOP_DATE": 201.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 96, "STOP_DATE": 201.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 103, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Goserelin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 230, "STOP_DATE": 278.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "28", "RADIATION_DOSAGE": "5040", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" }, { "START_DATE": 230, "STOP_DATE": 278.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 2", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "28", "RADIATION_DOSAGE": "5040", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" }, { "START_DATE": 230, "STOP_DATE": 278.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 3", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "5", "RADIATION_DOSAGE": "1000", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-A2-A0EQ": { "demographics": { "SUBTYPE": "BRCA_Her2", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "2192c1db-4718-4254-ba42-3ae7f30ad5a8", "AGE": 64, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 2426.0, "DAYS_TO_BIRTH": -23543.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "8/11/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 79.75803005, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 79.75803005, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 79.75803005, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 79.75803005, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-A2-A0EQ-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 21.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.272, "MSI_SENSOR_SCORE": 0.11, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 7.1, "TISSUE_SOURCE_SITE": "Walter Reed", "TBL_SCORE": 149.0 }, "treatments": [ { "START_DATE": 229, "STOP_DATE": 586.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Targeted Molecular Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Trastuzumab", "NUMBER_OF_CYCLES": "22", "PRESCRIBED_DOSE": "195-594", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "4", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "10543", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 84, "STOP_DATE": 146.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "122", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "488", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 84, "STOP_DATE": 146.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "1218", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "4872", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 167, "STOP_DATE": 167.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": "1", "PRESCRIBED_DOSE": "355", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "3", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "355", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 679, "STOP_DATE": 796.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Immunotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "AE37", "NUMBER_OF_CYCLES": "6", "PRESCRIBED_DOSE": "500", "PRESCRIBED_DOSE_UNITS": "ug", "REGIMEN_NUMBER": "5", "REGIMEN_INDICATION": "Other", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": "3000", "TOTAL_DOSE_UNITS": "Ug", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 203, "STOP_DATE": 251.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "33", "RADIATION_DOSAGE": "6040", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-A7-A13H": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "2E243F0E-9D7D-4CB0-9678-70607F90430A", "AGE": 61, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 899.0, "DAYS_TO_BIRTH": -22643.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "6/22/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "0:LIVING", "OS_MONTHS": 29.55584048, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 29.55584048, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 29.55584048, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 26.13669987, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A7-A13H-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "A7", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 5.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2918, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": NaN, "TISSUE_SOURCE_SITE": "Christiana Healthcare", "TBL_SCORE": 58.0 }, "treatments": [ { "START_DATE": 78, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-BH-A1F0": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "21ef1730-e5a7-47ce-b419-d000bb59ae15", "AGE": 80, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "5TH", "DAYS_LAST_FOLLOWUP": NaN, "DAYS_TO_BIRTH": -29335.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/7/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1C", "PATH_T_STAGE": "T1A", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": null, "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 25.80793635, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 25.80793635, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 25.80793635, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A1F0-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 7.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2616, "MSI_SENSOR_SCORE": 0.01, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.966666667, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 122.0 }, "treatments": [] }, "TCGA-E2-A1B1": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "8a0ef221-8070-43fc-9d98-def90abe4871", "AGE": 45, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 2653.0, "DAYS_TO_BIRTH": -16603.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/25/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 87.22096196, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 87.22096196, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 87.22096196, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 87.22096196, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E2-A1B1-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "E2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 2.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2713, "MSI_SENSOR_SCORE": 0.01, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.766666667, "TISSUE_SOURCE_SITE": "Roswell Park", "TBL_SCORE": 70.0 }, "treatments": [ { "START_DATE": 71, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Triptorelin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "3.75", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "3", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IM", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 155, "STOP_DATE": 491.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Trastuzumab", "NUMBER_OF_CYCLES": "24", "PRESCRIBED_DOSE": "672", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "16128", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 155, "STOP_DATE": 232.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": "11", "PRESCRIBED_DOSE": "195", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "2145", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 71, "STOP_DATE": 969.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Other", "TREATMENT_SUBTYPE": "Bisphosphonate Therapy", "AGENT": "Zoledronic Acid", "NUMBER_OF_CYCLES": "15", "PRESCRIBED_DOSE": "4", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "60", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 239, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "20", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "4", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 71, "STOP_DATE": 134.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "146", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "584", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 71, "STOP_DATE": 134.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "1464", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "5856", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 302, "STOP_DATE": 314.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "31", "RADIATION_DOSAGE": "6000", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-A2-A0YE": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "84a88e8d-1e65-4b88-aae6-bf4c7a7e4c33", "AGE": 48, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": 554.0, "DAYS_TO_BIRTH": -17727.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/10/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 18.21349903, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 18.21349903, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 18.21349903, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 18.21349903, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A2-A0YE-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 24.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3072, "MSI_SENSOR_SCORE": 1.48, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.933333333, "TISSUE_SOURCE_SITE": "Walter Reed", "TBL_SCORE": 165.0 }, "treatments": [ { "START_DATE": 225, "STOP_DATE": 267.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "30", "RADIATION_DOSAGE": "6000", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-D8-A1JN": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "28911b97-42bf-4189-9961-522fc0aeebc6", "AGE": 80, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIC", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 620.0, "DAYS_TO_BIRTH": -29331.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/29/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N3A", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 20.38333827, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 20.38333827, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 20.38333827, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 20.38333827, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D8-A1JN-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "D8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 7.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3103, "MSI_SENSOR_SCORE": 0.28, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 4.1, "TISSUE_SOURCE_SITE": "Greater Poland Cancer Center", "TBL_SCORE": 24.0 }, "treatments": [ { "START_DATE": 63, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-A8-A097": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "dcfd0b1d-5707-44a6-b225-5e8f7cea5ca1", "AGE": 65, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 365.0, "DAYS_TO_BIRTH": -23741.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "5/27/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": null, "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 11.9998685, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 11.9998685, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 11.9998685, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 11.9998685, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A8-A097-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 17.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.277, "MSI_SENSOR_SCORE": 0.29, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 3.033333333, "TISSUE_SOURCE_SITE": "Indivumed", "TBL_SCORE": 232.0 }, "treatments": [ { "START_DATE": 61, "STOP_DATE": 153.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 61, "STOP_DATE": 153.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 31, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 153, "STOP_DATE": 184.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "gy" } ] }, "TCGA-BH-A0AV": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "790ff5db-b7f3-4946-aaed-305f66b1dd6a", "AGE": 52, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE I", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 1820.0, "DAYS_TO_BIRTH": -19314.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "8/2/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 59.83496071, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 59.83496071, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 59.83496071, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 59.83496071, "GENETIC_ANCESTRY_LABEL": "AFR_ADMIX" }, "sample": { "SAMPLE_ID": "TCGA-BH-A0AV-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 12.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2952, "MSI_SENSOR_SCORE": 0.11, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.866666667, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 150.0 }, "treatments": [ { "START_DATE": 146, "STOP_DATE": 259.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 146, "STOP_DATE": 259.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 259, "STOP_DATE": 308.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "36", "RADIATION_DOSAGE": "66.4", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "gy" } ] }, "TCGA-AR-A1AJ": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "23e7a78a-1d56-4ad1-9bb4-72ec0178aff2", "AGE": 83, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE I", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 3072.0, "DAYS_TO_BIRTH": -30489.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "6/13/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T1", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 100.9961535, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 100.9961535, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 100.9961535, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 100.9961535, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AR-A1AJ-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AR", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 33.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2632, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.4, "TISSUE_SOURCE_SITE": "Mayo", "TBL_SCORE": 42.0 }, "treatments": [ { "START_DATE": 47, "STOP_DATE": 79.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "25", "RADIATION_DOSAGE": "5000", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-LL-A440": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "00B11CA8-8540-4A3D-B602-EC754B00230B", "AGE": 61, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 759.0, "DAYS_TO_BIRTH": -22497.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "10/26/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 24.9531512, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 24.9531512, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 24.9531512, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 24.9531512, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-LL-A440-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "LL", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.304, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.1, "TISSUE_SOURCE_SITE": "Candler", "TBL_SCORE": 59.0 }, "treatments": [ { "START_DATE": 200, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 60, "STOP_DATE": 123.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 60, "STOP_DATE": 123.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-AN-A0FV": { "demographics": { "SUBTYPE": "BRCA_Her2", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "2e8e70f2-c781-44c2-8f12-1f8c2f536aa3", "AGE": 58, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 10.0, "DAYS_TO_BIRTH": -21479.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/28/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 0.32876352, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 0.32876352, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 0.32876352, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 0.32876352, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AN-A0FV-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AN", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 19.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2554, "MSI_SENSOR_SCORE": 0.67, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.7, "TISSUE_SOURCE_SITE": "Cureline", "TBL_SCORE": 199.0 }, "treatments": [] }, "TCGA-A2-A0D2": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "99e32c59-aa73-43fa-88c9-399ddadb2c72", "AGE": 45, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 1027.0, "DAYS_TO_BIRTH": -16623.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/16/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I+)", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 33.76401355, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 33.76401355, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 33.76401355, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 33.76401355, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A2-A0D2-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 13.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2742, "MSI_SENSOR_SCORE": 0.35, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.7, "TISSUE_SOURCE_SITE": "Walter Reed", "TBL_SCORE": 316.0 }, "treatments": [ { "START_DATE": 74, "STOP_DATE": 123.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "108-109", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "435", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 74, "STOP_DATE": 123.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "1086", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "4344", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 137, "STOP_DATE": 179.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "325-329", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "3", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "1308", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 230, "STOP_DATE": 270.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "28", "RADIATION_DOSAGE": "5040", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" }, { "START_DATE": 230, "STOP_DATE": 270.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 2", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "28", "RADIATION_DOSAGE": "5040", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-AQ-A04L": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "78582fbc-dcc7-48ae-9f95-5271c9bc5b72", "AGE": 48, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "5TH", "DAYS_LAST_FOLLOWUP": 3957.0, "DAYS_TO_BIRTH": -17759.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/15/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "0:LIVING", "OS_MONTHS": 130.091725, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 130.091725, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 130.091725, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 130.091725, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AQ-A04L-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AQ", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 19.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": NaN, "MSI_SENSOR_SCORE": 1.8, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.0, "TISSUE_SOURCE_SITE": "UNC", "TBL_SCORE": 488.0 }, "treatments": [ { "START_DATE": 48, "STOP_DATE": 111.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "101", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "404", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 48, "STOP_DATE": 111.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "1014", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "4056", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 141, "STOP_DATE": 1957.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": "1", "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-A1-A0SD": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "c462e422-eb8d-4daf-9897-2a9c6cbd783a", "AGE": 59, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 437.0, "DAYS_TO_BIRTH": -21793.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/7/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": null, "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 14.36696584, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 14.36696584, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 14.36696584, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 14.36696584, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A1-A0SD-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A1", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 11.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2829, "MSI_SENSOR_SCORE": 0.02, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.1, "TISSUE_SOURCE_SITE": "UCSF", "TBL_SCORE": 66.0 }, "treatments": [] }, "TCGA-AN-A03Y": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "a991644b-3ee6-4cda-acf0-e37de48a49fc", "AGE": 66, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": 10.0, "DAYS_TO_BIRTH": -24232.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/29/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 0.32876352, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 0.32876352, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 0.32876352, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 0.32876352, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AN-A03Y-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AN", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 24.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2659, "MSI_SENSOR_SCORE": 0.92, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.933333333, "TISSUE_SOURCE_SITE": "Cureline", "TBL_SCORE": 41.0 }, "treatments": [] }, "TCGA-E9-A22E": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "64d4dfae-8d91-464b-adc3-80ba7caf54ae", "AGE": 56, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 1269.0, "DAYS_TO_BIRTH": -20574.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "8/2/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N2", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 41.72009074, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 41.72009074, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 41.72009074, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 41.72009074, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E9-A22E-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "E9", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 16.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.4072, "MSI_SENSOR_SCORE": 0.98, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 3.9, "TISSUE_SOURCE_SITE": "Asterand", "TBL_SCORE": 188.0 }, "treatments": [ { "START_DATE": 13, "STOP_DATE": 226.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "6", "PRESCRIBED_DOSE": "900", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "3600", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 13, "STOP_DATE": 226.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Fluorouracil", "NUMBER_OF_CYCLES": "6", "PRESCRIBED_DOSE": "900", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "3600", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 13, "STOP_DATE": 226.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "6", "PRESCRIBED_DOSE": "90", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "360", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 105, "STOP_DATE": 128.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "23", "RADIATION_DOSAGE": "4600", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-E9-A1NE": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "3d676bba-154b-4d22-ab59-d4d4da051b94", "AGE": 28, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 1088.0, "DAYS_TO_BIRTH": -10564.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "6/23/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8522/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 35.76947102, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 35.76947102, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 35.76947102, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 35.76947102, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E9-A1NE-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "E9", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 4.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2816, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.666666667, "TISSUE_SOURCE_SITE": "Asterand", "TBL_SCORE": 49.0 }, "treatments": [ { "START_DATE": 10, "STOP_DATE": 121.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 10, "STOP_DATE": 121.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 10, "STOP_DATE": 121.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Fluorouracil", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 184, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 141, "STOP_DATE": 171.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "23", "RADIATION_DOSAGE": "4600", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-B6-A402": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "75B3FE55-1A63-426E-867E-2EF52F54778D", "AGE": 47, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE I", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 2134.0, "DAYS_TO_BIRTH": -17314.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/20/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "0:LIVING", "OS_MONTHS": 74.990959, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 74.990959, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 49.84054969, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 49.84054969, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-B6-A402-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "B6", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 17.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3349, "MSI_SENSOR_SCORE": 0.48, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.0, "TISSUE_SOURCE_SITE": "Duke", "TBL_SCORE": 234.0 }, "treatments": [ { "START_DATE": 30, "STOP_DATE": 93.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Partial Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 30, "STOP_DATE": 93.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Partial Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 112, "STOP_DATE": 191.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Partial Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 2176, "STOP_DATE": 2232.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Partial Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 278, "STOP_DATE": 310.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "21", "RADIATION_DOSAGE": "5256", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-E2-A15A": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "73ccc949-01b7-48d3-a7c4-c4bcd261672a", "AGE": 45, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIC", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 710.0, "DAYS_TO_BIRTH": -16750.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/7/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N3A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 23.34220995, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 23.34220995, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 23.34220995, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 23.34220995, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E2-A15A-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "E2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 20.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2705, "MSI_SENSOR_SCORE": 0.29, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.933333333, "TISSUE_SOURCE_SITE": "Roswell Park", "TBL_SCORE": 316.0 }, "treatments": [ { "START_DATE": 47, "STOP_DATE": 89.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "948", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "3792", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 103, "STOP_DATE": 145.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "280", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "1120", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 47, "STOP_DATE": 89.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "95", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "380", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 103, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Zoledronic Acid", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "4", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "3", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": "44", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 145, "STOP_DATE": 222.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "33", "RADIATION_DOSAGE": "6040", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-BH-A0H5": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "cab38ea8-4555-413c-b81e-4621aac4ef85", "AGE": 45, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE I", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 1620.0, "DAYS_TO_BIRTH": -16719.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "8/12/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 53.25969031, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 53.25969031, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 53.25969031, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 53.25969031, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A0H5-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2885, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 7.633333333, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 0.0 }, "treatments": [ { "START_DATE": 174, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 174, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-A2-A04R": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "f3a058b9-fb7f-4098-8f0e-83c2acfa1ed5", "AGE": 36, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 3709.0, "DAYS_TO_BIRTH": -13483.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "10/8/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T1", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 121.9383897, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 121.9383897, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 121.9383897, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 121.9383897, "GENETIC_ANCESTRY_LABEL": "AFR_ADMIX" }, "sample": { "SAMPLE_ID": "TCGA-A2-A04R-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 5.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3005, "MSI_SENSOR_SCORE": 0.77, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.533333333, "TISSUE_SOURCE_SITE": "Walter Reed", "TBL_SCORE": 57.0 }, "treatments": [ { "START_DATE": 45, "STOP_DATE": 45.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": "1", "PRESCRIBED_DOSE": "354", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "354", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 119, "STOP_DATE": 184.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "120", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "3", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "480", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 119, "STOP_DATE": 184.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "1200", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "4800", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 910, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "5", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 399, "STOP_DATE": 909.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "20", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "4", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 300, "STOP_DATE": 342.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-AQ-A7U7": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "19015644-9C17-4AE7-A656-0FE8623C04AE", "AGE": 55, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 304.0, "DAYS_TO_BIRTH": -20239.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/18/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N2A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 19.19978959, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 19.19978959, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 19.19978959, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 19.19978959, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AQ-A7U7-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "AQ", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 10.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3192, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.933333333, "TISSUE_SOURCE_SITE": "UNC", "TBL_SCORE": 51.0 }, "treatments": [ { "START_DATE": 123, "STOP_DATE": 193.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Immunotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Rituximab", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 123, "STOP_DATE": 193.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 123, "STOP_DATE": 193.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 123, "STOP_DATE": 165.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Vincristine", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 123, "STOP_DATE": 193.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Prednisone", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 296, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Letrozole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 236, "STOP_DATE": 278.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "30", "RADIATION_DOSAGE": "6000", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-D8-A27W": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "bfa3dbc0-361c-400e-8c10-0aca7049fce9", "AGE": 55, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIB", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 373.0, "DAYS_TO_BIRTH": -20173.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/21/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8480/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T4B", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 12.26287931, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 12.26287931, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 12.26287931, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 12.26287931, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D8-A27W-01", "ONCOTREE_CODE": "IMMC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Mixed Mucinous Carcinoma", "TUMOR_TYPE": "Mucinous Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "D8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 34.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3101, "MSI_SENSOR_SCORE": 0.06, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.433333333, "TISSUE_SOURCE_SITE": "Greater Poland Cancer Center", "TBL_SCORE": 103.0 }, "treatments": [ { "START_DATE": 56, "STOP_DATE": 162.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin + Cyclophosphamide", "NUMBER_OF_CYCLES": "6", "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 226, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "20", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 189, "STOP_DATE": 221.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "25", "RADIATION_DOSAGE": "5500", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-BH-A1FC": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "b97bf89a-7a85-4eef-ae7e-f787aead1f0a", "AGE": 78, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "5TH", "DAYS_LAST_FOLLOWUP": NaN, "DAYS_TO_BIRTH": -28706.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/8/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8510/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1B", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": null, "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 114.1466943, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 114.1466943, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 114.1466943, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-BH-A1FC-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Medullary Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 25.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.326, "MSI_SENSOR_SCORE": 0.49, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 3.433333333, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 267.0 }, "treatments": [] }, "TCGA-E9-A247": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "636b0a90-c8c2-4ad6-a77d-6cd428a826d1", "AGE": 59, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 1186.0, "DAYS_TO_BIRTH": -21562.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "8/18/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 38.99135352, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 38.99135352, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 38.99135352, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 38.99135352, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E9-A247-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "E9", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 22.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3905, "MSI_SENSOR_SCORE": 3.51, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.3, "TISSUE_SOURCE_SITE": "Asterand", "TBL_SCORE": 132.0 }, "treatments": [ { "START_DATE": 10, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "20", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 33, "STOP_DATE": 64.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "23", "RADIATION_DOSAGE": "4600", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-BH-A0HN": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "a68a3361-48b4-4bd0-999d-b4cc3d43eb4a", "AGE": 67, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IA", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": 516.0, "DAYS_TO_BIRTH": -24731.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "11/11/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "0:LIVING", "OS_MONTHS": 16.96419765, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 16.96419765, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 16.96419765, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 16.96419765, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A0HN-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": NaN, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2759, "MSI_SENSOR_SCORE": 0.75, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.833333333, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 950.0 }, "treatments": [ { "START_DATE": 82, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-EW-A1PA": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "4cfef7f9-f1ee-401c-a2a3-c225d4adc3b6", "AGE": 59, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 575.0, "DAYS_TO_BIRTH": -21837.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/11/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 18.90390242, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 18.90390242, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 18.90390242, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 18.90390242, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-EW-A1PA-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "EW", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 9.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3289, "MSI_SENSOR_SCORE": 2.02, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.966666667, "TISSUE_SOURCE_SITE": "University of Miami", "TBL_SCORE": 185.0 }, "treatments": [ { "START_DATE": 143, "STOP_DATE": 206.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Fluorouracil", "NUMBER_OF_CYCLES": "3", "PRESCRIBED_DOSE": "1040", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "fec", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "3120", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 262, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "20", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "tam", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 143, "STOP_DATE": 206.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": "2", "PRESCRIBED_DOSE": "160", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "fec then t", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "320", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 143, "STOP_DATE": 206.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Epirubicin", "NUMBER_OF_CYCLES": "3", "PRESCRIBED_DOSE": "52.5", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "fec", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "157.5", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 143, "STOP_DATE": 206.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "3", "PRESCRIBED_DOSE": "1040", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "fec then t", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "3120", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 225, "STOP_DATE": 262.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "56", "RADIATION_DOSAGE": "11,032", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-BH-A0B0": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "66af34ea-f471-4092-aff6-9ac9a5b75b11", "AGE": 56, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE I", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 2477.0, "DAYS_TO_BIRTH": -20776.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "7/27/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 81.434724, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 81.434724, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 81.434724, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 81.434724, "GENETIC_ANCESTRY_LABEL": "AFR_ADMIX" }, "sample": { "SAMPLE_ID": "TCGA-BH-A0B0-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 9.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2849, "MSI_SENSOR_SCORE": 0.08, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.2, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 6.0 }, "treatments": [ { "START_DATE": 82, "STOP_DATE": 194.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 82, "STOP_DATE": 194.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 194, "STOP_DATE": 236.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "30", "RADIATION_DOSAGE": "6000", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-EW-A2FV": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "F45AA0B2-F3DE-4DB5-9730-E5C6C4E2ED3A", "AGE": 39, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIC", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 788.0, "DAYS_TO_BIRTH": -14316.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Hispanic Or Latino", "FORM_COMPLETION_DATE": "10/5/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8507/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N3A", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "No", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 25.90656541, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 25.90656541, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 25.90656541, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 25.90656541, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-EW-A2FV-01", "ONCOTREE_CODE": "BRCNOS", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Carcinoma (NOS)", "TUMOR_TYPE": "Other", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "EW", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 21.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3338, "MSI_SENSOR_SCORE": 1.49, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 130.3, "TISSUE_SOURCE_SITE": "University of Miami", "TBL_SCORE": 105.0 }, "treatments": [ { "START_DATE": 141, "STOP_DATE": 246.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 141, "STOP_DATE": 246.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 141, "STOP_DATE": 246.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 268, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 268, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Goserelin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 329, "STOP_DATE": 391.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "30", "RADIATION_DOSAGE": "9700", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-D8-A1JJ": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "f7ab565c-83b5-4988-b9be-8a46f65dca8c", "AGE": 54, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 611.0, "DAYS_TO_BIRTH": -19966.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/29/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 20.0874511, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 20.0874511, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 20.0874511, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 20.0874511, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D8-A1JJ-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "D8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 22.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2922, "MSI_SENSOR_SCORE": 0.05, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.166666667, "TISSUE_SOURCE_SITE": "Greater Poland Cancer Center", "TBL_SCORE": 161.0 }, "treatments": [ { "START_DATE": 137, "STOP_DATE": 143.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "108.6", "PRESCRIBED_DOSE_UNITS": "mg/m2/day", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "434.4", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 137, "STOP_DATE": 143.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 189, "STOP_DATE": 207.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "25+1 boost 1500cgy", "RADIATION_DOSAGE": "6500", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-E9-A1N5": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "f954de05-1b44-4087-8933-6cc72d81028d", "AGE": 45, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 1120.0, "DAYS_TO_BIRTH": -16736.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "6/23/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8522/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 36.82151429, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 36.82151429, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 36.82151429, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 36.82151429, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E9-A1N5-01", "ONCOTREE_CODE": "BRCNOS", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Carcinoma (NOS)", "TUMOR_TYPE": "Mixed Histology (NOS)", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "E9", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 7.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3403, "MSI_SENSOR_SCORE": 1.19, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.033333333, "TISSUE_SOURCE_SITE": "Asterand", "TBL_SCORE": 51.0 }, "treatments": [ { "START_DATE": 22, "STOP_DATE": 133.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "6", "PRESCRIBED_DOSE": "80", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "480", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 173, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "20", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 22, "STOP_DATE": 133.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "6", "PRESCRIBED_DOSE": "800", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "4800", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 22, "STOP_DATE": 133.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Fluorouracil", "NUMBER_OF_CYCLES": "6", "PRESCRIBED_DOSE": "800", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "4800", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-D8-A1JU": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "af2a8e2f-2ae1-48bc-bba5-0e2c077c4e48", "AGE": 51, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 447.0, "DAYS_TO_BIRTH": -18733.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/28/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 14.69572936, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 14.69572936, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 14.69572936, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 14.69572936, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D8-A1JU-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "D8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 4.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.4299, "MSI_SENSOR_SCORE": 0.88, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.433333333, "TISSUE_SOURCE_SITE": "Greater Poland Cancer Center", "TBL_SCORE": 10.0 }, "treatments": [ { "START_DATE": 87, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "20", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": "20", "TOTAL_DOSE_UNITS": "Mg/Day", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-Z7-A8R5": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "23F438BD-1DBB-4D46-972F-1E8E74DDBD37", "AGE": 61, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 3287.0, "DAYS_TO_BIRTH": -22280.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/9/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 108.0645692, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 108.0645692, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 5.950619719, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-Z7-A8R5-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "Z7", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 21.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3056, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.766666667, "TISSUE_SOURCE_SITE": "John Wayne Cancer Center", "TBL_SCORE": 7.0 }, "treatments": [ { "START_DATE": 61, "STOP_DATE": 181.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Stable Disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 61, "STOP_DATE": 181.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Stable Disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 61, "STOP_DATE": 181.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Stable Disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-B6-A0IJ": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "2c86c3ea-d926-4d39-a5ae-39ece4774287", "AGE": 42, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": 7106.0, "DAYS_TO_BIRTH": -15625.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "11/2/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 233.6193576, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 233.6193576, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 233.6193576, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 233.6193576, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-B6-A0IJ-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "B6", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 14.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2882, "MSI_SENSOR_SCORE": 0.38, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 4.4, "TISSUE_SOURCE_SITE": "Duke", "TBL_SCORE": 306.0 }, "treatments": [] }, "TCGA-AO-A0JC": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "03565036-b6d3-432f-8d9a-7099818e0788", "AGE": 64, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": 1547.0, "DAYS_TO_BIRTH": -23404.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/20/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 50.85971661, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 50.85971661, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 50.85971661, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 50.85971661, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AO-A0JC-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AO", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": NaN, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2592, "MSI_SENSOR_SCORE": 0.01, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 4.566666667, "TISSUE_SOURCE_SITE": "MSKCC", "TBL_SCORE": 0.0 }, "treatments": [ { "START_DATE": 292, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Letrozole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "2.5", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 70, "STOP_DATE": 221.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "8", "PRESCRIBED_DOSE": "600", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "8700", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 70, "STOP_DATE": 221.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Fluorouracil", "NUMBER_OF_CYCLES": "8", "PRESCRIBED_DOSE": "600", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "8700", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 70, "STOP_DATE": 221.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Methotrexate", "NUMBER_OF_CYCLES": "8", "PRESCRIBED_DOSE": "40", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "560", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 252, "STOP_DATE": 298.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "33", "RADIATION_DOSAGE": "21160", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-BH-A18K": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "50619f8c-10aa-464a-a227-90a7aa6ffd43", "AGE": 46, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE I", "AJCC_STAGING_EDITION": "5TH", "DAYS_LAST_FOLLOWUP": NaN, "DAYS_TO_BIRTH": -16824.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "6/9/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T1", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": null, "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 90.83736069, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 90.83736069, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 90.83736069, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A18K-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 18.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2769, "MSI_SENSOR_SCORE": 0.3, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.666666667, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 67.0 }, "treatments": [] }, "TCGA-AR-A0U1": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "17d9e646-6ab3-40b3-a0bc-2c834d3c3213", "AGE": 36, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 4052.0, "DAYS_TO_BIRTH": -13467.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "2/28/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "0:LIVING", "OS_MONTHS": 133.2149785, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 133.2149785, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 133.2149785, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 133.2149785, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AR-A0U1-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AR", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 6.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2682, "MSI_SENSOR_SCORE": 0.15, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.566666667, "TISSUE_SOURCE_SITE": "Mayo", "TBL_SCORE": 193.0 }, "treatments": [ { "START_DATE": 152, "STOP_DATE": 200.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "33", "RADIATION_DOSAGE": "6080", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-AC-A6IV": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "8E11C5EC-C15A-48D4-85AC-B7B08A9ED827", "AGE": 47, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 568.0, "DAYS_TO_BIRTH": -17521.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/19/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8524/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 18.67376796, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 18.67376796, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 18.67376796, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 18.67376796, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AC-A6IV-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "AC", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 6.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3393, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.6, "TISSUE_SOURCE_SITE": "International Genomics Consortium", "TBL_SCORE": 24.0 }, "treatments": [] }, "TCGA-A8-A06P": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "5f90d955-bbb0-4b44-a5ac-ba6fda9ca0fb", "AGE": 63, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 396.0, "DAYS_TO_BIRTH": -23011.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "5/27/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N2A", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": null, "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 13.01903541, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 13.01903541, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 13.01903541, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 13.01903541, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A8-A06P-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 5.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2424, "MSI_SENSOR_SCORE": 0.04, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.066666667, "TISSUE_SOURCE_SITE": "Indivumed", "TBL_SCORE": 33.0 }, "treatments": [] }, "TCGA-OL-A66J": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "96E1FC6D-693F-4F4F-B5F7-8D6E1C6C43F8", "AGE": 80, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE I", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 1996.0, "DAYS_TO_BIRTH": -29345.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "6/11/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 65.62119867, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 65.62119867, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 65.62119867, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 65.62119867, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-OL-A66J-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "OL", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 3.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3036, "MSI_SENSOR_SCORE": 0.05, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.533333333, "TISSUE_SOURCE_SITE": "University of Chicago", "TBL_SCORE": 30.0 }, "treatments": [] }, "TCGA-BH-A18T": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "30ec8b1f-28c4-4f46-8a1b-a8d51e558c7d", "AGE": 70, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": NaN, "DAYS_TO_BIRTH": -25674.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/2/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": null, "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 7.364302857, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 7.364302857, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 7.364302857, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A18T-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 22.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2724, "MSI_SENSOR_SCORE": 1.63, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.433333333, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 428.0 }, "treatments": [] }, "TCGA-LL-A7SZ": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "09A5E9FD-D816-4F8C-BAA9-0E40BA607B16", "AGE": 49, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 594.0, "DAYS_TO_BIRTH": -18161.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "1/7/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 19.52855311, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 19.52855311, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 19.52855311, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 19.52855311, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-LL-A7SZ-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "LL", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 15.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3272, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.866666667, "TISSUE_SOURCE_SITE": "Candler", "TBL_SCORE": 307.0 }, "treatments": [ { "START_DATE": 62, "STOP_DATE": 104.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 62, "STOP_DATE": 104.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 132, "STOP_DATE": 209.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": null, "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": "Taxol", "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 237, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 239, "STOP_DATE": 275.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "28", "RADIATION_DOSAGE": "45", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "gy" }, { "START_DATE": 239, "STOP_DATE": 275.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 2", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "28", "RADIATION_DOSAGE": "50.4", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "gy" } ] }, "TCGA-AR-A1AY": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "5fd9552a-c742-4388-940d-295d1107ae00", "AGE": 65, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE I", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 1026.0, "DAYS_TO_BIRTH": -23927.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "6/14/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T1", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 33.73113719, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 33.73113719, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 33.73113719, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 33.73113719, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AR-A1AY-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AR", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 13.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2776, "MSI_SENSOR_SCORE": 1.18, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.9, "TISSUE_SOURCE_SITE": "Mayo", "TBL_SCORE": 115.0 }, "treatments": [] }, "TCGA-EW-A1PD": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "4dfc233b-ed03-4825-8089-e04cdee99996", "AGE": 61, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 424.0, "DAYS_TO_BIRTH": -22536.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/18/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "0:LIVING", "OS_MONTHS": 13.93957327, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 13.93957327, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 13.93957327, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 13.93957327, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-EW-A1PD-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "EW", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 9.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3721, "MSI_SENSOR_SCORE": 4.09, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.366666667, "TISSUE_SOURCE_SITE": "University of Miami", "TBL_SCORE": 66.0 }, "treatments": [ { "START_DATE": 112, "STOP_DATE": 217.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": "6", "PRESCRIBED_DOSE": "145", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "872", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 112, "STOP_DATE": 217.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": "6", "PRESCRIBED_DOSE": "669", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "3933", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 112, "STOP_DATE": 405.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Trastuzumab", "NUMBER_OF_CYCLES": "14", "PRESCRIBED_DOSE": "500", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "7007", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-A2-A04W": { "demographics": { "SUBTYPE": "BRCA_Her2", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "00807dae-9f4a-4fd1-aac2-82eb11bf2afb", "AGE": 50, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 3102.0, "DAYS_TO_BIRTH": -18345.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "1/5/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8401/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1MI", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 101.982444, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 101.982444, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 101.982444, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 101.982444, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A2-A04W-01", "ONCOTREE_CODE": "BRCNOS", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Carcinoma (NOS)", "TUMOR_TYPE": "Other", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 17.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2769, "MSI_SENSOR_SCORE": 0.04, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 4.266666667, "TISSUE_SOURCE_SITE": "Walter Reed", "TBL_SCORE": 349.0 }, "treatments": [ { "START_DATE": 58, "STOP_DATE": 100.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "1100", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "4400", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 58, "STOP_DATE": 100.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "110", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "440", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 198, "STOP_DATE": 352.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Targeted Molecular Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Trastuzumab", "NUMBER_OF_CYCLES": "18", "PRESCRIBED_DOSE": "146-463", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "4", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "4187", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 114, "STOP_DATE": 191.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": "12", "PRESCRIBED_DOSE": "147-148", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "3", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "1768", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 1023, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Other", "TREATMENT_SUBTYPE": "Bisphosphonate Therapy", "AGENT": "Zoledronic Acid", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "4", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "5", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-E9-A3X8": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "95873E61-AFDB-496C-9F77-3F9BEB008CDA", "AGE": 48, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 926.0, "DAYS_TO_BIRTH": -17588.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "8/24/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 30.44350199, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 30.44350199, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 30.44350199, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 30.44350199, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E9-A3X8-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "E9", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 22.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2965, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.866666667, "TISSUE_SOURCE_SITE": "Asterand", "TBL_SCORE": 5.0 }, "treatments": [ { "START_DATE": 14, "STOP_DATE": 160.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 14, "STOP_DATE": 160.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 14, "STOP_DATE": 160.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Fluorouracil", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 324, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 52, "STOP_DATE": 78.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "16", "RADIATION_DOSAGE": "40", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "gy" } ] }, "TCGA-AN-A0XO": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "195b6731-6ae6-416e-a345-0eb8874a0ca2", "AGE": 59, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 375.0, "DAYS_TO_BIRTH": -21640.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/1/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N2", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 12.32863202, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 12.32863202, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 12.32863202, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 12.32863202, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AN-A0XO-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AN", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 4.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3185, "MSI_SENSOR_SCORE": 0.1, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.1, "TISSUE_SOURCE_SITE": "Cureline", "TBL_SCORE": 44.0 }, "treatments": [] }, "TCGA-B6-A0RH": { "demographics": { "SUBTYPE": "BRCA_Her2", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "c3148e68-1739-4334-abda-1dcbc2166846", "AGE": 51, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 5749.0, "DAYS_TO_BIRTH": -18759.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/15/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 212.2497288, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 212.2497288, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 71.17730217, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 71.17730217, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-B6-A0RH-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "B6", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 10.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2945, "MSI_SENSOR_SCORE": 0.22, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.266666667, "TISSUE_SOURCE_SITE": "Duke", "TBL_SCORE": 194.0 }, "treatments": [] }, "TCGA-BH-A0BJ": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "d6f911b5-e895-43f8-8f86-0ac2f1bc6fae", "AGE": 41, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": 660.0, "DAYS_TO_BIRTH": -15027.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "11/8/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 21.69839235, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 21.69839235, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 21.69839235, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 21.69839235, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A0BJ-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 16.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2558, "MSI_SENSOR_SCORE": 0.66, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.7, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 31.0 }, "treatments": [ { "START_DATE": 219, "STOP_DATE": 296.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": "10", "PRESCRIBED_DOSE": "164", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "1640", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 343, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 126, "STOP_DATE": 198.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "123", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "492", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 126, "STOP_DATE": 198.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "1230", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "4920", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 398, "STOP_DATE": 443.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "33", "RADIATION_DOSAGE": "6040", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-3C-AALK": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "C31900A4-5DCD-4022-97AC-638E86E889E4", "AGE": 52, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 1448.0, "DAYS_TO_BIRTH": -19074.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/28/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I+)", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 47.60495775, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 47.60495775, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 47.60495775, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-3C-AALK-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "3C", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 4.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3218, "MSI_SENSOR_SCORE": 0.03, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.5, "TISSUE_SOURCE_SITE": "Columbia University", "TBL_SCORE": 25.0 }, "treatments": [ { "START_DATE": 371, "STOP_DATE": 528.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 507, "STOP_DATE": 829.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Trastuzumab", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 371, "STOP_DATE": 528.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 371, "STOP_DATE": 528.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Trastuzumab", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-LQ-A4E4": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "4F321D41-3255-46A4-AE0D-1CF39699E624", "AGE": 73, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 849.0, "DAYS_TO_BIRTH": -26883.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/5/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "0:LIVING", "OS_MONTHS": 27.91202288, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 27.91202288, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 22.38879574, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-LQ-A4E4-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "LQ", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 7.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2937, "MSI_SENSOR_SCORE": 0.06, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": NaN, "TISSUE_SOURCE_SITE": "Gundersen Lutheran Health System", "TBL_SCORE": 49.0 }, "treatments": [ { "START_DATE": 111, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 63, "STOP_DATE": 111.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "33", "RADIATION_DOSAGE": "6040", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-E9-A22H": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "161917b8-88ad-407b-ade6-d6b98478b359", "AGE": 42, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 1232.0, "DAYS_TO_BIRTH": -15504.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "8/2/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 40.50366571, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 40.50366571, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 40.50366571, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 40.50366571, "GENETIC_ANCESTRY_LABEL": "EUR_ADMIX" }, "sample": { "SAMPLE_ID": "TCGA-E9-A22H-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "E9", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 4.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3074, "MSI_SENSOR_SCORE": 0.5, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.866666667, "TISSUE_SOURCE_SITE": "Asterand", "TBL_SCORE": 21.0 }, "treatments": [ { "START_DATE": 330, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "20", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": "130", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 15, "STOP_DATE": 226.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "6", "PRESCRIBED_DOSE": "90", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "3600", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 15, "STOP_DATE": 226.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Fluorouracil", "NUMBER_OF_CYCLES": "6", "PRESCRIBED_DOSE": "900", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "3600", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 15, "STOP_DATE": 226.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "6", "PRESCRIBED_DOSE": "900", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "3600", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 78, "STOP_DATE": 78.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "20", "RADIATION_DOSAGE": "4000", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-AC-A23E": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "e7bae6e7-f779-449d-92b9-66996041e00d", "AGE": 50, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 698.0, "DAYS_TO_BIRTH": -18500.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "7/18/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 22.94769372, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 22.94769372, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 22.94769372, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 22.94769372, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AC-A23E-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": null, "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": null, "TISSUE_SOURCE_SITE_CODE": "AC", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 19.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3013, "MSI_SENSOR_SCORE": 0.05, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.633333333, "TISSUE_SOURCE_SITE": "International Genomics Consortium", "TBL_SCORE": 11.0 }, "treatments": [ { "START_DATE": 111, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 127, "STOP_DATE": 158.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": "6000", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-AO-A03N": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "9435447e-d65f-408b-863b-6576b1d652dd", "AGE": 59, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 2031.0, "DAYS_TO_BIRTH": -21816.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "1/13/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 66.77187099, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 66.77187099, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 54.08159911, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 54.08159911, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AO-A03N-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AO", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 23.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": NaN, "MSI_SENSOR_SCORE": 0.23, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 3.0, "TISSUE_SOURCE_SITE": "MSKCC", "TBL_SCORE": 138.0 }, "treatments": [ { "START_DATE": 55, "STOP_DATE": 153.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "60", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 55, "STOP_DATE": 153.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "175", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 55, "STOP_DATE": 153.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "600", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 450, "STOP_DATE": 820.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Letrozole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "2.5", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 821, "STOP_DATE": 1007.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Exemestane", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "25", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 207, "STOP_DATE": 449.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 1007, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "20", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 1639, "STOP_DATE": 1667.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Fulvestrant", "NUMBER_OF_CYCLES": "3", "PRESCRIBED_DOSE": "250/5", "PRESCRIBED_DOSE_UNITS": "mg/ml", "REGIMEN_NUMBER": "8", "REGIMEN_INDICATION": "Recurrence", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IM", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "1500", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 1814, "STOP_DATE": 1828.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": "2", "PRESCRIBED_DOSE": "80", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "10", "REGIMEN_INDICATION": "Recurrence", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "280", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 1699, "STOP_DATE": 1762.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tesetaxel", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "27", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "9", "REGIMEN_INDICATION": "Recurrence", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "230", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 1835, "STOP_DATE": 1842.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Gemcitabine", "NUMBER_OF_CYCLES": "2", "PRESCRIBED_DOSE": "800", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "11", "REGIMEN_INDICATION": "Recurrence", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "2800", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 1857, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Vincristine", "NUMBER_OF_CYCLES": "16", "PRESCRIBED_DOSE": "25", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "12", "REGIMEN_INDICATION": "Recurrence", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": "704", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 1989, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Other", "TREATMENT_SUBTYPE": "Bone Metastases", "AGENT": "Denosumab", "NUMBER_OF_CYCLES": "2", "PRESCRIBED_DOSE": "120", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "13", "REGIMEN_INDICATION": "Progression", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "SC", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": "240", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-E9-A1ND": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "f06f09f3-8133-4a92-ac86-fbe64295e0d8", "AGE": 75, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 1266.0, "DAYS_TO_BIRTH": -27400.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "6/23/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 41.62146168, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 41.62146168, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 41.62146168, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 41.62146168, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E9-A1ND-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "E9", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 16.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3721, "MSI_SENSOR_SCORE": 1.26, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.833333333, "TISSUE_SOURCE_SITE": "Asterand", "TBL_SCORE": 231.0 }, "treatments": [ { "START_DATE": 31, "STOP_DATE": 78.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "20", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 31, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Exemestane", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "25", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-BH-A0BT": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "a32cb96a-78bf-456e-a6ab-2d47b2c67ad4", "AGE": 56, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 2365.0, "DAYS_TO_BIRTH": -20625.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "8/2/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1MI", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 77.75257258, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 77.75257258, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 77.75257258, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 77.75257258, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A0BT-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 21.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2597, "MSI_SENSOR_SCORE": 0.72, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.233333333, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 59.0 }, "treatments": [ { "START_DATE": 97, "STOP_DATE": 139.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 97, "STOP_DATE": 139.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 167, "STOP_DATE": 227.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "36", "RADIATION_DOSAGE": "66.4", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "gy" } ] }, "TCGA-E2-A155": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "01f50abf-fc15-446e-9d07-edeecc545a32", "AGE": 58, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 640.0, "DAYS_TO_BIRTH": -21348.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/7/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 21.04086531, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 21.04086531, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 21.04086531, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 21.04086531, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E2-A155-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "E2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 8.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2774, "MSI_SENSOR_SCORE": 0.92, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.966666667, "TISSUE_SOURCE_SITE": "Roswell Park", "TBL_SCORE": 146.0 }, "treatments": [ { "START_DATE": 30, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 30, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 249, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "4", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": "1", "TOTAL_DOSE_UNITS": "Mg/Day", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-BH-A1F5": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "e663954c-05a8-479a-a623-400c1eb5efc6", "AGE": 62, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "5TH", "DAYS_LAST_FOLLOWUP": NaN, "DAYS_TO_BIRTH": -22842.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/7/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": null, "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 89.16066673, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 89.16066673, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 89.16066673, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A1F5-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": NaN, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3214, "MSI_SENSOR_SCORE": 0.28, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.033333333, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 8.0 }, "treatments": [] }, "TCGA-C8-A12Z": { "demographics": { "SUBTYPE": "BRCA_Her2", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "42621dfa-abfd-4c7d-8bc5-a02a09d1c2b4", "AGE": 45, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 382.0, "DAYS_TO_BIRTH": -16508.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/13/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Asian", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 12.55876648, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 12.55876648, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 12.55876648, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 12.55876648, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-C8-A12Z-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "C8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 9.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2818, "MSI_SENSOR_SCORE": 0.06, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.433333333, "TISSUE_SOURCE_SITE": "ILSBio", "TBL_SCORE": 170.0 }, "treatments": [ { "START_DATE": 102, "STOP_DATE": 107.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Fluorouracil", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 102, "STOP_DATE": 107.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 102, "STOP_DATE": 107.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-AO-A0JG": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "58959e88-54e2-4558-9664-2effda7403dc", "AGE": 49, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": 798.0, "DAYS_TO_BIRTH": -18021.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/20/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8523/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N2A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 26.23532893, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 26.23532893, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 26.23532893, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AO-A0JG-01", "ONCOTREE_CODE": "BRCNOS", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Carcinoma (NOS)", "TUMOR_TYPE": "Other", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AO", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 6.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2799, "MSI_SENSOR_SCORE": 0.02, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.533333333, "TISSUE_SOURCE_SITE": "MSKCC", "TBL_SCORE": 109.0 }, "treatments": [ { "START_DATE": 80, "STOP_DATE": 122.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "60", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "440", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 80, "STOP_DATE": 122.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "600", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "4400", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 136, "STOP_DATE": 185.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "175", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "1280", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 197, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 238, "STOP_DATE": 273.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "25", "RADIATION_DOSAGE": "11400", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-D8-A1JG": { "demographics": { "SUBTYPE": "BRCA_Her2", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "7f2a63e6-64d5-4be1-9814-e8416fc9e688", "AGE": 62, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 1612.0, "DAYS_TO_BIRTH": -22878.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/28/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 52.99667949, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 52.99667949, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 52.99667949, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 52.99667949, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D8-A1JG-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "D8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 25.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.348, "MSI_SENSOR_SCORE": 0.33, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 4.466666667, "TISSUE_SOURCE_SITE": "Greater Poland Cancer Center", "TBL_SCORE": 218.0 }, "treatments": [ { "START_DATE": 269, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "60", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "ac", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": "Mg/M2", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 269, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 131, "STOP_DATE": 156.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "21", "RADIATION_DOSAGE": "42.5+10", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-AC-A5EI": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "01B9F68B-4DE4-4374-B4F2-8A0685E18153", "AGE": 88, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IB", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 442.0, "DAYS_TO_BIRTH": -32375.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/12/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "9020/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N1MI", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "0:LIVING", "OS_MONTHS": 14.5313476, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 14.5313476, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 14.5313476, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 14.5313476, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AC-A5EI-01", "ONCOTREE_CODE": "BRCNOS", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Carcinoma (NOS)", "TUMOR_TYPE": "Other", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "AC", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 8.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3203, "MSI_SENSOR_SCORE": 0.16, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.966666667, "TISSUE_SOURCE_SITE": "International Genomics Consortium", "TBL_SCORE": 48.0 }, "treatments": [] }, "TCGA-OL-A5RV": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "1D38D356-D126-4476-94D0-26616B9375B1", "AGE": 43, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIC", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 1062.0, "DAYS_TO_BIRTH": -15820.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "5/16/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N3", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 34.91468587, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 34.91468587, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 34.91468587, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 34.91468587, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-OL-A5RV-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "OL", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 2.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2967, "MSI_SENSOR_SCORE": 0.01, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.366666667, "TISSUE_SOURCE_SITE": "University of Chicago", "TBL_SCORE": 7.0 }, "treatments": [ { "START_DATE": 63, "STOP_DATE": 161.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 63, "STOP_DATE": 161.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 63, "STOP_DATE": 161.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 202, "STOP_DATE": 249.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": "5040", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-BH-A0B2": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "57a1604c-60b7-4b30-a75e-f70939532c5c", "AGE": 43, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE I", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 1242.0, "DAYS_TO_BIRTH": -15917.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/14/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T1A", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": null, "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "0:LIVING", "OS_MONTHS": 40.81498521, "DSS_STATUS": null, "DSS_MONTHS": NaN, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": null, "PFS_MONTHS": NaN, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A0B2-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 8.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": NaN, "MSI_SENSOR_SCORE": NaN, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.0, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 109.0 }, "treatments": [] }, "TCGA-BH-A1FR": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "bf3b1481-ae31-4406-b084-b6cc1d7163e3", "AGE": 73, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIB", "AJCC_STAGING_EDITION": "5TH", "DAYS_LAST_FOLLOWUP": NaN, "DAYS_TO_BIRTH": -26684.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/8/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8523/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T4B", "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": null, "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 53.98297005, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 53.98297005, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 53.98297005, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A1FR-01", "ONCOTREE_CODE": "BRCNOS", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Carcinoma (NOS)", "TUMOR_TYPE": "Other", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": NaN, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3198, "MSI_SENSOR_SCORE": 0.11, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.466666667, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 2.0 }, "treatments": [] }, "TCGA-AN-A0FK": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "2f4cbedf-ed7e-45a2-bf34-f1d1e696bdde", "AGE": 88, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIB", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": 213.0, "DAYS_TO_BIRTH": -32462.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/20/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T4", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 7.002662985, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 7.002662985, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 7.002662985, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 7.002662985, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AN-A0FK-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AN", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 23.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2848, "MSI_SENSOR_SCORE": 0.07, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.166666667, "TISSUE_SOURCE_SITE": "Cureline", "TBL_SCORE": 27.0 }, "treatments": [] }, "TCGA-E2-A1IO": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "71fc8941-4cfb-47ea-a533-873d38f8c95c", "AGE": 37, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE I", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 1855.0, "DAYS_TO_BIRTH": -13671.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/29/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 60.98563303, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 60.98563303, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 60.98563303, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 60.98563303, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E2-A1IO-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "E2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 10.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3354, "MSI_SENSOR_SCORE": 0.52, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.433333333, "TISSUE_SOURCE_SITE": "Roswell Park", "TBL_SCORE": 205.0 }, "treatments": [ { "START_DATE": 266, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "20", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": "20", "TOTAL_DOSE_UNITS": "Mg/Day", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 84, "STOP_DATE": 147.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "115.5", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "462", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 84, "STOP_DATE": 147.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "924", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "3696", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 175, "STOP_DATE": 220.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "33", "RADIATION_DOSAGE": "6040", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-A8-A0A4": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "2cb8c866-9296-4c70-a3ea-f9a9b707895c", "AGE": 73, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 396.0, "DAYS_TO_BIRTH": -26693.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "5/27/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": null, "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 13.01903541, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 13.01903541, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 13.01903541, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 13.01903541, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A8-A0A4-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 7.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2617, "MSI_SENSOR_SCORE": 0.25, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.8, "TISSUE_SOURCE_SITE": "Indivumed", "TBL_SCORE": 82.0 }, "treatments": [ { "START_DATE": 31, "STOP_DATE": 215.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 215, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Letrozole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-BH-A0HB": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "0c1023c0-d2ce-4940-8047-7642f1dc3965", "AGE": 55, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IA", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": 806.0, "DAYS_TO_BIRTH": -20448.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "11/10/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 26.49833974, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 26.49833974, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 26.49833974, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 26.49833974, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A0HB-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 8.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2732, "MSI_SENSOR_SCORE": 0.25, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.066666667, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 370.0 }, "treatments": [ { "START_DATE": 317, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 71, "STOP_DATE": 134.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "1068", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "4326", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 162, "STOP_DATE": 893.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Other", "TREATMENT_SUBTYPE": "Ancillary", "AGENT": "Zoledronic Acid", "NUMBER_OF_CYCLES": "12", "PRESCRIBED_DOSE": "4", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "48", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 71, "STOP_DATE": 134.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "133", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "539", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 175, "STOP_DATE": 221.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "33", "RADIATION_DOSAGE": "6040", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-D8-A1XS": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "1026e0bf-5640-4fa5-b65f-4f11e8e76b18", "AGE": 48, "SEX": "Male", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIC", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 496.0, "DAYS_TO_BIRTH": -17708.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/16/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8507/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N3A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "0:LIVING", "OS_MONTHS": 16.30667061, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 16.30667061, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 16.30667061, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 16.30667061, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D8-A1XS-01", "ONCOTREE_CODE": "BRCNOS", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Carcinoma (NOS)", "TUMOR_TYPE": "Other", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "D8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 8.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3248, "MSI_SENSOR_SCORE": 0.33, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.733333333, "TISSUE_SOURCE_SITE": "Greater Poland Cancer Center", "TBL_SCORE": 54.0 }, "treatments": [ { "START_DATE": 85, "STOP_DATE": 548.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin + Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "60+600", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "240+2400", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 218, "STOP_DATE": 258.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "25", "RADIATION_DOSAGE": "5000", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-AC-A2BM": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "8159FF7B-89F4-411A-9B9C-491F1CB3EB34", "AGE": 41, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 3022.0, "DAYS_TO_BIRTH": -15212.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "9/12/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 99.35233587, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 99.35233587, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 99.35233587, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 99.35233587, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-AC-A2BM-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AC", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 18.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3186, "MSI_SENSOR_SCORE": 0.26, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.7, "TISSUE_SOURCE_SITE": "International Genomics Consortium", "TBL_SCORE": 267.0 }, "treatments": [] }, "TCGA-AR-A24P": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "d1fd8ed2-be13-4272-b31e-df86911db3b1", "AGE": 47, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE I", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 84.0, "DAYS_TO_BIRTH": -17490.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "8/16/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T1", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": null, "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 2.761613571, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 2.761613571, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 2.761613571, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 2.761613571, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AR-A24P-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AR", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 8.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3262, "MSI_SENSOR_SCORE": 0.21, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.7, "TISSUE_SOURCE_SITE": "Mayo", "TBL_SCORE": 1.0 }, "treatments": [] }, "TCGA-A2-A0CX": { "demographics": { "SUBTYPE": "BRCA_Her2", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "c744fc13-3aca-4245-9e24-abd368cc8bef", "AGE": 52, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 1728.0, "DAYS_TO_BIRTH": -19152.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/10/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 56.81033633, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 56.81033633, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 56.81033633, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 56.81033633, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A2-A0CX-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 19.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2663, "MSI_SENSOR_SCORE": 0.41, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 8.333333333, "TISSUE_SOURCE_SITE": "Walter Reed", "TBL_SCORE": 163.0 }, "treatments": [ { "START_DATE": 686, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Letrozole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "2.5", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "6", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 1184, "STOP_DATE": 1273.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "20 mg daily", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "7", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 64, "STOP_DATE": 127.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "126", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "504", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 148, "STOP_DATE": 169.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "165", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "3", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "660", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 64, "STOP_DATE": 127.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "1250", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "5000", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 162, "STOP_DATE": 367.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Targeted Molecular Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Trastuzumab", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "200-600", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "4", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 601, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Other", "TREATMENT_SUBTYPE": "Given To Induce Menopause", "AGENT": "Goserelin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "3.6", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "5", "REGIMEN_INDICATION": "Other", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IM", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-GM-A2DO": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "5FD37868-4762-4109-9DCF-6FDBAB5B645D", "AGE": 54, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE I", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 2596.0, "DAYS_TO_BIRTH": -19842.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/30/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 85.3470099, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 85.3470099, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 85.3470099, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 85.3470099, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-GM-A2DO-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "GM", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 1.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3191, "MSI_SENSOR_SCORE": 0.02, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 4.666666667, "TISSUE_SOURCE_SITE": "MD Anderson", "TBL_SCORE": 35.0 }, "treatments": [ { "START_DATE": 219, "STOP_DATE": 2051.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 176, "STOP_DATE": 218.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-BH-A1F2": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "6a2972e3-cca9-47e5-aac0-b770f2399eeb", "AGE": 53, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIB", "AJCC_STAGING_EDITION": "5TH", "DAYS_LAST_FOLLOWUP": NaN, "DAYS_TO_BIRTH": -19701.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/7/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8541/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1B", "PATH_T_STAGE": "T4B", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": null, "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 31.52842161, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 31.52842161, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 31.52842161, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A1F2-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 18.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3331, "MSI_SENSOR_SCORE": 0.34, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.666666667, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 118.0 }, "treatments": [] }, "TCGA-EW-A1PF": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "848773a3-2f4a-4186-ab3f-de667129accf", "AGE": 50, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 439.0, "DAYS_TO_BIRTH": -18384.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/27/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "0:LIVING", "OS_MONTHS": 14.43271855, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 14.43271855, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 14.43271855, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 14.43271855, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-EW-A1PF-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "EW", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 8.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": NaN, "MSI_SENSOR_SCORE": NaN, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.0, "TISSUE_SOURCE_SITE": "University of Miami", "TBL_SCORE": 41.0 }, "treatments": [ { "START_DATE": 217, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 125, "STOP_DATE": 188.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "1038", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "4176", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 125, "STOP_DATE": 188.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "130", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "524", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-BH-A0C7": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "e1119732-3e97-4259-bc69-dc4269d9496d", "AGE": 48, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 2767.0, "DAYS_TO_BIRTH": -17871.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "8/11/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1MI", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 90.9688661, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 90.9688661, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 90.9688661, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 90.9688661, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A0C7-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 19.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2837, "MSI_SENSOR_SCORE": 0.03, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.433333333, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 146.0 }, "treatments": [ { "START_DATE": 50, "STOP_DATE": 113.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 50, "STOP_DATE": 113.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 50, "STOP_DATE": 113.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-A8-A07I": { "demographics": { "SUBTYPE": "BRCA_Her2", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "566792ae-f853-4a47-856d-f02cdcfcb18a", "AGE": 69, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 426.0, "DAYS_TO_BIRTH": -25263.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "5/27/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N2A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": null, "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 14.00532597, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 14.00532597, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 14.00532597, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 14.00532597, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A8-A07I-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 5.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2736, "MSI_SENSOR_SCORE": 0.43, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.333333333, "TISSUE_SOURCE_SITE": "Indivumed", "TBL_SCORE": 273.0 }, "treatments": [ { "START_DATE": 61, "STOP_DATE": 122.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Fluorouracil", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 61, "STOP_DATE": 122.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Epirubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 61, "STOP_DATE": 122.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 122, "STOP_DATE": 183.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 183, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Exemestane", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Clinical Progressive Disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 183, "STOP_DATE": 334.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Targeted Molecular Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Trastuzumab", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 245, "STOP_DATE": 304.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-AC-A3YJ": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "86CF879E-3B40-44DD-AAA7-6F49F54A15D9", "AGE": 66, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 754.0, "DAYS_TO_BIRTH": -24439.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "10/3/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8050/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 24.78876944, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 24.78876944, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 24.78876944, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 24.78876944, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AC-A3YJ-01", "ONCOTREE_CODE": "BRCNOS", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Carcinoma (NOS)", "TUMOR_TYPE": "Other", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "AC", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 1.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2942, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.566666667, "TISSUE_SOURCE_SITE": "International Genomics Consortium", "TBL_SCORE": 11.0 }, "treatments": [ { "START_DATE": 62, "STOP_DATE": 247.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 256, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Letrozole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-A8-A086": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "f9eb88f7-9293-46bf-ace4-a746e4ff80dc", "AGE": 59, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 396.0, "DAYS_TO_BIRTH": -21731.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "5/27/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": null, "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 13.01903541, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 13.01903541, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 13.01903541, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 13.01903541, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A8-A086-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 13.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": NaN, "MSI_SENSOR_SCORE": 0.31, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.6, "TISSUE_SOURCE_SITE": "Indivumed", "TBL_SCORE": 53.0 }, "treatments": [ { "START_DATE": 0, "STOP_DATE": 92.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 0, "STOP_DATE": 92.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 123, "STOP_DATE": 153.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": "62", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "gy" } ] }, "TCGA-E2-A1II": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "0fe1419e-a005-407c-8ae7-15c4c1579539", "AGE": 51, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE I", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 1025.0, "DAYS_TO_BIRTH": -18788.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/28/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 33.69826084, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 33.69826084, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 33.69826084, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 33.69826084, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E2-A1II-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "E2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 18.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.4355, "MSI_SENSOR_SCORE": 0.84, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.933333333, "TISSUE_SOURCE_SITE": "Roswell Park", "TBL_SCORE": 121.0 }, "treatments": [ { "START_DATE": 129, "STOP_DATE": 171.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "328", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "1312", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 73, "STOP_DATE": 115.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "1164", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "4656", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 73, "STOP_DATE": 115.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "116", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "460", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 181, "STOP_DATE": 236.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "33", "RADIATION_DOSAGE": "6040", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-A8-A076": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "23dabeef-8e3c-44bc-9a12-a9522d17be5c", "AGE": 66, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "5TH", "DAYS_LAST_FOLLOWUP": 1642.0, "DAYS_TO_BIRTH": -24230.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "5/27/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": null, "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 53.98297005, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 53.98297005, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 53.98297005, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 53.98297005, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A8-A076-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 20.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2648, "MSI_SENSOR_SCORE": 0.25, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.366666667, "TISSUE_SOURCE_SITE": "Indivumed", "TBL_SCORE": 136.0 }, "treatments": [ { "START_DATE": 59, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-AN-A0XS": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "95e949d3-b1f3-46c6-9451-8fe92c99e4cf", "AGE": 63, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 10.0, "DAYS_TO_BIRTH": -23358.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/28/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N2", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 0.32876352, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 0.32876352, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 0.32876352, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 0.32876352, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AN-A0XS-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AN", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 19.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2944, "MSI_SENSOR_SCORE": 0.04, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.866666667, "TISSUE_SOURCE_SITE": "Cureline", "TBL_SCORE": 6.0 }, "treatments": [] }, "TCGA-AR-A5QM": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "9C895825-D6F6-4D14-A662-23212200F6E5", "AGE": 62, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 2231.0, "DAYS_TO_BIRTH": -22780.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/15/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 73.3471414, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 73.3471414, "DFS_STATUS": null, "DFS_MONTHS": NaN, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 31.82430878, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AR-A5QM-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AR", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 19.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2924, "MSI_SENSOR_SCORE": 0.04, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.866666667, "TISSUE_SOURCE_SITE": "Mayo", "TBL_SCORE": 10.0 }, "treatments": [ { "START_DATE": 36, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 36, "STOP_DATE": 82.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "30", "RADIATION_DOSAGE": "6000", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-E2-A15P": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "a1674d7b-787a-45c4-bf16-1b7d0efce207", "AGE": 61, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 595.0, "DAYS_TO_BIRTH": -22524.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/14/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 19.56142946, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 19.56142946, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 19.56142946, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 19.56142946, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E2-A15P-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "E2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 6.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2833, "MSI_SENSOR_SCORE": 0.06, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.4, "TISSUE_SOURCE_SITE": "Roswell Park", "TBL_SCORE": 96.0 }, "treatments": [ { "START_DATE": 105, "STOP_DATE": 220.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "115", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 223, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Exemestane", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "25", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": "25", "TOTAL_DOSE_UNITS": "Mg/Day", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 51, "STOP_DATE": 98.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "33", "RADIATION_DOSAGE": "6040", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-BH-A0BC": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "327a2395-85c8-42e1-9638-8e037a1723ed", "AGE": 60, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIC", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": 974.0, "DAYS_TO_BIRTH": -21949.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "11/4/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N3", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 32.02156689, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 32.02156689, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 32.02156689, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 32.02156689, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BH-A0BC-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BH", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 3.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2513, "MSI_SENSOR_SCORE": 0.04, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.933333333, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 67.0 }, "treatments": [ { "START_DATE": 190, "STOP_DATE": 239.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": "12", "PRESCRIBED_DOSE": "164", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "1264", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 106, "STOP_DATE": 169.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "124", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "495", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 795, "STOP_DATE": 900.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": "6", "PRESCRIBED_DOSE": "130", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "785", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 106, "STOP_DATE": 169.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "1236", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "4944", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 106, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 312, "STOP_DATE": 361.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "32", "RADIATION_DOSAGE": "6640", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-B6-A1KN": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "271404de-24e8-43f6-806b-fb510c1124c4", "AGE": 57, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIB", "AJCC_STAGING_EDITION": "5TH", "DAYS_LAST_FOLLOWUP": 4233.0, "DAYS_TO_BIRTH": -21183.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/19/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T4B", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 139.1655982, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 139.1655982, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 139.1655982, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 139.1655982, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-B6-A1KN-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "B6", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 17.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3308, "MSI_SENSOR_SCORE": 0.82, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.966666667, "TISSUE_SOURCE_SITE": "Duke", "TBL_SCORE": 293.0 }, "treatments": [] }, "TCGA-A8-A0AD": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "af5453a9-cf1f-40de-aec4-0e0710908fb7", "AGE": 83, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE I", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 1157.0, "DAYS_TO_BIRTH": -30407.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "5/27/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8522/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T1C", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": null, "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 38.03793931, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 38.03793931, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 38.03793931, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 38.03793931, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A8-A0AD-01", "ONCOTREE_CODE": "BRCNOS", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Carcinoma (NOS)", "TUMOR_TYPE": "Mixed Histology (NOS)", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 8.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2601, "MSI_SENSOR_SCORE": 0.09, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.8, "TISSUE_SOURCE_SITE": "Indivumed", "TBL_SCORE": 248.0 }, "treatments": [ { "START_DATE": 61, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-D8-A27G": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "6f6e7356-3521-4674-8eec-ad01340d4b8e", "AGE": 75, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 409.0, "DAYS_TO_BIRTH": -27521.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/18/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 13.44642798, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 13.44642798, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 13.44642798, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 13.44642798, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D8-A27G-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "D8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 4.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3223, "MSI_SENSOR_SCORE": 0.08, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 27.13333333, "TISSUE_SOURCE_SITE": "Greater Poland Cancer Center", "TBL_SCORE": 119.0 }, "treatments": [] }, "TCGA-LL-A8F5": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "E1786E78-AC46-46FD-8CE0-8F7456E46082", "AGE": 61, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 596.0, "DAYS_TO_BIRTH": -22544.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "2/19/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 19.59430582, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 19.59430582, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 19.59430582, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 19.59430582, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-LL-A8F5-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "LL", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 17.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.35, "MSI_SENSOR_SCORE": 0.64, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 4.433333333, "TISSUE_SOURCE_SITE": "Candler", "TBL_SCORE": 378.0 }, "treatments": [ { "START_DATE": 112, "STOP_DATE": 154.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 112, "STOP_DATE": 154.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 175, "STOP_DATE": 175.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 189, "STOP_DATE": 259.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 315, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 282, "STOP_DATE": 316.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "22", "RADIATION_DOSAGE": "54.72", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "gy" } ] }, "TCGA-A7-A4SB": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "A947A945-4721-45CC-BC45-13B8EA41C10E", "AGE": 56, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 418.0, "DAYS_TO_BIRTH": -20539.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "2/20/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8520/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1MI", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "0:LIVING", "OS_MONTHS": 13.74231515, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 13.74231515, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 13.74231515, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 13.74231515, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A7-A4SB-01", "ONCOTREE_CODE": "ILC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Lobular Carcinoma", "TUMOR_TYPE": "Infiltrating Lobular Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "A7", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 18.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3188, "MSI_SENSOR_SCORE": 0.27, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.0, "TISSUE_SOURCE_SITE": "Christiana Healthcare", "TBL_SCORE": 75.0 }, "treatments": [ { "START_DATE": 61, "STOP_DATE": 124.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 61, "STOP_DATE": 124.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 218, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 167, "STOP_DATE": 217.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "31", "RADIATION_DOSAGE": "6100", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" }, { "START_DATE": 167, "STOP_DATE": 206.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 2", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": "4500", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-EW-A1PC": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "F45210D3-9E66-4F5E-BEF1-5EE5547CC893", "AGE": 66, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 187.0, "DAYS_TO_BIRTH": -24434.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/28/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N0 (I-)", "PATH_T_STAGE": "T3", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "0:LIVING", "OS_MONTHS": 6.147877832, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 6.147877832, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 6.147877832, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 6.147877832, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-EW-A1PC-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "EW", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 25.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3364, "MSI_SENSOR_SCORE": 0.87, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.0, "TISSUE_SOURCE_SITE": "University of Miami", "TBL_SCORE": 166.0 }, "treatments": [ { "START_DATE": 98, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "20", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "tam", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-A2-A0YG": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "c0892598-1f7b-4f23-9cd8-731f797753d5", "AGE": 63, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIC", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": 666.0, "DAYS_TO_BIRTH": -23058.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "1/3/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N3A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 21.89565046, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 21.89565046, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 21.89565046, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 21.89565046, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A2-A0YG-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 29.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2746, "MSI_SENSOR_SCORE": 0.29, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.733333333, "TISSUE_SOURCE_SITE": "Walter Reed", "TBL_SCORE": 395.0 }, "treatments": [ { "START_DATE": 68, "STOP_DATE": 131.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "1224", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "4896", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 173, "STOP_DATE": 173.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": "1", "PRESCRIBED_DOSE": "229", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "3", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "229", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 68, "STOP_DATE": 131.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "122", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "488", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 152, "STOP_DATE": 232.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": "12", "PRESCRIBED_DOSE": "178-185", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "4", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 152, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Targeted Molecular Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Trastuzumab", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "255-509", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "6", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 257, "STOP_DATE": 303.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "25", "RADIATION_DOSAGE": "5940", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-A8-A08G": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "719082cc-1ebe-4a51-a659-85a59db1d77d", "AGE": 41, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 607.0, "DAYS_TO_BIRTH": -14976.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "5/27/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": null, "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 19.95594569, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 19.95594569, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 19.95594569, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 19.95594569, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A8-A08G-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 24.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2544, "MSI_SENSOR_SCORE": 0.35, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.466666667, "TISSUE_SOURCE_SITE": "Indivumed", "TBL_SCORE": 257.0 }, "treatments": [ { "START_DATE": 28, "STOP_DATE": 89.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Fluorouracil", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 28, "STOP_DATE": 89.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Epirubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 28, "STOP_DATE": 89.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 89, "STOP_DATE": 150.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 181, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Exemestane", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 150, "STOP_DATE": 212.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "gy" } ] }, "TCGA-C8-A1HM": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "8b525ec6-d24b-49d4-bfcb-b354de4dae7c", "AGE": 74, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 375.0, "DAYS_TO_BIRTH": -27063.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "6/2/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "No", "PRIOR_DX": "No", "RACE": "Asian", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 12.32863202, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 12.32863202, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 12.32863202, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 12.32863202, "GENETIC_ANCESTRY_LABEL": "EAS" }, "sample": { "SAMPLE_ID": "TCGA-C8-A1HM-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "C8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 23.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2758, "MSI_SENSOR_SCORE": 0.68, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 10.43333333, "TISSUE_SOURCE_SITE": "ILSBio", "TBL_SCORE": 203.0 }, "treatments": [ { "START_DATE": 26, "STOP_DATE": 49.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 26, "STOP_DATE": 49.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 26, "STOP_DATE": 49.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "MEASURE_OF_RESPONSE": "Complete Response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null } ] }, "TCGA-A2-A1G0": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "2e538802-2a31-4774-89a8-c6e4381a887d", "AGE": 49, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 616.0, "DAYS_TO_BIRTH": -18002.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/21/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 20.25183286, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 20.25183286, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 20.25183286, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 20.25183286, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A2-A1G0-01", "ONCOTREE_CODE": "BRCNOS", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Carcinoma (NOS)", "TUMOR_TYPE": "Other", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "A2", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 16.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3449, "MSI_SENSOR_SCORE": 0.2, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.666666667, "TISSUE_SOURCE_SITE": "Walter Reed", "TBL_SCORE": 46.0 }, "treatments": [ { "START_DATE": 72, "STOP_DATE": 177.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "6", "PRESCRIBED_DOSE": "940-960", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "3", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "5720", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 52, "STOP_DATE": 177.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": "6", "PRESCRIBED_DOSE": "141-148", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "872", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 72, "STOP_DATE": 177.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "6", "PRESCRIBED_DOSE": "94-96", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "574", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 201, "STOP_DATE": 244.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "31", "RADIATION_DOSAGE": "6000", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-AO-A0JM": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "44bec761-b603-49c0-8634-f6bfe0319bb1", "AGE": 40, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": 2184.0, "DAYS_TO_BIRTH": -14653.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/20/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N1", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": null, "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 71.80195286, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 71.80195286, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 71.80195286, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 71.80195286, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-AO-A0JM-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AO", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 15.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2626, "MSI_SENSOR_SCORE": 0.38, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.166666667, "TISSUE_SOURCE_SITE": "MSKCC", "TBL_SCORE": 245.0 }, "treatments": [ { "START_DATE": 78, "STOP_DATE": 120.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "60", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "452", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 78, "STOP_DATE": 120.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "600", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "4520", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 134, "STOP_DATE": 498.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Targeted Molecular Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Trastuzumab", "NUMBER_OF_CYCLES": "23", "PRESCRIBED_DOSE": "6", "PRESCRIBED_DOSE_UNITS": "mg/kg", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "9095", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 134, "STOP_DATE": 177.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "175", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": "1", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "1360", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 330, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "20", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "3", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 260, "STOP_DATE": 294.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "25", "RADIATION_DOSAGE": "10000", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-AR-A0TY": { "demographics": { "SUBTYPE": "BRCA_LumB", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "da1c58a7-c6bd-47d9-95c2-8d2ac70e20e4", "AGE": 54, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIA", "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": NaN, "DAYS_TO_BIRTH": -19836.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/10/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N0", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 55.85692212, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 55.85692212, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 17.88473551, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 17.88473551, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AR-A0TY-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AR", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 8.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2519, "MSI_SENSOR_SCORE": 0.75, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.7, "TISSUE_SOURCE_SITE": "Mayo", "TBL_SCORE": 263.0 }, "treatments": [] }, "TCGA-AR-A24M": { "demographics": { "SUBTYPE": "BRCA_LumA", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "aa30ac3d-4216-45dd-a314-1ae192fafcb2", "AGE": 38, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIIA", "AJCC_STAGING_EDITION": "6TH", "DAYS_LAST_FOLLOWUP": 3660.0, "DAYS_TO_BIRTH": -14119.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "8/12/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8522/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "M0", "PATH_N_STAGE": "N2", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 120.3274485, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 120.3274485, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 120.3274485, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 120.3274485, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AR-A24M-01", "ONCOTREE_CODE": "BRCNOS", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Carcinoma (NOS)", "TUMOR_TYPE": "Mixed Histology (NOS)", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AR", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 4.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3199, "MSI_SENSOR_SCORE": 0.28, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.466666667, "TISSUE_SOURCE_SITE": "Mayo", "TBL_SCORE": 26.0 }, "treatments": [ { "START_DATE": 171, "STOP_DATE": 597.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "20", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "2", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 597, "STOP_DATE": NaN, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Letrozole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "2.5", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": "3", "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 172, "STOP_DATE": 221.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": "33", "RADIATION_DOSAGE": "6040", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] }, "TCGA-D8-A1XK": { "demographics": { "SUBTYPE": "BRCA_Basal", "CANCER_TYPE_ACRONYM": "BRCA", "OTHER_PATIENT_ID": "97943d87-fed7-4f14-a0a7-c5bfee64c392", "AGE": 55, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": "STAGE IIB", "AJCC_STAGING_EDITION": "7TH", "DAYS_LAST_FOLLOWUP": 441.0, "DAYS_TO_BIRTH": -20092.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "6/9/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C50.9", "ICD_O_3_HISTOLOGY": "8500/3", "ICD_O_3_SITE": "C50.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": "MX", "PATH_N_STAGE": "N1A", "PATH_T_STAGE": "T2", "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": "Yes", "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": NaN, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 14.49847125, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 14.49847125, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 14.49847125, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 14.49847125, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D8-A1XK-01", "ONCOTREE_CODE": "IDC", "CANCER_TYPE": "Breast Cancer", "CANCER_TYPE_DETAILED": "Breast Invasive Ductal Carcinoma", "TUMOR_TYPE": "Infiltrating Ductal Carcinoma", "GRADE": NaN, "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "D8", "TUMOR_TISSUE_SITE": "Breast", "ANEUPLOIDY_SCORE": 15.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.6238, "MSI_SENSOR_SCORE": 13.12, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 32.36666667, "TISSUE_SOURCE_SITE": "Greater Poland Cancer Center", "TBL_SCORE": 162.0 }, "treatments": [ { "START_DATE": 149, "STOP_DATE": 233.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": "12", "PRESCRIBED_DOSE": "80", "PRESCRIBED_DOSE_UNITS": "mg/m2/day", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "1560", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 65, "STOP_DATE": 128.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin + Cyclophosphamide", "NUMBER_OF_CYCLES": "4", "PRESCRIBED_DOSE": "97.2+972", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "THERAPY_ONGOING": "No", "TOTAL_DOSE": "388.8+3888", "TOTAL_DOSE_UNITS": "Mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": null }, { "START_DATE": 253, "STOP_DATE": 281.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": NaN, "NUMBER_OF_FRACTIONS": "45", "RADIATION_DOSAGE": "9000", "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_TYPE_NOTES": NaN, "RADIATION_UNITS": "cgy" } ] } }